Selection	O
of	O
cDNAs	O
encoding	O
putative	O
type	O
II	O
membrane	O
proteins	O
on	O
the	O
cell	O
surface	O
from	O
a	O
human	O
full	O
-	O
length	O
cDNA	O
bank	O
.	O

We	O
have	O
developed	O
a	O
simple	O
method	O
to	O
test	O
whether	O
a	O
hydrophobic	O
segment	O
near	O
the	O
N	O
-	O
terminus	O
of	O
a	O
protein	O
functions	O
as	O
a	O
type	O
II	O
signal	O
anchor	O
(	O
SA	O
)	O
in	O
which	O
the	O
N	O
-	O
terminus	O
faces	O
the	O
cytoplasm	O
.	O

A	O
cDNA	O
fragment	O
containing	O
the	O
putative	O
SA	O
sequence	O
of	O
a	O
target	O
clone	O
was	O
fused	O
in	O
-	O
frame	O
to	O
the	O
5	O
'	O
end	O
of	O
a	O
cDNA	O
fragment	O
encoding	O
the	O
protease	O
domain	O
of	O
urokinase	B
-	I
type	I
plasminogen	I
activator	I
(	O
u	B
-	I
PA	I
)	O
.	O

The	O
resulting	O
fused	O
gene	O
was	O
expressed	O
in	O
COS7	O
cells	O
.	O

Fibrinolytic	O
activity	O
on	O
the	O
cell	O
surface	O
was	O
measured	O
by	O
placing	O
a	O
fibrin	O
sheet	O
in	O
contact	O
with	O
the	O
transfected	O
COS7	O
cells	O
after	O
removing	O
the	O
medium	O
.	O

When	O
the	O
cDNA	O
fragment	O
encoded	O
a	O
SA	O
,	O
the	O
fibrin	O
sheet	O
was	O
lysed	O
by	O
the	O
u	B
-	I
PA	I
expressed	O
on	O
the	O
cell	O
surface	O
.	O

The	O
fibrinolytic	O
activity	O
was	O
not	O
detected	O
in	O
the	O
culture	O
medium	O
,	O
suggesting	O
that	O
the	O
u	B
-	I
PA	I
remains	O
on	O
the	O
cell	O
surface	O
anchored	O
via	O
the	O
SA	O
in	O
the	O
membrane	O
without	O
being	O
cleaved	O
by	O
signal	O
peptidase	O
.	O

This	O
fibrin	O
sheet	O
method	O
was	O
successfully	O
applied	O
to	O
select	O
five	O
novel	O
cDNA	O
clones	O
encoding	O
putative	O
type	O
II	O
membrane	O
proteins	O
from	O
a	O
human	O
full	O
-	O
length	O
cDNA	O
bank	O
.	O

C1qRP	B
is	O
a	O
heavily	O
O	O
-	O
glycosylated	O
cell	O
surface	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
phagocytic	O
activity	O
.	O

C1q	O
,	O
mannose	B
-	I
binding	I
lectin	I
(	O
MBL	B
)	O
,	O
and	O
pulmonary	B
surfactant	I
protein	I
A	I
(	O
SPA	B
)	O
interact	O
with	O
human	O
monocytes	O
and	O
macrophages	O
,	O
resulting	O
in	O
the	O
enhancement	O
of	O
phagocytosis	O
of	O
suboptimally	O
opsonized	O
targets	O
.	O

mAbs	O
that	O
recognize	O
a	O
cell	O
surface	O
molecule	O
of	O
126,000	O
Mr	O
,	O
designated	O
C1qRP	B
,	O
have	O
been	O
shown	O
to	O
inhibit	O
C1q-	O
and	O
MBL	B
-	O
mediated	O
enhancement	O
of	O
phagocytosis	O
.	O

Similar	O
inhibition	O
of	O
the	O
SPA	B
-	O
mediated	O
enhancement	O
of	O
phagocytosis	O
by	O
these	O
mAbs	O
now	O
suggests	O
that	O
C1qRP	B
is	O
a	O
common	O
component	O
of	O
a	O
receptor	O
for	O
these	O
macromolecules	O
.	O

Ligation	O
of	O
human	O
monocytes	O
with	O
immobilized	O
R3	O
,	O
a	O
IgM	O
mAb	O
recognizing	O
C1qRP	B
,	O
also	O
triggers	O
enhanced	O
phagocytic	O
capacity	O
of	O
these	O
cells	O
in	O
the	O
absence	O
of	O
ligand	O
,	O
verifying	O
the	O
direct	O
involvement	O
of	O
this	O
polypeptide	O
in	O
the	O
regulation	O
of	O
phagocytosis	O
.	O

While	O
the	O
cDNA	O
for	O
C1qRP	B
encodes	O
a	O
631	O
amino	O
acid	O
membrane	O
protein	O
,	O
Chinese	O
hamster	O
ovary	O
cells	O
transfected	O
with	O
the	O
cDNA	O
of	O
the	O
C1qRP	B
coding	O
region	O
express	O
a	O
surface	O
glycoprotein	O
with	O
the	O
identical	O
126,000	O
Mr	O
in	O
SDS	O
-	O
PAGE	O
as	O
the	O
native	O
C1qRP	B
.	O

Use	O
of	O
glycosylation	O
inhibitors	O
,	O
cleavage	O
of	O
the	O
mature	O
C1qRP	B
with	O
specific	O
glycosidases	O
,	O
and	O
in	O
vitro	O
translation	O
of	O
C1qRP	B
cDNA	O
demonstrated	O
that	O
both	O
posttranslational	O
glycosylation	O
and	O
the	O
nature	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
contribute	O
to	O
the	O
difference	O
between	O
its	O
predicted	O
m.w	O
.	O

and	O
its	O
migration	O
on	O
SDS	O
-	O
PAGE	O
.	O

These	O
results	O
verify	O
that	O
the	O
cDNA	O
cloned	O
codes	O
for	O
the	O
mature	O
C1qRP	B
,	O
that	O
C1qRP	B
contains	O
a	O
relatively	O
high	O
degree	O
of	O
O	O
-	O
linked	O
glycoslyation	O
,	O
and	O
that	O
C1qRP	B
cross	O
-	O
linked	O
directly	O
by	O
monoclonal	O
anti	O
-	O
C1qRP	B
or	O
engaged	O
as	O
a	O
result	O
of	O
cell	O
surface	O
ligation	O
of	O
SPA	B
,	O
as	O
well	O
as	O
C1q	O
and	O
MBL	B
,	O
enhances	O
phagocytosis	O
.	O

Myotilin	B
,	O
a	O
novel	O
sarcomeric	O
protein	O
with	O
two	O
Ig	O
-	O
like	O
domains	O
,	O
is	O
encoded	O
by	O
a	O
candidate	O
gene	O
for	O
limb	O
-	O
girdle	O
muscular	O
dystrophy	O
.	O

The	O
striated	O
muscle	O
sarcomeres	O
are	O
highly	O
organized	O
structures	O
composed	O
of	O
actin	O
(	O
thin	O
)	O
and	O
myosin	O
(	O
thick	O
)	O
filaments	O
that	O
slide	O
past	O
each	O
other	O
during	O
contraction	O
.	O

The	O
integrity	O
of	O
sarcomeres	O
is	O
controlled	O
by	O
a	O
set	O
of	O
structural	O
proteins	O
,	O
among	O
which	O
are	O
titin	B
,	O
a	O
giant	O
molecule	O
that	O
contains	O
several	O
immunoglobulin	O
(	O
Ig	O
)	O
-like	O
domains	O
and	O
associates	O
with	O
thin	O
and	O
thick	O
filaments	O
,	O
and	O
[	O
alpha	O
]	O
-actinin	O
,	O
an	O
actin	O
cross	O
-	O
linking	O
protein	O
.	O

Mutations	O
in	O
several	O
sarcomeric	O
and	O
sarcolemmal	O
proteins	O
have	O
been	O
shown	O
to	O
result	O
in	O
muscular	O
dystrophy	O
and	O
cardiomyopathy	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
disease	O
genes	O
underlying	O
several	O
disease	O
forms	O
remain	O
to	O
be	O
identified	O
.	O

Here	O
we	O
describe	O
a	O
novel	O
57	B
kDa	I
cytoskeletal	I
protein	I
,	O
myotilin	B
.	O

Its	O
N	O
-	O
terminal	O
sequence	O
is	O
unique	O
,	O
but	O
the	O
C	O
-	O
terminal	O
half	O
contains	O
two	O
Ig	O
-	O
like	O
domains	O
homologous	O
to	O
titin	B
.	O

Myotilin	B
is	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
,	O
it	O
co	O
-	O
localizes	O
with	O
[	O
alpha	O
]	O
-actinin	O
in	O
the	O
sarcomeric	O
I	O
--	O
bands	O
and	O
directly	O
interacts	O
with	O
[	O
alpha	O
]	O
-actinin	O
.	O

The	O
human	O
myotilin	B
gene	O
maps	O
to	O
chromosome	O
5q31	O
between	O
markers	O
AFM350yB1	O
and	O
D5S500	O
.	O

The	O
locus	O
of	O
a	O
dominantly	O
inherited	O
limb	O
-	O
girdle	O
muscular	O
dystrophy	O
(	O
LGMD1A	O
)	O
resides	O
in	O
an	O
overlapping	O
narrow	O
segment	O
,	O
and	O
a	O
new	O
type	O
of	O
distal	O
myopathy	O
with	O
vocal	O
cord	O
and	O
pharyngeal	O
weakness	O
(	O
VCPMD	O
)	O
has	O
been	O
mapped	O
to	O
the	O
same	O
locus	O
.	O

The	O
muscle	O
specificity	O
and	O
apparent	O
role	O
as	O
a	O
sarcomeric	O
structural	O
protein	O
raise	O
the	O
possibility	O
that	O
defects	O
in	O
the	O
myotilin	B
gene	O
may	O
cause	O
muscular	O
dystrophy	O
.	O

Redox	O
regulation	O
of	O
cell	O
signaling	O
by	O
selenocysteine	O
in	O
mammalian	O
thioredoxin	B
reductases	O
.	O

The	O
intracellular	O
generation	O
of	O
reactive	O
oxygen	O
species	O
,	O
together	O
with	O
the	O
thioredoxin	B
and	O
glutathione	O
systems	O
,	O
is	O
thought	O
to	O
participate	O
in	O
redox	O
signaling	O
in	O
mammalian	O
cells	O
.	O

The	O
activity	O
of	O
thioredoxin	B
is	O
dependent	O
on	O
the	O
redox	O
status	O
of	O
thioredoxin	B
reductase	O
(	O
TR	B
)	O
,	O
the	O
activity	O
of	O
which	O
in	O
turn	O
is	O
dependent	O
on	O
a	O
selenocysteine	O
residue	O
.	O

Two	O
mammalian	O
TR	B
isozymes	O
(	O
TR2	B
and	O
TR3	B
)	O
,	O
in	O
addition	O
to	O
that	O
previously	O
characterized	O
(	O
TR1	B
)	O
,	O
have	O
now	O
been	O
identified	O
in	O
humans	O
and	O
mice	O
.	O

All	O
three	O
TR	B
isozymes	O
contain	O
a	O
selenocysteine	O
residue	O
that	O
is	O
located	O
in	O
the	O
penultimate	O
position	O
at	O
the	O
carboxyl	O
terminus	O
and	O
which	O
is	O
encoded	O
by	O
a	O
UGA	O
codon	O
.	O

The	O
generation	O
of	O
reactive	O
oxygen	O
species	O
in	O
a	O
human	O
carcinoma	O
cell	O
line	O
was	O
shown	O
to	O
result	O
in	O
both	O
the	O
oxidation	O
of	O
the	O
selenocysteine	O
in	O
TR1	B
and	O
a	O
subsequent	O
increase	O
in	O
the	O
expression	O
of	O
this	O
enzyme	O
.	O

These	O
observations	O
identify	O
the	O
carboxyl	O
-	O
terminal	O
selenocysteine	O
of	O
TR1	B
as	O
a	O
cellular	O
redox	O
sensor	O
and	O
support	O
an	O
essential	O
role	O
for	O
mammalian	O
TR	B
isozymes	O
in	O
redox	O
-	O
regulated	O
cell	O
signaling	O
.	O

Hepatocyte	B
nuclear	I
factor-6	I
:	O
associations	O
between	O
genetic	O
variability	O
and	O
type	O
II	O
diabetes	O
and	O
between	O
genetic	O
variability	O
and	O
estimates	O
of	O
insulin	B
secretion	O
.	O

AIMS	O
/	O
HYPOTHESIS	O
:	O
The	O
transcription	O
factor	O
hepatocyte	B
nuclear	I
factor	I
(	I
HNF	I
)	I
-6	I
is	O
an	O
upstream	O
regulator	O
of	O
several	O
genes	O
involved	O
in	O
the	O
pathogenesis	O
of	O
maturity	O
-	O
onset	O
diabetes	O
of	O
the	O
young	O
.	O

We	O
therefore	O
tested	O
the	O
hypothesis	O
that	O
variability	O
in	O
the	O
HNF-6	B
gene	O
is	O
associated	O
with	O
subsets	O
of	O
Type	O
II	O
(	O
non	O
-	O
insulin	B
-	O
dependent	O
)	O
diabetes	O
mellitus	O
and	O
estimates	O
of	O
insulin	B
secretion	O
in	O
glucose	O
tolerant	O
subjects	O
.	O

METHODS	O
:	O
We	O
cloned	O
the	O
coding	O
region	O
as	O
well	O
as	O
the	O
intron	O
-	O
exon	O
boundaries	O
of	O
the	O
HNF-6	B
gene	O
.	O

We	O
then	O
examined	O
them	O
on	O
genomic	O
DNA	O
in	O
six	O
MODY	B
probands	O
without	O
mutations	O
in	O
the	O
MODY1	B
,	O
MODY3	B
and	O
MODY4	B
genes	O
and	O
in	O
54	O
patients	O
with	O
late	O
-	O
onset	O
Type	O
II	O
diabetes	O
by	O
combined	O
single	O
strand	O
conformational	O
polymorphism	O
-	O
heteroduplex	O
analysis	O
followed	O
by	O
direct	O
sequencing	O
of	O
identified	O
variants	O
.	O

An	O
identified	O
missense	O
variant	O
was	O
examined	O
in	O
association	O
studies	O
and	O
genotype	O
-	O
phenotype	O
studies	O
.	O

RESULTS	O
:	O
We	O
identified	O
two	O
silent	O
and	O
one	O
missense	O
(	O
Pro75	O
Ala	O
)	O
variant	O
.	O

In	O
an	O
association	O
study	O
the	O
allelic	O
frequency	O
of	O
the	O
Pro75Ala	O
polymorphism	O
was	O
3.2	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
1.9	O
-	O
4.5	O
)	O
in	O
330	O
patients	O
with	O
Type	O
II	O
diabetes	O
mellitus	O
compared	O
with	O
4.2	O
%	O
(	O
2.4	O
-	O
6.0	O
)	O
in	O
238	O
age	O
-	O
matched	O
glucose	O
tolerant	O
control	O
subjects	O
.	O

Moreover	O
,	O
in	O
studies	O
of	O
238	O
middle	O
-	O
aged	O
glucose	O
tolerant	O
subjects	O
,	O
of	O
226	O
glucose	O
tolerant	O
offspring	O
of	O
Type	O
II	O
diabetic	O
patients	O
and	O
of	O
367	O
young	O
healthy	O
subjects	O
,	O
the	O
carriers	O
of	O
the	O
polymorphism	O
did	O
not	O
differ	O
from	O
non	O
-	O
carriers	O
in	O
glucose	O
induced	O
serum	O
insulin	B
or	O
C	B
-	I
peptide	I
responses	O
.	O

CONCLUSION	O
/	O
INTERPRETATION	O
:	O
Mutations	O
in	O
the	O
coding	O
region	O
of	O
the	O
HNF-6	B
gene	O
are	O
not	O
associated	O
with	O
Type	O
II	O
diabetes	O
or	O
with	O
changes	O
in	O
insulin	B
responses	O
to	O
glucose	O
among	O
the	O
Caucasians	O
examined	O
.	O

Identification	O
of	O
a	O
family	O
of	O
human	O
F	O
-	O
box	O
proteins	O
.	O

F	O
-	O
box	O
proteins	O
are	O
an	O
expanding	O
family	O
of	O
eukaryotic	O
proteins	O
characterized	O
by	O
an	O
approximately	O
40	O
aminoacid	O
motif	O
,	O
the	O
F	O
box	O
(	O
so	O
named	O
because	O
cyclin	B
F	I
was	O
one	O
of	O
the	O
first	O
proteins	O
in	O
which	O
this	O
motif	O
was	O
identified	O
)	O
[	O
1	O
]	O
.	O

Some	O
F	O
-	O
box	O
proteins	O
have	O
been	O
shown	O
to	O
be	O
critical	O
for	O
the	O
controlled	O
degradation	O
of	O
cellular	O
regulatory	O
proteins	O
[	O
2	O
]	O
[	O
3	O
]	O
.	O

In	O
fact	O
,	O
F	O
-	O
box	O
proteins	O
are	O
one	O
of	O
the	O
four	O
subunits	O
of	O
ubiquitin	O
protein	O
ligases	O
called	O
SCFs	O
.	O

The	O
other	O
three	O
subunits	O
are	O
the	O
Skp1	B
protein	O
;	O
one	O
of	O
the	O
cullin	O
proteins	O
(	O
Cul1	B
in	O
metazoans	O
and	O
Cdc53	O
or	O
Cul	B
A	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
)	O
;	O
and	O
the	O
recently	O
identified	O
Roc1	B
protein	O
(	O
also	O
called	O
Rbx1	B
or	O
Hrt1	B
)	O
.	O

SCF	O
ligases	O
bring	O
ubiquitin	O
conjugating	O
enzymes	O
(	O
either	O
Ubc3	B
or	O
Ubc4	B
)	O
to	O
substrates	O
that	O
are	O
specifically	O
recruited	O
by	O
the	O
different	O
F	O
-	O
box	O
proteins	O
.	O

The	O
need	O
for	O
high	O
substrate	O
specificity	O
and	O
the	O
large	O
number	O
of	O
known	O
F	O
-	O
box	O
proteins	O
in	O
yeast	O
and	O
worms	O
[	O
2	O
]	O
[	O
4	O
]	O
suggest	O
the	O
existence	O
of	O
a	O
large	O
family	O
of	O
mammalian	O
F	O
-	O
box	O
proteins	O
.	O

Using	O
Skp1	B
as	O
a	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
and	O
by	O
searching	O
DNA	O
databases	O
,	O
we	O
identified	O
a	O
family	O
of	O
26	O
human	O
F	O
-	O
box	O
proteins	O
,	O
25	O
of	O
which	O
were	O
novel	O
.	O

Some	O
of	O
these	O
proteins	O
contained	O
WD-40	O
domains	O
or	O
leucine	O
-	O
rich	O
repeats	O
;	O
others	O
contained	O
either	O
different	O
protein	O
-	O
protein	O
interaction	O
modules	O
or	O
no	O
recognizable	O
motifs	O
.	O

We	O
have	O
named	O
the	O
F	O
-	O
box	O
proteins	O
that	O
contain	O
WD-40	O
domains	O
Fbws	O
,	O
those	O
containing	O
leucine	O
-	O
rich	O
repeats	O
,	O
Fbls	O
,	O
and	O
the	O
remaining	O
ones	O
Fbxs	O
.	O

We	O
have	O
further	O
characterized	O
representative	O
members	O
of	O
these	O
three	O
classes	O
of	O
F	O
-	O
box	O
proteins	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
localization	O
of	O
mouse	O
and	O
human	O
SPO11	B
.	O

Spo11	B
is	O
a	O
meiosis	O
-	O
specific	O
protein	O
in	O
yeast	O
that	O
has	O
been	O
found	O
covalently	O
bound	O
to	O
DNA	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
during	O
the	O
early	O
stages	O
of	O
meiosis	O
.	O

These	O
DSBs	O
initiate	O
homologous	O
recombination	O
,	O
which	O
is	O
required	O
for	O
proper	O
segregation	O
of	O
chromosomes	O
and	O
the	O
generation	O
of	O
genetic	O
diversity	O
during	O
meiosis	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
,	O
characterization	O
,	O
tissue	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
both	O
mouse	O
and	O
human	O
homologues	O
of	O
Spo11	B
.	O

The	O
putative	O
mouse	O
and	O
human	O
proteins	O
are	O
82	O
%	O
identical	O
and	O
share	O
approximately	O
25	O
%	O
identity	O
with	O
other	O
family	O
members	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
testis	O
-	O
specific	O
expression	O
for	O
both	O
genes	O
,	O
but	O
RT	O
-	O
PCR	O
results	O
showed	O
ubiquitous	O
expression	O
of	O
at	O
least	O
a	O
portion	O
of	O
Spo11	B
in	O
mouse	O
.	O

Human	O
SPO11	B
was	O
also	O
detected	O
in	O
several	O
somatic	O
tissues	O
.	O

Mouse	O
Spo11	B
was	O
localized	O
to	O
chromosome	O
2H4	O
,	O
and	O
human	O
SPO11	B
was	O
localized	O
to	O
chromosome	O
20q13.2-q13.3	O
,	O
a	O
region	O
amplified	O
in	O
some	O
breast	O
and	O
ovarian	O
tumors	O
.	O

Lad	O
,	O
an	O
adapter	O
protein	O
interacting	O
with	O
the	O
SH2	O
domain	O
of	O
p56lck	B
,	O
is	O
required	O
for	O
T	O
cell	O
activation	O
.	O

T	B
cell	I
-	I
specific	I
Src	I
family	I
tyrosine	I
kinase	I
,	O
p56lck	B
,	O
plays	O
crucial	O
roles	O
in	O
T	O
cell	O
differentiation	O
,	O
activation	O
,	O
and	O
proliferation	O
.	O

These	O
multiple	O
functions	O
of	O
p56lck	B
are	O
believed	O
to	O
be	O
conducted	O
through	O
the	O
protein	O
-	O
protein	O
interactions	O
with	O
various	O
cellular	O
signaling	O
proteins	O
.	O

To	O
clarify	O
the	O
mechanisms	O
through	O
which	O
p56lck	B
contributes	O
to	O
T	O
cell	O
signaling	O
,	O
we	O
identified	O
the	O
proteins	O
binding	O
to	O
the	O
Src	O
homology	O
2	O
(	O
SH2	O
)	O
domain	O
of	O
p56lck	B
through	O
a	O
tyrosine	O
phosphorylation	O
-	O
dependent	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

Subsequent	O
characterization	O
of	O
positive	O
clones	O
revealed	O
the	O
presence	O
of	O
a	O
protein	O
of	O
366	O
aa	O
named	O
Lad	O
(	O
Lck	B
-	O
associated	O
adapter	O
protein	O
)	O
,	O
which	O
is	O
a	O
potential	O
murine	O
homologue	O
of	O
previously	O
reported	O
TSAd	B
,	O
a	O
T	B
cell	I
-	I
specific	I
adapter	I
protein	I
.	O

Lad	O
contains	O
several	O
protein	O
-	O
protein	O
interaction	O
domains	O
including	O
a	O
zinc	O
-	O
finger	O
motif	O
,	O
an	O
SH2	O
domain	O
,	O
a	O
proline	O
-	O
rich	O
SH3	O
binding	O
motif	O
,	O
and	O
several	O
phosphotyrosine	O
sites	O
.	O

Furthermore	O
,	O
Lad	O
was	O
tyrosine	O
phosphorylated	O
and	O
associated	O
with	O
p56lck	B
in	O
vivo	O
and	O
redistributed	O
from	O
cytoplasm	O
to	O
the	O
plasma	O
membrane	O
in	O
a	O
T	O
cell	O
activation	O
-	O
dependent	O
manner	O
.	O

Moreover	O
in	O
T	O
cells	O
,	O
IL-2	B
promoter	O
activity	O
was	O
enhanced	O
upon	O
coexpression	O
of	O
Lad	O
but	O
was	O
inhibited	O
by	O
the	O
coexpression	O
of	O
antisense	O
Lad	O
RNA	O
.	O

These	O
characteristics	O
of	O
Lad	O
suggest	O
that	O
Lad	O
play	O
an	O
essential	O
role	O
as	O
an	O
adapter	O
protein	O
in	O
p56lck	B
-	O
mediated	O
T	O
cell	O
signaling	O
.	O

Functional	O
expression	O
of	O
the	O
human	B
hZIP2	I
zinc	I
transporter	I
.	O

Zinc	O
is	O
an	O
essential	O
nutrient	O
for	O
humans	O
,	O
yet	O
we	O
know	O
little	O
about	O
how	O
this	O
metal	O
ion	O
is	O
taken	O
up	O
by	O
mammalian	O
cells	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
hZip2	B
,	O
a	O
human	O
zinc	O
transporter	O
identified	O
by	O
its	O
similarity	O
to	O
zinc	O
transporters	O
recently	O
characterized	O
in	O
fungi	O
and	O
plants	O
.	O

hZip2	B
is	O
a	O
member	O
of	O
the	O
ZIP	B
family	O
of	O
eukaryotic	O
metal	O
ion	O
transporters	O
that	O
includes	O
two	O
other	O
human	O
genes	O
,	O
hZIP1	B
and	O
hZIP3	B
,	O
and	O
genes	O
in	O
mice	O
and	O
rats	O
.	O

To	O
test	O
whether	O
hZip2	B
is	O
a	O
zinc	O
transporter	O
,	O
we	O
examined	O
(	O
65	O
)	O
Zn	O
uptake	O
activity	O
in	O
transfected	O
K562	O
erythroleukemia	O
cells	O
expressing	O
hZip2	B
from	O
the	O
CMV	O
promoter	O
.	O

hZip2-expressing	B
cells	O
accumulated	O
more	O
zinc	O
than	O
control	O
cells	O
because	O
of	O
an	O
increased	O
initial	O
zinc	O
uptake	O
rate	O
.	O

This	O
activity	O
was	O
time-	O
,	O
temperature-	O
,	O
and	O
concentration	O
-	O
dependent	O
and	O
saturable	O
with	O
an	O
apparent	O
K	O
(	O
m	O
)	O
of	O
3	O
microM.	O
hZip2	B
zinc	O
uptake	O
activity	O
was	O
inhibited	O
by	O
several	O
other	O
transition	O
metals	O
,	O
suggesting	O
that	O
this	O
protein	O
may	O
transport	O
other	O
substrates	O
as	O
well	O
.	O

hZip2	B
activity	O
was	O
not	O
energy	O
-	O
dependent	O
,	O
nor	O
did	O
it	O
require	O
K	O
(	O
+	O
)	O
or	O
Na	O
(	O
+	O
)	O
gradients	O
.	O

Zinc	O
uptake	O
by	O
hZip2	B
was	O
stimulated	O
by	O
HCO	O
(	O
3	O
)	O
(	O
-	O
)	O
treatment	O
,	O
suggesting	O
a	O
Zn	O
(	O
2+	O
)	O
-HCO	O
(	O
3	O
)	O
(	O
-	O
)	O
cotransport	O
mechanism	O
.	O

Finally	O
,	O
hZip2	B
was	O
exclusively	O
localized	O
in	O
the	O
plasma	O
membrane	O
.	O

These	O
results	O
indicate	O
that	O
hZip2	B
is	O
a	O
zinc	O
transporter	O
,	O
and	O
its	O
identification	O
provides	O
one	O
of	O
the	O
first	O
molecular	O
tools	O
to	O
study	O
zinc	O
uptake	O
in	O
mammalian	O
cells	O
.	O

PEX19	B
binds	O
multiple	O
peroxisomal	O
membrane	O
proteins	O
,	O
is	O
predominantly	O
cytoplasmic	O
,	O
and	O
is	O
required	O
for	O
peroxisome	O
membrane	O
synthesis	O
.	O

Peroxisomes	O
are	O
components	O
of	O
virtually	O
all	O
eukaryotic	O
cells	O
.	O

While	O
much	O
is	O
known	O
about	O
peroxisomal	O
matrix	O
protein	O
import	O
,	O
our	O
understanding	O
of	O
how	O
peroxisomal	O
membrane	O
proteins	O
(	O
PMPs	O
)	O
are	O
targeted	O
and	O
inserted	O
into	O
the	O
peroxisome	O
membrane	O
is	O
extremely	O
limited	O
.	O

Here	O
,	O
we	O
show	O
that	O
PEX19	B
binds	O
a	O
broad	O
spectrum	O
of	O
PMPs	O
,	O
displays	O
saturable	O
PMP	O
binding	O
,	O
and	O
interacts	O
with	O
regions	O
of	O
PMPs	O
required	O
for	O
their	O
targeting	O
to	O
peroxisomes	O
.	O

Furthermore	O
,	O
mislocalization	O
of	O
PEX19	B
to	O
the	O
nucleus	O
leads	O
to	O
nuclear	O
accumulation	O
of	O
newly	O
synthesized	O
PMPs	O
.	O

At	O
steady	O
state	O
,	O
PEX19	B
is	O
bimodally	O
distributed	O
between	O
the	O
cytoplasm	O
and	O
peroxisome	O
,	O
with	O
most	O
of	O
the	O
protein	O
in	O
the	O
cytoplasm	O
.	O

We	O
propose	O
that	O
PEX19	B
may	O
bind	O
newly	O
synthesized	O
PMPs	O
and	O
facilitate	O
their	O
insertion	O
into	O
the	O
peroxisome	O
membrane	O
.	O

This	O
hypothesis	O
is	O
supported	O
by	O
the	O
observation	O
that	O
the	O
loss	O
of	O
PEX19	B
results	O
in	O
degradation	O
of	O
PMPs	O
and/or	O
mislocalization	O
of	O
PMPs	O
to	O
the	O
mitochondrion	O
.	O

Cloning	O
and	O
expression	O
of	O
the	O
histo	O
-	O
blood	O
group	O
Pk	B
UDP	B
-	I
galactose	I
:	I
Ga1beta-4G1cbeta1-cer	I
alpha1	I
,	I
4-galactosyltransferase	I
.	O

Molecular	O
genetic	O
basis	O
of	O
the	O
p	O
phenotype	O
.	O

The	O
molecular	O
genetic	O
basis	O
of	O
the	O
P	O
histo	O
-	O
blood	O
group	O
system	O
has	O
eluded	O
characterization	O
despite	O
extensive	O
studies	O
of	O
the	O
biosynthesis	O
of	O
the	O
P	O
(	O
1	O
)	O
,	O
P	O
,	O
and	O
P	O
(	O
k	O
)	O
glycolipids	O
.	O

The	O
main	O
controversy	O
has	O
been	O
whether	O
a	O
single	O
or	O
two	O
distinct	O
UDP	O
-	O
Gal	O
:	O
Galbeta1-R	O
4-alpha	O
-	O
galactosyltransferases	O
catalyze	O
the	O
syntheses	O
of	O
the	O
structurally	O
related	O
P	O
(	O
1	O
)	O
and	O
P	O
(	O
k	O
)	O
antigens	O
.	O

The	O
P	O
(	O
1	O
)	O
polymorphism	O
is	O
linked	O
to	O
22q11.3-ter	O
.	O

Data	O
base	O
searches	O
with	O
the	O
coding	O
region	O
of	O
an	O
alpha4GlcNAc	O
-	O
transferase	O
identified	O
a	O
novel	O
homologous	O
gene	O
at	O
22q13.2	O
designated	O
alpha4Gal	B
-	I
T1	I
.	O

Expression	O
of	O
full	O
coding	O
constructs	O
of	O
alpha4Gal	B
-	I
T1	I
in	O
insect	O
cells	O
revealed	O
it	O
encoded	O
P	O
(	O
k	O
)	O
but	O
not	O
P	O
(	O
1	O
)	O
synthase	O
activity	O
.	O

Northern	O
analysis	O
showed	O
expression	O
of	O
the	O
transcript	O
correlating	O
with	O
P	B
(	I
k	I
)	I
synthase	I
activity	O
and	O
antigen	O
expression	O
in	O
human	O
B	O
cell	O
lines	O
.	O

Transfection	O
of	O
P	O
(	O
k	O
)	O
-negative	O
Namalwa	O
cells	O
with	O
alpha4Gal	B
-	I
T1	I
resulted	O
in	O
strong	O
P	O
(	O
k	O
)	O
expression	O
.	O

A	O
single	O
homozygous	O
missense	O
mutation	O
,	O
M183	O
K	O
,	O
was	O
found	O
in	O
six	O
Swedish	O
individuals	O
of	O
the	O
rare	O
p	O
phenotype	O
,	O
confirming	O
that	O
alpha4Gal	B
-	I
T1	I
represented	O
the	O
P	B
(	I
k	I
)	I
gene	I
.	O

Sequence	O
analysis	O
of	O
the	O
coding	O
region	O
of	O
alpha4Gal	B
-	I
T1	I
in	O
P	O
(	O
1	O
)	O
+	O
/	O
-	O
individuals	O
did	O
not	O
reveal	O
polymorphisms	O
correlating	O
with	O
P	O
(	O
1	O
)	O
P	O
(	O
2	O
)	O
typing	O
.	O

Characterization	O
of	O
ABCB9	B
,	O
an	O
ATP	O
binding	O
cassette	O
protein	O
associated	O
with	O
lysosomes	O
.	O

We	O
have	O
cloned	O
full	O
-	O
length	O
human	O
and	O
mouse	O
cDNAs	O
of	O
ABCB9	B
,	O
which	O
encodes	O
a	O
predicted	O
multiple	O
-	O
spanning	O
transmembrane	O
domain	O
and	O
a	O
nucleotide	O
-	O
binding	O
domain	O
with	O
Walker	O
motifs	O
.	O

It	O
is	O
therefore	O
designated	O
as	O
a	O
""""	O
half	O
""""	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
.	O

Northern	O
analysis	O
shows	O
that	O
the	O
ABCB9	B
mRNA	O
is	O
expressed	O
at	O
a	O
high	O
level	O
in	O
testes	O
and	O
moderate	O
levels	O
in	O
brain	O
and	O
spinal	O
cord	O
.	O

A	O
splice	O
variant	O
mRNA	O
deleted	O
in	O
the	O
last	O
pair	O
of	O
predicted	O
transmembrane	O
segments	O
was	O
shown	O
to	O
be	O
expressed	O
in	O
human	O
tissues	O
.	O

Phylogenetic	O
analysis	O
indicates	O
that	O
ABCB9	B
is	O
closely	O
related	O
to	O
TAP1	B
and	O
TAP2	B
,	O
two	O
""""	O
half	O
""""	O
ABC	O
proteins	O
found	O
in	O
endoplasmic	O
reticulum	O
.	O

ABCB9	B
protein	O
colocalized	O
with	O
the	O
lysosomal	O
markers	O
,	O
LAMP1	B
and	O
LAMP2	B
,	O
in	O
transfected	O
cells	O
.	O

ABCB9	B
protein	O
appears	O
to	O
be	O
most	O
highly	O
expressed	O
in	O
the	O
Sertoli	O
cells	O
of	O
the	O
seminiferous	O
tubules	O
in	O
mouse	O
and	O
rat	O
testes	O
.	O

These	O
cells	O
have	O
high	O
levels	O
of	O
phagocytosis	O
and	O
secretory	O
activities	O
.	O

These	O
findings	O
pave	O
the	O
way	O
for	O
further	O
investigation	O
into	O
the	O
potential	O
novel	O
function	O
of	O
ABCB9	B
in	O
lysosomes	O
.	O

Identification	O
of	O
a	O
fourth	B
subunit	I
of	I
mammalian	I
DNA	I
polymerase	I
delta	I
.	O

A	O
12-kDa	O
and	O
two	O
25-kDa	O
polypeptides	O
were	O
isolated	O
with	O
highly	O
purified	O
calf	O
thymus	O
DNA	O
polymerase	O
delta	O
by	O
conventional	O
chromatography	O
.	O

A	O
16-mer	O
peptide	O
sequence	O
was	O
obtained	O
from	O
the	O
12-kDa	O
polypeptide	O
which	O
matched	O
a	O
new	O
open	O
reading	O
frame	O
from	O
a	O
human	O
EST	O
(	O
)	O
encoding	O
a	O
hypothetical	O
protein	O
of	O
unknown	O
function	O
.	O

The	O
protein	O
was	O
designated	O
as	O
p12	B
.	O

Human	O
EST	O
was	O
identified	O
as	O
the	O
putative	O
human	O
homologue	O
of	O
Schizosaccharomyces	O
pombe	O
Cdm1	O
by	O
a	O
tBlastn	O
search	O
of	O
the	O
EST	O
data	O
base	O
using	O
S.	O
pombe	O
Cdm1	O
.	O

The	O
open	O
reading	O
frame	O
of	O
human	O
EST	O
encoded	O
a	O
polypeptide	O
of	O
107	O
amino	O
acids	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
12.4	O
kDa	O
,	O
consistent	O
with	O
the	O
experimental	O
findings	O
.	O

p12	B
is	O
25	O
%	O
identical	O
to	O
S	O
pombe	O
Cdm1	O
.	O

Both	O
of	O
the	O
25-kDa	O
polypeptide	O
sequences	O
matched	O
the	O
hypothetical	O
KIAA0039	B
protein	O
sequence	O
,	O
recently	O
identified	O
as	O
the	O
third	B
subunit	I
of	I
pol	I
delta	I
.	O

Western	O
blotting	O
of	O
immunoaffinity	O
purified	O
calf	O
thymus	O
pol	O
delta	O
revealed	O
the	O
presence	O
of	O
p125	O
,	O
p50	O
,	O
p68	B
(	O
the	O
KIAA0039	B
product	O
)	O
,	O
and	O
p12	B
.	O

With	O
the	O
identification	O
of	O
p12	B
mammalian	O
pol	O
delta	O
can	O
now	O
be	O
shown	O
to	O
consist	O
of	O
four	O
subunits	O
.	O

These	O
studies	O
pave	O
the	O
way	O
for	O
more	O
detailed	O
analysis	O
of	O
the	O
possible	O
functions	O
of	O
the	O
mammalian	O
subunits	O
of	O
pol	O
delta	O
.	O

AAC-11	B
overexpression	O
induces	O
invasion	O
and	O
protects	O
cervical	O
cancer	O
cells	O
from	O
apoptosis	O
.	O

To	O
identify	O
the	O
genes	O
involved	O
in	O
cervical	O
carcinogenesis	O
,	O
we	O
applied	O
the	O
mRNA	O
differential	O
display	O
(	O
DD	O
)	O
method	O
to	O
analyze	O
normal	O
cervical	O
tissue	O
,	O
cervical	O
cancer	O
,	O
metastatic	O
lymph	O
node	O
,	O
and	O
cervical	O
cancer	O
cell	O
line	O
.	O

We	O
cloned	O
a	O
491-bp	O
cDNA	O
fragment	O
,	O
CC231	O
,	O
which	O
was	O
present	O
in	O
metastatic	O
tissue	O
and	O
cervical	O
cancer	O
cell	O
line	O
,	O
but	O
absent	O
in	O
normal	O
cervical	O
and	O
cervical	O
cancer	O
tissues	O
.	O

The	O
491	O
bp	O
cDNA	O
fragment	O
has	O
98	O
%	O
homology	O
to	O
the	O
previously	O
published	O
sequence	O
,	O
AAC-11	B
(	O
antiapoptosis	B
clone	I
11	I
)	O
.	O

The	O
levels	O
of	O
AAC-11	B
mRNA	O
expressions	O
in	O
nine	O
normal	O
cervical	O
and	O
nine	O
primary	O
cervical	O
cancer	O
tissues	O
were	O
low	O
.	O

Its	O
expression	O
was	O
higher	O
in	O
three	O
metastatic	O
tissues	O
and	O
five	O
cervical	O
cancer	O
cell	O
lines	O
(	O
HeLa	O
,	O
CaSki	O
,	O
SiHa	O
,	O
CUMC-3	O
,	O
and	O
CUMC-6	O
)	O
.	O

Invasion	O
of	O
matrigel	O
and	O
adhesion	O
to	O
laminin	O
by	O
AAC-11	B
transfected	O
CUMC-6	O
cells	O
were	O
increased	O
by	O
approximately	O
2-fold	O
and	O
4-fold	O
,	O
respectively	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
matrix	B
metalloproteinase	I
(	I
MMP	I
)	I
-2	I
and	I
membrane	I
type	I
1	I
MMP	I
(	O
MT1-MMP	B
)	O
genes	O
were	O
found	O
to	O
be	O
expressed	O
in	O
high	O
levels	O
in	O
AAC-11-transfected	B
cancer	O
cells	O
.	O

But	O
MMP-2	B
and	O
MT1-MMP	B
were	O
not	O
expressed	O
in	O
cells	O
transfected	O
with	O
vector	O
alone	O
or	O
wild	O
-	O
type	O
cells	O
.	O

AAC-11-transfected	B
cells	O
expressed	O
an	O
elevated	O
level	O
of	O
MMP-2	B
protein	O
as	O
assessed	O
by	O
immunoblotting	O
.	O

On	O
the	O
contrary	O
,	O
tissue	B
inhibitor	I
of	I
MMP	I
(	O
TIMP-2	B
)	O
expression	O
was	O
detectable	O
in	O
cells	O
transfected	O
with	O
vector	O
alone	O
or	O
wild	O
-	O
type	O
cells	O
,	O
respectively	O
.	O

Its	O
expression	O
was	O
undetectable	O
in	O
AAC-11	B
transfected	O
cells	O
.	O

In	O
cervical	O
cancer	O
cells	O
transfected	O
with	O
AAC-11	B
,	O
the	O
expression	O
of	O
beta	O
-	O
catenin	O
was	O
up	O
-	O
regulated	O
.	O

These	O
suggest	O
that	O
overexpressions	O
of	O
MMP-2	B
and	O
MT1-MMP	B
,	O
loss	O
of	O
TIMP-2	B
expression	O
,	O
and	O
up	O
-	O
regulation	O
of	O
beta	O
-	O
catenin	O
by	O
AAC-11	B
transfection	O
may	O
contribute	O
to	O
the	O
development	O
of	O
cervical	O
cancer	O
invasion	O
.	O

AAC-11	B
gene	O
transfection	O
increased	O
cervical	O
cancer	O
cell	O
colonization	O
.	O

The	O
effect	O
of	O
AAC-11	B
on	O
cultured	O
cervical	O
cancer	O
cells	O
was	O
associated	O
with	O
antiapoptotic	O
process	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
AAC-11	B
transfected	O
cells	O
in	O
serum	O
-	O
free	O
medium	O
died	O
after	O
2	O
weeks	O
,	O
compared	O
to	O
1	O
week	O
for	O
vector	O
alone	O
or	O
wild	O
-	O
type	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
AAC-11	B
may	O
serve	O
as	O
a	O
candidate	O
metastasis	O
-	O
related	O
and	O
apoptosis	O
-	O
inhibiting	O
gene	O
in	O
human	O
cervical	O
cancer	O
.	O

Molecular	O
cloning	O
,	O
chromosome	O
mapping	O
and	O
characterization	O
of	O
UBQLN3	B
a	O
testis	O
-	O
specific	O
gene	O
that	O
contains	O
an	O
ubiquitin	O
-	O
like	O
domain	O
.	O

The	O
sequence	O
of	O
the	O
ubiquitin	O
protein	O
is	O
highly	O
conserved	O
between	O
species	O
and	O
has	O
facilitated	O
the	O
cloning	O
of	O
numerous	O
ubiquitin	O
-	O
like	O
proteins	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
report	O
the	O
cloning	O
of	O
the	O
cDNA	O
for	O
human	O
ubiquilin	B
3	I
(	O
UBQLN3	B
)	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
UBQLN3	B
contains	O
a	O
UBQ	O
domain	O
(	O
ubiquitin	O
-	O
like	O
)	O
in	O
the	O
amino	O
terminus	O
as	O
well	O
as	O
two	O
highly	O
conserved	O
domains	O
found	O
in	O
several	O
recently	O
cloned	O
ubiquitin	O
-	O
like	O
proteins	O
.	O

One	O
of	O
these	O
domains	O
,	O
termed	O
the	O
NP	O
domain	O
,	O
is	O
a	O
highly	O
conserved	O
93	O
amino	O
acid	O
region	O
present	O
in	O
UBQLN3	B
and	O
several	O
ubiquitin	O
-	O
like	O
proteins	O
.	O

The	O
last	O
conserved	O
domain	O
is	O
the	O
UBA	O
domain	O
(	O
ubiquitin	O
-	O
associated	O
)	O
found	O
in	O
a	O
variety	O
of	O
proteins	O
of	O
the	O
ubiquination	O
pathway	O
.	O

The	O
human	O
UBQLN3	B
gene	O
was	O
mapped	O
to	O
the	O
11p15	O
region	O
of	O
chromosome	O
11	O
.	O

Northern	O
blot	O
analysis	O
of	O
multiple	O
human	O
and	O
mouse	O
tissues	O
demonstrated	O
UBQLN3	B
mRNA	O
expression	O
specifically	O
in	O
testis	O
.	O

DNMT1	B
binds	O
HDAC2	B
and	O
a	O
new	O
co	O
-	O
repressor	O
,	O
DMAP1	B
,	O
to	O
form	O
a	O
complex	O
at	O
replication	O
foci	O
.	O

DNA	O
methylation	O
can	O
contribute	O
to	O
transcriptional	O
silencing	O
through	O
several	O
transcriptionally	O
repressive	O
complexes	O
,	O
which	O
include	O
methyl	O
-	O
CpG	O
binding	O
domain	O
proteins	O
(	O
MBDs	O
)	O
and	O
histone	O
deacetylases	O
(	O
HDACs	O
)	O
.	O

We	O
show	O
here	O
that	O
the	O
chief	O
enzyme	O
that	O
maintains	O
mammalian	O
DNA	O
methylation	O
,	O
DNMT1	B
,	O
can	O
also	O
establish	O
a	O
repressive	O
transcription	O
complex	O
.	O

The	O
non	O
-	O
catalytic	O
amino	O
terminus	O
of	O
DNMT1	B
binds	O
to	O
HDAC2	B
and	O
a	O
new	O
protein	O
,	O
DMAP1	B
(	O
for	O
DNMT1	B
associated	I
protein	I
)	O
,	O
and	O
can	O
mediate	O
transcriptional	O
repression	O
.	O

DMAP1	B
has	O
intrinsic	O
transcription	O
repressive	O
activity	O
,	O
and	O
binds	O
to	O
the	O
transcriptional	O
co	O
-	O
repressor	O
TSG101	B
.	O

DMAP1	B
is	O
targeted	O
to	O
replication	O
foci	O
through	O
interaction	O
with	O
the	O
far	O
N	O
terminus	O
of	O
DNMT1	B
throughout	O
S	O
phase	O
,	O
whereas	O
HDAC2	B
joins	O
DNMT1	B
and	O
DMAP1	B
only	O
during	O
late	O
S	O
phase	O
,	O
providing	O
a	O
platform	O
for	O
how	O
histones	O
may	O
become	O
deacetylated	O
in	O
heterochromatin	O
following	O
replication	O
.	O

Thus	O
,	O
DNMT1	B
not	O
only	O
maintains	O
DNA	O
methylation	O
,	O
but	O
also	O
may	O
directly	O
target	O
,	O
in	O
a	O
heritable	O
manner	O
,	O
transcriptionally	O
repressive	O
chromatin	O
to	O
the	O
genome	O
during	O
DNA	O
replication	O
.	O

Cloning	O
and	O
characterization	O
of	O
cDNA	O
encoding	O
a	O
novel	O
human	O
leukotriene	O
B	O
(	O
4	O
)	O
receptor	O
.	O

By	O
homology	O
screening	O
using	O
BLAST	O
searches	O
of	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
,	O
we	O
have	O
found	O
a	O
previously	O
unidentified	O
cDNA	O
encoding	O
a	O
putative	O
seven	O
-	O
transmembrane	O
receptor	O
with	O
highest	O
similarity	O
to	O
the	O
leukotriene	O
B	O
(	O
4	O
)	O
receptor	O
,	O
BLTR	B
.	O

Analysis	O
of	O
calcium	O
flow	O
in	O
transfected	O
cells	O
,	O
along	O
with	O
sequence	O
analysis	O
,	O
revealed	O
that	O
the	O
EST	O
encoded	O
a	O
functionally	O
inactive	O
protein	O
,	O
lacking	O
the	O
segment	O
corresponding	O
to	O
the	O
C	O
-	O
terminal	O
part	O
of	O
the	O
putative	O
receptor	O
protein	O
.	O

The	O
missing	O
segment	O
was	O
obtained	O
by	O
PCR	O
amplification	O
of	O
a	O
human	O
leukocyte	O
cDNA	O
library	O
and	O
ligated	O
to	O
the	O
truncated	O
EST	O
cDNA	O
.	O

The	O
novel	O
cDNA	O
encodes	O
a	O
full	O
-	O
length	O
receptor	O
with	O
39	O
%	O
identity	O
to	O
the	O
previously	O
cloned	O
BLTR	B
.	O

Studies	O
of	O
intracellular	O
calcium	O
flow	O
of	O
transfected	O
HeLa	O
cells	O
exposed	O
to	O
various	O
leukotrienes	O
showed	O
that	O
also	O
the	O
novel	O
BLTR	B
-	O
like	O
receptor	O
can	O
be	O
activated	O
by	O
leukotriene	O
B	O
(	O
4	O
)	O
,	O
and	O
it	O
is	O
therefore	O
tentatively	O
named	O
BLTR2	B
.	O

XAB2	B
,	O
a	O
novel	O
tetratricopeptide	O
repeat	O
protein	O
involved	O
in	O
transcription	O
-	O
coupled	O
DNA	O
repair	O
and	O
transcription	O
.	O

Nucleotide	O
excision	O
repair	O
is	O
a	O
highly	O
versatile	O
DNA	O
repair	O
system	O
responsible	O
for	O
elimination	O
of	O
a	O
wide	O
variety	O
of	O
lesions	O
from	O
the	O
genome	O
.	O

It	O
is	O
comprised	O
of	O
two	O
subpathways	O
:	O
transcription	O
-	O
coupled	O
repair	O
that	O
accomplishes	O
efficient	O
removal	O
of	O
damage	O
blocking	O
transcription	O
and	O
global	O
genome	O
repair	O
.	O

Recently	O
,	O
the	O
basic	O
mechanism	O
of	O
global	O
genome	O
repair	O
has	O
emerged	O
from	O
biochemical	O
studies	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
transcription	O
-	O
coupled	O
repair	O
in	O
eukaryotes	O
.	O

Here	O
we	O
report	O
the	O
identification	O
of	O
a	O
novel	O
protein	O
designated	O
XAB2	B
(	O
XPA	B
-	I
binding	I
protein	I
2	I
)	O
that	O
was	O
identified	O
by	O
virtue	O
of	O
its	O
ability	O
to	O
interact	O
with	O
XPA	B
,	O
a	O
factor	O
central	O
to	O
both	O
nucleotide	O
excision	O
repair	O
subpathways	O
.	O

The	O
XAB2	B
protein	O
of	O
855	O
amino	O
acids	O
consists	O
mainly	O
of	O
15	O
tetratricopeptide	O
repeats	O
.	O

In	O
addition	O
to	O
interacting	O
with	O
XPA	B
,	O
immunoprecipitation	O
experiments	O
demonstrated	O
that	O
a	O
fraction	O
of	O
XAB2	B
is	O
able	O
to	O
interact	O
with	O
the	O
transcription	O
-	O
coupled	O
repair	O
-	O
specific	O
proteins	O
CSA	B
and	O
CSB	B
as	O
well	O
as	O
RNA	O
polymerase	O
II	O
.	O

Furthermore	O
,	O
antibodies	O
against	O
XAB2	B
inhibited	O
both	O
transcription	O
-	O
coupled	O
repair	O
and	O
transcription	O
in	O
vivo	O
but	O
not	O
global	O
genome	O
repair	O
when	O
microinjected	O
into	O
living	O
fibroblasts	O
.	O

These	O
results	O
indicate	O
that	O
XAB2	B
is	O
a	O
novel	O
component	O
involved	O
in	O
transcription	O
-	O
coupled	O
repair	O
and	O
transcription	O
.	O

Activation	B
-	I
induced	I
cytidine	I
deaminase	I
(	O
AID	B
)	O
deficiency	O
causes	O
the	O
autosomal	O
recessive	O
form	O
of	O
the	O
Hyper	O
-	O
IgM	O
syndrome	O
(	O
HIGM2	B
)	O
.	O

The	O
activation	B
-	I
induced	I
cytidine	I
deaminase	I
(	O
AID	B
)	O
gene	O
,	O
specifically	O
expressed	O
in	O
germinal	O
center	O
B	O
cells	O
in	O
mice	O
,	O
is	O
a	O
member	O
of	O
the	O
cytidine	O
deaminase	O
family	O
.	O

We	O
herein	O
report	O
mutations	O
in	O
the	O
human	O
counterpart	O
of	O
AID	B
in	O
patients	O
with	O
the	O
autosomal	O
recessive	O
form	O
of	O
hyper	O
-	O
IgM	O
syndrome	O
(	O
HIGM2	B
)	O
.	O

Three	O
major	O
abnormalities	O
characterize	O
AID	B
deficiency	O
:	O
(	O
1	O
)	O
the	O
absence	O
of	O
immunoglobulin	O
class	O
switch	O
recombination	O
,	O
(	O
2	O
)	O
the	O
lack	O
of	O
immunoglobulin	O
somatic	O
hypermutations	O
,	O
and	O
(	O
3	O
)	O
lymph	O
node	O
hyperplasia	O
caused	O
by	O
the	O
presence	O
of	O
giant	O
germinal	O
centers	O
.	O

The	O
phenotype	O
observed	O
in	O
HIGM2	B
patients	O
(	O
and	O
in	O
AID-	B
/	O
-	O
mice	O
)	O
demonstrates	O
the	O
absolute	O
requirement	O
for	O
AID	B
in	O
several	O
crucial	O
steps	O
of	O
B	O
cell	O
terminal	O
differentiation	O
necessary	O
for	O
efficient	O
antibody	O
responses	O
.	O

Molecular	O
cloning	O
of	O
a	O
human	O
,	O
hemicholinium-3-sensitive	B
choline	I
transporter	I
.	O

Under	O
many	O
physiological	O
circumstances	O
,	O
Na	O
(	O
+	O
)	O
-	O
and	O
Cl	O
(	O
-	O
)	O
-dependent	O
,	O
hemicholinium-3	O
(	O
HC-3	O
)	O
-sensitive	O
,	O
high	O
-	O
affinity	O
choline	O
uptake	O
(	O
HACU	O
)	O
in	O
cholinergic	O
neurons	O
is	O
thought	O
to	O
be	O
rate	O
-	O
limiting	O
in	O
the	O
biosynthesis	O
of	O
acetylcholine	O
(	O
ACh	O
)	O
.	O

Based	O
on	O
sequence	O
information	O
provided	O
by	O
the	O
Human	O
Genome	O
Project	O
and	O
the	O
recently	O
reported	O
rat	O
CHT1	B
(	O
rCHT1	O
)	O
,	O
we	O
cloned	O
a	O
human	O
CHT	B
cDNA	O
from	O
spinal	O
cord	O
.	O

The	O
hCHT	B
cDNA	O
encodes	O
a	O
protein	O
of	O
580	O
amino	O
acids	O
having	O
93	O
%	O
identity	O
to	O
rCHT1	O
and	O
51	O
%	O
identity	O
to	O
the	O
Caenorhabditis	O
elegans	O
homolog	O
CHO-1	O
,	O
and	O
is	O
distantly	O
related	O
to	O
members	O
of	O
the	O
Na	O
(	O
+	O
)	O
-coupled	O
glucose	O
transporter	O
(	O
SGLT	O
)	O
gene	O
family	O
of	O
Na	O
(	O
+	O
)	O
-coupled	O
glucose	O
(	O
SGLT	O
)	O
,	O
nucleoside	O
and	O
iodide	O
transporters	O
.	O

Northern	O
blot	O
analysis	O
reveals	O
the	O
expression	O
of	O
a	O
approximately	O
5	O
kb	O
transcript	O
in	O
human	O
brain	O
regions	O
rich	O
in	O
cholinergic	O
neurons	O
including	O
the	O
putamen	O
,	O
spinal	O
cord	O
,	O
and	O
medulla	O
.	O

Expression	O
of	O
hCHT	B
cDNA	O
in	O
COS-7	O
cells	O
results	O
in	O
saturable	O
,	O
Na	O
(	O
+	O
)	O
/	O
Cl	O
(	O
-	O
)	O
-dependent	O
choline	O
uptake	O
(	O
K	O
(	O
m	O
)	O
=	O
1.2	O
microM	O
)	O
in	O
membrane	O
vesicles	O
and	O
[	O
(	O
3	O
)	O
H	O
]	O
HC-3	O
binding	O
(	O
K	O
(	O
d	O
)	O
=	O
4	O
nM	O
)	O
in	O
membrane	O
fractions	O
,	O
consistent	O
with	O
characteristics	O
reported	O
in	O
mammalian	O
cholinergic	O
neurons	O
.	O

Using	O
radiation	O
hybrid	O
mapping	O
techniques	O
,	O
we	O
localized	O
the	O
hCHT	B
gene	O
to	O
human	O
chromosome	O
2q12	O
.	O

These	O
studies	O
elucidate	O
the	O
primary	O
structure	O
and	O
chromosomal	O
localization	O
of	O
hCHT	B
and	O
provide	O
a	O
basis	O
for	O
mechanistic	O
analysis	O
of	O
HACU	O
regulation	O
and	O
an	O
investigation	O
of	O
the	O
role	O
of	O
hCHT	B
in	O
disease	O
states	O
.	O

SMARCAD1	B
,	O
a	O
novel	O
human	O
helicase	O
family	O
-	O
defining	O
member	O
associated	O
with	O
genetic	O
instability	O
:	O
cloning	O
,	O
expression	O
,	O
and	O
mapping	O
to	O
4q22-q23	O
,	O
a	O
band	O
rich	O
in	O
breakpoints	O
and	O
deletion	O
mutants	O
involved	O
in	O
several	O
human	O
diseases	O
.	O

Members	O
of	O
the	O
DEAD	O
/	O
H	O
box	O
-	O
containing	O
helicase	O
superfamily	O
include	O
proteins	O
essential	O
to	O
genome	O
replication	O
,	O
repair	O
,	O
and	O
expression	O
.	O

We	O
report	O
here	O
the	O
cloning	O
and	O
initial	O
characterization	O
of	O
a	O
novel	O
human	O
member	O
of	O
this	O
protein	O
family	O
,	O
designated	O
hHel1	B
(	O
human	B
helicase	I
1	I
)	O
,	O
now	O
designated	O
SMARCAD1	B
by	O
HUGO	O
.	O

This	O
DEAD	O
/	O
H	O
box	O
-	O
containing	O
molecule	O
has	O
seven	O
highly	O
conserved	O
sequence	O
regions	O
that	O
allow	O
us	O
to	O
place	O
it	O
in	O
the	O
SNF2	O
family	O
of	O
the	O
helicase	O
superfamily	O
.	O

Uniquely	O
,	O
though	O
,	O
hHel1	B
contains	O
two	O
DEAD	O
/	O
H	O
box	O
motifs	O
,	O
a	O
property	O
not	O
reported	O
to	O
be	O
shared	O
by	O
any	O
other	O
SNF2	O
family	O
members	O
.	O

This	O
defines	O
a	O
new	O
subfamily	O
consisting	O
of	O
hHel1	B
and	O
its	O
homologues	O
.	O

In	O
addition	O
to	O
these	O
DEAD	O
/	O
H	O
box	O
/	O
ATP	O
-	O
binding	O
motifs	O
,	O
hHel1	B
has	O
a	O
putative	O
nuclear	O
localization	O
signal	O
and	O
several	O
regions	O
that	O
may	O
mediate	O
protein	O
-	O
protein	O
interactions	O
.	O

Expression	O
analysis	O
indicates	O
that	O
hHel1	B
transcripts	O
are	O
ubiquitous	O
,	O
with	O
particularly	O
high	O
levels	O
in	O
endocrine	O
tissue	O
.	O

We	O
have	O
mapped	O
the	O
gene	O
for	O
hHel1	B
to	O
human	O
chromosome	O
4q22-q23	O
;	O
this	O
region	O
is	O
rich	O
in	O
breakpoints	O
and	O
deletion	O
mutants	O
of	O
genes	O
involved	O
in	O
several	O
human	O
diseases	O
,	O
notably	O
soft	O
tissue	O
leiomyosarcoma	O
,	O
hepatocellular	O
carcinoma	O
,	O
and	O
hematologic	O
malignancies	O
.	O

Our	O
observation	O
that	O
human	O
Hel1	O
gene	O
overexpression	O
is	O
present	O
in	O
an	O
E1A	O
-	O
expressing	O
cell	O
line	O
with	O
increased	O
capacity	O
for	O
gene	O
reactivation	O
events	O
by	O
genomic	O
rearrangement	O
suggests	O
that	O
human	O
Hel1	O
may	O
play	O
a	O
role	O
in	O
genetic	O
instability	O
development	O
.	O

Two	O
-	O
amino	O
acid	O
molecular	O
switch	O
in	O
an	O
epithelial	O
morphogen	O
that	O
regulates	O
binding	O
to	O
two	O
distinct	O
receptors	O
.	O

Ectodysplasin	B
,	O
a	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
family	O
,	O
is	O
encoded	O
by	O
the	O
anhidrotic	B
ectodermal	I
dysplasia	I
(	O
EDA	B
)	O
gene	O
.	O

Mutations	O
in	O
EDA	B
give	O
rise	O
to	O
a	O
clinical	O
syndrome	O
characterized	O
by	O
loss	O
of	O
hair	O
,	O
sweat	O
glands	O
,	O
and	O
teeth	O
.	O

EDA	B
-	I
A1	I
and	O
EDA	B
-	I
A2	I
are	O
two	O
isoforms	O
of	O
ectodysplasin	B
that	O
differ	O
only	O
by	O
an	O
insertion	O
of	O
two	O
amino	O
acids	O
.	O

This	O
insertion	O
functions	O
to	O
determine	O
receptor	O
binding	O
specificity	O
,	O
such	O
that	O
EDA	B
-	I
A1	I
binds	O
only	O
the	O
receptor	O
EDAR	B
,	O
whereas	O
EDA	B
-	I
A2	I
binds	O
only	O
the	O
related	O
,	O
but	O
distinct	O
,	O
X	B
-	I
linked	I
ectodysplasin	I
-	I
A2	I
receptor	I
(	O
XEDAR	B
)	O
.	O

In	O
situ	O
binding	O
and	O
organ	O
culture	O
studies	O
indicate	O
that	O
EDA	B
-	I
A1	I
and	O
EDA	B
-	I
A2	I
are	O
differentially	O
expressed	O
and	O
play	O
a	O
role	O
in	O
epidermal	O
morphogenesis	O
.	O

Human	O
serine	B
racemase	I
:	O
moleular	O
cloning	O
,	O
genomic	O
organization	O
and	O
functional	O
analysis	O
.	O

High	O
levels	O
of	O
D	O
-	O
serine	O
are	O
found	O
in	O
mammalian	O
brain	O
,	O
where	O
it	O
is	O
an	O
endogenous	O
agonist	O
of	O
the	O
strichinine	O
-	O
insensitive	O
site	O
of	O
N	O
-	O
methyl	O
D	O
-	O
aspartate	O
type	O
of	O
glutamate	O
receptors	O
.	O

D	O
-	O
serine	O
is	O
enriched	O
in	O
protoplasmic	O
astrocytes	O
that	O
occur	O
in	O
gray	O
matter	O
areas	O
of	O
the	O
brain	O
and	O
was	O
shown	O
to	O
be	O
synthesized	O
from	O
L	O
-	O
serine	O
.	O

We	O
now	O
report	O
cloning	O
and	O
expression	O
of	O
human	O
serine	B
racemase	I
,	O
an	O
enzyme	O
that	O
catalyses	O
the	O
synthesis	O
of	O
D	O
-	O
serine	O
from	O
L	O
-	O
serine	O
.	O

The	O
enzyme	O
displays	O
a	O
high	O
homology	O
to	O
the	O
murine	O
serine	B
racemase	I
.	O

It	O
contains	O
a	O
pyridoxal	O
5'-phosphate	O
attachment	O
sequence	O
similar	O
to	O
bacterial	O
biosynthetic	O
threonine	O
dehydratase	O
.	O

Northern	O
-	O
blot	O
analysis	O
show	O
high	O
levels	O
of	O
human	O
serine	B
racemase	I
in	O
areas	O
known	O
to	O
contain	O
large	O
amounts	O
of	O
endogenous	O
D	O
-	O
serine	O
,	O
such	O
as	O
hippocampus	O
and	O
corpus	O
callosum	O
.	O

Robust	O
synthesis	O
of	O
D	O
-	O
serine	O
was	O
detected	O
in	O
cells	O
transfected	O
with	O
human	O
serine	B
racemase	I
,	O
demonstrating	O
the	O
conservation	O
of	O
D	O
-	O
amino	O
acid	O
metabolism	O
in	O
humans	O
.	O

Serine	B
racemase	I
may	O
be	O
a	O
therapeutic	O
target	O
in	O
psychiatric	O
diseases	O
as	O
supplementation	O
of	O
D	O
-	O
serine	O
greatly	O
improves	O
schizophrenia	O
symptoms	O
.	O

We	O
identify	O
the	O
human	O
serine	B
racemase	I
genomic	O
structure	O
and	O
show	O
that	O
the	O
gene	O
encompasses	O
seven	O
exons	O
and	O
localizes	O
to	O
chromosome	O
17q13.3	O
.	O

Identification	O
of	O
the	O
intron	O
-	O
exon	O
boundaries	O
of	O
the	O
human	O
serine	B
racemase	I
gene	O
will	O
be	O
useful	O
to	O
search	O
for	O
mutations	O
in	O
neuropsychiatric	O
disorders	O
.	O

IL-17E	B
,	O
a	O
novel	O
proinflammatory	O
ligand	O
for	O
the	O
IL-17	O
receptor	O
homolog	O
IL-17Rh1	B
.	O

We	O
report	O
identification	O
of	O
interleukin	B
(	I
IL	I
)	I
-17E	I
,	O
a	O
novel	O
member	O
of	O
the	O
IL-17	O
family	O
of	O
cytokines	O
.	O

IL-17E	B
is	O
a	O
ligand	O
for	O
the	O
recently	O
identified	O
protein	O
termed	O
EVI27	B
/	I
IL-17BR	I
,	O
which	O
we	O
term	O
IL-17	B
receptor	I
homolog	I
1	I
(	O
IL-17Rh1	B
)	O
in	O
light	O
of	O
the	O
multiple	O
reported	O
ligand	O
-	O
receptor	O
relationships	O
.	O

Murine	O
EVI27	B
was	O
identified	O
through	O
its	O
location	O
at	O
a	O
common	O
site	O
of	O
retroviral	O
integration	O
in	O
BXH2	O
murine	O
myeloid	O
leukemias	O
.	O

IL-17Rh1	B
shows	O
highest	O
level	O
expression	O
in	O
kidney	O
with	O
moderate	O
expression	O
in	O
multiple	O
other	O
organs	O
,	O
whereas	O
IL-17E	B
mRNA	O
was	O
detected	O
at	O
very	O
low	O
levels	O
in	O
several	O
peripheral	O
tissues	O
.	O

IL-17E	B
induces	O
activation	O
of	O
NF	O
-	O
kappaB	O
and	O
stimulates	O
production	O
of	O
the	O
proinflammatory	O
chemokine	O
IL-8	B
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
the	O
human	O
protein	B
kinase	I
D2	I
.	O

A	O
novel	O
member	O
of	O
the	O
protein	B
kinase	I
D	I
family	O
of	O
serine	O
threonine	O
kinases	O
.	O

We	O
have	O
isolated	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
a	O
novel	O
human	O
serine	O
threonine	O
protein	O
kinase	O
gene	O
.	O

The	O
deduced	O
protein	O
sequence	O
contains	O
two	O
cysteine	O
-	O
rich	O
motifs	O
at	O
the	O
N	O
terminus	O
,	O
a	O
pleckstrin	O
homology	O
domain	O
,	O
and	O
a	O
catalytic	O
domain	O
containing	O
all	O
the	O
characteristic	O
sequence	O
motifs	O
of	O
serine	O
protein	O
kinases	O
.	O

It	O
exhibits	O
the	O
strongest	O
homology	O
to	O
the	O
serine	O
threonine	O
protein	O
kinases	O
PKD	B
/	I
PKCmicro	I
and	O
PKCnu	B
,	O
particularly	O
in	O
the	O
duplex	O
zinc	O
finger	O
-	O
like	O
cysteine	O
-	O
rich	O
motif	O
,	O
in	O
the	O
pleckstrin	O
homology	O
domain	O
and	O
in	O
the	O
protein	O
kinase	O
domain	O
.	O

In	O
contrast	O
,	O
it	O
shows	O
only	O
a	O
low	O
degree	O
of	O
sequence	O
similarity	O
to	O
other	O
members	O
of	O
the	O
PKC	O
family	O
.	O

Therefore	O
,	O
the	O
new	O
protein	O
has	O
been	O
termed	O
protein	B
kinase	I
D2	I
(	O
PKD2	B
)	O
.	O

The	O
mRNA	O
of	O
PKD2	B
is	O
widely	O
expressed	O
in	O
human	O
and	O
murine	O
tissues	O
.	O

It	O
encodes	O
a	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
105	O
kDa	O
in	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
,	O
which	O
is	O
expressed	O
in	O
various	O
human	O
cell	O
lines	O
,	O
including	O
HL60	O
cells	O
,	O
which	O
do	O
not	O
express	O
PKCmicro	B
.	O

In	O
vivo	O
phorbol	O
ester	O
binding	O
studies	O
demonstrated	O
a	O
concentration	O
-	O
dependent	O
binding	O
of	O
[	O
(	O
3	O
)	O
H	O
]	O
phorbol	O
12,13-dibutyrate	O
to	O
PKD2	B
.	O

The	O
addition	O
of	O
phorbol	O
12,13-dibutyrate	O
in	O
the	O
presence	O
of	O
dioleoylphosphatidylserine	O
stimulated	O
the	O
autophosphorylation	O
of	O
PKD2	B
in	O
a	O
synergistic	O
fashion	O
.	O

Phorbol	O
esters	O
also	O
stimulated	O
autophosphorylation	O
of	O
PKD2	B
in	O
intact	O
cells	O
.	O

PKD2	B
activated	O
by	O
phorbol	O
esters	O
efficiently	O
phosphorylated	O
the	O
exogenous	O
substrate	O
histone	O
H1	O
.	O

In	O
addition	O
,	O
we	O
could	O
identify	O
the	O
C	O
-	O
terminal	O
Ser	O
(	O
876	O
)	O
residue	O
as	O
an	O
in	O
vivo	O
phosphorylation	O
site	O
within	O
PKD2	B
.	O

Phosphorylation	O
of	O
Ser	O
(	O
876	O
)	O
of	O
PKD2	B
correlated	O
with	O
the	O
activation	O
status	O
of	O
the	O
kinase	O
.	O

Finally	O
,	O
gastrin	B
was	O
found	O
to	O
be	O
a	O
physiological	O
activator	O
of	O
PKD2	B
in	O
human	O
AGS	O
-	O
B	O
cells	O
stably	O
transfected	O
with	O
the	O
CCK	B
(	I
B	I
)	I
/	O
gastrin	B
receptor	I
.	O

Thus	O
,	O
PKD2	B
is	O
a	O
novel	O
phorbol	O
ester-	O
and	O
growth	O
factor	O
-	O
stimulated	O
protein	O
kinase	O
.	O

FIF	B
[	O
fibroblast	B
growth	I
factor-2	I
(	I
FGF-2	I
)	I
-interacting	I
-	I
factor	I
]	O
,	O
a	O
nuclear	O
putatively	O
antiapoptotic	O
factor	O
,	O
interacts	O
specifically	O
with	O
FGF-2	B
.	O

Numerous	O
evidence	O
indicates	O
that	O
some	O
of	O
the	O
activities	O
of	O
fibroblast	B
growth	I
factor	I
2	I
(	O
FGF-2	B
)	O
depend	O
on	O
an	O
intracrine	O
mode	O
of	O
action	O
.	O

Recently	O
,	O
we	O
showed	O
that	O
three	O
high	O
molecular	O
mass	O
(	O
HMM	O
)	O
nuclear	O
forms	O
of	O
FGF-2	B
are	O
part	O
of	O
a	O
320-kDa	O
protein	O
complex	O
while	O
the	O
cytoplasmic	O
AUG	O
-	O
initiated	O
form	O
is	O
included	O
in	O
a	O
130-kDa	O
complex	O
.	O

Consequently	O
,	O
the	O
characterization	O
of	O
FGF	B
endogenous	O
targets	O
has	O
become	O
crucial	O
to	O
allow	O
the	O
elucidation	O
of	O
their	O
endogenous	O
activities	O
.	O

Through	O
the	O
screening	O
of	O
GAL4-based	O
yeast	O
two	O
-	O
hybrid	O
expression	O
libraries	O
,	O
we	O
have	O
isolated	O
a	O
gene	O
encoding	O
a	O
nuclear	O
protein	O
of	O
55	O
kDa	O
,	O
FIF	B
(	O
FGF-2-interacting	B
-	I
factor	I
)	O
,	O
which	O
interacts	O
specifically	O
with	O
FGF-2	B
but	O
not	O
with	O
FGF-1	B
,	O
FGF-3	B
,	O
or	O
FGF-6	B
.	O

In	O
this	O
system	O
,	O
FIF	B
interacts	O
equally	O
well	O
with	O
the	O
NH2-extended	O
24-kDa	O
FGF	B
form	O
as	O
with	O
the	O
18-kDa	O
form	O
,	O
indicating	O
that	O
the	O
FIF	B
-	O
binding	O
motif	O
is	O
located	O
in	O
the	O
last	O
155	O
amino	O
acids	O
of	O
FGF-2	B
.	O

Nevertheless	O
,	O
coimmunoprecipitation	O
experiments	O
showed	O
an	O
exclusive	O
association	O
with	O
HMM	O
FGF-2	B
.	O

The	O
predicted	O
protein	O
contains	O
a	O
canonical	O
leucine	O
zipper	O
domain	O
and	O
three	O
overlapping	O
hydrophobic	O
heptad	O
repeats	O
.	O

The	O
region	O
spanning	O
these	O
repeats	O
is	O
,	O
together	O
with	O
a	O
region	O
located	O
in	O
the	O
N	O
-	O
terminal	O
part	O
of	O
the	O
FIF	B
protein	O
,	O
implicated	O
in	O
the	O
binding	O
to	O
FGF-2	B
.	O

In	O
contrast	O
to	O
the	O
full	O
-	O
length	O
FIF	B
protein	O
,	O
several	O
deletion	O
constructs	O
were	O
able	O
to	O
transactivate	O
a	O
lac	O
-	O
Z	O
reporter	O
gene	O
.	O

Furthermore	O
,	O
the	O
COOH	O
-	O
terminal	O
part	O
,	O
but	O
not	O
the	O
full	O
-	O
length	O
FIF	B
protein	O
,	O
has	O
previously	O
been	O
shown	O
to	O
exhibit	O
antiapoptotic	O
properties	O
.	O

Thus	O
we	O
discuss	O
the	O
possibility	O
that	O
these	O
activities	O
could	O
reflect	O
a	O
physiological	O
function	O
of	O
FIF	B
through	O
its	O
interaction	O
with	O
FGF-2	B
.	O

Human	B
orthologs	I
of	I
yeast	I
vacuolar	I
protein	I
sorting	I
proteins	I
Vps26	I
,	I
29	I
,	I
and	I
35	I
:	O
assembly	O
into	O
multimeric	O
complexes	O
.	O

Sorting	B
nexin	I
(	I
SNX	I
)	I
1	I
and	O
SNX2	B
are	O
mammalian	O
orthologs	O
of	O
Vps5p	O
,	O
a	O
yeast	O
protein	O
that	O
is	O
a	O
subunit	O
of	O
a	O
large	O
multimeric	O
complex	O
,	O
termed	O
the	O
retromer	B
complex	O
,	O
involved	O
in	O
retrograde	O
transport	O
of	O
proteins	O
from	O
endosomes	O
to	O
the	O
trans	O
-	O
Golgi	O
network	O
.	O

We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
human	B
orthologs	I
of	I
three	I
additional	I
components	I
of	I
the	I
complex	I
:	I
Vps26p	I
,	I
Vps29p	I
,	I
and	I
Vps35p	I
.	O

The	O
close	O
structural	O
similarity	O
between	O
the	O
yeast	O
and	O
human	O
proteins	O
suggests	O
a	O
similarity	O
in	O
function	O
.	O

We	O
used	O
both	O
yeast	O
two	O
-	O
hybrid	O
assays	O
and	O
expression	O
in	O
mammalian	O
cells	O
to	O
define	O
the	O
binding	O
interactions	O
among	O
these	O
proteins	O
.	O

The	O
data	O
suggest	O
a	O
model	O
in	O
which	O
hVps35	B
serves	O
as	O
the	O
core	O
of	O
a	O
multimeric	O
complex	O
by	O
binding	O
directly	O
to	O
hVps26	B
,	O
hVps29	B
,	O
and	O
SNX1	B
.	O

Deletional	O
analyses	O
of	O
hVps35	B
demonstrate	O
that	O
amino	O
acid	O
residues	O
1	O
-	O
53	O
and	O
307	O
-	O
796	O
of	O
hVps35	B
bind	O
to	O
the	O
coiled	O
coil	O
-	O
containing	O
domain	O
of	O
SNX1	B
.	O

In	O
contrast	O
,	O
hVps26	B
binds	O
to	O
amino	O
acid	O
residues	O
1	O
-	O
172	O
of	O
hVps35	B
,	O
whereas	O
hVps29	B
binds	O
to	O
amino	O
acid	O
residues	O
307	O
-	O
796	O
of	O
hVps35	B
.	O

Furthermore	O
,	O
hVps35	B
,	O
hVps29	B
,	O
and	O
hVps26	B
have	O
been	O
found	O
in	O
membrane	O
-	O
associated	O
and	O
cytosolic	O
compartments	O
.	O

Gel	O
filtration	O
chromatography	O
of	O
COS7	O
cell	O
cytosol	O
showed	O
that	O
both	O
recombinant	O
and	O
endogenous	O
hVps35	B
,	O
hVps29	B
,	O
and	O
hVps26	B
coelute	O
as	O
a	O
large	O
complex	O
(	O
approximately	O
220	O
-	O
440	O
kDa	O
)	O
.	O

In	O
the	O
absence	O
of	O
hVps35	B
,	O
neither	O
hVps26	B
nor	O
hVps29	B
is	O
found	O
in	O
the	O
large	O
complex	O
.	O

These	O
data	O
provide	O
the	O
first	O
insights	O
into	O
the	O
binding	O
interactions	O
among	O
subunits	O
of	O
a	O
putative	O
mammalian	O
retromer	B
complex	O
.	O

Characterization	O
of	O
human	O
sialoadhesin	B
,	O
a	O
sialic	O
acid	O
binding	O
receptor	O
expressed	O
by	O
resident	O
and	O
inflammatory	O
macrophage	O
populations	O
.	O

Sialoadhesin	B
is	O
a	O
macrophage	O
-	O
restricted	O
cellular	O
interaction	O
molecule	O
and	O
a	O
prototypic	O
member	O
of	O
the	O
Siglec	O
family	O
of	O
sialic	O
acid	O
binding	O
immunoglobulin	O
(	O
Ig	O
)	O
-like	O
lectins	O
.	O

So	O
far	O
,	O
it	O
has	O
only	O
been	O
characterized	O
in	O
rodents	O
.	O

Here	O
,	O
we	O
report	O
the	O
molecular	O
cloning	O
,	O
binding	O
properties	O
,	O
and	O
expression	O
pattern	O
of	O
human	O
sialoadhesin	B
.	O

The	O
predicted	O
protein	O
sequences	O
of	O
human	O
and	O
mouse	O
sialoadhesin	B
are	O
about	O
72	O
%	O
identical	O
,	O
with	O
the	O
greatest	O
similarity	O
in	O
the	O
extracellular	O
region	O
,	O
which	O
comprises	O
17	O
Ig	O
domains	O
in	O
both	O
species	O
.	O

A	O
recombinant	O
protein	O
consisting	O
of	O
the	O
first	O
4	O
N	O
-	O
terminal	O
domains	O
of	O
human	O
sialoadhesin	B
fused	O
to	O
the	O
Fc	O
region	O
of	O
human	O
IgG1	O
mediated	O
sialic	O
acid	O
-	O
dependent	O
binding	O
with	O
a	O
specificity	O
similar	O
to	O
its	O
mouse	O
counterpart	O
,	O
preferring	O
sialic	O
acid	O
in	O
the	O
alpha2,3	O
glycosidic	O
linkage	O
over	O
the	O
alpha2,6	O
linkage	O
.	O

By	O
flow	O
cytometry	O
with	O
peripheral	O
blood	O
leukocytes	O
,	O
recombinant	O
sialoadhesin	B
bound	O
strongly	O
to	O
granulocytes	O
with	O
intermediate	O
binding	O
to	O
monocytes	O
,	O
natural	O
killer	O
cells	O
,	O
B	O
cells	O
,	O
and	O
a	O
subset	O
of	O
CD8	O
T	O
cells	O
.	O

Using	O
antibodies	O
raised	O
to	O
the	O
recombinant	O
protein	O
,	O
sialoadhesin	B
was	O
immunoprecipitated	O
from	O
the	O
THP-1	O
human	O
monocytic	O
cell	O
line	O
as	O
an	O
approximate	O
200-kd	O
glycoprotein	O
.	O

The	O
expression	O
pattern	O
of	O
human	O
sialoadhesin	B
was	O
found	O
to	O
be	O
similar	O
to	O
that	O
of	O
the	O
mouse	O
receptor	O
,	O
being	O
absent	O
from	O
monocytes	O
and	O
other	O
peripheral	O
blood	O
leukocytes	O
,	O
but	O
expressed	O
strongly	O
by	O
tissue	O
macrophages	O
in	O
the	O
spleen	O
,	O
lymph	O
node	O
,	O
bone	O
marrow	O
,	O
liver	O
,	O
colon	O
,	O
and	O
lungs	O
.	O

High	O
expression	O
was	O
also	O
found	O
on	O
inflammatory	O
macrophages	O
present	O
in	O
affected	O
tissues	O
from	O
patients	O
with	O
rheumatoid	O
arthritis	O
.	O

Identification	O
of	O
two	O
novel	O
transmembrane	O
gamma	O
-	O
carboxyglutamic	O
acid	O
proteins	O
expressed	O
broadly	O
in	O
fetal	O
and	O
adult	O
tissues	O
.	O

The	O
proline	B
-	I
rich	I
gamma	I
-	I
carboxyglutamic	I
acid	I
(	I
Gla	I
)	I
proteins	I
(	I
PRGPs	I
)	I
1	I
and	I
2	I
are	O
the	O
founding	O
members	O
of	O
a	O
family	O
of	O
vitamin	O
K	O
-	O
dependent	O
single	O
-	O
pass	O
integral	O
membrane	O
proteins	O
characterized	O
by	O
an	O
extracellular	O
amino	O
terminal	O
domain	O
of	O
approximately	O
45	O
amino	O
acids	O
that	O
is	O
rich	O
in	O
Gla	O
.	O

The	O
intracellular	O
carboxyl	O
terminal	O
region	O
of	O
these	O
two	O
proteins	O
contains	O
one	O
or	O
two	O
copies	O
of	O
the	O
sequence	O
PPXY	O
,	O
a	O
motif	O
present	O
in	O
a	O
variety	O
of	O
proteins	O
involved	O
in	O
such	O
diverse	O
cellular	O
functions	O
as	O
signal	O
transduction	O
,	O
cell	O
cycle	O
progression	O
,	O
and	O
protein	O
turnover	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
cloning	O
of	O
the	O
cDNAs	O
for	O
two	O
additional	O
human	O
transmembrane	O
Gla	O
proteins	O
(	O
TMG	B
)	O
of	O
20	O
-	O
24	O
kDa	O
named	O
TMG3	B
and	O
TMG4	B
.	O

These	O
two	O
proteins	O
possess	O
extracellular	O
Gla	O
domains	O
with	O
13	O
or	O
9	O
potential	O
Gla	O
residues	O
,	O
respectively	O
,	O
followed	O
by	O
membrane	O
-	O
spanning	O
hydrophobic	O
regions	O
and	O
cytoplasmic	O
carboxyl	O
terminal	O
regions	O
that	O
contain	O
PPXY	O
motifs	O
.	O

This	O
emerging	O
family	O
of	O
integral	O
membrane	O
Gla	O
proteins	O
includes	O
proline	B
-	I
rich	I
Gla	I
protein	I
(	I
PRGP	I
)	I
1	I
,	O
PRGP2	B
,	O
TMG3	B
,	O
and	O
TMG4	B
,	O
all	O
of	O
which	O
are	O
characterized	O
by	O
broad	O
and	O
variable	O
distribution	O
in	O
both	O
fetal	O
and	O
adult	O
tissues	O
.	O

Members	O
of	O
this	O
family	O
can	O
be	O
grouped	O
into	O
two	O
subclasses	O
on	O
the	O
basis	O
of	O
their	O
gene	O
organization	O
and	O
amino	O
acid	O
sequence	O
.	O

These	O
observations	O
suggest	O
novel	O
physiological	O
functions	O
for	O
vitamin	O
K	O
beyond	O
its	O
known	O
role	O
in	O
the	O
biosynthesis	O
of	O
proteins	O
involved	O
in	O
blood	O
coagulation	O
and	O
bone	O
development	O
.	O

The	O
identification	O
and	O
characterization	O
of	O
these	O
proteins	O
may	O
allow	O
a	O
more	O
complete	O
understanding	O
of	O
the	O
teratogenic	O
consequences	O
of	O
exposure	O
in	O
utero	O
to	O
vitamin	O
K	O
antagonists	O
,	O
such	O
as	O
warfarin	O
-	O
based	O
anticoagulants	O
.	O

Functional	O
characterization	O
of	O
novel	O
human	O
ARFGAP3	B
.	O

ADP	O
ribosylation	O
factors	O
(	O
ARFs	O
)	O
are	O
critical	O
in	O
the	O
vesicular	O
trafficking	O
pathway	O
.	O

ARF	B
activity	O
is	O
controlled	O
by	O
GTPase	O
-	O
activating	O
proteins	O
(	O
GAPs	O
)	O
.	O

We	O
have	O
identified	O
recently	O
a	O
novel	O
tentative	O
ARF	B
GAP	O
derived	O
from	O
human	O
fetal	O
liver	O
,	O
ARFGAP3	B
(	O
originally	O
named	O
as	O
ARFGAP1	B
)	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrated	O
that	O
ARFGAP3	B
had	O
GAP	O
activity	O
in	O
vitro	O
and	O
remarked	O
that	O
the	O
GAP	O
activity	O
of	O
ARFGAP3	B
was	O
regulated	O
by	O
phospholipids	O
,	O
i.e.	O
phosphatidylinositol	O
4,5-diphosphate	O
as	O
agonist	O
and	O
phosphatidylcholine	O
as	O
antagonist	O
.	O

ARFGAP3	B
is	O
a	O
predominantly	O
cytosolic	O
protein	O
,	O
and	O
concentrated	O
in	O
the	O
perinuclear	O
region	O
.	O

Its	O
transient	O
ectopic	O
overexpression	O
in	O
cultured	O
mammalian	O
cells	O
reduced	O
the	O
constitutive	O
secretion	O
of	O
secreted	O
alkaline	O
phosphatase	O
,	O
indicating	O
that	O
ectopic	O
overexpression	O
of	O
ARFGAP3	B
inhibits	O
the	O
early	O
secretory	O
pathway	O
of	O
proteins	O
in	O
vivo	O
.	O

These	O
results	O
demonstrated	O
that	O
ARFGAP3	B
is	O
a	O
novel	O
GAP	O
for	O
ARF1	B
and	O
might	O
be	O
involved	O
in	O
intracellular	O
traffic	O
of	O
proteins	O
and	O
vesicular	O
transport	O
as	O
predicted	O
.	O

Identification	O
of	O
the	O
platelet	B
ADP	I
receptor	I
targeted	O
by	O
antithrombotic	O
drugs	O
.	O

Platelets	O
have	O
a	O
crucial	O
role	O
in	O
the	O
maintenance	O
of	O
normal	O
haemostasis	O
,	O
and	O
perturbations	O
of	O
this	O
system	O
can	O
lead	O
to	O
pathological	O
thrombus	O
formation	O
and	O
vascular	O
occlusion	O
,	O
resulting	O
in	O
stroke	O
,	O
myocardial	O
infarction	O
and	O
unstable	O
angina	O
.	O

ADP	O
released	O
from	O
damaged	O
vessels	O
and	O
red	O
blood	O
cells	O
induces	O
platelet	O
aggregation	O
through	O
activation	O
of	O
the	O
integrin	O
GPIIb	O
-	O
IIIa	O
and	O
subsequent	O
binding	O
of	O
fibrinogen	O
.	O

ADP	O
is	O
also	O
secreted	O
from	O
platelets	O
on	O
activation	O
,	O
providing	O
positive	O
feedback	O
that	O
potentiates	O
the	O
actions	O
of	O
many	O
platelet	O
activators	O
.	O

ADP	O
mediates	O
platelet	O
aggregation	O
through	O
its	O
action	O
on	O
two	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
subtypes	O
.	O

The	O
P2Y1	B
receptor	I
couples	O
to	O
Gq	O
and	O
mobilizes	O
intracellular	O
calcium	O
ions	O
to	O
mediate	O
platelet	O
shape	O
change	O
and	O
aggregation	O
.	O

The	O
second	O
ADP	O
receptor	O
required	O
for	O
aggregation	O
(	O
variously	O
called	O
P2Y	B
(	I
ADP	I
)	I
,	O
P2Y	B
(	I
AC	I
)	I
,	O
P2Ycyc	B
or	O
P2T	B
(	I
AC	I
)	I
)	O
is	O
coupled	O
to	O
the	O
inhibition	O
of	O
adenylyl	O
cyclase	O
through	O
Gi	B
.	O

The	O
molecular	O
identity	O
of	O
the	O
Gi	B
-	O
linked	O
receptor	O
is	O
still	O
elusive	O
,	O
even	O
though	O
it	O
is	O
the	O
target	O
of	O
efficacious	O
antithrombotic	O
agents	O
,	O
such	O
as	O
ticlopidine	O
and	O
clopidogrel	O
and	O
AR	O
-	O
C66096	O
(	O
ref	O
.	O

9	O
)	O
.	O

Here	O
we	O
describe	O
the	O
cloning	O
of	O
this	O
receptor	O
,	O
designated	O
P2Y12	B
,	O
and	O
provide	O
evidence	O
that	O
a	O
patient	O
with	O
a	O
bleeding	O
disorder	O
has	O
a	O
defect	O
in	O
this	O
gene	O
.	O

Cloning	O
of	O
the	O
P2Y12	B
receptor	O
should	O
facilitate	O
the	O
development	O
of	O
better	O
antiplatelet	O
agents	O
to	O
treat	O
cardiovascular	O
diseases	O
.	O

ULBPs	O
,	O
novel	O
MHC	O
class	O
I	O
-	O
related	O
molecules	O
,	O
bind	O
to	O
CMV	O
glycoprotein	O
UL16	O
and	O
stimulate	O
NK	O
cytotoxicity	O
through	O
the	O
NKG2D	B
receptor	I
.	O

The	O
human	O
cytomegalovirus	O
glycoprotein	O
,	O
UL16	O
,	O
binds	O
to	O
two	O
members	O
of	O
a	O
novel	O
family	O
of	O
molecules	O
,	O
the	O
ULBPs	O
,	O
and	O
to	O
the	O
MHC	O
class	O
I	O
homolog	O
,	O
MICB	B
.	O

The	O
ULBPs	O
are	O
GPI	O
-	O
linked	O
glycoproteins	O
belonging	O
to	O
the	O
extended	O
MHC	O
class	O
I	O
family	O
but	O
are	O
only	O
distantly	O
related	O
to	O
MICB	B
.	O

The	O
ULBP	O
and	O
MICB	B
molecules	O
are	O
ligands	O
for	O
the	O
activating	O
receptor	O
,	O
NKG2D	B
/	O
DAP10	B
,	O
and	O
this	O
interaction	O
is	O
blocked	O
by	O
a	O
soluble	O
form	O
of	O
UL16	O
.	O

The	O
ULBPs	O
stimulate	O
cytokine	O
and	O
chemokine	O
production	O
from	O
NK	O
cells	O
,	O
and	O
expression	O
of	O
ULBPs	O
in	O
NK	O
cell	O
-	O
resistant	O
target	O
cells	O
confers	O
susceptibility	O
to	O
NK	O
cell	O
cytotoxicity	O
.	O

Masking	O
of	O
NK	O
cell	O
recognition	O
of	O
ULBP	O
or	O
MIC	O
antigens	O
by	O
UL16	O
provides	O
a	O
potential	O
mechanism	O
by	O
which	O
human	O
cytomegalovirus	O
-	O
infected	O
cells	O
might	O
evade	O
attack	O
by	O
the	O
immune	O
system	O
.	O

Molecular	O
cloning	O
and	O
mapping	O
of	O
the	O
human	O
nicotinic	B
acetylcholine	I
receptor	I
alpha10	I
(	O
CHRNA10	B
)	O
.	O

We	O
report	O
the	O
isolation	O
and	O
initial	O
characterization	O
of	O
a	O
new	O
member	O
of	O
the	O
human	O
nicotinic	O
acetylcholine	O
receptor	O
(	O
nAChR	O
)	O
subunit	O
family	O
,	O
alpha10	O
(	O
CHRNA10	B
)	O
,	O
from	O
both	O
inner	O
-	O
ear	O
neuroepithelium	O
and	O
lymphoid	O
tissue	O
.	O

The	O
cDNA	O
is	O
1959	O
nucleotides	O
in	O
length	O
,	O
with	O
a	O
coding	O
region	O
predicting	O
a	O
protein	O
of	O
451	O
amino	O
acids	O
that	O
is	O
90	O
%	O
identical	O
to	O
rat	O
alpha10	O
.	O

The	O
alpha10	O
gene	O
was	O
localized	O
to	O
chromosome	O
11p15.5	O
.	O

Human	O
alpha10	O
was	O
detected	O
in	O
human	O
inner	O
-	O
ear	O
tissue	O
,	O
tonsil	O
,	O
immortalized	O
B	O
-	O
cells	O
,	O
cultured	O
T	O
-	O
cells	O
and	O
peripheral	O
blood	O
lymphocytes	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
,	O
Northern	O
blot	O
hybridization	O
,	O
and	O
immunohistochemistry	O
.	O

We	O
also	O
detected	O
the	O
expression	O
of	O
the	O
human	O
nAChR	B
alpha9	I
(	O
CHRNA9	B
)	O
mRNA	O
in	O
these	O
same	O
tissues	O
using	O
RT	O
-	O
PCR	O
and	O
Northern	O
blot	O
hybridization	O
.	O

Large	O
-	O
scale	O
identification	O
of	O
mammalian	O
proteins	O
localized	O
to	O
nuclear	O
sub	O
-	O
compartments	O
.	O

Many	O
nuclear	O
components	O
participating	O
in	O
related	O
pathways	O
appear	O
concentrated	O
in	O
specific	O
areas	O
of	O
the	O
mammalian	O
nucleus	O
.	O

The	O
importance	O
of	O
this	O
organization	O
is	O
attested	O
to	O
by	O
the	O
dysfunction	O
that	O
correlates	O
with	O
mis	O
-	O
localization	O
of	O
nuclear	O
proteins	O
in	O
human	O
disease	O
and	O
cancer	O
.	O

Determining	O
the	O
sub	O
-	O
nuclear	O
localization	O
of	O
proteins	O
is	O
therefore	O
important	O
for	O
understanding	O
genome	O
regulation	O
and	O
function	O
,	O
and	O
it	O
also	O
provides	O
clues	O
to	O
function	O
for	O
novel	O
proteins	O
.	O

However	O
,	O
the	O
complexity	O
of	O
proteins	O
in	O
the	O
mammalian	O
nucleus	O
is	O
too	O
large	O
to	O
tackle	O
this	O
on	O
a	O
protein	O
by	O
protein	O
basis	O
.	O

Large	O
-	O
scale	O
approaches	O
to	O
determining	O
protein	O
function	O
and	O
sub	O
-	O
cellular	O
localization	O
are	O
required	O
.	O

We	O
have	O
used	O
a	O
visual	O
gene	O
trap	O
screen	O
to	O
identify	O
more	O
than	O
100	O
proteins	O
,	O
many	O
of	O
which	O
are	O
normal	O
,	O
located	O
within	O
compartments	O
of	O
the	O
mouse	O
nucleus	O
.	O

The	O
most	O
common	O
discrete	O
localizations	O
detected	O
are	O
at	O
the	O
nucleolus	O
and	O
the	O
splicing	O
speckles	O
and	O
on	O
chromosomes	O
.	O

Proteins	O
at	O
the	O
nuclear	O
periphery	O
,	O
or	O
in	O
other	O
nuclear	O
foci	O
,	O
have	O
also	O
been	O
identified	O
.	O

Several	O
of	O
the	O
proteins	O
have	O
been	O
implicated	O
in	O
human	O
disease	O
or	O
cancer	O
,	O
e.g.	O
ATRX	B
,	O
HMGI	B
-	I
C	I
,	O
NBS1	B
and	O
EWS	B
,	O
and	O
the	O
gene	O
-	O
trapped	O
proteins	O
provide	O
a	O
route	O
into	O
further	O
understanding	O
their	O
function	O
.	O

We	O
find	O
that	O
sequence	O
motifs	O
are	O
often	O
shared	O
amongst	O
proteins	O
co	O
-	O
localized	O
within	O
the	O
same	O
sub	O
-	O
nuclear	O
compartment	O
.	O

Conversely	O
,	O
some	O
generally	O
abundant	O
motifs	O
are	O
lacking	O
from	O
the	O
proteins	O
concentrated	O
in	O
specific	O
areas	O
of	O
the	O
nucleus	O
.	O

This	O
suggests	O
that	O
we	O
may	O
be	O
able	O
to	O
predict	O
sub	O
-	O
nuclear	O
localization	O
for	O
proteins	O
in	O
databases	O
based	O
on	O
their	O
sequence	O
.	O

CHMP1	B
is	O
a	O
novel	O
nuclear	O
matrix	O
protein	O
affecting	O
chromatin	O
structure	O
and	O
cell	O
-	O
cycle	O
progression	O
.	O

The	O
Polycomb	O
-	O
group	O
(	O
PcG	O
)	O
is	O
a	O
diverse	O
set	O
of	O
proteins	O
required	O
for	O
maintenance	O
of	O
gene	O
silencing	O
during	O
development	O
.	O

In	O
a	O
screen	O
for	O
conserved	O
partners	O
of	O
the	O
PcG	O
protein	O
Polycomblike	B
(	O
Pcl	B
)	O
,	O
we	O
have	O
identified	O
a	O
new	O
protein	O
,	O
human	O
CHMP1	B
(	O
CHromatin	O
Modifying	O
Protein	O
;	O
CHarged	O
Multivesicular	O
body	O
Protein	O
)	O
,	O
which	O
is	O
encoded	O
by	O
an	O
alternative	O
open	O
reading	O
frame	O
in	O
the	O
PRSM1	B
gene	O
and	O
is	O
conserved	O
in	O
both	O
complex	O
and	O
simple	O
eukaryotes	O
.	O

CHMP1	B
contains	O
a	O
predicted	O
bipartite	O
nuclear	O
localization	O
signal	O
and	O
distributes	O
as	O
distinct	O
forms	O
to	O
the	O
cytoplasm	O
and	O
the	O
nuclear	O
matrix	O
in	O
all	O
cell	O
lines	O
tested	O
.	O

We	O
have	O
constructed	O
a	O
stable	O
HEK293	O
cell	O
line	O
that	O
inducibly	O
overexpresses	O
CHMP1	B
under	O
ecdysone	O
control	O
.	O

Overexpressed	O
CHMP1	B
localizes	O
to	O
a	O
punctate	O
subnuclear	O
pattern	O
,	O
encapsulating	O
regions	O
of	O
nuclease	O
-	O
resistant	O
,	O
condensed	O
chromatin	O
.	O

These	O
novel	O
structures	O
are	O
also	O
frequently	O
surrounded	O
by	O
increased	O
histone	O
H3	O
phosphorylation	O
and	O
acetylation	O
.	O

CHMP1	B
can	O
recruit	O
a	O
PcG	O
protein	O
,	O
BMI1	B
,	O
to	O
these	O
regions	O
of	O
condensed	O
chromatin	O
and	O
can	O
cooperate	O
with	O
co	O
-	O
expressed	O
vertebrate	O
Pcl	B
in	O
a	O
Xenopus	O
embryo	O
PcG	O
assay	O
;	O
this	O
is	O
consistent	O
with	O
a	O
role	O
in	O
PcG	O
function	O
.	O

In	O
combination	O
,	O
these	O
observations	O
suggest	O
that	O
CHMP1	B
plays	O
a	O
role	O
in	O
stable	O
gene	O
silencing	O
within	O
the	O
nucleus	O
.	O

The	O
p53	B
family	O
member	O
genes	O
are	O
involved	O
in	O
the	O
Notch	O
signal	O
pathway	O
.	O

The	O
p53	B
tumor	O
suppressor	O
is	O
a	O
transcription	O
factor	O
that	O
regulates	O
cell	O
growth	O
and	O
death	O
in	O
response	O
to	O
environmental	O
stimuli	O
such	O
as	O
DNA	O
damage	O
.	O

p63	B
/	O
p51	B
and	O
p73	B
were	O
recently	O
identified	O
as	O
members	O
of	O
the	O
p53	B
gene	O
family	O
.	O

In	O
contrast	O
to	O
p53	B
however	O
,	O
p63	B
and	O
p73	B
are	O
rarely	O
mutated	O
in	O
human	O
cancers	O
.	O

Mice	O
that	O
lack	O
p53	B
are	O
developmentally	O
normal	O
,	O
while	O
p63	B
and	O
p73	B
appear	O
to	O
play	O
critical	O
roles	O
in	O
normal	O
development	O
.	O

To	O
determine	O
how	O
p63	B
and	O
p73	B
are	O
involved	O
in	O
normal	O
development	O
,	O
we	O
attempted	O
to	O
identify	O
target	O
genes	O
that	O
are	O
specifically	O
regulated	O
by	O
p63	B
and/or	O
p73	B
but	O
not	O
by	O
p53	B
.	O

We	O
found	O
that	O
the	O
Jagged1	B
(	O
JAG1	B
)	O
and	O
Jagged2	B
(	O
JAG2	B
)	O
genes	O
,	O
encoding	O
ligands	O
for	O
the	O
Notch	O
receptors	O
,	O
are	O
up	O
-	O
regulated	O
by	O
p63	B
and	O
p73	B
.	O

Furthermore	O
,	O
we	O
identified	O
a	O
p63-binding	B
site	O
in	O
the	O
second	O
intron	O
of	O
the	O
JAG1	B
gene	O
,	O
which	O
can	O
directly	O
interact	O
with	O
the	O
p63	B
protein	I
in	O
vivo	O
,	O
as	O
assessed	O
by	O
a	O
chromatin	O
immunoprecipitation	O
assay	O
.	O

A	O
heterologous	O
reporter	O
assay	O
revealed	O
that	O
this	O
p63-binding	B
site	O
is	O
a	O
functional	O
response	O
element	O
and	O
is	O
specific	O
for	O
p63	B
.	O

We	O
also	O
found	O
a	O
target	O
of	O
Notch	O
signaling	O
,	O
HES-1	B
was	O
up	O
-	O
regulated	O
in	O
Jurkat	O
cells	O
,	O
in	O
which	O
Notch1	B
is	O
highly	O
expressed	O
,	O
when	O
co	O
-	O
cultured	O
with	O
p63-transfected	B
cells	O
,	O
suggesting	O
that	O
p63	B
can	O
trigger	O
the	O
Notch	O
signal	O
pathway	O
in	O
neighboring	O
cells	O
.	O

Our	O
findings	O
show	O
an	O
association	O
between	O
the	O
p53	B
family	O
genes	O
and	O
Notch	O
signaling	O
and	O
suggest	O
a	O
potential	O
molecular	O
mechanism	O
for	O
the	O
involvement	O
of	O
the	O
p53	B
family	O
genes	O
in	O
normal	O
development	O
.	O

Activation	O
of	O
NK	O
cell	O
-	O
mediated	O
cytotoxicity	O
by	O
a	O
SAP	B
-	O
independent	O
receptor	O
of	O
the	O
CD2	O
family	O
.	O

Some	O
CD2	O
family	O
receptors	O
stimulate	O
NK	O
cell	O
-	O
mediated	O
cytotoxicity	O
through	O
a	O
signaling	O
pathway	O
,	O
which	O
is	O
dependent	O
on	O
the	O
recruitment	O
of	O
an	O
adapter	O
protein	O
called	O
SLAM	B
-	I
associated	I
protein	I
(	O
SAP	B
)	O
.	O

In	O
this	O
work	O
we	O
identify	O
a	O
novel	O
leukocyte	O
cell	O
surface	O
receptor	O
of	O
the	O
CD2	O
family	O
called	O
CD2-like	B
receptor	I
activating	I
cytotoxic	I
cells	I
(	O
CRACC	B
)	O
.	O

CRACC	B
is	O
expressed	O
on	O
cytotoxic	O
lymphocytes	O
,	O
activated	O
B	O
cells	O
,	O
and	O
mature	O
dendritic	O
cells	O
,	O
and	O
activates	O
NK	O
cell	O
-	O
mediated	O
cytotoxicity	O
.	O

Remarkably	O
,	O
although	O
CRACC	B
displays	O
cytoplasmic	O
motifs	O
similar	O
to	O
those	O
recruiting	O
SAP	B
,	O
CRACC	B
-	O
mediated	O
cytotoxicity	O
occurs	O
in	O
the	O
absence	O
of	O
SAP	B
and	O
requires	O
activation	O
of	O
extracellular	B
signal	I
-	I
regulated	I
kinases-1	I
/	I
2	I
.	O

Thus	O
,	O
CRACC	B
is	O
a	O
unique	O
CD2-like	O
receptor	O
which	O
mediates	O
NK	O
cell	O
activation	O
through	O
a	O
SAP	B
-	O
independent	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
-	O
mediated	O
pathway	O
.	O

FENS-1	B
and	O
DFCP1	B
are	O
FYVE	O
domain	O
-	O
containing	O
proteins	O
with	O
distinct	O
functions	O
in	O
the	O
endosomal	O
and	O
Golgi	O
compartments	O
.	O

FENS-1	B
and	O
DFCP1	B
are	O
recently	O
discovered	O
proteins	O
containing	O
one	O
or	O
two	O
FYVE	O
-	O
domains	O
respectively	O
.	O

We	O
show	O
that	O
the	O
FYVE	O
domains	O
in	O
these	O
proteins	O
can	O
bind	O
PtdIns3P	O
in	O
vitro	O
with	O
high	O
specificity	O
over	O
other	O
phosphoinositides	O
.	O

Exogenously	O
expressed	O
FENS-1	B
localises	O
to	O
early	O
endosomes	O
:	O
this	O
localisation	O
requires	O
an	O
intact	O
FYVE	O
domain	O
and	O
is	O
sensitive	O
to	O
wortmannin	O
inhibition	O
.	O

The	O
isolated	O
FYVE	O
domain	O
of	O
FENS-1	B
also	O
localises	O
to	O
endosomes	O
.	O

These	O
results	O
are	O
consistent	O
with	O
current	O
models	O
of	O
FYVE	O
-	O
domain	O
function	O
in	O
this	O
cellular	O
compartment	O
.	O

By	O
contrast	O
,	O
exogenously	O
expressed	O
DFCP1	B
displays	O
a	O
predominantly	O
Golgi	O
,	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
and	O
vesicular	O
distribution	O
with	O
little	O
or	O
no	O
overlap	O
with	O
FENS-1	B
or	O
other	O
endosomal	O
markers	O
.	O

Overexpression	O
of	O
DFCP1	B
was	O
found	O
to	O
cause	O
dispersal	O
of	O
the	O
Golgi	O
compartment	O
defined	O
by	O
giantin	B
and	O
gpp130-staining	B
.	O

Disruption	O
of	O
the	O
FYVE	O
domains	O
of	O
DFCP1	B
causes	O
a	O
shift	O
to	O
more	O
condensed	O
and	O
compact	O
Golgi	O
structures	O
and	O
overexpression	O
of	O
this	O
mutant	O
was	O
found	O
to	O
confer	O
significant	O
protection	O
to	O
the	O
Golgi	O
against	O
brefeldin	O
-	O
induced	O
dispersal	O
.	O

These	O
properties	O
of	O
DFCP1	B
are	O
surprising	O
,	O
and	O
suggest	O
FYVE	O
domain	O
-	O
localisation	O
and	O
function	O
may	O
not	O
be	O
exclusively	O
endosomal	O
.	O

Movies	O
available	O
on	O
-	O
line	O

Identification	O
of	O
human	O
CD93	B
as	O
the	O
phagocytic	B
C1q	I
receptor	I
(	O
C1qRp	B
)	O
by	O
expression	O
cloning	O
.	O

CD93	B
is	O
a	O
approximately	O
120	O
kDa	O
O	O
-	O
sialoglycoprotein	O
that	O
within	O
the	O
hematopoietic	O
system	O
is	O
selectively	O
expressed	O
on	O
cells	O
of	O
the	O
myeloid	O
lineage	O
.	O

So	O
far	O
,	O
its	O
primary	O
structure	O
and	O
function	O
were	O
unknown	O
.	O

We	O
used	O
retroviral	O
-	O
expression	O
cloning	O
to	O
isolate	O
the	O
CD93	B
cDNA	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
CD93	B
is	O
identical	O
to	O
a	O
protein	O
on	O
human	O
phagocytes	O
termed	O
C1q	B
receptor	I
(	O
C1qRp	B
)	O
.	O

C1qRp	B
was	O
shown	O
previously	O
to	O
mediate	O
enhancement	O
of	O
phagocytosis	O
in	O
monocytes	O
and	O
was	O
suggested	O
to	O
be	O
a	O
receptor	O
of	O
C1q	O
and	O
two	O
other	O
structurally	O
related	O
molecules	O
.	O

When	O
studying	O
CD93	B
transductants	O
and	O
control	O
cells	O
,	O
we	O
found	O
that	O
cells	O
expressing	O
CD93	B
have	O
enhanced	O
capacity	O
to	O
bind	O
C1q	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
immature	O
dendritic	O
cells	O
(	O
DC	O
)	O
express	O
CD93	B
/	O
C1qRp	B
,	O
and	O
mature	O
DC	O
,	O
known	O
to	O
have	O
reduced	O
capacity	O
for	O
antigen	O
uptake	O
and	O
to	O
have	O
lost	O
the	O
ability	O
to	O
phagocytose	O
,	O
show	O
weak	O
-	O
to	O
-	O
negative	O
CD93	B
/	O
C1qRp	B
expression	O
.	O

A	O
novel	O
immunoglobulin	O
superfamily	O
receptor	O
(	O
19A	B
)	O
related	O
to	O
CD2	B
is	O
expressed	O
on	O
activated	O
lymphocytes	O
and	O
promotes	O
homotypic	O
B	O
-	O
cell	O
adhesion	O
.	O

A	O
novel	O
lymphocyte	O
-	O
specific	O
immunoglobulin	O
superfamily	O
protein	O
(	O
19A	B
)	O
has	O
been	O
cloned	O
.	O

The	O
predicted	O
335-amino	O
-	O
acid	O
sequence	O
of	O
19A	B
represents	O
a	O
Type	O
1	O
membrane	O
protein	O
with	O
homology	O
with	O
the	O
CD2	B
family	O
of	O
receptors	O
.	O

A	O
molecular	O
model	O
of	O
the	O
two	O
predicted	O
extracellular	O
immunoglobulin	O
-	O
like	O
domains	O
of	O
19A	B
has	O
been	O
generated	O
using	O
the	O
crystal	O
structure	O
of	O
CD2	B
as	O
a	O
template	O
.	O

In	O
isolated	O
lymphocytes	O
,	O
expression	O
of	O
19A	B
is	O
induced	O
by	O
various	O
activation	O
stimuli	O
,	O
and	O
enforced	O
expression	O
of	O
the	O
19A	B
gene	O
promotes	O
homotypic	O
cell	O
adhesion	O
in	O
a	O
B	O
-	O
cell	O
-	O
line	O
model	O
.	O

Collectively	O
these	O
data	O
imply	O
that	O
the	O
19A	B
protein	O
plays	O
a	O
role	O
in	O
regulation	O
of	O
lymphocyte	O
adhesion	O
.	O

The	O
telomeric	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
,	O
tankyrase	B
1	I
,	O
contains	O
multiple	O
binding	O
sites	O
for	O
telomeric	B
repeat	I
binding	I
factor	I
1	I
(	O
TRF1	B
)	O
and	O
a	O
novel	O
acceptor	O
,	O
182-kDa	B
tankyrase	I
-	I
binding	I
protein	I
(	O
TAB182	B
)	O
.	O

Tankyrase	B
1	I
,	O
a	O
human	O
telomeric	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
,	O
was	O
originally	O
identified	O
through	O
its	O
interaction	O
with	O
TRF1	B
,	O
a	O
negative	O
regulator	O
of	O
telomere	O
length	O
.	O

Tankyrase	B
1	I
ADP	O
-	O
ribosylates	O
TRF1	B
in	O
vitro	O
,	O
and	O
its	O
overexpression	O
induces	O
telomere	O
elongation	O
in	O
human	O
cancer	O
cells	O
.	O

In	O
addition	O
to	O
its	O
telomeric	O
localization	O
,	O
tankyrase	B
1	I
resides	O
at	O
multiple	O
subcellular	O
sites	O
,	O
suggesting	O
additional	O
functions	O
for	O
this	O
protein	O
.	O

Here	O
we	O
identify	O
TAB182	B
,	O
a	O
novel	O
tankyrase	B
1-binding	I
protein	O
of	O
182	O
kDa	O
.	O

TAB182	B
displays	O
a	O
complex	O
pattern	O
of	O
subcellular	O
localization	O
.	O

TAB182	B
localizes	O
to	O
the	O
nucleus	O
in	O
a	O
heterochromatic	O
staining	O
pattern	O
and	O
to	O
the	O
cytoplasm	O
,	O
where	O
it	O
co	O
-	O
stains	O
with	O
the	O
cortical	O
actin	O
network	O
.	O

TAB182	B
coimmunoprecipitates	O
with	O
tankyrase	B
1	I
from	O
human	O
cells	O
and	O
serves	O
as	O
an	O
acceptor	O
of	O
poly	O
(	O
ADP	O
-	O
ribosyl	O
)	O
ation	O
by	O
tankyrase	B
1	I
in	O
vitro	O
.	O

Like	O
TRF1	B
,	O
TAB182	B
binds	O
to	O
the	O
ankyrin	O
domain	O
(	O
comprising	O
24	O
ankyrin	O
repeats	O
)	O
of	O
tankyrase	B
1	I
.	O

Surprisingly	O
,	O
dissection	O
of	O
this	O
domain	O
reveals	O
multiple	O
discrete	O
and	O
overlapping	O
binding	O
sites	O
for	O
TRF1	B
and	O
TAB182	B
.	O

Thus	O
,	O
we	O
demonstrate	O
five	O
well	O
conserved	O
ankyrin	O
repeat	O
clusters	O
in	O
tankyrase	B
1	I
.	O

Although	O
each	O
of	O
the	O
five	O
ankyrin	O
repeat	O
clusters	O
independently	O
binds	O
to	O
TRF1	B
,	O
only	O
three	O
of	O
the	O
five	O
bind	O
toTAB182	O
.	O

These	O
findings	O
suggest	O
that	O
tankyrase	B
1	I
may	O
act	O
as	O
a	O
scaffold	O
for	O
large	O
molecular	O
mass	O
complexes	O
made	O
up	O
of	O
multiple	O
binding	O
proteins	O
.	O

We	O
discuss	O
potential	O
roles	O
for	O
tankyrase	B
1-mediated	I
higher	O
order	O
complexes	O
at	O
telomeres	O
and	O
at	O
other	O
subcellular	O
sites	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
Nrap	B
,	O
that	O
is	O
conserved	O
from	O
yeast	O
to	O
humans	O
.	O

BACKGROUND	O
:	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O

RESULTS	O
:	O
We	O
have	O
identified	O
a	O
novel	O
nucleolar	B
RNA	I
-	I
associated	I
protein	I
(	O
Nrap	B
)	O
which	O
is	O
highly	O
conserved	O
from	O
yeast	O
(	O
Saccharomyces	O
cerevisiae	O
)	O
to	O
human	O
,	O
with	O
homologues	O
in	O
mouse	O
,	O
Drosophila	O
melanogaster	O
,	O
Caenorhabditis	O
elegans	O
,	O
Arabidopsis	O
thaliana	O
,	O
Schizosaccharomyces	O
pombe	O
,	O
and	O
other	O
species	O
.	O

In	O
the	O
mouse	O
,	O
we	O
have	O
found	O
that	O
Nrap	B
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O

We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
human	O
and	O
mouse	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
human	O
Nrap	B
gene	O
.	O

Nrap	B
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O

RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
Nrap	B
is	O
RNA	O
dependent	O
.	O

The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
Nrap	B
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
Nrap	B
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O

CONCLUSIONS	O
:	O
Nrap	B
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O

Nrap	B
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
of	O
a	O
genomic	O
clone	O
containing	O
the	O
promoter	O
region	O
of	O
the	O
human	O
ATP	O
binding	O
cassette	O
(	O
ABC	B
)	O
transporter	O
,	O
ABCB6	B
.	O

We	O
previously	O
reported	O
on	O
the	O
isolation	O
of	O
a	O
new	O
rat	O
ATP	O
binding	O
cassette	O
(	O
ABC	B
)	O
transporter	O
,	O
ABCB6	B
.	O

We	O
now	O
report	O
the	O
isolation	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
clones	O
containing	O
the	O
human	O
ABCB6	B
gene	O
.	O

ABCB6	B
is	O
100	O
%	O
identical	O
to	O
the	O
cloned	O
MTABC3	B
human	O
ABC	B
transporter	O
and	O
contains	O
the	O
typical	O
ABC	B
signature	O
,	O
Walker	O
A	O
and	O
B	O
motifs	O
.	O

We	O
found	O
that	O
HuABCB6	B
is	O
expressed	O
at	O
low	O
levels	O
in	O
normal	O
human	O
liver	O
.	O

We	O
found	O
that	O
ABCB6	B
was	O
overexpressed	O
in	O
human	O
hepatocellular	O
carcinomas	O
compared	O
to	O
paired	O
surrounding	O
non	O
-	O
malignant	O
tissue	O
.	O

We	O
found	O
that	O
there	O
was	O
no	O
difference	O
in	O
ABCB6	B
gene	O
copy	O
between	O
human	O
liver	O
cancer	O
and	O
its	O
paired	O
non	O
-	O
malignant	O
tissue	O
.	O

Because	O
HuABCB6	B
was	O
overexpressed	O
in	O
human	O
cancers	O
compared	O
to	O
peri	O
-	O
tumoral	O
tissue	O
in	O
the	O
absence	O
of	O
gene	O
amplification	O
,	O
transcriptional	O
regulation	O
may	O
play	O
an	O
important	O
role	O
in	O
its	O
expression	O
.	O

Therefore	O
,	O
we	O
isolated	O
a	O
14	O
kb	O
genomic	O
DNA	O
clone	O
containing	O
the	O
HuABCB6	B
promoter	O
and	O
5'-flanking	O
region	O
.	O

The	O
5'-flanking	O
region	O
contains	O
a	O
CpG	O
island	O
,	O
lacks	O
an	O
appropriately	O
positioned	O
TATA	O
element	O
and	O
contains	O
a	O
number	O
of	O
putative	O
transcription	O
factor	O
binding	O
sites	O
.	O

Two	O
transcription	O
start	O
sites	O
were	O
identified	O
by	O
S1	O
nuclease	O
mapping	O
at	O
-274	O
and	O
-296	O
bp	O
from	O
the	O
start	O
codon	O
.	O

Transient	O
transfection	O
of	O
the	O
HuABCB6	B
promoter	O
constructs	O
(	O
HuABCB6	B
/	O
1.68	O
,	O
1.39	O
,	O
1.13	O
,	O
0.90	O
,	O
0.52	O
)	O
containing	O
the	O
luciferase	O
reporter	O
gene	O
resulted	O
in	O
a	O
1100	O
-	O
2300-fold	O
increase	O
in	O
luciferase	O
activity	O
compared	O
to	O
the	O
empty	O
vector	O
control	O
whereas	O
HuABCB6	B
/	O
1.68	O
subcloned	O
in	O
the	O
reverse	O
orientation	O
resulted	O
in	O
no	O
activity	O
.	O

We	O
observed	O
a	O
significant	O
decrease	O
in	O
luciferase	O
activity	O
with	O
the	O
promoter	O
constructs	O
,	O
HuABCB6	B
/	O
0.25	O
,	O
0.15	O
and	O
0.06	O
,	O
which	O
indicates	O
that	O
an	O
orientation	O
-	O
dependent	O
functional	O
promoter	O
is	O
contained	O
within	O
our	O
previously	O
predicted	O
promoter	O
region	O
of	O
-315	O
bp	O
to	O
-565	O
bp	O
as	O
deletion	O
of	O
this	O
250	O
bp	O
sequence	O
resulted	O
in	O
a	O
loss	O
of	O
promoter	O
activity	O
.	O

Identification	O
and	O
characterization	O
of	O
Gemin7	B
,	O
a	O
novel	O
component	O
of	O
the	O
survival	O
of	O
motor	O
neuron	O
complex	O
.	O

The	O
survival	O
of	O
motor	O
neurons	O
(	O
SMN	O
)	O
protein	O
is	O
the	O
product	O
of	O
the	O
gene	O
mutated	O
or	O
deleted	O
in	O
the	O
neurodegenerative	O
disease	O
,	O
spinal	O
muscular	O
atrophy	O
.	O

SMN	O
is	O
part	O
of	O
a	O
large	O
macromolecular	O
complex	O
that	O
also	O
contains	O
Gemin2	B
,	O
Gemin3	B
,	O
Gemin4	B
,	O
Gemin5	B
,	O
and	O
Gemin6	B
.	O

The	O
SMN	O
complex	O
functions	O
in	O
the	O
assembly	O
of	O
spliceosomal	O
small	O
nuclear	O
ribonucleoproteins	O
and	O
probably	O
other	O
ribonucleoprotein	O
particles	O
.	O

We	O
have	O
identified	O
a	O
novel	O
protein	O
component	O
of	O
the	O
SMN	O
complex	O
termed	O
Gemin7	B
using	O
native	O
purified	O
SMN	O
complexes	O
and	O
peptide	O
sequencing	O
by	O
mass	O
spectrometry	O
.	O

Coimmunoprecipitation	O
and	O
immunolocalization	O
experiments	O
demonstrate	O
that	O
Gemin7	B
is	O
a	O
component	O
of	O
the	O
SMN	O
complex	O
and	O
colocalizes	O
with	O
SMN	O
in	O
the	O
cytoplasm	O
and	O
in	O
gems	O
.	O

Binding	O
experiments	O
show	O
that	O
Gemin7	B
interacts	O
directly	O
with	O
SMN	O
and	O
Gemin6	B
and	O
mediates	O
the	O
association	O
of	O
Gemin6	B
with	O
the	O
SMN	O
complex	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
Gemin7	B
does	O
not	O
contain	O
any	O
recognizable	O
motifs	O
with	O
the	O
exception	O
of	O
several	O
arginine	O
and	O
glycine	O
repeats	O
that	O
are	O
necessary	O
for	O
its	O
interaction	O
with	O
SMN	O
.	O

Moreover	O
,	O
Gemin7	B
interacts	O
with	O
several	O
Sm	O
proteins	O
of	O
spliceosomal	O
small	O
nuclear	O
ribonucleoproteins	O
,	O
in	O
particular	O
,	O
with	O
SmE.	B
With	O
the	O
identification	O
of	O
Gemin7	B
,	O
the	O
inventory	O
of	O
the	O
core	O
components	O
of	O
the	O
SMN	O
complex	O
appears	O
essentially	O
complete	O
.	O

FANCE	B
:	O
the	O
link	O
between	O
Fanconi	O
anaemia	O
complex	O
assembly	O
and	O
activity	O
.	O

The	O
Fanconi	O
anaemia	O
(	O
FA	B
)	O
nuclear	O
complex	O
(	O
composed	O
of	O
the	O
FA	B
proteins	I
A	I
,	I
C	I
,	I
G	I
and	I
F	I
)	O
is	O
essential	O
for	O
protection	O
against	O
chromosome	O
breakage	O
.	O

It	O
activates	O
the	O
downstream	O
protein	O
FANCD2	B
by	O
monoubiquitylation	O
;	O
this	O
then	O
forges	O
an	O
association	O
with	O
the	O
BRCA1	B
protein	O
at	O
sites	O
of	O
DNA	O
damage	O
.	O

Here	O
we	O
show	O
that	O
the	O
recently	O
identified	O
FANCE	B
protein	O
is	O
part	O
of	O
this	O
nuclear	O
complex	O
,	O
binding	O
both	O
FANCC	B
and	O
FANCD2	B
.	O

Indeed	O
,	O
FANCE	B
is	O
required	O
for	O
the	O
nuclear	O
accumulation	O
of	O
FANCC	B
and	O
provides	O
a	O
critical	O
bridge	O
between	O
the	O
FA	B
complex	O
and	O
FANCD2	B
.	O

Disease	O
-	O
associated	O
FANCC	B
mutants	O
do	O
not	O
bind	O
to	O
FANCE	B
,	O
can	O
not	O
accumulate	O
in	O
the	O
nucleus	O
and	O
are	O
unable	O
to	O
prevent	O
chromosome	O
breakage	O
.	O

Molecular	O
,	O
functional	O
,	O
and	O
genomic	O
characterization	O
of	O
human	O
KCC2	B
,	O
the	O
neuronal	B
K	I
-	I
Cl	I
cotransporter	I
.	O

The	O
expression	O
level	O
of	O
the	O
neuronal	B
-	I
specific	I
K	I
-	I
Cl	I
cotransporter	I
KCC2	I
(	O
SLC12A5	B
)	O
is	O
a	O
major	O
determinant	O
of	O
whether	O
neurons	O
will	O
respond	O
to	O
GABA	O
with	O
a	O
depolarizing	O
,	O
excitatory	O
response	O
or	O
a	O
hyperpolarizing	O
,	O
inhibitory	O
response	O
.	O

In	O
view	O
of	O
the	O
potential	O
role	O
in	O
human	O
neuronal	O
excitability	O
we	O
have	O
characterized	O
the	O
hKCC2	B
cDNA	O
and	O
gene	O
.	O

The	O
5.9	O
kb	O
hKCC2	B
transcript	O
is	O
specific	O
to	O
brain	O
,	O
and	O
is	O
induced	O
during	O
in	O
vitro	O
differentiation	O
of	O
NT2	O
teratocarcinoma	O
cells	O
into	O
neuronal	O
NT2-N	O
cells	O
.	O

The	O
24-exon	O
SLC12A5	B
gene	O
is	O
on	O
human	O
chromosome	O
20q13	O
,	O
and	O
contains	O
a	O
polymorphic	O
dinucleotide	O
repeat	O
within	O
intron	O
1	O
near	O
a	O
potential	O
binding	O
site	O
for	O
neuron	O
-	O
restrictive	O
silencing	O
factor	O
.	O

Expression	O
of	O
hKCC2	B
cRNA	O
in	O
Xenopus	O
laevis	O
oocytes	O
results	O
in	O
significant	O
Cl	O
(	O
-	O
)	O
-dependent	O
(	O
86	O
)	O
Rb	O
(	O
+	O
)	O
uptake	O
under	O
isotonic	O
conditions	O
;	O
cell	O
swelling	O
under	O
hypotonic	O
conditions	O
causes	O
a	O
20-fold	O
activation	O
,	O
which	O
is	O
blocked	O
by	O
the	O
protein	O
phosphatase	O
inhibitor	O
calyculin	O
-	O
A.	O
In	O
contrast	O
,	O
oocytes	O
expressing	O
mouse	O
KCC4	B
do	O
not	O
mediate	O
isotonic	O
K	O
-	O
Cl	O
cotransport	O
but	O
express	O
much	O
higher	O
absolute	O
transport	O
activity	O
than	O
KCC2	B
oocytes	O
under	O
hypotonic	O
conditions	O
.	O

Initial	O
and	O
steady	O
state	O
kinetics	O
of	O
hKCC2-injected	B
oocytes	O
were	O
performed	O
in	O
both	O
isotonic	O
and	O
hypotonic	O
conditions	O
,	O
revealing	O
K	O
(	O
m	O
)	O
s	O
for	O
K	O
(	O
+	O
)	O
and	O
Cl	O
(	O
-	O
)	O
of	O
9.3+	O
/	O
-1.8	O
mM	O
and	O
6.8+	O
/	O
-0.9	O
mM	O
,	O
respectively	O
;	O
both	O
affinities	O
are	O
significantly	O
higher	O
than	O
KCC1	B
and	O
KCC4	B
.	O

The	O
K	O
(	O
m	O
)	O
for	O
Cl	O
(	O
-	O
)	O
is	O
close	O
to	O
the	O
intracellular	O
Cl	O
(	O
-	O
)	O
activity	O
of	O
mature	O
neurons	O
,	O
as	O
befits	O
a	O
neuronal	O
efflux	O
mechanism	O
.	O

Enzymes	O
of	O
the	O
SUMO	O
modification	O
pathway	O
localize	O
to	O
filaments	O
of	O
the	O
nuclear	O
pore	O
complex	O
.	O

SUMOs	O
are	O
small	O
ubiquitin	O
-	O
related	O
polypeptides	O
that	O
are	O
reversibly	O
conjugated	O
to	O
many	O
nuclear	O
proteins	O
.	O

Although	O
the	O
number	O
of	O
identified	O
substrates	O
has	O
grown	O
rapidly	O
,	O
relatively	O
little	O
is	O
still	O
understood	O
about	O
when	O
,	O
where	O
,	O
and	O
why	O
most	O
proteins	O
are	O
modified	O
by	O
SUMO	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
enzymes	O
involved	O
in	O
the	O
SUMO	O
modification	O
and	O
demodification	O
of	O
proteins	O
are	O
components	O
of	O
the	O
nuclear	O
pore	O
complex	O
(	O
NPC	O
)	O
.	O

We	O
show	O
that	O
SENP2	B
,	O
a	O
SUMO	O
protease	O
that	O
is	O
able	O
to	O
demodify	O
both	O
SUMO-1	B
and	O
SUMO-2	B
or	O
SUMO-3	B
protein	O
conjugates	O
,	O
localizes	O
to	O
the	O
nucleoplasmic	O
face	O
of	O
the	O
NPC	O
.	O

The	O
unique	O
amino	O
-	O
terminal	O
domain	O
of	O
SENP2	B
interacts	O
with	O
the	O
FG	O
repeat	O
domain	O
of	O
Nup153	B
,	O
indicating	O
that	O
SENP2	B
associates	O
with	O
the	O
nucleoplasmic	O
basket	O
of	O
the	O
NPC	O
.	O

We	O
also	O
investigated	O
the	O
localization	O
of	O
the	O
SUMO	O
conjugating	O
enzyme	O
,	O
Ubc9	B
.	O

Using	O
immunogold	O
labeling	O
of	O
isolated	O
nuclear	O
envelopes	O
,	O
we	O
found	O
that	O
Ubc9	B
localizes	O
to	O
both	O
the	O
cytoplasmic	O
and	O
the	O
nucleoplasmic	O
filaments	O
of	O
the	O
NPC	O
.	O

In	O
vitro	O
binding	O
studies	O
revealed	O
that	O
Ubc9	B
and	O
SUMO-1-modified	B
RanGAP1	B
bind	O
synergistically	O
to	O
form	O
a	O
trimeric	O
complex	O
with	O
a	O
component	O
of	O
the	O
cytoplasmic	O
filaments	O
of	O
the	O
NPC	O
,	O
Nup358	B
.	O

Our	O
results	O
indicate	O
that	O
both	O
SUMO	O
modification	O
and	O
demodification	O
of	O
proteins	O
may	O
occur	O
at	O
the	O
NPC	O
and	O
suggest	O
a	O
connection	O
between	O
the	O
SUMO	O
modification	O
pathway	O
and	O
nucleocytoplasmic	O
transport	O
.	O

A	O
C	O
-	O
terminal	O
inhibitory	O
domain	O
controls	O
the	O
activity	O
of	O
p63	B
by	O
an	O
intramolecular	O
mechanism	O
.	O

The	O
human	O
genome	O
is	O
far	O
smaller	O
than	O
originally	O
estimated	O
,	O
and	O
one	O
explanation	O
is	O
that	O
alternative	O
splicing	O
creates	O
greater	O
proteomic	O
complexity	O
than	O
a	O
simple	O
count	O
of	O
open	O
reading	O
frames	O
would	O
suggest	O
.	O

The	O
p53	B
homologue	O
p63	B
,	O
for	O
example	O
,	O
is	O
a	O
tetrameric	O
transcription	O
factor	O
implicated	O
in	O
epithelial	O
development	O
and	O
expressed	O
as	O
at	O
least	O
six	O
isoforms	O
with	O
widely	O
differing	O
transactivation	O
potential	O
.	O

In	O
particular	O
,	O
p63alpha	B
isoforms	O
contain	O
a	O
27-kDa	O
C	O
-	O
terminal	O
region	O
that	O
drastically	O
reduces	O
their	O
activity	O
and	O
is	O
of	O
clear	O
biological	O
importance	O
,	O
since	O
patients	O
with	O
deletions	O
in	O
this	O
C	O
terminus	O
have	O
phenotypes	O
very	O
similar	O
to	O
patients	O
with	O
mutations	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
.	O

We	O
have	O
identified	O
a	O
novel	O
domain	O
within	O
this	O
C	O
terminus	O
that	O
is	O
necessary	O
and	O
sufficient	O
for	O
transcriptional	O
inhibition	O
and	O
which	O
acts	O
by	O
binding	O
to	O
a	O
region	O
in	O
the	O
N	O
-	O
terminal	O
transactivation	O
domain	O
of	O
p63	B
homologous	O
to	O
the	O
MDM2	O
binding	O
site	O
in	O
p53	B
.	O

Based	O
on	O
this	O
mechanism	O
,	O
we	O
provide	O
a	O
model	O
that	O
explains	O
the	O
transactivation	O
potential	O
of	O
homo-	O
and	O
heterotetramers	O
composed	O
of	O
different	O
p63	B
isoforms	O
and	O
their	O
effect	O
on	O
p53	B
.	O

The	O
AVIT	O
protein	O
family	O
.	O

Secreted	O
cysteine	O
-	O
rich	O
vertebrate	O
proteins	O
with	O
diverse	O
functions	O
.	O

Homologues	O
of	O
a	O
protein	O
originally	O
isolated	O
from	O
snake	O
venom	O
and	O
frog	O
skin	O
secretions	O
are	O
present	O
in	O
many	O
vertebrate	O
species	O
.	O

They	O
contain	O
80	O
-	O
90	O
amino	O
acids	O
,	O
10	O
of	O
which	O
are	O
cysteines	O
with	O
identical	O
spacing	O
.	O

Various	O
names	O
have	O
been	O
given	O
to	O
these	O
proteins	O
,	O
such	O
as	O
mamba	B
intestinal	I
protein	I
1	I
(	O
MIT1	B
)	O
,	O
Bv8	B
(	O
Bombina	B
variegata	I
molecular	I
mass	I
approximately	I
8	I
kDa	I
)	O
,	O
prokineticins	O
and	O
endocrine	B
-	I
gland	I
vascular	I
endothelial	I
growth	I
factor	I
(	O
EG	B
-	I
VEGF	I
)	O
.	O

Their	O
amino	O
-	O
terminal	O
sequences	O
are	O
identical	O
,	O
and	O
so	O
we	O
propose	O
that	O
the	O
sequence	O
of	O
their	O
first	O
four	O
residues	O
,	O
AVIT	O
,	O
is	O
used	O
as	O
a	O
name	O
for	O
this	O
family	O
.	O

From	O
a	O
comparison	O
of	O
the	O
sequences	O
,	O
two	O
types	O
of	O
AVIT	O
proteins	O
can	O
be	O
discerned	O
.	O

These	O
proteins	O
seem	O
to	O
be	O
distributed	O
widely	O
in	O
mammalian	O
tissues	O
and	O
are	O
known	O
to	O
bind	O
to	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
.	O

Members	O
of	O
this	O
family	O
have	O
been	O
shown	O
to	O
stimulate	O
contraction	O
of	O
the	O
guinea	O
pig	O
ileum	O
,	O
to	O
cause	O
hyperalgesia	O
after	O
injection	O
into	O
rats	O
and	O
to	O
be	O
active	O
as	O
specific	O
growth	O
factors	O
.	O

Moreover	O
,	O
the	O
messenger	O
RNA	O
level	O
of	O
one	O
of	O
these	O
AVIT	O
proteins	O
changes	O
rhythmically	O
in	O
the	O
region	O
of	O
the	O
brain	O
known	O
as	O
the	O
suprachiasmatic	O
nucleus	O
.	O

This	O
shows	O
that	O
members	O
of	O
this	O
new	O
family	O
of	O
small	O
proteins	O
are	O
involved	O
in	O
diverse	O
biological	O
processes	O
.	O

Golgi	O
localization	O
of	O
carbohydrate	O
sulfotransferases	O
is	O
a	O
determinant	O
of	O
L	B
-	I
selectin	I
ligand	O
biosynthesis	O
.	O

Sulfation	O
of	O
endothelial	O
glycoproteins	O
by	O
the	O
sulfotransferase	B
GlcNAc6ST-2	I
is	O
a	O
regulatory	O
modification	O
that	O
promotes	O
binding	O
of	O
the	O
leukocyte	O
adhesion	O
molecule	O
L	B
-	I
selectin	I
.	O

GlcNAc6ST-2	B
is	O
a	O
member	O
of	O
a	O
family	O
of	O
related	O
enzymes	O
that	O
act	O
on	O
similar	O
carbohydrate	O
substrates	O
in	O
vitro	O
but	O
discrete	O
glycoproteins	O
in	O
vivo	O
.	O

We	O
demonstrate	O
that	O
GlcNAc6ST-1	B
,	I
-2	I
,	I
and	I
-3	I
have	O
distinct	O
Golgi	O
distributions	O
,	O
with	O
GlcNAc6ST-1	B
confined	O
to	O
the	O
trans	O
-	O
Golgi	O
network	O
,	O
GlcNAc6ST-3	B
confined	O
to	O
the	O
early	O
secretory	O
pathway	O
,	O
and	O
GlcNAc6ST-2	B
distributed	O
throughout	O
the	O
Golgi	O
.	O

Their	O
localization	O
was	O
correlated	O
with	O
preferred	O
activity	O
on	O
either	O
N	O
-	O
linked	O
or	O
O	O
-	O
linked	O
glycoproteins	O
.	O

A	O
chimera	O
comprising	O
the	O
localization	O
domain	O
of	O
GlcNAc6ST-1	B
fused	O
to	O
the	O
catalytic	O
domain	O
of	O
GlcNAc6ST-2	B
was	O
confined	O
to	O
the	O
trans	O
-	O
Golgi	O
network	O
and	O
adopted	O
the	O
substrate	O
preference	O
of	O
GlcNAc6ST-1	B
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
Golgi	O
enzyme	O
localization	O
and	O
competition	O
orchestrate	O
the	O
biosynthesis	O
of	O
L	B
-	I
selectin	I
ligands	O
.	O

The	O
netrin	B
-	I
G1	I
ligand	I
NGL-1	B
promotes	O
the	O
outgrowth	O
of	O
thalamocortical	O
axons	O
.	O

Netrin	B
-	I
G1	I
is	O
a	O
lipid	O
-	O
anchored	O
protein	O
that	O
is	O
structurally	O
related	O
to	O
the	O
netrin	O
family	O
of	O
axon	O
guidance	O
molecules	O
.	O

Netrin	B
-	I
G1	I
does	O
not	O
bind	O
any	O
of	O
the	O
known	O
netrin	O
receptors	O
and	O
its	O
function	O
is	O
not	O
known	O
.	O

Here	O
we	O
identify	O
human	O
netrin	B
-	I
G1	I
ligand	I
(	O
NGL-1	B
)	O
,	O
a	O
transmembrane	O
protein	O
containing	O
leucine	O
-	O
rich	O
repeat	O
(	O
LRR	O
)	O
and	O
immunoglobulin	O
(	O
Ig	O
)	O
domains	O
that	O
specifically	O
interacts	O
with	O
netrin	B
-	I
G1	I
through	O
its	O
LRR	O
region	O
.	O

Whereas	O
netrin	B
-	I
G1	I
is	O
expressed	O
highly	O
in	O
mouse	O
thalamic	O
axons	O
,	O
NGL-1	B
is	O
most	O
abundant	O
in	O
the	O
striatum	O
and	O
the	O
cerebral	O
cortex	O
--	O
the	O
intermediate	O
and	O
final	O
targets	O
,	O
respectively	O
,	O
of	O
thalamocortical	O
axons	O
(	O
TCAs	O
)	O
.	O

Surface	O
-	O
bound	O
NGL-1	B
stimulates	O
,	O
but	O
soluble	O
NGL-1	B
disrupts	O
,	O
the	O
growth	O
of	O
embryonic	O
thalamic	O
axons	O
,	O
and	O
in	O
vitro	O
data	O
indicate	O
that	O
NGL-1	B
activity	O
may	O
be	O
mediated	O
at	O
least	O
partially	O
by	O
netrin	B
-	I
G1	I
.	O

Our	O
findings	O
provide	O
evidence	O
that	O
netrin	B
-	I
G1	I
functions	O
as	O
an	O
important	O
component	O
of	O
the	O
NGL-1	B
receptor	O
to	O
promote	O
TCA	O
outgrowth	O
and	O
that	O
membrane	O
-	O
bound	O
netrins	O
can	O
participate	O
in	O
receiving	O
axonal	O
signaling	O
pathways	O
.	O

Viruses	O
as	O
hijackers	O
of	O
PML	B
nuclear	O
bodies	O
.	O

Promyelocytic	B
leukemia	I
nuclear	O
bodies	O
(	O
PML	B
-	O
NBs	O
)	O
are	O
discrete	O
interchromosomal	O
macromolecular	O
structures	O
.	O

The	O
integrity	O
of	O
this	O
dynamic	O
nuclear	O
subcompartment	O
critically	O
depends	O
on	O
the	O
presence	O
of	O
the	O
name	O
-	O
giving	O
PML	B
protein	I
.	O

Among	O
the	O
permanent	O
or	O
transient	O
residents	O
of	O
PML	B
-	O
NBs	O
are	O
various	O
regulatory	O
proteins	O
,	O
including	O
Sp100	B
,	O
CBP	B
,	O
pRb	B
,	O
HIPK2	B
,	O
RAD51	B
and	O
p53	B
.	O

PML	B
-	O
NBs	O
are	O
frequently	O
targeted	O
by	O
viral	O
infections	O
,	O
as	O
a	O
number	O
of	O
different	O
RNA	O
and	O
DNA	O
viruses	O
,	O
including	O
herpesviruses	O
,	O
adenoviruses	O
,	O
papovaviruses	O
,	O
papillomaviruses	O
and	O
arenaviruses	O
,	O
cause	O
changes	O
in	O
PML	B
-	O
NBs	O
.	O

Viruses	O
interfere	O
with	O
PML	B
-	O
NB	O
in	O
two	O
ways	O
:	O
1	O
)	O
some	O
viral	O
proteins	O
can	O
associate	O
with	O
PML	B
-	O
NB	O
proteins	O
and/or	O
lead	O
to	O
the	O
destruction	O
and	O
lysis	O
of	O
this	O
subnuclear	O
compartment	O
,	O
thus	O
aiding	O
viral	O
gene	O
expression	O
and	O
disabling	O
the	O
host	O
's	O
innate	O
immunity	O
;	O
2	O
)	O
the	O
parental	O
genomes	O
of	O
some	O
nuclear	O
-	O
replicating	O
DNA	O
viruses	O
associate	O
preferentially	O
with	O
PML	B
-	O
NBs	O
,	O
which	O
presumably	O
serves	O
to	O
assist	O
in	O
viral	O
gene	O
expression	O
or	O
replication	O
.	O

Here	O
we	O
feature	O
the	O
different	O
viral	O
strategies	O
leading	O
to	O
the	O
hijacking	O
of	O
PML	B
-	O
NBs	O
and	O
discuss	O
the	O
consequences	O
for	O
the	O
immune	O
response	O
.	O

An	O
RNF11	B
:	O
Smurf2	B
complex	O
mediates	O
ubiquitination	O
of	O
the	O
AMSH	B
protein	O
.	O

RING	O
-	O
finger	O
proteins	O
play	O
crucial	O
roles	O
in	O
ubiquitination	O
events	O
involved	O
in	O
diverse	O
cellular	O
processes	O
including	O
signal	O
transduction	O
,	O
differentiation	O
and	O
apoptosis	O
.	O

Most	O
of	O
the	O
RING	O
-	O
finger	O
proteins	O
have	O
E3-ubiquitin	O
ligase	O
activity	O
.	O

RNF11	B
is	O
a	O
small	O
RING	O
-	O
finger	O
protein	O
and	O
harbors	O
a	O
RING	O
-	O
H2	O
domain	O
and	O
a	O
PY	O
motif	O
that	O
could	O
facilitate	O
protein	O
:	O
protein	O
interaction	O
(	O
s	O
)	O
involved	O
in	O
oncogenesis	O
.	O

To	O
isolate	O
RNF11	B
protein	O
partners	O
and	O
determine	O
its	O
role	O
in	O
normal	O
and	O
cancer	O
cells	O
,	O
we	O
performed	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

Among	O
18	O
in	O
-	O
frame	O
positive	O
clones	O
,	O
three	O
were	O
found	O
to	O
be	O
ZBRK1	B
,	O
Eps15	B
and	O
AMSH	B
(	O
associated	B
molecule	I
with	I
the	I
SH3	I
domain	I
of	I
STAM	I
)	O
.	O

ZBRK1	B
is	O
a	O
KRAB	O
domain	O
containing	O
Zinc	O
-	O
finger	O
protein	O
and	O
is	O
known	O
to	O
repress	O
target	O
gene	O
transcription	O
in	O
a	O
BRCA1-dependent	B
manner	O
.	O

Eps15	B
is	O
monoubiquitinated	O
and	O
is	O
part	O
of	O
an	O
essential	O
complex	O
involved	O
in	O
the	O
endocytosis	O
of	O
plasma	O
membrane	O
receptors	O
via	O
the	O
clathrin	O
-	O
mediated	O
internalization	O
pathway	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
AMSH	B
protein	O
is	O
involved	O
in	O
BMP	O
/	O
TGF	O
-	O
beta	O
signaling	O
pathway	O
by	O
binding	O
to	O
Smad6	B
and	O
Smad7	B
.	O

The	O
association	O
of	O
RNF11	B
with	O
these	O
binding	O
partners	O
suggests	O
that	O
it	O
would	O
be	O
involved	O
in	O
biological	O
processes	O
such	O
as	O
gene	O
transcription	O
,	O
BMP	O
/	O
TGF	O
-	O
beta	O
signaling	O
and	O
ubiquitination	O
-	O
associated	O
events	O
.	O

Previously	O
,	O
we	O
have	O
shown	O
that	O
RNF11	B
interacts	O
with	O
the	O
HECT	O
-	O
type	O
E3	O
ligases	O
AIP4	B
and	O
Smurf2	B
.	O

Here	O
,	O
we	O
show	O
that	O
RNF11	B
binds	O
to	O
AMSH	B
in	O
mammalian	O
cells	O
and	O
that	O
this	O
interaction	O
is	O
independent	O
of	O
the	O
RNF11	B
RING	O
-	O
finger	O
domain	O
and	O
the	O
PY	O
motif	O
.	O

Our	O
results	O
also	O
demonstrate	O
that	O
AMSH	B
is	O
ubiquitinated	O
by	O
Smurf2	B
E3	O
ligase	O
in	O
the	O
presence	O
of	O
RNF11	B
and	O
that	O
a	O
consequent	O
reduction	O
in	O
its	O
steady	O
-	O
state	O
level	O
requires	O
both	O
RNF11	B
and	O
Smurf2	B
.	O

RNF11	B
therefore	O
recruits	O
AMSH	B
to	O
Smurf2	B
for	O
ubiquitination	O
,	O
leading	O
to	O
its	O
degradation	O
by	O
the	O
26S	O
proteasome	O
.	O

The	O
potential	O
functions	O
of	O
RNF11-mediated	B
degradation	O
of	O
AMSH	B
in	O
breast	O
cancer	O
are	O
discussed	O
.	O

SLIT2-mediated	B
ROBO2	B
signaling	O
restricts	O
kidney	O
induction	O
to	O
a	O
single	O
site	O
.	O

Kidney	O
development	O
occurs	O
in	O
a	O
stereotypic	O
position	O
along	O
the	O
body	O
axis	O
.	O

It	O
begins	O
when	O
a	O
single	O
ureteric	O
bud	O
emerges	O
from	O
the	O
nephric	O
duct	O
in	O
response	O
to	O
GDNF	B
secreted	O
by	O
the	O
adjacent	O
nephrogenic	O
mesenchyme	O
.	O

Posterior	O
restriction	O
of	O
Gdnf	B
expression	O
is	O
considered	O
critical	O
for	O
correct	O
positioning	O
of	O
ureteric	O
bud	O
development	O
.	O

Here	O
we	O
show	O
that	O
mouse	O
mutants	O
lacking	O
either	O
SLIT2	B
or	O
its	O
receptor	O
ROBO2	B
,	O
molecules	O
known	O
primarily	O
for	O
their	O
function	O
in	O
axon	O
guidance	O
and	O
cell	O
migration	O
,	O
develop	O
supernumerary	O
ureteric	O
buds	O
that	O
remain	O
inappropriately	O
connected	O
to	O
the	O
nephric	O
duct	O
,	O
and	O
that	O
the	O
SLIT2	B
/	O
ROBO2	B
signal	O
is	O
transduced	O
in	O
the	O
nephrogenic	O
mesenchyme	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
Gdnf	B
expression	O
is	O
inappropriately	O
maintained	O
in	O
anterior	O
nephrogenic	O
mesenchyme	O
in	O
these	O
mutants	O
.	O

Thus	O
our	O
data	O
identify	O
an	O
intercellular	O
signaling	O
system	O
that	O
restricts	O
,	O
directly	O
or	O
indirectly	O
,	O
the	O
extent	O
of	O
the	O
Gdnf	B
expression	O
domain	O
,	O
thereby	O
precisely	O
positioning	O
the	O
site	O
of	O
kidney	O
induction	O
.	O

Self	O
-	O
assembling	O
protein	O
microarrays	O
.	O

Protein	O
microarrays	O
provide	O
a	O
powerful	O
tool	O
for	O
the	O
study	O
of	O
protein	O
function	O
.	O

However	O
,	O
they	O
are	O
not	O
widely	O
used	O
,	O
in	O
part	O
because	O
of	O
the	O
challenges	O
in	O
producing	O
proteins	O
to	O
spot	O
on	O
the	O
arrays	O
.	O

We	O
generated	O
protein	O
microarrays	O
by	O
printing	O
complementary	O
DNAs	O
onto	O
glass	O
slides	O
and	O
then	O
translating	O
target	O
proteins	O
with	O
mammalian	O
reticulocyte	O
lysate	O
.	O

Epitope	O
tags	O
fused	O
to	O
the	O
proteins	O
allowed	O
them	O
to	O
be	O
immobilized	O
in	O
situ	O
.	O

This	O
obviated	O
the	O
need	O
to	O
purify	O
proteins	O
,	O
avoided	O
protein	O
stability	O
problems	O
during	O
storage	O
,	O
and	O
captured	O
sufficient	O
protein	O
for	O
functional	O
studies	O
.	O

We	O
used	O
the	O
technology	O
to	O
map	O
pairwise	O
interactions	O
among	O
29	O
human	O
DNA	O
replication	O
initiation	O
proteins	O
,	O
recapitulate	O
the	O
regulation	O
of	O
Cdt1	B
binding	O
to	O
select	O
replication	O
proteins	O
,	O
and	O
map	O
its	O
geminin	O
-	O
binding	O
domain	O
.	O

Induction	O
of	O
apoptosis	O
by	O
X	B
-	I
linked	I
ectodermal	I
dysplasia	I
receptor	I
via	O
a	O
caspase	B
8-dependent	I
mechanism	O
.	O

X	B
-	I
linked	I
ectodermal	I
dysplasia	I
receptor	I
(	O
XEDAR	B
)	O
is	O
a	O
recently	O
isolated	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
receptor	O
family	O
that	O
is	O
highly	O
expressed	O
during	O
embryonic	O
development	O
and	O
binds	O
to	O
ectodysplasin	B
-	I
A2	I
(	O
EDA	B
-	I
A2	I
)	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
although	O
XEDAR	B
lacks	O
a	O
death	O
domain	O
,	O
it	O
nevertheless	O
induces	O
apoptosis	O
in	O
an	O
EDA	B
-	I
A2-dependent	I
fashion	O
.	O

The	O
apoptosis	O
-	O
inducing	O
ability	O
of	O
XEDAR	B
is	O
dependent	O
on	O
the	O
activation	O
of	O
caspase	B
8	I
and	O
can	O
be	O
blocked	O
by	O
its	O
genetic	O
and	O
pharmacological	O
inhibitors	O
.	O

Although	O
XEDAR	B
-	O
induced	O
apoptosis	O
can	O
be	O
blocked	O
by	O
dominant	O
-	O
negative	O
Fas	B
-	I
associated	I
death	I
domain	I
(	O
FADD	B
)	O
protein	O
and	O
FADD	B
small	O
interfering	O
RNA	O
,	O
XEDAR	B
does	O
not	O
directly	O
bind	O
to	O
FADD	B
,	O
tumor	B
necrosis	I
factor	I
receptor	I
-	I
associated	I
death	I
domain	I
(	O
TRADD	B
)	O
protein	O
,	O
or	O
RIP1	B
.	O

Instead	O
,	O
XEDAR	B
signaling	O
leads	O
to	O
the	O
formation	O
of	O
a	O
secondary	O
complex	O
containing	O
FADD	B
,	O
caspase	B
8	I
,	O
and	O
caspase	B
10	I
,	O
which	O
results	O
in	O
caspase	B
activation	O
.	O

Thus	O
,	O
XEDAR	B
belongs	O
to	O
a	O
novel	O
class	O
of	O
death	O
receptors	O
that	O
lack	O
a	O
discernible	O
death	O
domain	O
but	O
are	O
capable	O
of	O
activating	O
apoptosis	O
in	O
a	O
caspase	B
8-	I
and	O
FADD	B
-	O
dependent	O
fashion	O
.	O

XEDAR	B
may	O
represent	O
an	O
early	O
stage	O
in	O
the	O
evolution	O
of	O
death	O
receptors	O
prior	O
to	O
the	O
emergence	O
of	O
the	O
death	O
domain	O
and	O
may	O
play	O
a	O
role	O
in	O
the	O
induction	O
of	O
apoptosis	O
during	O
embryonic	O
development	O
and	O
adult	O
life	O
.	O

Characterization	O
of	O
a	O
novel	O
gene	O
in	O
the	O
human	O
major	O
histocompatibility	O
complex	O
that	O
encodes	O
a	O
potential	O
new	O
member	O
of	O
the	O
I	O
kappa	O
B	O
family	O
of	O
proteins	O
.	O

At	O
least	O
110	O
genes	O
are	O
now	O
known	O
to	O
be	O
located	O
in	O
the	O
4000	O
kb	O
of	O
DNA	O
encompassing	O
the	O
human	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
in	O
the	O
chromosome	O
band	O
6p21.3	O
.	O

Recent	O
genomic	O
sequence	O
analysis	O
of	O
a	O
90	O
kb	O
segment	O
of	O
DNA	O
containing	O
the	O
tumour	O
necrosis	O
factor	O
genes	O
in	O
the	O
class	O
III	O
region	O
of	O
the	O
MHC	O
has	O
predicted	O
the	O
presence	O
of	O
three	O
potential	O
exons	O
mapping	O
between	O
the	O
BAT1	B
and	O
TNFB	B
genes	O
(	O
12	O
)	O
.	O

A	O
near	O
full	O
-	O
length	O
cDNA	O
clone	O
corresponding	O
to	O
a	O
novel	O
gene	O
located	O
between	O
BAT1	B
and	O
TNFB	B
that	O
contains	O
sequence	O
corresponding	O
to	O
one	O
of	O
these	O
putative	O
exons	O
,	O
has	O
been	O
isolated	O
from	O
a	O
premonocytic	O
leukaemic	O
cell	O
line	O
cDNA	O
library	O
.	O

Characterization	O
of	O
this	O
gene	O
reveals	O
that	O
it	O
spans	O
13.5	O
kb	O
of	O
DNA	O
,	O
with	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
lying	O
approximately	O
12	O
kb	O
from	O
the	O
5	O
'	O
end	O
of	O
the	O
TNFB	B
gene	O
.	O

The	O
cDNA	O
hybridizes	O
to	O
a	O
approximately	O
1.6	O
kb	O
mRNA	O
in	O
a	O
number	O
of	O
different	O
cell	O
types	O
,	O
including	O
monocytes	O
,	O
T	O
cells	O
,	O
B	O
cells	O
and	O
hepatocytes	O
.	O

The	O
putative	O
polypeptide	O
encoded	O
by	O
this	O
cDNA	O
is	O
381	O
amino	O
acids	O
in	O
length	O
,	O
with	O
a	O
non	O
-	O
glycosylated	O
M	O
(	O
r	O
)	O
of	O
43214	O
.	O

It	O
contains	O
one	O
partial	O
and	O
two	O
full	O
ANK	O
repeats	O
,	O
which	O
bear	O
a	O
marked	O
similarity	O
to	O
those	O
in	O
the	O
I	O
kappa	O
B	O
family	O
of	O
proteins	O
,	O
suggesting	O
that	O
the	O
protein	O
encoded	O
by	O
the	O
novel	O
gene	O
could	O
represent	O
a	O
divergent	O
member	O
of	O
this	O
family	O
.	O

cDNA	O
cloning	O
and	O
expression	O
of	O
two	O
new	O
members	O
of	O
the	O
human	O
liver	O
UDP	O
-	O
glucuronosyltransferase	O
2B	O
subfamily	O
.	O

Two	O
new	O
UDP	O
-	O
glucuronosyltransferase	O
cDNAs	O
,	O
designated	O
UGT2B10	B
and	O
UGT2B11	B
,	O
encoding	O
528	O
amino	O
acid	O
proteins	O
were	O
isolated	O
from	O
a	O
human	O
liver	O
cDNA	O
library	O
.	O

The	O
deduced	O
amino	O
acid	O
sequences	O
of	O
UGTs	B
2B10	I
and	I
2B11	I
share	O
>	O
76	O
%	O
sequence	O
similarity	O
with	O
other	O
known	O
human	O
liver	O
UGT2B	O
subfamily	O
isoforms	O
and	O
<	O
48	O
%	O
sequence	O
similarity	O
with	O
UGT1	O
family	O
proteins	O
.	O

COS-7	O
cells	O
transfected	O
with	O
UGT	O
2B10	O
and	O
2B11	O
synthesized	O
proteins	O
with	O
respective	O
molecular	O
masses	O
of	O
49kDa	O
and	O
51kDa	O
.	O

UGT2B11	B
expressed	O
in	O
COS-7	O
cells	O
glucuronidated	O
a	O
number	O
of	O
polyhydroxylated	O
estrogens	O
(	O
estriol	O
,	O
4-hydroxyestrone	O
and	O
2-hydroxyestriol	O
)	O
and	O
xenobiotics	O
(	O
4-methylumbelliferone	O
,	O
1-naphthol	O
,	O
4-nitrophenol	O
,	O
2-aminophenol	O
,	O
4-hydroxybiphenyl	O
and	O
menthol	O
)	O
.	O

Despite	O
the	O
screening	O
of	O
more	O
than	O
forty	O
potential	O
substrates	O
,	O
glucuronidation	O
activity	O
was	O
not	O
observed	O
for	O
expressed	O
UGT2B10	B
.	O

Isolation	O
and	O
characterization	O
of	O
cDNA	O
clones	O
for	O
Humly9	B
:	O
the	B
human	I
homologue	I
of	I
mouse	I
Ly9	I
.	O

Ly9	B
is	O
a	O
mouse	O
cell	O
membrane	O
antigen	O
found	O
on	O
all	O
lymphocytes	O
and	O
coded	O
for	O
by	O
a	O
gene	O
that	O
maps	O
to	O
chromosome	O
1	O
.	O

We	O
previously	O
described	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
for	O
mouse	O
Ly9	B
.	O

Using	O
cross	O
-	O
species	O
hybridization	O
we	O
isolated	O
cDNA	O
clones	O
encoding	O
the	O
human	O
homologue	O
Humly9	B
.	O

Analysis	O
of	O
the	O
predicted	O
protein	O
sequence	O
suggests	O
that	O
the	O
extra	O
-	O
cellular	O
portion	O
of	O
the	O
Humly9	B
molecules	O
is	O
composed	O
of	O
four	O
Ig	O
-	O
like	O
domains	O
:	O
a	O
V	O
domain	O
(	O
V	O
)	O
without	O
disulphide	O
bonds	O
and	O
a	O
truncated	O
C2	O
domain	O
(	O
tC2	O
)	O
with	O
two	O
disulphide	O
bonds	O
,	O
a	O
second	O
V	O
domain	O
without	O
disulphide	O
bonds	O
and	O
a	O
second	O
tC2	O
with	O
two	O
disulphide	O
bonds	O
,	O
i.e.	O
,	O
as	O
V	O
-	O
tC2-V	O
-	O
tC2	O
.	O

The	O
gene	O
encoding	O
Humly9	B
was	O
mapped	O
to	O
chromosome	O
1	O
by	O
analysis	O
of	O
human	O
/	O
hamster	O
hybrids	O
,	O
and	O
more	O
specifically	O
to	O
the	O
1q22	O
region	O
by	O
in	O
situ	O
hybridization	O
.	O

The	O
protein	O
sequence	O
data	O
support	O
the	O
view	O
that	O
Humly9	B
belongs	O
to	O
the	O
immunoglobulin	O
-	O
superfamily	O
subgroup	O
which	O
includes	O
CD48	B
,	O
CD2	B
,	O
and	O
LFA-3	B
.	O

SM-20	B
is	O
a	O
novel	O
40-kd	O
protein	O
whose	O
expression	O
in	O
the	O
arterial	O
wall	O
is	O
restricted	O
to	O
smooth	O
muscle	O
.	O

We	O
have	O
previously	O
reported	O
the	O
identification	O
of	O
a	O
novel	O
cDNA	O
,	O
SM-20	B
,	O
whose	O
corresponding	O
mRNA	O
levels	O
are	O
regulated	O
by	O
growth	O
factors	O
in	O
rat	O
aortic	O
smooth	O
muscle	O
cell	O
(	O
SMC	O
)	O
culture	O
.	O

Affinity	O
-	O
purified	O
polyclonal	O
and	O
monoclonal	O
antibodies	O
were	O
made	O
against	O
a	O
230	O
amino	O
acid	O
region	O
of	O
the	O
SM-20	B
putative	O
peptide	O
expressed	O
in	O
the	O
bacterial	O
vector	O
,	O
pET-3b	O
.	O

Western	O
blot	O
analyses	O
of	O
rat	O
and	O
human	O
SMC	O
lysates	O
detected	O
a	O
single	O
protein	O
species	O
of	O
approximately	O
40	O
kd	O
.	O

SM-20	B
was	O
not	O
detected	O
in	O
concentrates	O
of	O
the	O
culture	O
medium	O
.	O

By	O
immunohistochemistry	O
,	O
SM-20	B
was	O
localized	O
to	O
filaments	O
in	O
the	O
cytoplasm	O
of	O
cultured	O
SMC	O
.	O

Like	O
SM-20	B
mRNA	O
,	O
levels	O
of	O
SM-20	B
protein	O
were	O
increased	O
1	O
-	O
3	O
hours	O
after	O
serum	O
stimulation	O
of	O
rat	O
aortic	O
SMC	O
.	O

In	O
rat	O
tissues	O
,	O
SM-20	B
antigen	O
was	O
detected	O
in	O
abundance	O
in	O
smooth	O
,	O
cardiac	O
,	O
and	O
skeletal	O
muscle	O
.	O

SM-20	B
was	O
also	O
detected	O
in	O
some	O
epithelial	O
cells	O
of	O
the	O
kidney	O
,	O
pancreas	O
,	O
gastrointestinal	O
tract	O
,	O
and	O
skin	O
,	O
but	O
was	O
not	O
found	O
in	O
the	O
parenchyma	O
of	O
the	O
liver	O
,	O
spleen	O
,	O
or	O
testis	O
.	O

In	O
the	O
rat	O
arterial	O
wall	O
,	O
SM-20	B
antigen	O
was	O
restricted	O
to	O
the	O
SMC	O
of	O
the	O
media	O
and	O
,	O
after	O
balloon	O
arterial	O
injury	O
,	O
was	O
found	O
most	O
abundantly	O
in	O
the	O
neointima	O
.	O

In	O
human	O
atherosclerotic	O
coronary	O
arteries	O
,	O
SM-20	B
antigen	O
predominated	O
in	O
the	O
SMC	O
of	O
the	O
intimal	O
plaques	O
and	O
was	O
not	O
detected	O
in	O
macrophages	O
,	O
endothelium	O
,	O
or	O
adventitial	O
cells	O
.	O

Thus	O
,	O
SM-20	B
encodes	O
a	O
protein	O
which	O
serves	O
as	O
a	O
novel	O
SMC	O
-	O
specific	O
marker	O
within	O
the	O
vessel	O
wall	O
.	O

Prk	B
,	O
a	O
cytokine	O
-	O
inducible	O
human	O
protein	O
serine	O
/	O
threonine	O
kinase	O
whose	O
expression	O
appears	O
to	O
be	O
down	O
-	O
regulated	O
in	O
lung	O
carcinomas	O
.	O

We	O
have	O
cloned	O
and	O
characterized	O
a	O
putative	O
protein	O
serine	O
/	O
threonine	O
kinase	O
termed	O
prk	B
through	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
conventional	O
cDNA	O
library	O
screening	O
approaches	O
.	O

There	O
are	O
apparently	O
two	O
distinct	O
domains	O
within	O
prk	B
protein	O
deduced	O
from	O
its	O
nucleotide	O
sequences	O
.	O

The	O
amino	O
-	O
terminal	O
portion	O
has	O
the	O
feature	O
of	O
the	O
catalytic	O
domain	O
of	O
a	O
serine	O
/	O
threonine	O
kinase	O
and	O
shows	O
strong	O
homology	O
to	O
mouse	O
fnk	B
and	O
other	O
polo	O
family	O
kinases	O
including	O
mouse	O
snk	O
,	O
human	O
and	O
murine	O
plk	B
,	O
Drosophila	O
polo	O
,	O
and	O
yeast	O
Cdc5	O
.	O

The	O
carboxyl	O
-	O
terminal	O
portion	O
,	O
presumably	O
the	O
regulatory	O
domain	O
,	O
shares	O
extensive	O
homology	O
to	O
mouse	O
fnk	B
.	O

Northern	O
blotting	O
analyses	O
reveal	O
that	O
prk	B
expression	O
is	O
restricted	O
to	O
a	O
very	O
limited	O
number	O
of	O
tissues	O
with	O
placenta	O
,	O
ovaries	O
,	O
and	O
lung	O
containing	O
detectable	O
amounts	O
of	O
prk	B
mRNA	O
.	O

prk	B
mRNA	O
expression	O
is	O
also	O
detected	O
at	O
a	O
low	O
level	O
in	O
the	O
megakaryocytic	O
cell	O
line	O
Dami	O
,	O
MO7e	O
,	O
and	O
three	O
brain	O
glioma	O
cell	O
lines	O
.	O

In	O
addition	O
,	O
refeeding	O
of	O
serum	O
-	O
deprived	O
MO7e	O
,	O
Dami	O
,	O
and	O
K562	O
cells	O
of	O
hematopoietic	O
origin	O
and	O
GMOO637D	O
of	O
lung	O
fibroblasts	O
rapidly	O
activates	O
prk	B
mRNA	O
expression	O
with	O
its	O
peak	O
induction	O
around	O
2	O
h	O
after	O
serum	O
addition	O
.	O

prk	B
gene	O
activation	O
by	O
the	O
serum	O
requires	O
no	O
new	O
protein	O
synthesis	O
.	O

The	O
recombinant	O
cytokines	O
such	O
as	O
interleukin-3	B
and	O
thrombopoietin	B
also	O
activate	O
prk	B
mRNA	O
expression	O
in	O
MO7e	O
cells	O
.	O

Furthermore	O
,	O
a	O
survey	O
of	O
RNAs	O
isolated	O
from	O
the	O
tumor	O
and	O
the	O
uninvolved	O
tissues	O
from	O
18	O
lung	O
cancer	O
patients	O
reveals	O
that	O
prk	B
mRNA	O
expression	O
is	O
significantly	O
down	O
-	O
regulated	O
in	O
tumor	O
tissues	O
.	O

Southern	O
blotting	O
analysis	O
indicates	O
that	O
the	O
prk	B
gene	O
is	O
present	O
in	O
a	O
single	O
copy	O
in	O
the	O
genome	O
of	O
tumors	O
and	O
normal	O
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
prk	B
expression	O
may	O
be	O
restricted	O
to	O
proliferating	O
cells	O
and	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
cycle	O
progression	O
.	O

The	O
molecular	O
cloning	O
of	O
prk	B
cDNA	O
will	O
facilitate	O
the	O
study	O
of	O
its	O
biological	O
role	O
as	O
well	O
as	O
its	O
potential	O
role	O
in	O
tumorigenesis	O
.	O

Pathway	O
leading	O
to	O
correctly	O
folded	O
beta	O
-	O
tubulin	O
.	O

We	O
describe	O
the	O
complete	O
beta	O
-	O
tubulin	O
folding	O
pathway	O
.	O

Folding	O
intermediates	O
produced	O
via	O
ATP	O
-	O
dependent	O
interaction	O
with	O
cytosolic	O
chaperonin	O
undergo	O
a	O
sequence	O
of	O
interactions	O
with	O
four	O
proteins	O
(	O
cofactors	B
A	I
,	I
D	I
,	I
E	I
,	I
and	I
C	I
)	O
.	O

The	O
postchaperonin	O
steps	O
in	O
the	O
reaction	O
cascade	O
do	O
not	O
depend	O
on	O
ATP	O
or	O
GTP	O
hydrolysis	O
,	O
although	O
GTP	O
plays	O
a	O
structural	O
role	O
in	O
tubulin	O
folding	O
.	O

Cofactors	B
A	I
and	I
D	I
function	O
by	O
capturing	O
and	O
stabilizing	O
beta	O
-	O
tubulin	O
in	O
a	O
quasi	O
-	O
native	O
conformation	O
.	O

Cofactor	B
E	I
binds	O
to	O
the	O
cofactor	O
D	O
-	O
beta	O
-	O
tubulin	O
complex	O
;	O
interaction	O
with	O
cofactor	B
C	I
then	O
causes	O
the	O
release	O
of	O
beta	O
-	O
tubulin	O
polypeptides	O
that	O
are	O
committed	O
to	O
the	O
native	O
state	O
.	O

Sequence	O
analysis	O
identifies	O
yeast	O
homologs	O
of	O
cofactors	B
D	I
(	I
cin1	I
)	I
and	I
E	I
(	I
pac2	I
)	I
,	O
characterized	O
by	O
mutations	O
that	O
affect	O
microtubule	O
function	O
.	O

cDNA	O
cloning	O
and	O
primary	O
structure	O
analysis	O
of	O
C1qR	B
(	I
P	I
)	I
,	O
the	O
human	O
C1q	O
/	O
MBL	B
/	O
SPA	B
receptor	O
that	O
mediates	O
enhanced	O
phagocytosis	O
in	O
vitro	O
.	O

The	O
complement	O
protein	O
C1q	O
,	O
mannose	B
-	I
binding	I
lectin	I
(	O
MBL	B
)	O
,	O
and	O
pulmonary	B
surfactant	I
protein	I
A	I
(	O
SPA	B
)	O
are	O
structurally	O
similar	O
molecules	O
that	O
enhance	O
phagocytic	O
function	O
in	O
vitro	O
.	O

Monoclonal	O
antibodies	O
R3	O
and	O
R139	O
,	O
which	O
inhibit	O
the	O
enhancement	O
triggered	O
by	O
these	O
three	O
ligands	O
,	O
were	O
used	O
to	O
purify	O
a	O
126,000	O
M	O
(	O
r	O
)	O
cell	O
surface	O
protein	O
designated	O
C1qR	B
(	I
P	I
)	I
.	O

Amino	O
acid	O
sequence	O
was	O
obtained	O
and	O
the	O
corresponding	O
cDNA	O
was	O
cloned	O
.	O

C1qR	B
(	I
P	I
)	I
is	O
a	O
novel	O
type	O
I	O
membrane	O
protein	O
with	O
the	O
following	O
putative	O
structural	O
elements	O
:	O
a	O
C	O
-	O
type	O
carbohydrate	O
recognition	O
domain	O
,	O
five	O
EGF	O
-	O
like	O
domains	O
,	O
a	O
transmembrane	O
domain	O
,	O
and	O
a	O
short	O
cytoplasmic	O
tail	O
.	O

All	O
peptides	O
identified	O
by	O
amino	O
acid	O
sequencing	O
are	O
encoded	O
by	O
the	O
cDNA	O
.	O

Additionally	O
,	O
an	O
anti	O
-	O
peptide	O
antiserum	O
was	O
generated	O
,	O
which	O
is	O
reactive	O
with	O
C1qR	B
(	I
P	I
)	I
.	O

The	O
data	O
indicate	O
that	O
the	O
cloned	O
cDNA	O
encodes	O
the	O
receptor	O
that	O
plays	O
a	O
role	O
in	O
C1q	O
/	O
MBL	B
/	O
SPA	B
-	O
mediated	O
removal	O
or	O
destruction	O
of	O
pathogens	O
and	O
immune	O
complexes	O
by	O
phagocytosis	O
.	O

Three	O
human	O
RNA	O
polymerase	O
III	O
-	O
specific	O
subunits	O
form	O
a	O
subcomplex	O
with	O
a	O
selective	O
function	O
in	O
specific	O
transcription	O
initiation	O
.	O

Transcription	O
by	O
RNA	O
polymerase	O
III	O
involves	O
recruitment	O
of	O
the	O
polymerase	O
by	O
template	O
-	O
bound	O
accessory	O
factors	O
,	O
followed	O
by	O
initiation	O
,	O
elongation	O
,	O
and	O
termination	O
steps	O
.	O

An	O
immunopurification	O
approach	O
has	O
been	O
used	O
to	O
demonstrate	O
that	O
human	O
RNA	O
Pol	O
III	O
is	O
composed	O
of	O
16	O
subunits	O
,	O
some	O
of	O
which	O
are	O
apparently	O
modified	O
in	O
HeLa	O
cells	O
.	O

Partial	O
denaturing	O
conditions	O
and	O
sucrose	O
gradient	O
sedimentation	O
at	O
high	O
salt	O
result	O
in	O
the	O
dissociation	O
of	O
a	O
subcomplex	O
that	O
includes	O
hRPC32	B
,	O
hRPC39	B
,	O
and	O
hRPC62	B
.	O

Cognate	O
cDNAs	O
were	O
isolated	O
and	O
shown	O
to	O
encode	O
three	O
subunits	O
that	O
are	O
specific	O
to	O
RNA	O
Pol	O
III	O
and	O
homologous	O
to	O
three	O
yeast	O
subunits	O
.	O

The	O
human	O
RNA	O
Pol	O
III	O
core	O
lacking	O
the	O
subcomplex	O
functions	O
in	O
transcription	O
elongation	O
and	O
termination	O
following	O
nonspecific	O
initiation	O
on	O
a	O
tailed	O
template	O
,	O
but	O
fails	O
to	O
show	O
promoter	O
-	O
dependent	O
transcription	O
initiation	O
in	O
conjunction	O
with	O
accessory	O
factors	O
.	O

The	O
capability	O
for	O
specific	O
transcription	O
initiation	O
can	O
be	O
restored	O
either	O
by	O
the	O
natural	O
subcomplex	O
or	O
by	O
a	O
stable	O
subcomplex	O
composed	O
of	O
recombinant	O
hRPC32	B
,	O
hRPC39	B
,	O
and	O
hRPC62	B
polypeptides	O
.	O

One	O
component	O
(	O
hRPC39	B
)	O
of	O
this	O
subcomplex	O
interacts	O
physically	O
with	O
both	O
hTBP	B
and	O
hTFIIIB90	B
,	O
two	O
subunits	O
of	O
human	O
RNA	O
Pol	O
III	O
transcription	B
initiation	I
factor	I
IIIB	I
.	O

These	O
data	O
strongly	O
suggest	O
that	O
the	O
hRPC32-hRPC39-hRPC62	B
subcomplex	O
directs	O
RNA	O
Pol	O
III	O
binding	O
to	O
the	O
TFIIIB	O
-	O
DNA	O
complex	O
via	O
the	O
interactions	O
between	O
TFIIIB	O
and	O
hRPC39	B
.	O

Identification	O
of	O
a	O
novel	O
Ran	B
binding	I
protein	I
2	I
related	O
gene	O
(	O
RANBP2L1	B
)	O
and	O
detection	O
of	O
a	O
gene	O
cluster	O
on	O
human	O
chromosome	O
2q11-q12	O
.	O

The	O
giant	O
358-kDa	O
protein	O
Ran	B
binding	I
protein	I
2	I
(	O
RanBP2	B
/	O
Nup358	B
)	O
is	O
localized	O
at	O
the	O
cytoplasmic	O
side	O
of	O
the	O
nuclear	O
pore	O
complex	O
and	O
likely	O
constitutes	O
the	O
Ran	O
-	O
GTP	O
binding	O
site	O
at	O
the	O
cytoplasmic	O
face	O
of	O
the	O
complex	O
.	O

RanBP2	B
/	O
Nup358	B
furthermore	O
acts	O
as	O
a	O
chaperone	O
for	O
red	O
/	O
green	O
opsin	O
molecules	O
.	O

Here	O
,	O
we	O
report	O
on	O
the	O
physical	O
mapping	O
of	O
human	O
RanBP2	B
between	O
markers	O
D2S340	O
and	O
D2S1893	O
.	O

A	O
duplication	O
of	O
the	O
5'-end	O
sequence	O
of	O
RanBP2	B
occurs	O
within	O
3	O
Mb	O
distal	O
to	O
RanBP2	B
.	O

Detailed	O
sequence	O
analysis	O
resulted	O
in	O
primers	O
specific	O
for	O
this	O
distal	O
duplication	O
.	O

Polymerase	O
chain	O
reaction	O
-	O
based	O
screening	O
of	O
cDNA	O
libraries	O
indicates	O
that	O
this	O
transcript	O
,	O
called	O
RanBP2alpha	B
(	O
HGMW	O
-	O
approved	O
symbol	O
RANBP2L1	B
)	O
,	O
is	O
expressed	O
in	O
several	O
tissues	O
.	O

Screening	O
of	O
a	O
fetal	O
brain	O
cDNA	O
library	O
yielded	O
a	O
4057-bp	O
partial	O
cDNA	O
clone	O
for	O
RanBP2alpha	B
.	O

Its	O
5'-end	O
is	O
almost	O
identical	O
to	O
RanBP2	B
,	O
whereas	O
its	O
3'-part	O
is	O
distinct	O
from	O
RanBP2	B
.	O

Northern	O
blot	O
analysis	O
using	O
a	O
probe	O
of	O
the	O
3'-untranslated	O
sequence	O
of	O
RanBP2alpha	B
detected	O
in	O
several	O
tissues	O
an	O
8-kb	O
transcript	O
representing	O
the	O
full	O
length	O
of	O
the	O
transcript	O
.	O

In	O
pancreas	O
and	O
placenta	O
,	O
an	O
additional	O
transcript	O
of	O
14	O
kb	O
was	O
detected	O
.	O

PAC	O
clones	O
containing	O
the	O
bona	O
fide	O
RanBP2	B
sequences	O
were	O
localized	O
to	O
2q11-q12	O
by	O
FISH	O
analysis	O
,	O
and	O
a	O
region	O
of	O
high	O
similarity	O
was	O
detected	O
on	O
2p11-p12	O
.	O

In	O
summary	O
,	O
we	O
have	O
identified	O
a	O
RanBP2	B
gene	O
cluster	O
on	O
2q11-q12	O
together	O
with	O
a	O
novel	O
gene	O
termed	O
RanBP2alpha	B
,	O
with	O
high	O
sequence	O
similarity	O
to	O
RanBP2	B
.	O

Human	O
mitochondrial	O
function	O
during	O
cardiac	O
growth	O
and	O
development	O
.	O

Little	O
information	O
is	O
presently	O
available	O
concerning	O
mitochondrial	O
respiratory	O
and	O
oxidative	O
phosphorylation	O
function	O
in	O
the	O
normal	O
human	O
heart	O
during	O
growth	O
and	O
development	O
.	O

We	O
investigated	O
the	O
levels	O
of	O
specific	O
mitochondrial	O
enzyme	O
activities	O
and	O
content	O
during	O
cardiac	O
growth	O
and	O
development	O
from	O
the	O
early	O
neonatal	O
period	O
(	O
10	O
-	O
20	O
days	O
)	O
to	O
adulthood	O
(	O
67	O
years	O
)	O
.	O

Biochemical	O
analysis	O
of	O
enzyme	O
specific	O
activities	O
and	O
content	O
and	O
mitochondrial	O
DNA	O
(	O
mtDNA	O
)	O
copy	O
number	O
was	O
performed	O
with	O
left	O
ventricular	O
tissues	O
derived	O
from	O
30	O
control	O
individuals	O
.	O

The	O
levels	O
of	O
cytochrome	O
c	O
oxidase	O
(	O
COX	O
)	O
and	O
complex	O
V	O
specific	O
activity	O
,	O
mtDNA	O
copy	O
number	O
and	O
COX	B
subunit	I
II	I
content	O
remained	O
unchanged	O
in	O
contrast	O
to	O
increased	O
citrate	B
synthase	I
(	O
CS	B
)	O
activity	O
and	O
content	O
.	O

The	O
developmental	O
increase	O
in	O
CS	B
activity	O
paralleled	O
increasing	O
CS	B
polypeptide	O
content	O
,	O
but	O
was	O
neither	O
related	O
to	O
overall	O
increases	O
in	O
mitochondrial	O
number	O
nor	O
coordinately	O
regulated	O
with	O
mitochondrial	O
respiratory	O
enzyme	O
activities	O
.	O

Our	O
findings	O
of	O
unchanged	O
levels	O
of	O
cardiac	O
mitochondrial	O
respiratory	O
enzyme	O
activity	O
during	O
the	O
progression	O
from	O
early	O
childhood	O
to	O
older	O
adult	O
contrasts	O
with	O
the	O
age	O
-	O
specific	O
regulation	O
found	O
with	O
CS	B
,	O
a	O
Krebs	O
cycle	O
mitochondrial	O
enzyme	O
.	O

Interaction	O
of	O
polyadenylate	O
-	O
binding	O
protein	O
with	O
the	O
eIF4	B
G	I
homologue	O
PAIP	B
enhances	O
translation	O
.	O

In	O
the	O
initiation	O
of	O
translation	O
in	O
eukaryotes	O
,	O
binding	O
of	O
the	O
small	O
ribosomal	O
subunit	O
to	O
the	O
messenger	O
RNA	O
results	O
from	O
recognition	O
of	O
the	O
5	O
'	O
cap	O
structure	O
(	O
m7GpppX	O
)	O
of	O
the	O
mRNA	O
by	O
the	O
cap	O
-	O
binding	O
complex	O
eIF4F	B
.	O

eIF4F	B
is	O
itself	O
a	O
three	O
-	O
subunit	O
complex	O
comprising	O
the	O
cap	O
-	O
binding	O
protein	O
eIF4E	B
,	O
eIF4A	O
,	O
an	O
ATP	O
-	O
dependent	O
RNA	O
helicase	O
,	O
and	O
eIF4	B
G	I
,	O
which	O
interacts	O
with	O
both	O
eIF4A	O
and	O
eIF4E	B
and	O
enhances	O
cap	O
binding	O
by	O
eIF4E	B
.	O

The	O
mRNA	O
3	O
'	O
polyadenylate	O
tail	O
and	O
the	O
associated	O
poly	B
(	I
A	I
)	I
-binding	I
protein	I
(	O
PABP	B
)	O
also	O
regulate	O
translational	O
initiation	O
,	O
probably	O
by	O
interacting	O
with	O
the	O
5	O
'	O
end	O
of	O
the	O
mRNA	O
.	O

In	O
yeast	O
and	O
plants	O
,	O
PABP	B
interacts	O
with	O
eIF4	B
G	I
but	O
no	O
such	O
interaction	O
has	O
been	O
reported	O
in	O
mammalian	O
cells	O
.	O

Here	O
,	O
we	O
describe	O
a	O
new	O
human	O
PABP	B
-	O
interacting	O
protein	O
,	O
PAIP	B
-	I
I	I
,	O
whose	O
sequence	O
is	O
similar	O
to	O
the	O
central	O
portion	O
of	O
eIF4	B
G	I
and	O
which	O
interacts	O
with	O
eIF4A	O
.	O

Overexpression	O
of	O
PAIP-1	B
in	O
COS-7	O
cells	O
stimulates	O
translation	O
,	O
perhaps	O
by	O
providing	O
a	O
physical	O
link	O
between	O
the	O
mRNA	O
termini	O
.	O

Mutations	O
in	O
the	O
human	O
alpha	B
-	I
tectorin	I
gene	O
cause	O
autosomal	O
dominant	O
non	O
-	O
syndromic	O
hearing	O
impairment	O
.	O

The	O
tectorial	O
membrane	O
is	O
an	O
extracellular	O
matrix	O
of	O
the	O
inner	O
ear	O
that	O
contacts	O
the	O
stereocilia	O
bundles	O
of	O
specialized	O
sensory	O
hair	O
cells	O
.	O

Sound	O
induces	O
movement	O
of	O
these	O
hair	O
cells	O
relative	O
to	O
the	O
tectorial	O
membrane	O
,	O
deflects	O
the	O
stereocilia	O
,	O
and	O
leads	O
to	O
fluctuations	O
in	O
hair	O
-	O
cell	O
membrane	O
potential	O
,	O
transducing	O
sound	O
into	O
electrical	O
signals	O
.	O

Alpha	B
-	I
tectorin	I
is	O
one	O
of	O
the	O
major	O
non	O
-	O
collagenous	O
components	O
of	O
the	O
tectorial	O
membrane	O
.	O

Recently	O
,	O
the	O
gene	O
encoding	O
mouse	O
alpha	B
-	I
tectorin	I
(	O
Tecta	B
)	O
was	O
mapped	O
to	O
a	O
region	O
of	O
mouse	O
chromosome	O
9	O
,	O
which	O
shows	O
evolutionary	O
conservation	O
with	O
human	O
chromosome	O
11q	O
(	O
ref	O
.	O

3	O
)	O
,	O
where	O
linkage	O
was	O
found	O
in	O
two	O
families	O
,	O
one	O
Belgian	O
(	O
DFNA12	B
;	O
ref	O
.	O

4	O
)	O
and	O
the	O
other	O
,	O
Austrian	O
(	O
DFNA8	B
;	O
unpublished	O
data	O
)	O
,	O
with	O
autosomal	O
dominant	O
non	O
-	O
syndromic	O
hearing	O
impairment	O
.	O

We	O
determined	O
the	O
complete	O
sequence	O
and	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
human	O
TECTA	B
gene	O
.	O

In	O
both	O
families	O
,	O
mutation	O
analysis	O
revealed	O
missense	O
mutations	O
which	O
replace	O
conserved	O
amino	O
-	O
acid	O
residues	O
within	O
the	O
zona	O
pellucida	O
domain	O
of	O
TECTA	B
.	O

These	O
findings	O
indicate	O
that	O
mutations	O
in	O
TECTA	B
are	O
responsible	O
for	O
hearing	O
impairment	O
in	O
these	O
families	O
,	O
and	O
implicate	O
a	O
new	O
type	O
of	O
protein	O
in	O
the	O
pathogenesis	O
of	O
hearing	O
impairment	O
.	O

p63	B
,	O
a	O
p53	B
homolog	I
at	O
3q27	O
-	O
29	O
,	O
encodes	O
multiple	O
products	O
with	O
transactivating	O
,	O
death	O
-	O
inducing	O
,	O
and	O
dominant	O
-	O
negative	O
activities	O
.	O

We	O
describe	O
the	O
cloning	O
of	O
p63	B
,	O
a	O
gene	O
at	O
chromosome	O
3q27	O
-	O
29	O
that	O
bears	O
strong	O
homology	O
to	O
the	O
tumor	O
suppressor	O
p53	B
and	O
to	O
the	O
related	O
gene	O
,	O
p73	B
.	O

p63	B
was	O
detected	O
in	O
a	O
variety	O
of	O
human	O
and	O
mouse	O
tissues	O
,	O
including	O
proliferating	O
basal	O
cells	O
of	O
epithelial	O
layers	O
in	O
the	O
epidermis	O
,	O
cervix	O
,	O
urothelium	O
,	O
and	O
prostate	O
.	O

Unlike	O
p53	B
,	O
the	O
p63	B
gene	O
encodes	O
multiple	O
isotypes	O
with	O
remarkably	O
divergent	O
abilities	O
to	O
transactivate	O
p53	B
reporter	O
genes	O
and	O
induce	O
apoptosis	O
.	O

Importantly	O
,	O
the	O
predominant	O
p63	B
isotypes	O
in	O
many	O
epithelial	O
tissues	O
lack	O
an	O
acidic	O
N	O
terminus	O
corresponding	O
to	O
the	O
transactivation	O
domain	O
of	O
p53	B
.	O

We	O
demonstrate	O
that	O
these	O
truncated	O
p63	B
variants	O
can	O
act	O
as	O
dominant	O
-	O
negative	O
agents	O
toward	O
transactivation	O
by	O
p53	B
and	O
p63	B
,	O
and	O
we	O
suggest	O
the	O
possibility	O
of	O
physiological	O
interactions	O
among	O
members	O
of	O
the	O
p53	B
family	O
.	O

Diva	B
,	O
a	O
Bcl-2	B
homologue	O
that	O
binds	O
directly	O
to	O
Apaf-1	B
and	O
induces	O
BH3-independent	O
cell	O
death	O
.	O

We	O
have	O
identified	O
and	O
characterized	O
Diva	B
,	O
which	O
is	O
a	O
novel	O
regulator	O
of	O
apoptosis	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
Diva	B
is	O
a	O
member	O
of	O
the	O
Bcl-2	B
family	O
of	O
proteins	O
containing	O
Bcl-2	B
homology	O
domain	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
(	O
BH1	O
,	O
BH2	O
,	O
BH3	O
,	O
and	O
BH4	O
)	O
regions	O
and	O
a	O
carboxyl	O
-	O
terminal	O
hydrophobic	O
domain	O
.	O

The	O
expression	O
of	O
Diva	B
mRNA	O
was	O
detected	O
in	O
multiple	O
embryonic	O
tissues	O
but	O
was	O
restricted	O
to	O
the	O
ovary	O
and	O
testis	O
in	O
adult	O
mice	O
.	O

The	O
expression	O
of	O
Diva	B
promoted	O
the	O
death	O
of	O
293	O
T	O
,	O
Ramsey	O
,	O
and	O
T47D	O
cells	O
as	O
well	O
as	O
that	O
of	O
primary	O
sensory	O
neurons	O
,	O
indicating	O
that	O
Diva	B
is	O
a	O
proapoptotic	O
protein	O
.	O

Significantly	O
,	O
Diva	B
lacks	O
critical	O
residues	O
in	O
the	O
conserved	O
BH3	O
region	O
that	O
mediate	O
the	O
interaction	O
between	O
BH3-containing	O
proapoptotic	O
Bcl-2	B
homologues	O
and	O
their	O
prosurvival	O
binding	O
partners	O
.	O

Consistent	O
with	O
this	O
,	O
Diva	B
did	O
not	O
bind	O
to	O
cellular	O
Bcl-2	B
family	O
members	O
including	O
Bcl-2	B
,	O
Bcl	B
-	I
XL	I
,	O
Bcl	B
-	I
w	I
,	O
Mcl-1	B
,	O
and	O
A1	B
/	O
Bfl-1	B
.	O

Furthermore	O
,	O
mutants	O
of	O
Diva	B
lacking	O
the	O
BH3	O
region	O
fully	O
retained	O
their	O
proapoptotic	O
activity	O
,	O
confirming	O
that	O
Diva	B
promotes	O
apoptosis	O
in	O
a	O
BH3-independent	O
manner	O
.	O

Significantly	O
,	O
Diva	B
interacted	O
with	O
a	O
viral	O
Bcl-2	B
homologue	O
(	O
vBcl-2	O
)	O
encoded	O
by	O
the	O
Kaposi	O
's	O
sarcoma	O
-	O
associated	O
herpesvirus	O
.	O

Consistent	O
with	O
these	O
associations	O
,	O
apoptosis	O
induced	O
by	O
Diva	B
was	O
inhibited	O
by	O
vBcl-2	O
but	O
not	O
by	O
Bcl	B
-	I
XL	I
.	O

Importantly	O
,	O
Diva	B
interacted	O
with	O
Apaf-1	B
,	O
an	O
adapter	O
molecule	O
that	O
activates	O
caspase-9	B
,	O
a	O
central	O
death	O
protease	O
of	O
the	O
apoptotic	O
pathway	O
.	O

The	O
expression	O
of	O
Diva	B
inhibited	O
the	O
binding	O
of	O
Bcl	B
-	I
XL	I
to	O
Apaf-1	B
,	O
as	O
determined	O
by	O
immunoprecipitation	O
assays	O
.	O

Thus	O
,	O
Diva	B
represents	O
a	O
novel	O
type	O
of	O
proapoptotic	O
Bcl-2	B
homologue	O
that	O
promotes	O
apoptosis	O
independently	O
of	O
the	O
BH3	O
region	O
through	O
direct	O
binding	O
to	O
Apaf-1	B
,	O
thus	O
preventing	O
Bcl	B
-	I
XL	I
from	O
binding	O
to	O
the	O
caspase-9	B
regulator	O
Apaf-1	B
.	O

Nhp2p	B
and	O
Nop10p	B
are	O
essential	O
for	O
the	O
function	O
of	O
H	O
/	O
ACA	O
snoRNPs	O
.	O

The	O
small	O
nucleolar	O
ribonucleoprotein	O
particles	O
containing	O
H	O
/	O
ACA	O
-	O
type	O
snoRNAs	O
(	O
H	O
/	O
ACA	O
snoRNPs	O
)	O
are	O
crucial	O
trans	O
-	O
acting	O
factors	O
intervening	O
in	O
eukaryotic	O
ribosome	O
biogenesis	O
.	O

Most	O
of	O
these	O
particles	O
generate	O
the	O
site	O
-	O
specific	O
pseudouridylation	O
of	O
rRNAs	O
while	O
a	O
subset	O
are	O
required	O
for	O
18S	O
rRNA	O
synthesis	O
.	O

To	O
understand	O
in	O
detail	O
how	O
these	O
particles	O
carry	O
out	O
these	O
functions	O
,	O
all	O
of	O
their	O
protein	O
components	O
have	O
to	O
be	O
characterized	O
.	O

For	O
that	O
purpose	O
,	O
we	O
have	O
affinity	O
-	O
purified	O
complexes	O
containing	O
epitope	O
-	O
tagged	O
Gar1p	B
protein	O
,	O
previously	O
shown	O
to	O
be	O
part	O
of	O
H	O
/	O
ACA	O
snoRNPs	O
.	O

Under	O
the	O
conditions	O
used	O
,	O
three	O
polypeptides	O
of	O
65	O
,	O
22	O
and	O
10	O
kDa	O
apparent	O
molecular	O
weight	O
specifically	O
copurify	O
with	O
epitope	O
-	O
tagged	O
Gar1p	B
.	O

The	O
22	O
and	O
10	O
kDa	O
polypeptides	O
were	O
identified	O
as	O
Nhp2p	B
and	O
a	O
novel	O
protein	O
we	O
termed	O
Nop10p	B
,	O
respectively	O
.	O

Both	O
proteins	O
are	O
conserved	O
,	O
essential	O
and	O
present	O
in	O
the	O
dense	O
fibrillar	O
component	O
of	O
the	O
nucleolus	O
.	O

Nhp2p	B
and	O
Nop10p	B
are	O
specifically	O
associated	O
with	O
all	O
H	O
/	O
ACA	O
snoRNAs	O
and	O
are	O
essential	O
to	O
the	O
function	O
of	O
H	O
/	O
ACA	O
snoRNPs	O
.	O

Cells	O
lacking	O
Nhp2p	B
or	O
Nop10p	B
are	O
impaired	O
in	O
global	O
rRNA	O
pseudouridylation	O
and	O
in	O
the	O
A1	O
and	O
A2	O
cleavage	O
steps	O
of	O
the	O
pre	O
-	O
rRNA	O
required	O
for	O
the	O
synthesis	O
of	O
mature	O
18S	O
rRNA	O
.	O

These	O
phenotypes	O
are	O
probably	O
a	O
direct	O
consequence	O
of	O
the	O
instability	O
of	O
H	O
/	O
ACA	O
snoRNAs	O
and	O
Gar1p	B
observed	O
in	O
cells	O
deprived	O
of	O
Nhp2p	B
or	O
Nop10p	B
.	O

Our	O
results	O
suggest	O
that	O
Nhp2p	B
and	O
Nop10p	B
,	O
together	O
with	O
Cbf5p	O
,	O
constitute	O
the	O
core	O
of	O
H	O
/	O
ACA	O
snoRNPs	O
.	O

Cloning	O
and	O
characterization	O
of	O
CRF	B
,	O
a	O
novel	O
C1q	B
-	I
related	I
factor	I
,	O
expressed	O
in	O
areas	O
of	O
the	O
brain	O
involved	O
in	O
motor	O
function	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
a	O
novel	O
cDNA	O
,	O
C1q	B
-	I
Related	I
Factor	I
(	O
CRF	B
)	O
,	O
that	O
is	O
predicted	O
to	O
encode	O
a	O
258	O
amino	O
acid	O
polypeptide	O
with	O
a	O
hydrophobic	O
signal	O
sequence	O
,	O
a	O
collagenous	O
region	O
,	O
and	O
a	O
globular	O
domain	O
at	O
the	O
carboxy	O
terminus	O
that	O
shares	O
homology	O
to	O
the	O
C1q	O
signature	O
domain	O
.	O

Human	O
CRF	B
transcript	O
is	O
expressed	O
at	O
highest	O
levels	O
in	O
the	O
brain	O
,	O
particularly	O
in	O
the	O
brainstem	O
.	O

In	O
situ	O
hybridization	O
to	O
mouse	O
brain	O
sections	O
demonstrated	O
that	O
CRF	B
transcripts	O
are	O
most	O
abundant	O
in	O
areas	O
of	O
the	O
nervous	O
system	O
involved	O
in	O
motor	O
function	O
,	O
such	O
as	O
the	O
Purkinje	O
cells	O
of	O
the	O
cerebellum	O
,	O
the	O
accessory	O
olivary	O
nucleus	O
,	O
the	O
pons	O
and	O
the	O
red	O
nucleus	O
.	O

The	O
mouse	O
CRF	B
homolog	O
is	O
highly	O
similar	O
to	O
the	O
human	O
gene	O
at	O
both	O
the	O
nucleotide	O
and	O
protein	O
level	O
,	O
suggesting	O
an	O
important	O
conserved	O
role	O
for	O
this	O
protein	O
.	O

Mutations	O
in	O
the	O
Punch	B
locus	O
result	O
in	O
loss	O
of	O
GTP	B
cyclohydrolase	I
activity	O
,	O
but	O
all	O
mutations	O
do	O
not	O
affect	O
the	O
enzyme	O
in	O
the	O
same	O
way	O
.	O

There	O
are	O
at	O
least	O
three	O
classes	O
of	O
Punch	B
mutations	O
.	O

One	O
class	O
results	O
in	O
a	O
dominant	O
eye	O
color	O
,	O
recessive	O
lethal	O
phenotype	O
.	O

A	O
second	O
class	O
of	O
mutations	O
also	O
causes	O
a	O
recessive	O
lethal	O
phenotype	O
,	O
but	O
heterozygous	O
mutants	O
have	O
normal	O
eye	O
color	O
.	O

They	O
show	O
loss	O
of	O
GTP	B
cyclohydrolase	I
function	O
in	O
all	O
tissues	O
where	O
activity	O
can	O
be	O
measured	O
.	O

Alleles	O
comprising	O
a	O
third	O
class	O
are	O
recessive	O
eye	O
color	O
mutations	O
that	O
are	O
homozygous	O
viable	O
.	O

Individuals	O
with	O
this	O
third	O
type	O
of	O
mutation	O
show	O
loss	O
of	O
enzyme	O
activity	O
in	O
the	O
eye	O
,	O
but	O
show	O
normal	O
or	O
near	O
-	O
normal	O
activity	O
elsewhere	O
.	O

In	O
order	O
to	O
examine	O
the	O
organization	O
and	O
function	O
of	O
this	O
locus	O
further	O
,	O
we	O
have	O
performed	O
interallelic	O
complementation	O
tests	O
on	O
25	O
Punch	B
mutations	O
,	O
monitoring	O
viability	O
and	O
enzyme	O
activity	O
in	O
prepupae	O
and	O
adults	O
.	O

Most	O
allele	O
combinations	O
are	O
lethal	O
.	O

Those	O
that	O
complement	O
do	O
so	O
in	O
ways	O
that	O
are	O
tissue	O
-	O
or	O
stage	O
-	O
specific	O
and	O
unpredictable	O
.	O

Tests	O
of	O
mutants	O
with	O
tissue	O
-	O
specific	O
phenotypes	O
and	O
of	O
individuals	O
mutant	O
for	O
complementing	O
Punch	B
lethal	O
alleles	O
lead	O
us	O
to	O
conclude	O
that	O
Punch	B
is	O
a	O
complex	O
locus	O
,	O
both	O
with	O
respect	O
to	O
its	O
organization	O
and	O
to	O
its	O
products	O
.	O

Screening	O
a	O
genomic	O
library	O
of	O
Drosophila	O
melanogaster	O
DNA	O
with	O
a	O
human	O
fur	O
cDNA	O
probe	O
resulted	O
in	O
the	O
isolation	O
of	O
DNA	O
clones	O
that	O
apparently	O
belonged	O
to	O
two	O
different	O
DNA	O
regions	O
of	O
the	O
Drosophila	O
genome	O
.	O

Subsequently	O
,	O
corresponding	O
Drosophila	O
cDNA	O
clones	O
were	O
isolated	O
.	O

Nucleotide	O
sequence	O
analysis	O
indicated	O
that	O
these	O
cDNA	O
clones	O
originated	O
from	O
two	O
different	O
genes	O
,	O
which	O
were	O
called	O
Dfur1	B
and	O
Dfur2	B
.	O

From	O
overlapping	O
Dfur1	B
cDNA	O
clones	O
,	O
a	O
composite	O
cDNA	O
could	O
be	O
constructed	O
and	O
analysis	O
of	O
its	O
nucleotide	O
sequence	O
revealed	O
the	O
coding	O
sequence	O
for	O
a	O
protein	O
of	O
899	O
amino	O
acid	O
residues	O
.	O

This	O
protein	O
,	O
designated	O
Dfurin1	B
,	O
exhibited	O
striking	O
sequence	O
homology	O
to	O
human	O
furin	B
and	O
contained	O
the	O
same	O
protein	O
domains	O
except	O
for	O
the	O
cysteine	O
-	O
rich	O
region	O
.	O

Furthermore	O
,	O
unlike	O
human	O
furin	B
,	O
Dfurin1	B
possessed	O
an	O
extended	O
amino	O
-	O
terminal	O
region	O
in	O
which	O
a	O
potential	O
transmembrane	O
anchor	O
was	O
present	O
.	O

Mutations	O
at	O
the	O
pipsqueak	B
locus	O
affect	O
early	O
patterning	O
in	O
the	O
Drosophila	O
egg	O
and	O
embryo	O
.	O

We	O
have	O
cloned	O
pipsqueak	B
and	O
found	O
that	O
it	O
is	O
a	O
large	O
and	O
complex	O
gene	O
,	O
encoding	O
multiple	O
transcripts	O
and	O
protein	O
isoforms	O
.	O

One	O
protein	O
,	O
PsqA	O
,	O
is	O
absent	O
in	O
all	O
of	O
the	O
mutants	O
that	O
we	O
have	O
examined	O
.	O

We	O
show	O
that	O
PsqA	O
is	O
a	O
nuclear	O
protein	O
present	O
in	O
the	O
germ	O
cells	O
and	O
somatically	O
derived	O
follicle	O
cells	O
throughout	O
oogenesis	O
and	O
that	O
it	O
is	O
required	O
prior	O
to	O
stage	O
one	O
of	O
oogenesis	O
.	O

PsqA	O
contains	O
a	O
BTB	O
(	O
POZ	O
)	O
domain	O
at	O
its	O
amino	O
terminus	O
;	O
additionally	O
,	O
we	O
have	O
identified	O
an	O
evolutionarily	O
conserved	O
motif	O
of	O
unknown	O
function	O
present	O
four	O
times	O
in	O
tandem	O
at	O
the	O
C	O
terminus	O
of	O
the	O
protein	O
.	O

PZ	O
pipsqueak	B
mutants	O
produce	O
a	O
putative	O
fusion	O
protein	O
containing	O
the	O
pipsqueak	B
BTB	O
domain	O
fused	O
to	O
sequences	O
resident	O
on	O
the	O
PZ	O
element	O
(	O
H.	O
Horowitz	O
and	O
C.	O
Berg	O
,	O
1995	O
Genetics	O
139	O
,	O
327	O
-	O
335	O
)	O
.	O

We	O
demonstrate	O
here	O
that	O
expression	O
of	O
this	O
fusion	O
protein	O
in	O
wild	O
-	O
type	O
flies	O
has	O
a	O
dominant	O
effect	O
,	O
resulting	O
in	O
infertility	O
and	O
eggshell	O
defects	O
.	O

These	O
dominant	O
phenotypes	O
are	O
discussed	O
in	O
light	O
of	O
current	O
theories	O
on	O
the	O
role	O
of	O
the	O
BTB	O
domain	O
in	O
protein	O
-	O
protein	O
interactions	O
.	O

Complementary	O
DNA	O
sequences	O
were	O
cloned	O
from	O
a	O
Drosophila	O
library	O
encoding	O
a	O
1,101	O
amino	O
acid	O
polypeptide	O
that	O
we	O
have	O
named	O
dKLIP-1	B
.	O

The	O
deduced	O
protein	O
is	O
structurally	O
similar	O
to	O
the	O
yeast	O
KEX2	O
prohormone	O
endoprotease	O
including	O
the	O
conserved	O
Asp	O
,	O
His	O
,	O
and	O
Ser	O
catalytic	O
triad	O
residues	O
characteristic	O
of	O
the	O
subtilisin	O
family	O
.	O

When	O
coexpressed	O
in	O
vivo	O
with	O
pro	O
-	O
beta	O
-	O
NGF	O
,	O
dKLIP-1	B
greatly	O
enhanced	O
the	O
endoproteolytic	O
conversion	O
of	O
the	O
precursor	O
to	O
mature	O
beta	O
-	O
NGF	O
by	O
cleavage	O
at	O
a	O
-Lys	O
-	O
Arg-	O
doublet	O
.	O

In	O
adults	O
,	O
dKLIP-1	B
transcripts	O
were	O
detected	O
in	O
cortical	O
regions	O
of	O
the	O
CNS	O
and	O
fat	O
body	O
.	O

Most	O
striking	O
,	O
however	O
,	O
was	O
the	O
high	O
level	O
of	O
maternal	O
transcripts	O
deposited	O
into	O
developing	O
oocytes	O
.	O

The	O
temporal	O
and	O
spatial	O
expression	O
of	O
dKLIP-1	B
mRNAs	O
during	O
embryonic	O
development	O
indicates	O
a	O
potential	O
role	O
for	O
this	O
novel	O
Kex2p	O
-	O
like	O
endoprotease	O
in	O
early	O
embryogenesis	O
and	O
neurogenesis	O
.	O

A	O
transient	O
expression	O
assay	O
was	O
used	O
to	O
localize	O
cis	O
-	O
acting	O
DNA	O
regulatory	O
elements	O
near	O
the	O
Drosophila	O
heat	O
shock	O
protein	O
(	O
hsp	O
)	O
22	B
gene	O
,	O
that	O
are	O
involved	O
in	O
heat	O
shock	O
expression	O
and	O
in	O
ecdysterone	O
-	O
induced	O
expression	O
.	O

The	O
results	O
identify	O
a	O
region	O
between	O
positions	O
-320	O
and	O
-232	O
that	O
is	O
essential	O
for	O
ecdysterone	O
control	O
,	O
but	O
not	O
for	O
heat	O
-	O
induced	O
expression	O
,	O
and	O
a	O
sequence	O
between	O
-199	O
and	O
-156	O
,	O
which	O
,	O
when	O
deleted	O
,	O
leads	O
to	O
the	O
loss	O
of	O
heat	O
shock	O
induction	O
.	O

To	O
investigate	O
the	O
function	O
of	O
these	O
DNA	O
sequences	O
,	O
transfection	O
-	O
competition	O
experiments	O
were	O
carried	O
out	O
.	O

The	O
evidence	O
suggests	O
that	O
the	O
DNA	O
regulatory	O
sequences	O
identified	O
by	O
transient	O
expression	O
studies	O
contain	O
binding	O
sites	O
for	O
transacting	O
transcription	O
factors	O
.	O

Unique	O
amino	O
acid	O
substitutions	O
occur	O
in	O
D.	O
lebanonensis	O
ADH	B
.	O

They	O
are	O
found	O
within	O
the	O
putative	O
NAD	O
(	O
+	O
)	O
-binding	O
domain	O
and	O
affect	O
residues	O
that	O
are	O
otherwise	O
highly	O
conserved	O
in	O
all	O
other	O
species	O
of	O
the	O
genus	O
.	O

To	O
restore	O
the	O
consensus	O
amino	O
acids	O
,	O
we	O
have	O
constructed	O
an	O
expression	O
system	O
for	O
this	O
enzyme	O
in	O
E.	O
coli	O
,	O
and	O
engineered	O
two	O
mutants	O
,	O
Ala13Gly	O
and	O
Asn56Thr	O
.	O

The	O
biochemical	O
and	O
kinetic	O
features	O
of	O
these	O
retromutants	O
are	O
consistent	O
with	O
increased	O
catalytic	O
efficiency	O
and	O
thermal	O
stability	O
.	O

Thus	O
,	O
results	O
show	O
that	O
wild	O
-	O
type	O
D.	O
lebanonensis	O
ADH	B
can	O
be	O
improved	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O

A	O
recombinant	O
Charon	O
4	B
bacteriophage	O
has	O
been	O
isolated	O
on	O
the	O
basis	O
of	O
RNAs	O
which	O
are	O
enriched	O
in	O
the	O
head	O
of	O
the	O
adult	O
Drosophila	O
melanogaster	O
and	O
hence	O
are	O
likely	O
to	O
be	O
of	O
neural	O
origin	O
.	O

The	O
cloned	O
insert	O
maps	O
to	O
the	O
near	O
vicinity	O
of	O
the	O
uncoordinated	B
locus	O
in	O
polytene	O
chromosome	O
band	O
19E8	O
.	O

This	O
band	O
is	O
within	O
the	O
transition	O
zone	O
between	O
the	O
euchromatic	O
and	O
heterochromatic	O
regions	O
of	O
the	O
X	O
chromosome	O
,	O
a	O
region	O
which	O
has	O
been	O
well	O
characterized	O
cytogenetically	O
.	O

The	O
insert	O
contains	O
both	O
repetitious	O
and	O
low	O
copy	O
number	O
sequences	O
,	O
some	O
of	O
which	O
vary	O
extensively	O
in	O
both	O
frequency	O
and	O
restriction	O
fragment	O
size	O
between	O
different	O
laboratory	O
strains	O
.	O

One	O
particular	O
family	O
of	O
moderately	O
repeated	O
sequences	O
occurs	O
predominantly	O
in	O
divisions	O
19	O
and	O
20	B
of	O
the	O
X	O
chromosome	O
and	O
perhaps	O
the	O
distally	O
located	O
X	O
heterochromatin	O
.	O

The	O
molecular	O
landscape	O
surrounding	O
the	O
initial	O
entry	O
point	O
contains	O
many	O
repeated	O
sequences	O
and	O
is	O
thus	O
unlike	O
those	O
observed	O
in	O
most	O
published	O
chromosomal	O
walks	O
.	O

The	O
possible	O
significance	O
of	O
the	O
presence	O
of	O
repeated	O
families	O
in	O
the	O
distinct	O
properties	O
of	O
this	O
region	O
are	O
discussed	O
.	O

Homoeo	O
-	O
box	O
genes	O
play	O
a	O
central	O
role	O
in	O
the	O
regulation	O
of	O
embryogenesis	O
in	O
Drosophila	O
melanogaster	O
.	O

Their	O
widespread	O
phylogenetic	O
distribution	O
,	O
and	O
the	O
tissue	O
and	O
stage	O
specificity	O
of	O
their	O
expression	O
in	O
other	O
organisms	O
,	O
argue	O
that	O
they	O
play	O
a	O
general	O
and	O
significant	O
role	O
in	O
animal	O
development	O
.	O

In	O
D.	O
melanogaster	O
,	O
all	O
homoeo	O
-	O
box	O
genes	O
characterized	O
to	O
date	O
are	O
involved	O
in	O
major	O
aspects	O
of	O
embryogenesis	O
.	O

We	O
report	O
here	O
the	O
molecular	O
characterization	O
of	O
a	O
Drosophila	O
homoeo	O
-	O
box	O
gene	O
that	O
has	O
no	O
apparent	O
involvement	O
in	O
early	O
embryogenesis	O
.	O

The	O
gene	O
appears	O
to	O
be	O
rough	B
,	O
a	O
gene	O
implicated	O
in	O
pattern	O
formation	O
in	O
the	O
developing	O
eye	O
.	O

It	O
is	O
expressed	O
in	O
cells	O
within	O
,	O
and	O
posterior	O
to	O
,	O
the	O
morphogenetic	O
furrow	O
,	O
the	O
site	O
of	O
the	O
primary	O
pattern	O
forming	O
events	O
in	O
the	O
developing	O
retina	O
,	O
and	O
also	O
in	O
a	O
region	O
of	O
the	O
brain	O
of	O
the	O
third	O
instar	O
larva	O
.	O

We	O
have	O
found	O
no	O
genetic	O
or	O
molecular	O
evidence	O
of	O
a	O
role	O
for	O
this	O
gene	O
in	O
other	O
aspects	O
of	O
fly	O
development	O
.	O

An	O
MR	O
element	O
that	O
maps	O
to	O
a	O
specific	O
locus	O
in	O
chromosome	O
3	O
of	O
Drosophila	O
melanogaster	O
has	O
the	O
unusual	O
feature	O
of	O
producing	O
complete	O
P	B
(	O
a	O
mobile	O
element	O
)	O
sequence	O
mutations	O
at	O
several	O
X	B
chromosome	O
loci	O
.	O

This	O
MR	O
also	O
increases	O
the	O
frequency	O
of	O
mitotic	O
recombination	O
.	O

Evidence	O
is	O
given	O
for	O
the	O
transposition	O
of	O
MR	O
.	O

The	O
complete	O
P	B
insertion	O
mutations	O
are	O
autonomously	O
unstable	O
and	O
are	O
capable	O
of	O
causing	O
otherwise	O
stable	O
incomplete	O
(	O
defective	O
)	O
P	B
insertion	O
mutations	O
to	O
revert	O
.	O

These	O
results	O
complement	O
the	O
analysis	O
of	O
P	B
element	I
functions	O
with	O
a	O
synthetic	O
complete	O
P	B
derivative	O
.	O

The	O
genetic	O
basis	O
for	O
the	O
mutational	O
-	O
mitotic	O
recombinational	O
components	O
of	O
""""	O
hybrid	O
dysgenesis	O
""""	O
is	O
conveniently	O
explicable	O
in	O
terms	O
of	O
MR	O
elements	O
present	O
in	O
the	O
genomes	O
of	O
flies	O
present	O
in	O
the	O
wild	O
.	O

Recombinant	O
DNA	O
carrying	O
the	O
3-kilobase	O
transposable	O
element	O
was	O
injected	O
into	O
Drosophila	O
embryos	O
of	O
a	O
strain	O
that	O
lacked	O
such	O
elements	O
.	O

Under	O
optimum	O
conditions	O
,	O
half	O
of	O
the	O
surviving	O
embryos	O
showed	O
evidence	O
of	O
P	B
element	I
-	O
induced	O
mutations	O
in	O
a	O
fraction	O
of	O
their	O
progeny	O
.	O

Direct	O
analysis	O
of	O
the	O
DNA	O
of	O
strains	O
derived	O
from	O
such	O
flies	O
showed	O
them	O
to	O
contain	O
from	O
one	O
to	O
five	O
intact	O
3-kilobase	O
P	B
elements	O
located	O
at	O
a	O
wide	O
variety	O
of	O
chromosomal	O
sites	O
.	O

DNA	O
sequences	O
located	O
outside	O
the	O
P	B
element	I
on	O
the	O
injected	O
DNA	O
were	O
not	O
transferred	O
.	O

Thus	O
P	B
elements	O
can	O
efficiently	O
and	O
selectively	O
transpose	O
from	O
extrachromosomal	O
DNA	O
to	O
the	O
DNA	O
of	O
germ	O
line	O
chromosomes	O
in	O
Drosophila	O
embryos	O
.	O

These	O
observations	O
provide	O
the	O
basis	O
for	O
efficient	O
DNA	O
-	O
mediated	O
gene	O
transfer	O
in	O
Drosophila	O
.	O

In	O
Drosophila	O
,	O
MR	O
(	O
male	O
recombination	O
)	O
second	O
chromosomes	O
are	O
known	O
to	O
act	O
as	O
mutators	O
and	O
recombination	O
inducers	O
in	O
males	O
.	O

The	O
induction	O
of	O
visible	O
mutations	O
by	O
MR	O
is	O
observed	O
at	O
only	O
a	O
limited	O
number	O
of	O
genes	O
,	O
such	O
as	O
singed	B
bristle	O
(	O
sn	B
)	O
,	O
raspberry	B
eye	O
colour	O
(	O
ras	B
)	O
,	O
yellow	B
body	O
colour	O
(	O
y	B
)	O
and	O
a	O
carmine	B
eye	O
colour	O
(	O
car	O
)	O
.	O

Furthermore	O
,	O
sn	B
mutations	O
induced	O
by	O
MR	O
are	O
highly	O
unstable	O
,	O
changing	O
from	O
a	O
strong	O
to	O
a	O
weak	O
expression	O
or	O
reverting	O
to	O
the	O
wild	O
-	O
type	O
.	O

It	O
has	O
been	O
hypothesized	O
by	O
analogy	O
with	O
IS	O
mutations	O
in	O
microorganisms	O
,	O
that	O
MR	O
-	O
induced	O
mutations	O
also	O
represent	O
mutations	O
of	O
the	O
insertion	O
type	O
.	O

In	O
this	O
investigation	O
the	O
stability	O
of	O
two	O
MR	O
-	O
h12-induced	O
X	B
-	O
linked	O
visible	O
mutations	O
was	O
tested	O
,	O
one	O
singed	B
(	O
snMR	O
)	O
and	O
one	O
raspberry	B
(	O
rasMR	O
)	O
.	O

The	O
reversion	O
frequency	O
of	O
both	O
MR	O
-	O
induced	O
mutations	O
was	O
low	O
in	O
the	O
base	O
population	O
as	O
well	O
as	O
upon	O
outcrossing	O
to	O
C	O
(	O
1	O
)	O
DX	O
,	O
yw	O
f	O
females	O
.	O

The	O
data	O
reported	O
here	O
show	O
that	O
the	O
MR	O
-	O
induced	O
mutations	O
become	O
highly	O
unstable	O
when	O
MR	O
is	O
re	O
-	O
introduced	O
.	O

The	O
change	O
of	O
expression	O
of	O
an	O
MR	O
-	O
induced	O
mutation	O
to	O
a	O
weaker	O
phenotype	O
or	O
to	O
the	O
wild	O
-	O
type	O
occurred	O
at	O
a	O
frequency	O
of	O
3.3	O
X	B
10	O
(	O
-3	O
)	O
(	O
ras	B
)	O
to	O
20.4	O
X	B
10	O
(	O
-3	O
)	O
(	O
sn	B
)	O
.	O

Recessive	O
lethal	O
mutations	O
induced	O
by	O
MR	O
in	O
the	O
X	B
-	O
chromosomes	O
carrying	O
the	O
MR	O
-	O
induced	O
singed	B
or	O
raspberry	B
mutation	O
were	O
isolated	O
and	O
analysed	O
.	O

Among	O
11	O
independently	O
MR	O
-	O
induced	O
lethals	O
in	O
the	O
rasMR	O
-	O
carrying	O
X	B
-	O
chromosome	O
,	O
4	O
were	O
found	O
to	O
be	O
allelic	O
to	O
a	O
small	O
deficiency	O
that	O
included	O
the	O
raspberry	B
gene	O
.	O

13	O
lethals	O
were	O
induced	O
by	O
MR	O
in	O
the	O
snMR	O
-	O
carrying	O
X	B
-	O
chromosome	O
.	O

Of	O
these	O
,	O
3	O
were	O
located	O
near	O
the	O
sn	B
locus	O
but	O
none	O
was	O
allelic	O
to	O
a	O
deficiency	O
including	O
the	O
singed	B
gene	O
.	O

Myocyte	O
-	O
specific	O
enhancer	O
-	O
binding	O
factor	O
2	O
(	O
MEF2	B
)	O
is	O
a	O
myogenic	O
regulatory	O
factor	O
in	B
vertebrates	O
and	O
Drosophila	O
.	O

Whereas	O
the	O
role	O
of	O
MEF2	B
in	B
regulating	O
vertebrate	O
myogenesis	O
and	O
muscle	O
genes	O
has	O
been	O
extensively	O
studied	O
,	O
little	O
is	O
known	O
of	O
the	O
role	O
of	O
MEF2	B
in	B
regulating	O
Drosophila	O
myogenesis	O
.	O

We	O
have	O
shown	O
in	B
a	O
recent	O
analysis	O
of	O
the	O
regulation	O
of	O
the	O
Drosophila	O
Tropomyosin	B
I	I
(	O
TmI	B
)	O
gene	O
in	B
transgenic	O
flies	O
that	O
MEF2	B
is	O
a	O
positive	O
regulator	O
of	O
TmI	B
expression	O
in	B
the	O
somatic	O
body	O
-	O
wall	O
muscles	O
of	O
embryos	O
,	O
larvae	O
,	O
and	O
adults	O
.	O

To	O
understand	O
further	O
the	O
role	O
of	O
MEF2	B
in	B
myogenesis	O
and	O
test	O
the	O
role	O
of	O
MEF2	B
in	B
regulating	O
TmI	B
expression	O
,	O
we	O
have	O
used	O
the	O
yeast	O
GAL4	B
/	O
UAS	O
system	O
to	O
generate	O
embryos	O
in	B
which	O
MEF2	B
is	O
ectopically	O
expressed	O
in	B
tissues	O
where	O
it	O
is	O
not	O
normally	O
expressed	O
or	O
embryos	O
in	B
which	O
MEF2	B
is	O
overexpressed	O
in	B
the	O
mesoderm	O
and	O
muscles	O
.	O

We	O
observe	O
that	O
ectopic	O
expression	O
of	O
MEF2	B
in	B
the	O
epidermis	O
and	O
the	O
ventral	O
midline	O
cells	O
in	B
embryos	O
activates	O
the	O
expression	O
of	O
TmI	B
and	O
other	O
muscle	O
genes	O
in	B
these	O
tissues	O
and	O
that	O
this	O
activation	O
is	O
stage	O
-	O
dependent	O
suggesting	O
a	O
requirement	O
for	O
additional	O
factors	O
.	O

Furthermore	O
,	O
ectopic	O
expression	O
of	O
MEF2	B
in	B
the	O
epidermis	O
results	O
in	B
a	O
decrease	O
in	B
the	O
expression	O
of	O
signaling	O
molecules	O
in	B
the	O
epidermis	O
and	O
a	O
failure	O
of	O
the	O
embryo	O
to	O
properly	O
form	O
body	O
-	O
wall	O
muscles	O
.	O

These	O
results	O
indicate	O
that	O
MEF2	B
can	O
function	O
out	O
of	O
context	O
in	B
the	O
epidermis	O
to	O
induce	O
the	O
expression	O
of	O
muscle	O
genes	O
and	O
interfere	O
with	O
a	O
requirement	O
for	O
the	O
epidermis	O
in	B
muscle	O
development	O
.	O

We	O
also	O
find	O
that	O
the	O
level	O
of	O
MEF2	B
in	B
the	O
mesoderm	O
and/or	O
muscles	O
in	B
embryos	O
is	O
critical	O
to	O
body	O
-	O
wall	O
muscle	O
formation	O
;	O
however	O
,	O
no	O
effect	O
is	O
observed	O
on	O
the	O
development	O
of	O
the	O
visceral	O
muscle	O
or	O
dorsal	O
vessel	O
.	O

Since	O
the	O
development	O
of	O
the	O
enhancer	O
trap	O
technique	O
,	O
many	O
large	O
libraries	O
of	O
nuclear	O
localized	O
lacZ	B
P	B
-	I
element	I
stocks	O
have	O
been	O
generated	O
.	O

These	O
lines	O
can	O
lend	O
themselves	O
to	O
the	O
molecular	O
and	O
biological	O
characterization	O
of	O
new	O
genes	O
.	O

However	O
they	O
are	O
not	O
as	O
useful	O
for	O
the	O
study	O
of	O
development	O
of	O
cellular	O
morphologies	O
.	O

With	O
the	O
advent	O
of	O
the	O
GAL4	B
expression	O
system	O
,	O
enhancer	O
traps	O
have	O
a	O
far	O
greater	O
potential	O
for	O
utility	O
in	O
biological	O
studies	O
.	O

Yet	O
generation	O
of	O
GAL4	B
lines	O
by	O
standard	O
random	O
mobilization	O
has	O
been	O
reported	O
to	O
have	O
a	O
low	O
efficiency	O
.	O

To	O
avoid	O
this	O
problem	O
we	O
have	O
employed	O
targeted	O
transposition	O
to	O
generate	O
glial	O
-	O
specific	O
GAL4	B
lines	O
for	O
the	O
study	O
of	O
glial	O
cellular	O
development	O
.	O

Targeted	O
transposition	O
is	O
the	O
precise	O
exchange	O
of	O
one	O
P	B
element	I
for	O
another	O
.	O

We	O
report	O
the	O
successful	O
and	O
complete	O
replacement	O
of	O
two	O
glial	O
enhancer	O
trap	O
P	B
[	O
lacZ	B
,	O
ry+	O
]	O
elements	O
with	O
the	O
P	B
[	O
GAL4	B
,	O
w+	O
]	O
element	O
.	O

The	O
frequencies	O
of	O
transposition	O
to	O
the	O
target	O
loci	O
were	O
1.3	O
%	O
and	O
0.4	O
%	O
.	O

We	O
have	O
thus	O
found	O
it	O
more	O
efficient	O
to	O
generate	O
GAL4	B
lines	O
from	O
preexisting	O
P	B
-	I
element	I
lines	O
than	O
to	O
obtain	O
tissue	O
-	O
specific	O
expression	O
of	O
GAL4	B
by	O
random	O
P	B
-	I
element	I
mobilization	O
.	O

It	O
is	O
likely	O
that	O
similar	O
screens	O
can	O
be	O
performed	O
to	O
convert	O
many	O
other	O
P	B
-	I
element	I
lines	O
to	O
the	O
GAL4	B
system	O
.	O

We	O
have	O
characterized	O
two	O
previously	O
cloned	O
genes	O
,	O
F1	B
and	O
F2	B
(	O
1	O
)	O
that	O
code	O
for	O
elongation	O
factor	O
EF	B
-	O
1	O
alpha	O
of	O
Drosophila	O
melanogaster	O
.	O

Genomic	O
Southern	O
blot	O
hybridization	O
revealed	O
that	O
they	O
are	O
the	O
only	O
gene	O
copies	O
present	O
.	O

We	O
isolated	O
cDNA	O
clones	O
of	O
both	O
transcripts	O
from	O
embryonal	O
and	O
pupal	O
stage	O
of	O
development	O
that	O
cover	O
the	O
entire	O
transcription	O
unit	O
.	O

The	O
5	O
'	O
ends	O
of	O
both	O
genes	O
have	O
been	O
determined	O
by	O
primer	O
extension	O
and	O
for	O
F1	B
also	O
by	O
RNA	O
sequencing	O
.	O

These	O
start	O
sites	O
have	O
been	O
shown	O
to	O
be	O
used	O
consistently	O
during	O
development	O
.	O

Comparison	O
of	O
cDNA	O
and	O
genomic	O
sequences	O
revealed	O
that	O
EF	B
-	O
1	O
alpha	B
,	I
F1	I
consists	O
of	O
two	O
and	O
EF	B
-	O
1	O
alpha	B
,	I
F2	I
of	O
five	O
exons	O
.	O

The	O
two	O
described	O
elongation	O
factor	O
genes	O
exhibit	O
several	O
regions	O
of	O
strong	O
sequence	O
conservation	O
when	O
compared	O
to	O
five	O
recently	O
cloned	O
eucaryotic	O
elongation	O
factors	O
.	O

P	B
-	I
element	I
-	O
induced	O
recombination	O
in	O
Drosophila	O
melanogaster	O
occurs	O
premeiotically	O
.	O

Recombinants	O
are	O
therefore	O
expected	O
to	O
accumulate	O
in	O
the	O
stem	O
cells	O
of	O
the	O
germline	O
of	O
P	B
-	I
element	I
-	O
carrying	O
males	O
.	O

We	O
show	O
that	O
both	O
the	O
recombination	O
frequency	O
and	O
the	O
incidence	O
of	O
""""	O
clustering	O
""""	O
increase	O
with	O
the	O
age	O
of	O
males	O
carrying	O
various	O
P	B
-	I
element	I
derivatives	O
.	O

The	O
combination	O
of	O
end	O
-	O
deleted	O
elements	O
can	O
lead	O
to	O
average	O
recombination	O
frequencies	O
>	O
50	O
%	O
with	O
individual	O
instances	O
of	O
100	O
%	O
recombination	O
.	O

These	O
elements	O
also	O
lowered	O
the	O
fertility	O
of	O
the	O
carriers	O
.	O

We	O
investigated	O
these	O
features	O
by	O
constructing	O
an	O
analytical	O
and	O
a	O
computer	O
simulation	O
model	O
of	O
the	O
course	O
of	O
events	O
in	O
the	O
germline	O
,	O
incorporating	O
the	O
recently	O
proposed	O
hybrid	O
element	O
insertion	O
(	O
HEI	O
)	O
model	O
of	O
P	B
-	I
element	I
activity	O
.	O

The	O
model	O
is	O
able	O
to	O
predict	O
extreme	O
recombination	O
levels	O
,	O
segregation	O
ratio	O
biases	O
and	O
lowered	O
fertility	O
through	O
cell	O
death	O
in	O
a	O
single	O
analysis	O
.	O

In	O
vertebrate	O
embryos	O
,	O
the	O
precursor	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
are	O
induced	O
by	O
signaling	O
from	O
the	O
organizer	O
region	O
.	O

Here	O
we	O
report	O
the	O
isolation	O
of	O
a	O
novel	O
vertebrate	O
achaete	B
-	I
scute	I
homolog	O
,	O
cash4	B
,	O
which	O
is	O
expressed	O
in	O
the	O
presumptive	O
posterior	O
nervous	O
system	O
in	O
response	O
to	O
such	O
signaling	O
.	O

cash4	B
is	O
first	O
expressed	O
in	O
epiblast	O
cells	O
flanking	O
the	O
late	O
-	O
phase	O
organizer	O
(	O
Hensen	O
's	O
node	O
)	O
,	O
which	O
retains	O
its	O
ability	O
to	O
induce	O
cash4	B
during	O
regression	O
to	O
the	O
caudal	O
end	O
of	O
the	O
embryo	O
.	O

We	O
show	O
that	O
these	O
node	O
-	O
derived	O
signals	O
can	O
be	O
mimicked	O
in	O
vivo	O
by	O
the	O
activity	O
of	O
fibroblast	O
growth	O
factor	O
(	O
FGF	O
)	O
.	O

We	O
demonstrate	O
that	O
cash4	B
can	O
substitute	O
for	O
the	O
achaete	B
/	O
scute	B
genes	O
in	O
the	O
fly	O
and	O
that	O
it	O
also	O
has	O
proneural	O
activity	O
in	O
vertebrate	O
embryos	O
.	O

Together	O
these	O
results	O
suggest	O
that	O
cash4	B
functions	O
as	O
a	O
proneural	O
gene	O
downstream	O
of	O
node	O
-	O
derived	O
signals	O
(	O
including	O
FGF	O
)	O
to	O
promote	O
the	O
formation	O
of	O
the	O
neural	O
precursors	O
that	O
will	O
give	O
rise	O
to	O
the	O
posterior	O
CNS	O
in	O
the	O
chick	O
embryo	O
.	O

We	O
have	O
studied	O
the	O
influence	O
of	O
the	O
K	O
(	O
+	O
)	O
-current	O
mutations	O
eag	B
and	O
Sh	B
and	O
the	O
Na	O
(	O
+	O
)	O
-current	O
mutation	O
napts	B
upon	O
two	O
well	O
-	O
defined	O
neural	O
circuits	O
that	O
underlie	O
flight	O
and	O
an	O
escape	O
response	O
in	O
Drosophila	O
,	O
recording	O
from	O
dorsal	O
longitudinal	O
and	O
tergotrochanteral	O
muscles	O
.	O

Mutations	O
of	O
Sh	B
and	O
eag	B
affected	O
refractory	O
period	O
and	O
following	O
frequency	O
,	O
but	O
not	O
latency	O
,	O
of	O
the	O
jump	O
-	O
and	O
-	O
flight	O
escape	O
response	O
.	O

The	O
napts	B
mutation	O
altered	O
these	O
3	O
physiological	O
parameters	O
of	O
the	O
""""	O
jump	O
""""	O
(	O
TTM	O
)	O
,	O
but	O
not	O
the	O
""""	O
flight	O
""""	O
(	O
DLM	O
)	O
,	O
branch	O
,	O
suggesting	O
differences	O
in	O
the	O
vulnerability	O
of	O
different	O
circuit	O
components	O
to	O
the	O
mutation	O
.	O

In	O
contrast	O
to	O
their	O
interaction	O
in	O
some	O
other	O
systems	O
,	O
napts	B
did	O
not	O
counteract	O
the	O
effects	O
of	O
eag	B
and	O
Sh	B
upon	O
these	O
physiological	O
parameters	O
in	O
eag	B
Sh	B
;	O
nap	B
triple	O
mutants	O
.	O

In	O
eag	B
Sh	B
double	O
mutants	O
,	O
in	O
which	O
multiple	O
K+	O
currents	O
may	O
be	O
diminished	O
,	O
flight	O
muscles	O
showed	O
abnormal	O
rhythmic	O
activity	O
not	O
associated	O
with	O
flight	O
,	O
and	O
some	O
flies	O
also	O
had	O
an	O
abnormal	O
wings	O
-	O
down	O
posture	O
.	O

The	O
low	O
-	O
frequency	O
spikes	O
probably	O
originated	O
in	O
the	O
flight	O
muscle	O
motoneurons	O
,	O
but	O
the	O
coordination	O
between	O
muscle	O
fibers	O
during	O
this	O
""""	O
non	O
-	O
flight	O
activity	O
""""	O
was	O
distinct	O
from	O
flight	O
.	O

Nevertheless	O
,	O
in	O
spite	O
of	O
the	O
presence	O
of	O
this	O
non	O
-	O
flight	O
activity	O
in	O
resting	O
eag	B
Sh	B
flies	O
,	O
those	O
animals	O
with	O
normal	O
wing	O
posture	O
were	O
also	O
able	O
to	O
fly	O
,	O
with	O
a	O
normal	O
pattern	O
of	O
muscle	O
activity	O
.	O

This	O
suggests	O
that	O
in	O
these	O
mutants	O
,	O
the	O
DLM	O
motoneuron	O
circuit	O
is	O
able	O
to	O
switch	O
between	O
two	O
patterns	O
of	O
output	O
,	O
non	O
-	O
flight	O
activity	O
and	O
flight.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Activity	O
of	O
tyrosine	B
hydroxylase	I
(	O
TH	B
)	O
was	O
examined	O
in	O
adult	O
flies	O
from	O
stress	O
lines	O
of	O
Drosophila	O
virilis	O
resistant	O
and	O
nonresistant	O
to	O
heat	O
and	O
from	O
their	O
hybrids	O
under	O
heat	O
stress	O
and	O
normal	O
conditions	O
.	O

The	O
resistant	O
line	O
was	O
shown	O
to	O
have	O
higher	O
enzyme	O
activity	O
and	O
dominate	O
for	O
this	O
character	O
.	O

Gene	O
(	O
s	O
)	O
controlling	O
the	O
level	O
of	O
TH	B
activity	O
under	O
normal	O
conditions	O
were	O
not	O
sex	O
-	O
linked	O
.	O

It	O
was	O
shown	O
than	O
30-min	O
heat	O
stress	O
caused	O
a	O
decrease	O
in	O
TH	B
activity	O
;	O
with	O
120-min	O
stress	O
,	O
the	O
activity	O
increased	O
.	O

A	O
possible	O
mechanism	O
of	O
these	O
changes	O
is	O
discussed	O
.	O

In	O
the	O
nonresistant	O
line	O
,	O
the	O
TH	B
activity	O
does	O
not	O
change	O
under	O
heat	O
stress	O
;	O
the	O
line	O
dominates	O
at	O
this	O
trait	O
.	O

Gene	O
(	O
s	O
)	O
controlling	O
the	O
level	O
of	O
the	O
enzyme	O
activity	O
under	O
stress	O
are	O
not	O
sex	O
-	O
linked	O
.	O

Toll	B
is	O
a	O
maternally	O
required	O
Drosophila	O
gene	O
that	O
encodes	O
a	O
transmembrane	O
protein	O
with	O
an	O
important	O
function	O
in	O
embryonic	O
dorsal	O
-	O
ventral	O
patterning	O
.	O

The	O
Toll	B
protein	O
is	O
widely	O
expressed	O
zygotically	O
,	O
but	O
its	O
roles	O
in	O
late	O
embryo	O
-	O
genesis	O
have	O
not	O
been	O
described	O
in	O
detail	O
.	O

We	O
have	O
examined	O
the	O
expression	O
of	O
Toll	B
protein	O
in	O
the	O
late	O
embryonic	O
central	O
nervous	O
system	O
and	O
somatic	O
musculature	O
.	O

Toll	B
is	O
expressed	O
in	O
a	O
dynamic	O
pattern	O
in	O
teh	O
musculature	O
,	O
initially	O
in	O
several	O
muscle	O
fibers	O
in	O
each	O
hemisegment	O
,	O
with	O
a	O
later	O
narrowing	O
of	O
expression	O
to	O
a	O
single	O
muscle	O
fiber	O
pair	O
.	O

Zygotic	O
Toll	B
mutants	O
were	O
used	O
to	O
investigate	O
the	O
development	O
consequences	O
of	O
loss	O
of	O
Toll	B
expression	O
.	O

We	O
found	O
that	O
loss	O
of	O
one	O
or	O
both	O
copies	O
of	O
the	O
Toll	B
gene	O
leads	O
to	O
widespread	O
defects	O
in	O
motoneuron	O
number	O
and	O
muscle	O
patterning	O
.	O

Loss	O
of	O
motoneurons	O
prevents	O
certain	O
muscle	O
fibers	O
from	O
receiving	O
their	O
wild	O
-	O
type	O
innervation	O
.	O

Denervation	O
in	O
the	O
mutants	O
results	O
in	O
collateral	O
sprouting	O
from	O
nearby	O
nerve	O
branches	O
and	O
leads	O
to	O
the	O
appearance	O
of	O
ectopically	O
placed	O
motor	O
endings	O
.	O

The	O
limited	O
expressivity	O
observed	O
suggests	O
that	O
Toll	B
is	O
only	O
one	O
of	O
several	O
genes	O
required	O
for	O
proper	O
motoneuron	O
and	O
muscle	O
specification	O
.	O

Drosophila	O
melanogaster	O
F	B
elements	O
are	O
mobile	O
,	O
oligo	O
(	O
A	O
)	O
-terminated	O
DNA	O
sequences	O
that	O
likely	O
propagate	O
by	O
the	O
retrotranscription	O
of	O
RNA	O
intermediates	O
.	O

Plasmids	O
bearing	O
DNA	O
segments	O
from	O
the	O
left	O
-	O
hand	O
region	O
of	O
a	O
full	O
-	O
length	O
F	B
element	I
fused	O
to	O
the	O
CAT	B
gene	O
were	O
used	O
as	O
templates	O
for	O
transient	O
expression	O
assays	O
in	O
Drosophila	O
Schneider	O
II	O
cultured	O
cells	O
.	O

Protein	O
and	O
RNA	O
analyses	O
led	O
to	O
the	O
identification	O
of	O
two	O
promoters	O
,	O
Fin	O
and	O
Fout	O
,	O
that	O
transcribe	O
in	O
opposite	O
orientations	O
.	O

The	O
Fin	O
promoter	O
drives	O
the	O
synthesis	O
of	O
transcripts	O
that	O
initiate	O
around	O
residue	O
+	O
6	O
and	O
are	O
directed	O
toward	O
the	O
element	O
.	O

Fin	O
,	O
that	O
probably	O
controls	O
the	O
formation	O
of	O
F	B
transposition	O
RNA	O
intermediates	O
and	O
gene	O
products	O
,	O
is	O
internal	O
to	O
the	O
transcribed	O
region	O
.	O

Sequences	O
important	O
for	O
accumulation	O
of	O
Fin	O
transcripts	O
are	O
included	O
within	O
the	O
+	O
1	O
to	O
+	O
30	O
interval	O
;	O
an	O
additional	O
regulatory	O
element	O
may	O
coincide	O
with	O
a	O
heptamer	O
located	O
downstream	O
of	O
this	O
region	O
also	O
found	O
in	O
the	O
5	O
'	O
end	O
regions	O
of	O
F	B
-	O
like	O
Drosophila	O
retrotransposons	O
.	O

Analysis	O
of	O
the	O
template	O
activity	O
of	O
3	O
'	O
deletion	O
derivatives	O
indicates	O
that	O
the	O
level	O
of	O
accumulation	O
of	O
Fin	O
RNA	O
is	O
also	O
dependent	O
upon	O
the	O
presence	O
of	O
sequences	O
located	O
within	O
the	O
+	O
175	O
to	O
+	O
218	O
interval	O
.	O

The	O
Fout	O
promoter	O
drives	O
transcription	O
in	O
the	O
opposite	O
orientation	O
with	O
respect	O
to	O
Fin	O
.	O

Fout	O
transcripts	O
initiate	O
at	O
nearby	O
sites	O
within	O
the	O
+	O
92	O
to	O
+	O
102	O
interval	O
.	O

Sequences	O
downstream	O
of	O
these	O
multiple	O
RNA	O
start	O
sites	O
are	O
not	O
required	O
for	O
the	O
activity	O
of	O
the	O
Fout	O
promoter	O
.	O

Deletions	O
knocking	O
out	O
the	O
Fin	O
promoter	O
do	O
not	O
impair	O
Fout	O
transcription	O
;	O
conversely	O
,	O
initiation	O
at	O
the	O
Fin	O
promoter	O
still	O
takes	O
place	O
in	O
templates	O
that	O
lack	O
the	O
Fout	O
promoter	O
.	O

At	O
a	O
low	O
level	O
,	O
both	O
promoters	O
are	O
active	O
in	O
cultured	O
cells	O
.	O

The	O
level	O
of	O
amylase	B
activity	O
in	O
larvae	O
and	O
adults	O
of	O
Drosophila	O
melanogaster	O
is	O
dependent	O
on	O
the	O
dietary	O
carbohydrate	O
source	O
;	O
flies	O
or	O
larvae	O
from	O
a	O
food	O
medium	O
containing	O
starch	O
show	O
higher	O
levels	O
of	O
activity	O
than	O
individuals	O
from	O
a	O
food	O
containing	O
simple	O
sugars	O
.	O

This	O
is	O
shown	O
to	O
be	O
due	O
to	O
repression	O
of	O
activity	O
by	O
sugars	O
rather	O
than	O
enhancement	O
of	O
activity	O
by	O
starch	O
.	O

Moreover	O
,	O
the	O
changes	O
in	O
enzyme	O
activity	O
reflect	O
a	O
change	O
in	O
enzyme	O
quantity	O
rather	O
than	O
a	O
change	O
in	O
catalytic	O
efficiency	O
.	O

The	O
seeming	O
stimulation	O
of	O
amylase	B
activity	O
by	O
sucrose	O
in	O
some	O
experiments	O
is	O
due	O
,	O
simply	O
,	O
to	O
comparisons	O
with	O
""""	O
starvation	O
""""	O
diets	O
which	O
cause	O
a	O
large	O
nonspecific	O
reduction	O
in	O
enzyme	O
activity	O
.	O

Though	O
all	O
strains	O
tested	O
showed	O
repression	O
of	O
enzyme	O
activity	O
by	O
simple	O
sugars	O
,	O
the	O
degree	O
of	O
repression	O
varies	O
between	O
strains	O
.	O

Also	O
,	O
in	O
those	O
strains	O
which	O
carry	O
a	O
duplication	O
of	O
the	O
amylase	B
structural	O
gene	O
,	O
the	O
two	O
isozymal	O
forms	O
of	O
amylase	B
can	O
be	O
differentially	O
repressed	O
by	O
dietary	O
sugars	O
.	O

Migration	O
of	O
the	O
Drosophila	O
tracheal	O
cells	O
relies	O
on	O
cues	O
provided	O
by	O
nearby	O
cells	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
how	O
these	O
signals	O
specify	O
a	O
migratory	O
path	O
.	O

Here	O
we	O
investigate	O
the	O
role	O
of	O
cell	O
surface	O
proteins	O
in	B
the	O
definition	O
of	O
such	O
a	O
pathway	O
.	O

We	O
have	O
found	O
that	O
the	O
PS1	B
integrin	I
is	O
required	O
in	B
the	O
tracheal	O
cells	O
of	O
the	O
visceral	O
branch	O
,	O
whereas	O
the	O
PS2	B
integrin	O
is	O
required	O
in	B
the	O
visceral	O
mesoderm	O
;	O
both	O
integrins	O
are	O
necessary	O
for	O
the	O
spreading	O
of	O
the	O
visceral	O
branch	O
over	O
its	O
substratum	O
.	O

This	O
is	O
the	O
first	O
identification	O
of	O
a	O
cell	O
surface	O
molecule	O
with	O
expression	O
restricted	O
to	O
a	O
subset	O
of	O
tracheal	O
cells	O
that	O
all	O
migrate	O
in	B
a	O
given	O
direction	O
.	O

We	O
have	O
also	O
found	O
that	O
expression	O
of	O
PS1	B
in	B
the	O
visceral	O
branch	O
is	O
regulated	O
by	O
the	O
genes	O
that	O
direct	O
tracheal	O
cell	O
migration	O
,	O
showing	O
that	O
integrin	O
expression	O
is	O
part	O
of	O
the	O
cell	O
-	O
fate	O
program	O
that	O
they	O
specify	O
.	O

These	O
results	O
support	O
a	O
model	O
in	B
which	O
signal	O
transduction	O
determines	O
the	O
tracheal	O
migratory	O
pathways	O
by	O
regulating	O
the	O
expression	O
of	O
cell	O
surface	O
proteins	O
,	O
which	O
in	B
turn	O
interact	O
with	O
surface	O
molecules	O
on	O
the	O
surrounding	O
cell	O
population	O
.	O

Dominant	O
autosomal	O
mutation	O
l	B
(	I
2	I
)	I
M66	I
DCS	O
induced	O
in	O
Drosophila	O
melanogaster	O
by	O
ethyl	O
-	O
methane	O
-	O
sulfonate	O
was	O
studied	O
.	O

Electron	O
-	O
microscopic	O
studies	O
of	O
asynchronous	O
(	O
fibrillar	O
)	O
and	O
synchronous	O
(	O
tubular	O
)	O
muscles	O
in	O
24-hour	O
old	O
mutants	O
showed	O
pathological	O
changes	O
in	O
their	O
fine	O
structure	O
.	O

All	O
systems	O
were	O
affected	O
:	O
the	O
fragmentation	O
of	O
the	O
Z	O
-	O
lines	O
,	O
disappearance	O
of	O
protofibrils	O
,	O
degenerative	O
changes	O
of	O
mitochondria	O
,	O
sarcoplasmic	O
reticulum	O
,	O
and	O
the	O
T	O
-	O
system	O
,	O
the	O
appearance	O
of	O
membrane	O
aggregates	O
and	O
lysosomes	O
,	O
the	O
presence	O
of	O
a	O
large	O
amount	O
of	O
glycogen	O
were	O
detected	O
.	O

These	O
changes	O
in	O
the	O
ultrastructure	O
of	O
the	O
flight	O
muscles	O
in	O
mutants	O
are	O
similar	O
to	O
those	O
observed	O
in	O
the	O
process	O
of	O
physiological	O
degeneration	O
of	O
insect	O
muscles	O
.	O

In	O
virtually	O
all	O
eukaryotes	O
the	O
centromeric	O
regions	O
of	O
chromosomes	O
are	O
composed	O
of	O
heterochromatin	O
,	O
a	O
specialized	O
form	O
of	O
chromatin	O
that	O
is	O
rich	O
in	O
repetitive	O
DNA	O
sequences	O
and	O
is	O
transcriptionally	O
relatively	O
silent	O
.	O

The	O
Drosophila	O
GAGA	B
transcription	I
factor	I
binds	O
to	O
GA	O
/	O
CT	O
-	O
rich	O
sequences	O
in	O
many	O
Drosophila	O
promoters	O
,	O
where	O
it	O
activates	O
transcription	O
,	O
apparently	O
by	O
locally	O
altering	O
chromatin	O
structure	O
and	O
allowing	O
other	O
transcription	O
factors	O
access	O
to	O
the	O
DNA	O
.	O

Here	O
we	O
report	O
the	O
paradoxical	O
finding	O
that	O
GAGA	B
factor	I
is	O
associated	O
with	O
specific	O
regions	O
of	O
heterochromatin	O
at	O
all	O
stages	O
of	O
the	O
cell	O
cycle	O
.	O

A	O
subset	O
of	O
the	O
highly	O
repetitive	O
DNA	O
sequences	O
that	O
make	O
up	O
the	O
bulk	O
of	O
heterochromatin	O
in	O
D.	O
melanogaster	O
are	O
GA	O
/	O
CT	O
-	O
rich	O
and	O
we	O
find	O
a	O
striking	O
correlation	O
between	O
the	O
distribution	O
of	O
GAGA	B
factor	I
and	O
this	O
class	O
of	O
repeat	O
.	O

We	O
propose	O
that	O
GAGA	B
factor	I
binds	O
directly	O
to	O
these	O
repeats	O
and	O
may	O
thereby	O
play	O
a	O
role	O
in	O
modifying	O
heterochromatin	O
structure	O
in	O
these	O
regions	O
.	O

Our	O
observations	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
a	O
transcriptional	O
regulator	O
can	O
associate	O
with	O
specific	O
DNA	O
sequences	O
in	O
a	O
fully	O
condensed	O
mitotic	O
chromosome	O
.	O

This	O
may	O
help	O
explain	O
how	O
the	O
distinctive	O
character	O
of	O
a	O
committed	O
or	O
differentiated	O
cell	O
can	O
be	O
maintained	O
during	O
cell	O
proliferation	O
.	O

Hox	O
transcription	O
factors	O
,	O
in	O
combination	O
with	O
cofactors	O
such	O
as	O
PBC	O
proteins	O
,	O
provide	O
diverse	O
developmental	O
fates	O
to	O
cells	O
on	O
the	O
anteroposterior	O
body	O
axis	O
of	O
animal	O
embryos	O
.	O

However	O
,	O
the	O
mechanisms	O
by	O
which	O
the	O
different	O
Hox	O
proteins	O
and	O
their	O
cofactors	O
generate	O
those	O
diverse	O
fates	O
remain	O
unclear	O
.	O

Recent	O
findings	O
have	O
provided	O
support	O
for	O
a	O
model	O
where	O
the	O
DNA	O
binding	O
sites	O
that	O
directly	O
interact	O
with	O
Hox	O
-	O
PBC	O
heterodimers	O
determine	O
which	O
member	O
of	O
the	O
Hox	O
protein	O
family	O
occupies	O
and	O
thereby	O
regulates	O
a	O
given	O
target	O
element	O
.	O

In	O
the	O
experiments	O
reported	O
here	O
,	O
we	O
test	O
the	O
function	O
of	O
chimeric	O
Hox	O
response	O
elements	O
and	O
,	O
surprisingly	O
,	O
find	O
evidence	O
that	O
runs	O
counter	O
to	O
this	O
view	O
.	O

A	O
21	O
bp	O
cofactor	O
binding	O
sequence	O
from	O
an	O
embryonic	O
Deformed	B
Hox	O
response	O
element	O
,	O
containing	O
no	O
Hox	O
or	O
Hox	O
-	O
PBC	O
binding	O
sites	O
,	O
was	O
combined	O
with	O
single	O
or	O
multimeric	O
sites	O
that	O
bind	O
heterodimers	O
of	O
Labial	B
-	O
type	O
Hox	O
and	O
PBC	O
proteins	O
.	O

Normally	O
,	O
multimerized	O
Labial	B
-	O
PBC	O
binding	O
sites	O
are	O
sufficient	O
to	O
trigger	O
a	O
Labial	B
-	O
specific	O
activation	O
response	O
in	O
either	O
Drosophila	O
or	O
mouse	O
embryos	O
.	O

Here	O
we	O
find	O
that	O
the	O
21	O
bp	O
sequence	O
element	O
plays	O
an	O
important	O
role	O
in	O
Deformed	B
specificity	O
,	O
as	O
it	O
is	O
capable	O
of	O
switching	O
a	O
Labial	B
-	O
PBC	O
binding	O
site	O
/	O
response	O
element	O
to	O
a	O
Deformed	B
response	O
element	O
.	O

Thus	O
,	O
cofactor	O
binding	O
sites	O
that	O
are	O
separate	O
and	O
distinct	O
from	O
homeodomain	O
binding	O
sites	O
can	O
dictate	O
the	O
regulatory	O
specificity	O
of	O
a	O
Hox	O
response	O
element	O
.	O

As	O
a	O
member	O
of	O
the	O
trithorax	B
-	O
group	O
,	O
the	O
Trithorax	B
-	I
like	I
(	O
Trl	B
)	O
gene	O
of	O
Drosophila	O
melanogaster	O
contributes	O
to	O
the	O
expression	O
of	O
homeotic	O
genes	O
and	O
many	O
other	O
genes	O
.	O

Trl	B
encodes	O
different	O
isoforms	O
of	O
the	O
GAGA	B
factor	I
which	O
is	O
thought	O
to	O
act	O
as	O
an	O
""""	O
antirepressor	O
""""	O
of	O
transcription	O
by	O
remodelling	O
chromatin	O
structure	O
and	O
thereby	O
rendering	O
control	O
regions	O
accessible	O
for	O
transcriptional	O
activators	O
.	O

A	O
more	O
global	O
role	O
of	O
the	O
GAGA	B
factor	I
in	O
chromatin	O
structure	O
and	O
function	O
is	O
suggested	O
by	O
various	O
phenotypes	O
of	O
Trl	B
mutations	O
,	O
such	O
as	O
modification	O
of	O
position	O
effect	O
variegation	O
.	O

To	O
better	O
define	O
the	O
molecular	O
basis	O
of	O
these	O
pleiotropic	O
effects	O
,	O
we	O
cloned	O
cDNAs	O
encoding	O
the	O
GAGA	B
isoforms	O
of	O
D.	O
melanogaster	O
and	O
a	O
distantly	O
related	O
species	O
,	O
D.	O
virilis	O
.	O

We	O
also	O
characterized	O
the	O
genomic	O
organization	O
of	O
both	O
the	O
D.	O
melanogaster	O
and	O
D.	O
virilis	O
genes	O
,	O
and	O
analysed	O
the	O
expression	O
patterns	O
of	O
isoform	O
-	O
specific	O
mRNAs	O
.	O

The	O
D.	O
virilis	O
GAGA	B
isoforms	O
show	O
high	O
similarity	O
to	O
their	O
D.	O
melanogaster	O
counterparts	O
,	O
particularly	O
within	O
the	O
BTB	O
/	O
POZ	O
protein	O
-	O
interaction	O
and	O
the	O
zinc	O
finger	O
DNA	O
-	O
binding	O
domains	O
.	O

Interestingly	O
,	O
conservation	O
clearly	O
extends	O
beyond	O
the	O
previously	O
defined	O
limits	O
of	O
these	O
domains	O
.	O

Moreover	O
,	O
the	O
comparison	O
reveals	O
a	O
completely	O
conserved	O
block	O
of	O
amino	O
acid	O
residues	O
located	O
between	O
the	O
BTB	O
/	O
POZ	O
and	O
DNA	O
-	O
binding	O
domains	O
,	O
and	O
a	O
high	O
conservation	O
of	O
the	O
C	O
-	O
terminus	O
specific	O
for	O
one	O
of	O
the	O
GAGA	B
isoforms	O
.	O

Thus	O
,	O
sequences	O
of	O
as	O
yet	O
unknown	O
functions	O
are	O
defined	O
as	O
rewarding	O
targets	O
for	O
further	O
mutational	O
analyses	O
.	O

The	O
high	O
conservation	O
of	O
the	O
GAGA	B
proteins	O
of	O
the	O
two	O
species	O
is	O
in	O
accord	O
with	O
the	O
nearly	O
identical	O
genomic	O
organization	O
and	O
expression	O
patterns	O
of	O
the	O
corresponding	O
genes	O
.	O

We	O
present	O
a	O
molecular	O
and	O
genetic	O
analysis	O
which	O
elucidates	O
the	O
role	O
of	O
deltex	B
in	O
the	O
Notch	B
signaling	O
pathway	O
.	O

Using	O
the	O
yeast	O
'	O
interaction	O
trap	O
'	O
assay	O
,	O
we	O
define	O
the	O
protein	O
regions	O
responsible	O
for	O
heterotypic	O
interactions	O
between	O
Deltex	B
and	O
the	O
intracellular	O
domain	O
of	O
Notch	B
as	O
well	O
as	O
uncover	O
homotypic	O
interaction	O
among	O
Deltex	B
molecules	O
.	O

The	O
function	O
of	O
the	O
Deltex	B
-	O
Notch	B
interaction	O
domains	O
is	O
examined	O
by	O
in	O
vivo	O
expression	O
studies	O
.	O

Taken	O
together	O
,	O
data	O
from	O
overexpression	O
of	O
Deltex	B
fragments	O
and	O
from	O
studies	O
of	O
physical	O
interactions	O
between	O
Deltex	B
and	O
Notch	B
,	O
suggest	O
that	O
Deltex	B
positively	O
regulates	O
the	O
Notch	B
pathway	O
through	O
interactions	O
with	O
the	O
Notch	B
ankyrin	B
repeats	O
.	O

Experiments	O
involving	O
cell	O
cultures	O
indicate	O
that	O
the	O
Deltex	B
-	O
Notch	B
interaction	O
prevents	O
the	O
cytoplasmic	O
retention	O
of	O
the	O
Suppressor	B
of	I
Hairless	I
protein	O
,	O
which	O
otherwise	O
is	O
sequestered	O
in	O
the	O
cytoplasm	O
via	O
association	O
with	O
the	O
Notch	B
ankyrin	B
repeats	O
and	O
translocates	O
to	O
the	O
nucleus	O
when	O
Notch	B
binds	O
to	O
its	O
ligand	O
Delta	B
.	O

On	O
the	O
basis	O
of	O
these	O
findings	O
,	O
we	O
propose	O
a	O
model	O
wherein	O
Deltex	B
regulates	O
Notch	B
activity	O
by	O
antagonizing	O
the	O
interaction	O
between	O
Notch	B
and	O
Suppressor	B
of	I
Hairless	I
.	O

Quinoid	O
precursors	O
of	O
melanin	O
and/or	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
generated	O
during	O
melanogenesis	O
have	O
been	O
implicated	O
as	O
cytotoxic	O
molecules	O
in	O
the	O
immune	O
responses	O
of	O
insects	O
against	O
their	O
internal	O
metazoan	O
parasites	O
.	O

No	O
study	O
has	O
yet	O
identified	O
the	O
killing	O
components	O
produced	O
in	O
conjunction	O
with	O
melanotic	O
encapsulation	O
responses	O
,	O
or	O
explained	O
how	O
cytotoxic	O
molecules	O
generated	O
in	O
the	O
open	O
circulatory	O
system	O
of	O
an	O
insect	O
can	O
selectively	O
destroy	O
foreign	O
tissues	O
.	O

Strains	O
of	O
Drosophila	O
melanogaster	O
with	O
differing	O
immune	O
capabilities	O
against	O
the	O
wasp	O
parasitoid	O
Leptopilina	O
boulardi	O
were	O
examined	O
for	O
superoxide	O
anion	O
(	O
O2-	O
.	O
)	O
formation	O
during	O
parasitization	O
.	O

Elevated	O
levels	O
of	O
O2-	O
.	O
were	O
produced	O
by	O
immune	O
reactive	O
(	O
R	O
-	O
strain	O
)	O
hosts	O
during	O
melanotic	O
encapsulation	O
of	O
the	O
parasitoid	O
,	O
but	O
not	O
by	O
susceptible	O
(	O
S	O
-	O
strain	O
)	O
hosts	O
in	O
which	O
the	O
parasitoid	O
developed	O
unmolested	O
.	O

Both	O
a	O
superoxide	B
dismutase	I
(	O
SOD	B
)	O
-deficient	O
strain	O
(	O
cSODn108	O
,	O
red	O
/	O
TM3	O
/	O
Sb	O
Ser	O
)	O
and	O
a	O
catalase	B
(	O
CAT	B
)	O
-deficient	O
strain	O
(	O
Catn1	O
)	O
also	O
produced	O
melanotic	O
capsules	O
and	O
elevated	O
levels	O
of	O
O2-	O
.	O

when	O
infected	O
,	O
but	O
these	O
reactions	O
were	O
unsuccessful	O
and	O
the	O
parasitoids	O
survived	O
,	O
indicating	O
that	O
neither	O
the	O
quinoid	O
precursors	O
of	O
melanin	O
nor	O
O2-	O
.	O

per	O
se	O
were	O
cytotoxic	O
.	O

Immune	O
incompetence	O
in	O
SOD	B
-	O
deficient	O
and	O
CAT	B
-	O
deficient	O
hosts	O
is	O
attributed	O
in	O
part	O
to	O
defects	O
in	O
hydrogen	O
peroxide	O
(	O
H2O2	O
)	O
metabolism	O
,	O
and/or	O
the	O
inability	O
of	O
these	O
metalloenzyme	O
-	O
deficient	O
strains	O
to	O
initiate	O
the	O
metal	O
-	O
mediated	O
reductive	O
cleavage	O
of	O
H2O2	O
required	O
for	O
the	O
production	O
of	O
the	O
cytotoxic	O
hydroxyl	O
radical	O
(	O
.OH	O
)	O
.	O

The	O
role	O
proposed	O
for	O
O2-	O
.	O
in	O
Drosophila	O
cellular	O
immunity	O
is	O
one	O
of	O
potentiating	O
the	O
formation	O
of	O
.OH	O
.	O

Melanin	O
,	O
which	O
contains	O
both	O
oxidizing	O
and	O
reducing	O
components	O
,	O
may	O
serve	O
a	O
dual	O
role	O
in	O
producing	O
O2-	O
.	O
and	O
sequestering	O
redox	O
-	O
active	O
metal	O
ions	O
,	O
thereby	O
confining	O
the	O
production	O
of	O
ROS	O
.	O

Host	O
-	O
parasite	O
susceptibility	O
in	O
the	O
Drosophila	O
-	O
Leptopilina	O
system	O
may	O
be	O
determined	O
by	O
the	O
ability	O
of	O
the	O
parasitoid	O
to	O
modulate	O
hemocyte	O
activity	O
and	O
prevent	O
both	O
effective	O
melanotic	O
encapsulation	O
and	O
the	O
generation	O
of	O
cytotoxic	O
levels	O
of	O
ROS	O
.	O

Genomic	O
clones	O
from	O
the	O
Rdl	B
locus	O
of	O
Drosophila	O
,	O
whose	O
mutant	O
phenotype	O
is	O
resistant	O
to	O
cyclodiene	O
insecticides	O
and	O
picrotoxin	O
,	O
were	O
characterized	O
by	O
restriction	O
mapping	O
and	O
partial	O
sequencing	O
to	O
determine	O
intron	O
/	O
exon	O
structure	O
.	O

The	O
coding	O
region	O
of	O
the	O
gene	O
comprises	O
nine	O
identified	O
exons	O
and	O
spans	O
greater	O
than	O
25	O
kb	O
of	O
genomic	O
DNA	O
.	O

The	O
structure	O
of	O
the	O
Drosophila	O
Rdl	B
receptor	O
subunit	O
was	O
compared	O
with	O
those	O
of	O
vertebrate	O
gamma	O
-	O
aminobutyric	O
acid	O
subtype	O
A	O
(	O
GABAA	B
)	O
receptors	O
and	O
nicotinic	O
acetylcholine	O
receptors	O
(	O
nAChRs	O
)	O
.	O

The	O
first	O
six	O
introns	O
in	O
Rdl	B
show	O
positions	O
similar	O
to	O
those	O
in	O
vertebrate	O
GABAA	B
receptors	O
,	O
whereas	O
the	O
last	O
two	O
differ	O
.	O

It	O
is	O
interesting	O
that	O
the	O
last	O
intron	O
appears	O
to	O
be	O
in	O
a	O
position	O
similar	O
to	O
that	O
in	O
nAChRs	O
.	O

These	O
results	O
are	O
examined	O
in	O
relation	O
to	O
the	O
proposal	O
,	O
based	O
on	O
amino	O
acid	O
identities	O
,	O
that	O
Rdl	B
codes	O
for	O
a	O
novel	O
class	O
of	O
GABAA	B
receptor	I
subunit	O
more	O
closely	O
related	O
to	O
glycine	O
receptors	O
,	O
and	O
the	O
possible	O
place	O
of	O
Rdl	B
in	O
the	O
lineage	O
of	O
the	O
receptor	O
superfamily	O
is	O
discussed	O
.	O

An	O
attempt	O
to	O
quantify	O
the	O
effects	O
of	O
modifier	O
gene	O
polymorphisms	O
on	O
the	O
operation	O
of	O
natural	O
selection	O
on	O
a	O
major	O
locus	O
has	O
been	O
carried	O
out	O
.	O

The	O
modifier	O
system	O
we	O
have	O
investigated	O
is	O
constituted	O
by	O
a	O
set	O
of	O
polygenic	O
modifier	O
loci	O
affecting	O
the	O
morphological	O
expression	O
of	O
the	O
Bare	B
(	O
Ba	B
)	O
bristle	O
mutant	O
of	O
Drosophila	O
subobscura	O
.	O

Ba	B
is	O
a	O
dominant	O
mutant	O
that	O
is	O
lethal	O
in	O
homozygous	O
condition	O
and	O
both	O
the	O
polygenic	O
modifiers	O
and	O
Ba	B
are	O
located	O
on	O
the	O
O	O
chromosome	O
of	O
this	O
species	O
.	O

Experimental	O
populations	O
were	O
found	O
with	O
Ba	B
/	O
+	O
individuals	O
and	O
two	O
different	O
types	O
of	O
populations	O
were	O
started	O
according	O
to	O
their	O
modifier	O
genetic	O
background	O
:	O
populations	O
with	O
wild	O
O	O
chromosomes	O
of	O
either	O
high	O
or	O
low	O
modifier	O
effect	O
(	O
cages	O
H	O
and	O
L	O
,	O
respectively	O
)	O
.	O

Fitness	O
estimates	O
(	O
total	O
fitness	O
,	O
viability	O
and	O
fertility	O
)	O
for	O
genotypes	O
of	O
the	O
Ba	B
locus	O
were	O
obtained	O
under	O
the	O
two	O
different	O
modifier	O
backgrounds	O
.	O

In	O
the	O
populations	O
with	O
high	O
modifier	O
background	O
the	O
total	O
fitness	O
of	O
the	O
Ba	B
/	O
+	O
heterozygote	O
was	O
very	O
similar	O
to	O
that	O
of	O
the	O
+	O
/+	O
homozygote	O
(	O
fitness	O
equal	O
to	O
1	O
)	O
.	O

However	O
,	O
in	O
cages	O
with	O
low	O
modifier	O
background	O
a	O
strong	O
selection	O
against	O
the	O
Ba	B
/	O
+	O
heterozygote	O
was	O
detected	O
(	O
average	O
of	O
total	O
fitnesses	O
over	O
generations	O
was	O
0.66	O
+	O
/-	O

0.10	O
)	O
,	O
and	O
fertility	O
appears	O
to	O
be	O
the	O
fitness	O
component	O
responsible	O
for	O
this	O
effect	O
(	O
mean	O
fertility	O
was	O
0.55	O
+	O
/-	O

0.08	O
)	O
.	O

These	O
findings	O
demonstrate	O
that	O
modifier	O
gene	O
polymorphisms	O
affecting	O
the	O
expression	O
of	O
the	O
Ba	B
mutant	O
may	O
be	O
associated	O
with	O
large	O
selective	O
effects	O
on	O
the	O
major	O
locus	O
.	O

Previous	O
work	O
has	O
provided	O
conclusive	O
support	O
for	O
a	O
role	O
of	O
various	O
protein	O
kinases	O
in	O
processes	O
underlying	O
learning	O
and	O
memory	O
formation	O
.	O

While	O
these	O
processes	O
are	O
not	O
yet	O
established	O
in	O
full	O
detail	O
,	O
it	O
is	O
interesting	O
to	O
entertain	O
the	O
idea	O
of	O
protein	O
phosphatases	O
being	O
involved	O
in	O
such	O
mechanisms	O
as	O
well	O
.	O

Recent	O
advances	O
in	O
this	O
respect	O
have	O
provided	O
preliminary	O
support	O
of	O
this	O
view	O
.	O

From	O
the	O
pharmacological	O
as	O
well	O
as	O
the	O
transgenic	O
analysis	O
,	O
it	O
appears	O
that	O
especially	O
the	O
calcineurin	B
/	O
inhibitor-1	O
cascade	O
plays	O
an	O
important	O
role	O
in	O
the	O
transition	O
of	O
intermediate	O
-	O
term	O
into	O
long	O
-	O
term	O
memory	O
formation	O
.	O

Cytogenetic	O
and	O
molecular	O
analyses	O
of	O
primary	O
sporadic	O
human	O
breast	O
carcinomas	O
have	O
documented	O
at	O
least	O
12	O
different	O
chromosome	O
arms	O
affected	O
by	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
.	O

This	O
has	O
been	O
taken	O
as	O
evidence	O
for	O
the	O
presence	O
of	O
putative	O
tumour	O
suppressor	O
genes	O
in	O
the	O
remaining	O
allele	O
within	O
the	O
affected	O
regions	O
.	O

We	O
have	O
previously	O
identified	O
three	O
regions	O
on	O
chromosome	O
17q	O
that	O
are	O
affected	O
by	O
LOH	O
in	O
primary	O
human	O
breast	O
tumours	O
.	O

A	O
physical	O
map	O
of	O
one	O
of	O
these	O
regions	O
(	O
17q21	O
)	O
has	O
been	O
prepared	O
.	O

The	O
putative	O
target	O
gene	O
appears	O
to	O
be	O
located	O
between	O
the	O
D17S846	O
and	O
D17S746	O
loci	O
.	O

We	O
are	O
currently	O
determining	O
whether	O
either	O
of	O
two	O
genes	O
located	O
in	O
this	O
region	O
is	O
the	O
target	O
for	O
LOH	O
.	O

The	O
mouse	O
mammary	O
tumour	O
model	O
system	O
provides	O
an	O
approach	O
for	O
identifying	O
genes	O
which	O
,	O
when	O
activated	O
or	O
inactivated	O
by	O
mouse	O
mammary	O
tumour	O
virus	O
(	O
MMTV	O
)	O
integration	O
,	O
contribute	O
to	O
specific	O
stages	O
of	O
mammary	O
tumorigenesis	O
.	O

Using	O
this	O
approach	O
we	O
have	O
identified	O
two	O
genes	O
,	O
designated	O
NOTCH4	B
/	O
INT3	B
and	O
INT6	O
respectively	O
.	O

Interruption	O
of	O
NOTCH4	B
/	O
INT3	B
by	O
MMTV	O
represents	O
a	O
gain	O
-	O
of	O
-	O
function	O
mutation	O
that	O
has	O
profound	O
consequences	O
for	O
mammary	O
gland	O
development	O
and	O
tumorigenesis	O
.	O

INT6	O
was	O
found	O
to	O
be	O
interrupted	O
by	O
an	O
integrated	O
MMTV	O
genome	O
in	O
a	O
mammary	O
hyperplastic	O
outgrowth	O
line	O
and	O
two	O
independent	O
mammary	O
tumours	O
.	O

In	O
each	O
case	O
the	O
transcriptional	O
orientation	O
of	O
the	O
viral	O
genome	O
was	O
opposite	O
to	O
that	O
of	O
INT6	O
.	O

The	O
rearranged	O
allele	O
was	O
expressed	O
as	O
a	O
truncated	O
chimaeric	O
RNA	O
species	O
composed	O
of	O
INT6	O
coding	O
sequences	O
,	O
intron	O
sequences	O
and	O
MMTV	O
sequences	O
.	O

Since	O
the	O
non	O
-	O
rearranged	O
allele	O
contained	O
no	O
mutations	O
,	O
we	O
conclude	O
that	O
MMTV	O
integration	O
into	O
INT6	O
causes	O
a	O
dominant	O
-	O
negative	O
mutation	O
or	O
biologically	O
activates	O
its	O
function	O
.	O

The	O
nucleotide	O
sequence	O
of	O
INT6	O
is	O
unrelated	O
to	O
any	O
of	O
the	O
known	O
genes	O
in	O
the	O
GenBank	O
database	O
,	O
but	O
is	O
evolutionarily	O
highly	O
conserved	O
.	O

To	O
investigate	O
the	O
role	O
of	O
the	O
receptor	O
-	O
type	O
tyrosine	O
kinase	O
,	O
c	B
-	I
kit	I
and	O
its	O
ligand	O
,	O
stem	B
cell	I
factor	I
(	O
SCF	B
)	O
in	O
T	O
cell	O
development	O
,	O
we	O
analyzed	O
c	B
-	I
kit	I
(	O
W	B
/	O
W	B
)	O
and	O
SCF	B
(	O
SI	O
/	O
SI	O
)	O
deficient	O
mice	O
.	O

We	O
also	O
engrafted	O
wild	O
-	O
type	O
or	O
SCF	B
-	O
deficient	O
fetal	O
thymi	O
onto	O
wild	O
-	O
type	O
recipient	O
mice	O
and	O
analyzed	O
the	O
rate	O
of	O
proliferation	O
by	O
in	O
vivo	O
bromodeoxyuridine	O
labeling	O
.	O

The	O
results	O
show	O
that	O
the	O
most	O
immature	O
thymocyte	O
compartment	O
defined	O
as	O
CD3-CD4-CD8-	O
is	O
significantly	O
reduced	O
in	O
SI	O
/	O
SI	O
grafts	O
and	O
W	B
/	O
W	B
thymi	O
compared	O
with	O
wild	O
-	O
type	O
counterparts	O
.	O

Also	O
,	O
the	O
expansion	O
rate	O
of	O
these	O
immature	O
thymocytes	O
in	O
SI	O
/	O
SI	O
graft	O
is	O
reduced	O
by	O
-50	O
%	O
.	O

These	O
experiments	O
provide	O
direct	O
evidence	O
for	O
an	O
important	O
role	O
for	O
c	B
-	I
kit	I
-	O
SCF	B
interactions	O
in	O
expansion	O
of	O
very	O
early	O
thymocytes	O
.	O

Reverse	O
transcription	O
and	O
cDNA	O
amplification	O
(	O
polymerase	O
chain	O
reaction	O
)	O
of	O
total	O
RNA	O
preparations	O
were	O
used	O
to	O
characterize	O
the	O
expression	O
of	O
EGF	B
mRNA	O
in	O
the	O
mandibular	O
arch	O
of	O
day	O
9	O
-	O
17	O
mouse	O
embryos	O
.	O

EGF	B
mRNA	O
was	O
present	O
in	O
mandibles	O
at	O
day	O
9	O
and	O
10	O
but	O
not	O
at	O
days	O
11	O
-	O
17	O
.	O

Separate	O
RNA	O
preparations	O
from	O
epithelium	O
and	O
mesenchyme	O
at	O
day	O
10	O
revealed	O
EGF	B
mRNA	O
in	O
both	O
components	O
.	O

Numerous	O
mouse	O
models	O
of	O
polycystic	O
kidney	O
disease	O
(	O
PKD	O
)	O
have	O
been	O
described	O
in	O
which	O
the	O
mutant	O
phenotypes	O
closely	O
resemble	O
human	O
PKD	O
with	O
regard	O
to	O
morphology	O
,	O
cyst	O
localization	O
,	O
and	O
disease	O
progression	O
.	O

As	O
in	O
human	O
PKD	O
,	O
genetic	O
background	O
affects	O
the	O
disease	O
phenotype	O
in	O
mouse	O
PKD	O
models	O
.	O

Using	O
experimental	O
crosses	O
,	O
these	O
modifying	O
effects	O
can	O
be	O
dissected	O
into	O
discrete	O
genetic	O
factors	O
referred	O
to	O
as	O
quantitative	O
trait	O
loci	O
.	O

The	O
locus	O
for	O
the	O
mouse	O
bpk	O
model	O
was	O
recently	O
mapped	O
to	O
chromosome	O
(	O
Chr	O
)	O
10	O
.	O

In	O
the	O
course	O
of	O
these	O
studies	O
,	O
marked	O
variability	O
was	O
observed	O
in	O
the	O
renal	O
cystic	O
disease	O
expressed	O
in	O
F2	O
bpk	O
/	O
bpk	O
homozygotes	O
of	O
a	O
(	O
BALB	O
/	O
c-+	O
/	O
bpk	O
x	B
CAST	O
/	O
Ei	O
)	O
F1	O
intercross	O
.	O

The	O
current	O
study	O
was	O
undertaken	O
to	O
further	O
characterize	O
the	O
renal	O
cystic	O
disease	O
as	O
quantitative	O
trait	O
in	O
this	O
F2	O
cohort	O
and	O
to	O
map	O
the	O
genetic	O
modifiers	O
that	O
modulate	O
this	O
phenotype	O
.	O

Whole	O
-	O
genome	O
scans	O
revealed	O
a	O
CAST	O
-	O
derived	O
locus	O
on	O
distal	O
Chr	O
6	O
,	O
near	O
D6Mit14	B
,	O
that	O
affects	O
renal	B
cystic	I
disease	I
severity	I
.	O

Additional	O
analyses	O
identified	O
loci	O
on	O
Chr	O
1	O
,	O
Chr	O
2	O
,	O
and	O
Chr	O
4	O
,	O
as	O
well	O
as	O
a	O
possible	O
interaction	O
between	O
the	O
Chr	O
6	O
locus	O
and	O
a	O
locus	O
on	O
distal	O
Chr	O
1	O
,	O
near	O
D1Mit17	B
.	O

Interestingly	O
,	O
the	O
gene	O
encoding	O
RGS7	B
,	O
a	O
regulator	O
of	O
G	O
protein	O
signaling	O
that	O
binds	O
to	O
polycystin-1	B
,	O
was	O
mapped	O
to	O
the	O
same	O
Chr	O
1	O
interval	O
.	O

It	O
is	O
concluded	O
that	O
the	O
severity	O
of	O
the	O
bpk	O
renal	O
cystic	O
disease	O
phenotype	O
is	O
modulated	O
by	O
multiple	O
loci	O
and	O
possibly	O
by	O
epistatic	O
interaction	O
among	O
them	O
.	O

It	O
is	O
hypothesized	O
that	O
the	O
gene	O
encoding	O
the	O
polycystin	O
-	O
binding	O
partner	O
RGS7	B
is	O
a	O
candidate	O
for	O
the	O
Chr	O
1	O
genetic	O
modifier	O
.	O

We	O
have	O
cloned	O
a	O
cDNA	O
that	O
codes	O
for	O
mouse	O
liver	O
-	O
specific	O
transporter-1	O
,	O
mouse	O
lst-1	B
.	O

The	O
cDNA	O
is	O
comprised	O
of	O
3296	O
base	O
pairs	O
and	O
it	O
contains	O
a	O
coding	O
sequence	O
for	O
a	O
protein	O
of	O
689	O
amino	O
acids	O
with	O
12	O
putative	O
transmembrane	O
domains	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
the	O
mouse	O
lst-1	B
shares	O
64	O
and	O
77	O
%	O
identities	O
with	O
the	O
reported	O
human	O
and	O
rat	O
lsts	O
,	O
respectively	O
.	O

Northern	O
blot	O
analysis	O
demonstrates	O
that	O
mouse	O
lst-1	B
mRNA	O
is	O
expressed	O
exclusively	O
in	O
liver	O
.	O

We	O
also	O
report	O
here	O
the	O
structural	O
organization	O
of	O
the	O
mouse	O
lst-1	B
gene	O
as	O
the	O
first	O
evidence	O
for	O
the	O
structure	O
of	O
a	O
gene	O
encoding	O
an	O
lst	O
.	O

The	O
mouse	O
lst-1	B
gene	O
spans	O
approximately	O
60	O
kbp	O
in	O
length	O
and	O
consists	O
of	O
16	O
exons	O
,	O
including	O
two	O
noncoding	O
exons	O
.	O

All	O
the	O
introns	O
are	O
flanked	O
by	O
GT	O
-	O
AG	O
consensus	O
splice	O
sequences	O
.	O

5'-Rapid	O
Amplification	O
of	O
cDNA	O
Ends	O
(	O
RACE	O
)	O
analyses	O
demonstrate	O
three	O
splice	O
variant	O
mRNAs	O
involving	O
the	O
noncoding	O
exon	O
2	O
and	O
exon	O
3	O
.	O

The	O
5'-flanking	O
region	O
of	O
the	O
gene	O
contains	O
consensus	O
CAAT	O
and	O
TATA	O
boxes	O
and	O
several	O
potential	O
binding	O
sites	O
for	O
transcription	O
factors	O
for	O
CAAT	O
enhancer	O
binding	O
protein	O
(	O
C	O
/	O
EBP	O
)	O
and	O
hepatocyte	O
nuclear	O
factors	O
(	O
HNF-3beta	O
,	O
HFH-1	B
,	O
and	O
HFH-2	O
)	O
,	O
transcription	O
factors	O
important	O
for	O
liver	O
-	O
specific	O
gene	O
expression	O
.	O

PURPOSE	O
:	O
To	O
determine	O
whether	O
early	O
retinal	O
degeneration	O
(	O
erd	O
)	O
and	O
progressive	O
rod	O
cone	O
degeneration	O
(	O
prcd	O
)	O
,	O
two	O
canine	O
hereditary	O
retinal	O
degenerations	O
,	O
are	O
caused	O
by	O
allelic	O
mutations	O
;	O
to	O
determine	O
the	O
cDNA	O
sequence	O
of	O
the	O
canine	O
RDS	B
/	O
peripherin	O
homolog	O
(	O
CFRDSP	O
)	O
;	O
and	O
to	O
test	O
whether	O
mutations	O
(	O
s	O
)	O
in	O
CFRDSP	O
cause	O
(	O
s	O
)	O
either	O
erd	O
or	O
prcd	O
.	O

METHODS	O
:	O
Three	O
erd	O
-	O
affected	O
dogs	O
were	O
crossbred	O
to	O
three	O
prcd	O
-	O
affected	O
dogs	O
,	O
and	O
their	O
progeny	O
were	O
tested	O
by	O
electroretinography	O
and	O
retinal	O
morphology	O
for	O
evidence	O
of	O
retinal	O
degeneration	O
.	O

Canine	O
RDS	B
/	O
peripherin	O
cDNA	O
was	O
cloned	O
and	O
sequenced	O
after	O
reverse	O
-	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
of	O
total	O
retinal	O
RNA	O
.	O

A	O
set	O
of	O
overlapping	O
fragments	O
of	O
CFRDSP	O
cDNA	O
amplified	O
from	O
normal	O
and	O
prcd	O
-	O
affected	O
retinal	O
RNA	O
was	O
examined	O
by	O
double	O
-	O
stranded	O
conformational	O
polymorphism	O
analysis	O
for	O
evidence	O
of	O
any	O
mutation	O
in	O
prcd	O
-	O
affected	O
dogs	O
.	O

RDS	B
/	O
peripherin	O
-	O
specific	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
allelic	O
differences	O
within	O
informative	O
prcd	O
and	O
erd	O
pedigrees	O
were	O
sought	O
by	O
digestion	O
of	O
amplified	O
regions	O
of	O
the	O
CFRDSP	O
gene	O
with	O
different	O
restriction	O
enzymes	O
.	O

A	O
Hinf	O
I	O
RFLP	O
was	O
identified	O
with	O
alleles	O
segregating	O
in	O
a	O
set	O
of	O
prcd	O
and	O
erd	O
informative	O
pedigrees	O
.	O

Linkage	O
of	O
CFRDSP	O
to	O
either	O
prcd	O
or	O
erd	O
was	O
tested	O
using	O
the	O
LINKAGE	O
analysis	O
package	O
.	O

RESULTS	O
:	O
All	O
progeny	O
from	O
the	O
erd	O
x	O
prcd	O
cross	O
were	O
phenotypically	O
normal	O
at	O
ages	O
beyond	O
the	O
age	O
of	O
diagnosis	O
for	O
both	O
parental	O
disorders	O
.	O

The	O
sequence	O
of	O
CFRDSP	O
cDNA	O
is	O
reported	O
(	O
Genbank	O
accession	O
U27349	O
)	O
.	O

It	O
is	O
,	O
overall	O
,	O
79	O
%	O
identical	O
at	O
the	O
nucleotide	O
level	O
with	O
the	O
corresponding	O
human	O
sequence	O
.	O

The	O
coding	O
region	O
shares	O
89	O
%	O
and	O
93	O
%	O
nucleotide	O
identity	O
with	O
the	O
corresponding	O
human	O
and	O
feline	O
sequences	O
,	O
respectively	O
.	O

No	O
mutation	O
has	O
been	O
identified	O
in	O
the	O
coding	O
region	O
of	O
CFRDSP	O
in	O
prcd	O
-	O
affected	O
dogs	O
.	O

In	O
prcd	O
pedigrees	O
informative	O
for	O
both	O
prcd	O
and	O
the	O
CFRDSP	O
Hinf	O
I	O
RFLP	O
,	O
a	O
minimum	O
of	O
six	O
obligate	O
recombinants	O
were	O
identified	O
.	O

Similarly	O
,	O
in	O
erd	O
pedigrees	O
,	O
14	O
of	O
29	O
progeny	O
informative	O
for	O
both	O
erd	O
and	O
this	O
RFLP	O
were	O
obligate	O
recombinants	O
.	O

CONCLUSIONS	O
:	O
The	O
canine	O
erd	O
and	O
prcd	O
mutations	O
are	O
nonallelic	O
.	O

The	O
canine	O
RDS	B
/	O
peripherin	O
gene	O
(	O
CFRDSP	O
)	O
has	O
been	O
excluded	O
as	O
a	O
candidate	O
for	O
both	O
prcd	O
and	O
erd	O
.	O

The	O
demonstrated	O
informativeness	O
of	O
the	O
canine	O
pedigrees	O
on	O
which	O
these	O
studies	O
were	O
based	O
will	O
enable	O
testing	O
other	O
candidate	O
genes	O
for	O
prcd	O
and	O
erd	O
.	O

Sequence	O
information	O
of	O
CFRDSP	O
will	O
enable	O
testing	O
this	O
locus	O
as	O
a	O
candidate	O
in	O
other	O
canine	O
hereditary	O
retinal	O
degenerations	O
.	O

The	O
process	O
of	O
evaluating	O
the	O
in	O
vivo	O
efficacy	O
of	O
non	O
-	O
peptidyl	O
receptor	O
antagonists	O
in	O
animal	O
models	O
is	O
frequently	O
complicated	O
by	O
failure	O
of	O
compounds	O
displaying	O
high	O
affinity	O
against	O
the	O
human	O
receptors	O
to	O
show	O
measurable	O
affinity	O
at	O
the	O
corresponding	O
rodent	O
receptors	O
.	O

In	O
order	O
to	O
generate	O
a	O
suitable	O
animal	O
model	O
in	O
which	O
to	O
evaluate	O
the	O
in	O
vivo	O
activity	O
of	O
non	O
-	O
peptidyl	O
glucagon	B
receptor	I
antagonists	O
,	O
we	O
have	O
utilized	O
a	O
direct	O
targeting	O
approach	O
to	O
replace	O
the	O
murine	O
glucagon	B
receptor	I
with	O
the	O
human	O
glucagon	B
receptor	I
gene	O
by	O
homologous	O
recombination	O
.	O

Specific	O
expression	O
of	O
the	O
human	O
glucagon	B
receptor	I
(	O
GR	B
)	O
in	O
the	O
livers	O
of	O
transgenic	O
mice	O
was	O
confirmed	O
with	O
an	O
RNase	O
protection	O
assay	O
,	O
and	O
the	O
pharmacology	O
of	O
the	O
human	O
GRs	O
expressed	O
in	O
the	O
livers	O
of	O
these	O
mice	O
parallels	O
that	O
of	O
human	O
GR	B
in	O
a	O
recombinant	O
CHO	O
cell	O
line	O
with	O
respect	O
to	O
both	O
binding	O
of	O
125I	O
-	O
glucagon	O
and	O
the	O
ability	O
of	O
glucagon	O
to	O
stimulate	O
cAMP	O
production	O
.	O

L-168,049	O
,	O
a	O
non	O
-	O
peptidyl	O
GR	B
antagonist	O
selective	O
for	O
the	O
human	O
GR	B
shows	O
a	O
3.5	O
fold	O
higher	O
affinity	O
for	O
liver	O
membrane	O
preparations	O
of	O
human	O
GR	B
expressing	O
mice	O
(	O
IC50	O
=	O
172	O
+	O
/-	O

98	O
nM	O
)	O
in	O
the	O
presence	O
of	O
MgCl2	O
in	O
marked	O
contrast	O
to	O
the	O
measured	O
affinity	O
of	O
the	O
murine	O
receptor	O
(	O
IC50	O
=	O
611	O
+	O
/-	O

197	O
nM	O
)	O
for	O
this	O
non	O
-	O
peptidyl	O
antagonist	O
.	O

The	O
human	O
receptors	O
expressed	O
are	O
functional	O
as	O
measured	O
by	O
the	O
ability	O
of	O
glucagon	O
to	O
stimulate	O
cAMP	O
production	O
and	O
the	O
selectivity	O
of	O
this	O
antagonist	O
for	O
the	O
human	O
receptor	O
is	O
further	O
verified	O
by	O
its	O
ability	O
to	O
block	O
glucagon	O
-	O
stimulated	O
cyclase	O
activity	O
with	O
5	O
fold	O
higher	O
potency	O
(	O
IC50	O
=	O
97.2	O
+	O
/-	O

13.9	O
nM	O
)	O
than	O
for	O
the	O
murine	O
receptor	O
(	O
IC50	O
=	O
504	O
+	O
/-	O

247	O
nM	O
)	O
.	O

Thus	O
we	O
have	O
developed	O
a	O
novel	O
animal	O
model	O
for	O
evaluating	O
GR	B
antagonists	O
in	O
vivo	O
.	O

These	O
mice	O
offer	O
the	O
advantage	O
that	O
the	O
regulatory	O
sequences	O
which	O
direct	O
tissue	O
specific	O
and	O
temporal	O
expression	O
of	O
the	O
GR	B
have	O
been	O
unaltered	O
and	O
thus	O
expression	O
of	O
the	O
human	O
gene	O
in	O
these	O
mice	O
remains	O
in	O
the	O
normal	O
chromosomal	O
context	O
.	O

We	O
have	O
identified	O
a	O
murine	O
gene	O
,	O
metaxin	O
,	O
that	O
spans	O
the	O
6-kb	O
interval	O
separating	O
the	O
glucocerebrosidase	B
gene	O
(	O
GC	B
)	O
from	O
the	O
thrombospondin	B
3	I
gene	O
on	O
chromosome	O
3E3-F1	O
.	O

Metaxin	O
and	O
GC	B
are	O
transcribed	O
convergently	O
;	O
their	O
major	O
polyadenylylation	O
sites	O
are	O
only	O
431	O
bp	O
apart	O
.	O

On	O
the	O
other	O
hand	O
,	O
metaxin	O
and	O
the	O
thrombospondin	B
3	I
gene	O
are	O
transcribed	O
divergently	O
and	O
share	O
a	O
common	O
promoter	O
sequence	O
.	O

The	O
cDNA	O
for	O
metaxin	O
encodes	O
a	O
317-aa	O
protein	O
,	O
without	O
either	O
a	O
signal	O
sequence	O
or	O
consensus	O
for	O
N	O
-	O
linked	O
glycosylation	O
.	O

Metaxin	O
protein	O
is	O
expressed	O
ubiquitously	O
in	O
tissues	O
of	O
the	O
young	O
adult	O
mouse	O
,	O
but	O
no	O
close	O
homologues	O
have	O
been	O
found	O
in	O
the	O
DNA	O
or	O
protein	O
data	O
bases	O
.	O

A	O
targeted	O
mutation	O
(	O
A-->G	O
in	O
exon	O
9	O
)	O
was	O
introduced	O
into	O
GC	B
by	O
homologous	O
recombination	O
in	O
embryonic	O
stem	O
cells	O
to	O
establish	O
a	O
mouse	O
model	O
for	O
a	O
mild	O
form	O
of	O
Gaucher	O
disease	O
.	O

A	O
phosphoglycerate	O
kinase	O
-	O
neomycin	O
gene	O
cassette	O
was	O
also	O
inserted	O
into	O
the	O
3'-flanking	O
region	O
of	O
GC	B
as	O
a	O
selectable	O
marker	O
,	O
at	O
a	O
site	O
later	O
identified	O
as	O
the	O
terminal	O
exon	O
of	O
metaxin	O
.	O

Mice	O
homozygous	O
for	O
the	O
combined	O
mutations	O
die	O
early	O
in	O
gestation	O
.	O

Since	O
the	O
same	O
amino	O
acid	O
mutation	O
in	O
humans	O
is	O
associated	O
with	O
mild	O
type	O
1	O
Gaucher	O
disease	O
,	O
we	O
suggest	O
that	O
metaxin	O
protein	O
is	O
likely	O
to	O
be	O
essential	O
for	O
embryonic	O
development	O
in	O
mice	O
.	O

Clearly	O
,	O
the	O
contiguous	O
gene	O
organization	O
at	O
this	O
locus	O
limits	O
targeting	O
strategies	O
for	O
the	O
production	O
of	O
murine	O
models	O
of	O
Gaucher	O
disease	O
.	O

It	O
is	O
known	O
that	O
mice	O
homozygous	O
for	O
the	O
retinal	O
degeneration	O
(	O
rd	B
)	O
mutation	O
are	O
able	O
to	O
synchronize	O
their	O
circadian	O
rhythms	O
to	O
light	O
-	O
dark	O
cycles	O
.	O

In	O
the	O
present	O
experiments	O
mice	O
were	O
given	O
a	O
choice	O
of	O
a	O
dark	O
or	O
an	O
illuminated	O
living	O
and	O
nesting	O
area	O
.	O

C3H	O
,	O
CBA	O
and	O
C57	O
rd	B
/	O
rd	B
mice	O
spent	O
more	O
time	O
in	O
the	O
dark	O
than	O
in	O
the	O
illuminated	O
area	O
.	O

Also	O
,	O
they	O
spent	O
as	O
much	O
time	O
in	O
the	O
dark	O
area	O
as	O
did	O
wildtype	O
controls	O
.	O

This	O
shows	O
that	O
,	O
despite	O
advanced	O
retinal	O
degeneration	O
,	O
light	O
can	O
be	O
used	O
to	O
control	O
behaviour	O
in	O
space	O
as	O
well	O
as	O
in	O
time	O
.	O

This	O
was	O
true	O
of	O
mutant	O
mice	O
over	O
a	O
year	O
old	O
,	O
when	O
retinal	O
degeneration	O
is	O
very	O
severe	O
,	O
and	O
also	O
of	O
a	O
transgenic	O
strain	O
of	O
mice	O
whose	O
rods	O
are	O
destroyed	O
as	O
they	O
begin	O
to	O
develop	O
in	O
the	O
first	O
few	O
weeks	O
after	O
birth	O
.	O

Glutamine	O
:	O
fructose-6-phosphate	O
amidotransferase	B
(	I
GFAT	I
)	I
is	O
the	O
rate	O
-	O
limiting	O
enzyme	O
of	O
the	O
hexosamine	O
synthesis	O
pathway	O
.	O

Products	O
of	O
this	O
pathway	O
have	O
been	O
implicated	O
in	O
insulin	O
resistance	O
and	O
glucose	O
toxicity	O
.	O

GFAT1	B
is	O
ubiquitous	O
,	O
whereas	O
GFAT2	B
is	O
expressed	O
mainly	O
in	O
the	O
central	O
nervous	O
system	O
.	O

In	O
the	O
course	O
of	O
developing	O
a	O
competitive	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
assay	O
,	O
we	O
noted	O
that	O
GFAT1	B
cDNA	O
from	O
muscle	O
but	O
not	O
from	O
other	O
tissues	O
migrated	O
as	O
a	O
doublet	O
.	O

Subsequent	O
cloning	O
and	O
sequencing	O
revealed	O
two	O
GFAT1	B
mRNAs	O
in	O
both	O
mouse	O
and	O
human	O
skeletal	O
muscles	O
.	O

The	O
novel	O
GFAT1	B
mRNA	O
(	O
GFAT1Alt	O
[	O
muscle	O
selective	O
variant	O
of	O
GFAT1	B
]	O
)	O
is	O
likely	O
a	O
splice	O
variant	O
.	O

It	O
is	O
identical	O
to	O
GFAT1	B
except	O
for	O
a	O
48	O
or	O
54	O
bp	O
insert	O
in	O
the	O
mouse	O
and	O
human	O
,	O
respectively	O
,	O
at	O
nucleotide	O
position	O
686	O
of	O
the	O
coding	O
sequence	O
,	O
resulting	O
in	O
a	O
16	O
or	O
18	O
amino	O
acid	O
insert	O
at	O
position	O
229	O
of	O
the	O
protein	O
.	O

GFAT1Alt	O
is	O
the	O
predominant	O
GFAT1	B
mRNA	O
in	O
mouse	O
hindlimb	O
muscle	O
,	O
is	O
weakly	O
expressed	O
in	O
the	O
heart	O
,	O
and	O
is	O
undetectable	O
in	O
the	O
brain	O
,	O
liver	O
,	O
kidney	O
,	O
lung	O
,	O
intestine	O
,	O
spleen	O
,	O
and	O
3T3-L1	O
adipocytes	O
.	O

In	O
humans	O
,	O
it	O
is	O
strongly	O
expressed	O
in	O
skeletal	O
muscle	O
but	O
not	O
in	O
the	O
brain	O
.	O

GFAT1	B
and	O
GFAT1Alt	O
expressed	O
by	O
recombinant	O
adenovirus	O
infection	O
in	O
COS-7	O
cells	O
displayed	O
robust	O
enzyme	O
activity	O
and	O
kinetic	O
differences	O
.	O

The	O
apparent	O
K	O
(	O
m	O
)	O
of	O
GFAT1Alt	O
for	O
fructose-6-phosphate	O
was	O
approximately	O
twofold	O
higher	O
than	O
that	O
of	O
GFAT1	B
,	O
whereas	O
K	O
(	O
i	O
)	O
for	O
UDP	O
-	O
N	O
-	O
acetylglucosamine	O
was	O
approximately	O
fivefold	O
lower	O
.	O

Muscle	O
insulin	O
resistance	O
is	O
a	O
hallmark	O
and	O
predictor	O
of	O
type	O
2	O
diabetes	O
.	O

Variations	O
in	O
the	O
expression	O
of	O
GFAT	B
isoforms	O
in	O
muscle	O
may	O
contribute	O
to	O
predisposition	O
to	O
insulin	O
resistance	O
.	O

Lurcher	B
mutant	O
mice	O
were	O
compared	O
to	O
normal	O
littermate	O
controls	O
for	O
body	O
weight	O
,	O
body	O
righting	O
,	O
negative	O
geotropism	O
,	O
sensorimotor	O
coordination	O
(	O
rotating	O
grid	O
,	O
wire	O
suspension	O
,	O
rotorod	O
)	O
,	O
and	O
visuomotor	O
coordination	O
requiring	O
swimming	O
toward	O
a	O
pole	O
during	O
postnatal	O
(	O
P	O
)	O
days	O
0	O
-	O
30	O
.	O

Lurcher	B
mutants	O
had	O
a	O
lower	O
body	O
weight	O
on	O
P20-P30	O
and	O
were	O
slower	O
before	O
performing	O
the	O
complete	O
body	O
righting	O
response	O
on	O
P13-P30	O
.	O

Because	O
of	O
postural	O
instability	O
during	O
the	O
negative	O
geotropism	O
test	O
,	O
lurcher	B
mutants	O
turned	O
quicker	O
up	O
the	O
slope	O
than	O
normal	O
mice	O
.	O

The	O
mutants	O
fell	O
sooner	O
from	O
the	O
rotating	O
grid	O
on	O
P11-P14	O
,	O
from	O
the	O
horizontal	O
wire	O
on	O
P15-P16	O
,	O
and	O
from	O
the	O
rotorod	O
on	O
P14-P30	O
.	O

Lurcher	B
mutants	O
were	O
also	O
slower	O
before	O
swimming	O
to	O
the	O
pole	O
or	O
climbing	O
to	O
the	O
top	O
of	O
the	O
pole	O
and	O
were	O
inferior	O
in	O
pole	O
climbing	O
height	O
on	O
P22-P30	O
.	O

These	O
results	O
indicate	O
test	O
-	O
selective	O
and	O
time	O
-	O
selective	O
neurobehavioral	O
deficits	O
during	O
ontogeny	O
in	O
a	O
spontaneous	O
cerebellar	O
mutant	O
.	O

We	O
have	O
recently	O
reported	O
that	O
female	O
mice	O
are	O
protected	O
to	O
a	O
much	O
greater	O
extent	O
from	O
the	O
injurious	O
effects	O
of	O
reduced	O
-	O
size	O
liver	O
ischemia	O
and	O
reperfusion	O
(	O
RSL+I	O
/	O
R	O
)	O
than	O
are	O
males	O
by	O
an	O
estrogen	O
-	O
dependent	O
mechanism	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
possibility	O
that	O
the	O
protective	O
effect	O
observed	O
in	O
female	O
mice	O
depends	O
on	O
the	O
up	O
-	O
regulation	O
and/or	O
activation	O
of	O
endothelial	O
cell	O
NO	O
synthase	O
(	O
eNOS	B
)	O
.	O

Anesthetized	O
female	O
and	O
male	O
wild	O
-	O
type	O
or	O
eNOS	B
-	O
deficient	O
C57BL	O
/	O
6	O
mice	O
were	O
subjected	O
to	O
70	O
%	O
liver	O
ischemia	O
for	O
45	O
min	O
followed	O
by	O
resection	O
of	O
the	O
remaining	O
30	O
%	O
nonischemic	O
lobes	O
and	O
reperfusion	O
of	O
ischemic	O
tissue	O
.	O

Survival	O
was	O
monitored	O
daily	O
,	O
whereas	O
liver	O
injury	O
was	O
quantified	O
by	O
using	O
serum	O
alanine	O
aminotransferase	O
determinations	O
and	O
histopathology	O
.	O

Hepatic	O
eNOS	B
mRNA	O
,	O
protein	O
,	O
and	O
enzymatic	O
activity	O
were	O
determined	O
in	O
male	O
and	O
female	O
mice	O
subjected	O
to	O
RSL+I	O
/	O
R.	O
We	O
found	O
that	O
liver	O
injury	O
was	O
reduced	O
and	O
survival	O
increased	O
in	O
female	O
mice	O
compared	O
with	O
males	O
.	O

This	O
protective	O
effect	O
correlated	O
with	O
significant	O
increases	O
in	O
hepatic	O
eNOS	B
message	O
levels	O
and	O
enzyme	O
activity	O
but	O
not	O
protein	O
expression	O
compared	O
with	O
males	O
subjected	O
to	O
the	O
surgery	O
.	O

Furthermore	O
,	O
N	O
(	O
omega	O
)	O
-nitro	O
-	O
L	O
-	O
arginine	O
methyl	O
ester	O
-	O
treated	O
or	O
eNOS	B
-	O
deficient	O
female	O
mice	O
responded	O
to	O
RSL+I	O
/	O
R	O
with	O
dramatic	O
increases	O
in	O
liver	O
injury	O
and	O
100	O
%	O
mortality	O
within	O
2	O
days	O
of	O
surgery	O
.	O

Finally	O
,	O
we	O
found	O
that	O
pravastatin	O
pretreatment	O
significantly	O
attenuated	O
hepatocellular	O
injury	O
and	O
increased	O
survival	O
of	O
male	O
mice	O
,	O
which	O
was	O
associated	O
with	O
enhanced	O
expression	O
of	O
eNOS	B
message	O
.	O

We	O
conclude	O
that	O
the	O
protective	O
effect	O
afforded	O
female	O
mice	O
is	O
due	O
to	O
the	O
activation	O
of	O
hepatic	O
eNOS	B
activity	O
and	O
enhanced	O
NO	O
production	O
.	O

The	O
murine	O
homologs	O
of	O
two	O
viral	O
oncogenes	O
associated	O
with	O
tyrosine	O
-	O
specific	O
kinase	O
activity	O
have	O
been	O
assigned	O
to	O
different	O
loci	O
in	O
the	O
mouse	O
genome	O
.	O

The	O
segregation	O
of	O
restriction	O
site	O
polymorphisms	O
,	O
as	O
detected	O
by	O
probes	O
that	O
are	O
specific	O
for	O
endogenous	O
c	B
-	I
fes	I
and	O
c	B
-	O
src	B
sequences	O
,	O
was	O
followed	O
in	O
the	O
DNA	O
of	O
recombinant	O
inbred	O
strains	O
.	O

The	O
c	B
-	I
fes	I
gene	O
was	O
mapped	O
to	O
the	O
proximal	O
portion	O
of	O
chromosome	O
7	O
,	O
very	O
close	O
to	O
the	O
Gpi-1	B
locus	O
,	O
whereas	O
c	B
-	O
src	B
was	O
linked	O
to	O
the	O
Psp	B
locus	O
on	O
the	O
distal	O
half	O
of	O
chromosome	O
2	O
.	O

To	O
characterize	O
further	O
the	O
radiosensitivity	O
of	O
severe	B
combined	I
immunodeficiency	I
(	O
scid	B
)	O
mice	O
,	O
the	O
induction	O
of	O
micronuclei	O
(	O
MN	O
)	O
in	O
polychromatic	O
erythrocytes	O
as	O
well	O
as	O
cell	O
killing	O
and	O
translocation	O
induction	O
in	O
stem	O
cell	O
spermatogonia	O
was	O
studied	O
.	O

Scid	B
mice	O
turned	O
out	O
to	O
be	O
clearly	O
hypersensitive	O
for	O
X	O
-	O
ray	O
-	O
induced	O
cell	O
killing	O
of	O
both	O
bonemarrow	O
cells	O
and	O
spermatogonial	O
stem	O
cells	O
.	O

The	O
frequencies	O
of	O
recorded	O
micronuclei	O
in	O
polychromatic	O
erythrocytes	O
were	O
comparable	O
with	O
that	O
reported	O
for	O
the	O
normal	O
mouse	O
,	O
whereas	O
the	O
recovery	O
of	O
translocations	O
was	O
extremely	O
low	O
in	O
the	O
scid	B
mouse	O
.	O

The	O
dose	O
-	O
response	O
relationship	O
for	O
induced	O
translocations	O
was	O
bell	O
shaped	O
with	O
a	O
maximum	O
of	O
about	O
0.5	O
%	O
around	O
doses	O
of	O
0.5	O
-	O
1.5	O
Gy	O
X	O
-	O
rays	O
.	O

The	O
transcription	O
regulatory	O
properties	O
of	O
murine	O
B	O
-	O
myb	B
protein	O
were	O
compared	O
to	O
those	O
of	O
c	B
-	I
myb	I
.	O

Whereas	O
c	B
-	I
Myb	I
trans	O
-	O
activated	O
an	O
SV40	O
early	O
promoter	O
containing	O
multiple	O
copies	O
of	O
an	O
upstream	O
c	B
-	I
Myb	I
DNA	O
-	O
binding	O
site	O
(	O
MBS-1	O
)	O
,	O
and	O
similarly	O
the	O
human	O
c	O
-	O
myc	O
promoter	O
,	O
B	O
-	O
Myb	B
was	O
unable	O
to	O
do	O
so	O
.	O

Full	O
-	O
length	O
B	O
-	O
Myb	B
translated	O
in	O
vitro	O
did	O
not	O
bind	O
MBS-1	O
;	O
however	O
,	O
truncation	O
of	O
the	O
B	O
-	O
Myb	B
C	O
-	O
terminus	O
or	O
fusion	O
of	O
the	O
B	O
-	O
Myb	B
DNA	O
-	O
binding	O
domain	O
to	O
the	O
c	B
-	I
Myb	I
C	O
-	O
terminus	O
showed	O
that	O
it	O
was	O
inherently	O
competent	O
to	O
interact	O
with	O
this	O
motif	O
.	O

Further	O
evidence	O
from	O
co	O
-	O
transfection	O
experiments	O
,	O
demonstrating	O
that	O
B	O
-	O
Myb	B
inhibited	O
trans	O
-	O
activation	O
by	O
c	B
-	I
Myb	I
,	O
suggested	O
that	O
failure	O
of	O
B	O
-	O
Myb	B
to	O
trans	O
-	O
activate	O
these	O
promoters	O
did	O
not	O
simply	O
occur	O
through	O
lack	O
of	O
binding	O
to	O
MBS-1	O
.	O

Moreover	O
,	O
using	O
GAL4	O
/	O
B	O
-	O
Myb	B
fusions	O
,	O
it	O
was	O
found	O
that	O
an	O
acidic	O
region	O
of	O
B	O
-	O
Myb	B
,	O
which	O
by	O
comparison	O
to	O
c	B
-	I
Myb	I
was	O
expected	O
to	O
contain	O
a	O
transcription	O
activation	O
domain	O
,	O
actually	O
had	O
no	O
inherent	O
trans	O
-	O
activation	O
activity	O
and	O
indeed	O
appeared	O
to	O
trans	O
-	O
inhibit	O
c	B
-	I
Myb	I
.	O

In	O
contrast	O
to	O
the	O
above	O
findings	O
,	O
both	O
B	O
-	O
Myb	B
and	O
c	B
-	I
Myb	I
were	O
able	O
to	O
weakly	O
trans	O
-	O
activate	O
the	O
DNA	O
polymerase	O
alpha	O
promoter	O
.	O

Results	O
obtained	O
here	O
demonstrate	O
that	O
the	O
activities	O
of	O
B	O
-	O
Myb	B
and	O
c	B
-	I
Myb	I
are	O
clearly	O
distinct	O
and	O
suggest	O
that	O
these	O
related	O
proteins	O
may	O
have	O
different	O
functions	O
in	O
regulation	O
of	O
target	O
gene	O
expression	O
.	O

Mammary	O
glands	O
from	O
the	O
estrogen	O
receptor	O
-	O
a	O
knockout	O
(	O
alphaERKO	O
)	O
mouse	O
do	O
not	O
undergo	O
ductal	O
morphogenesis	O
or	O
alveolar	O
development	O
.	O

Disrupted	O
ERalpha	B
signaling	O
may	O
result	O
in	O
reduced	O
estrogen	O
-	O
responsive	O
gene	O
products	O
in	O
the	O
mammary	O
gland	O
or	O
reduced	O
mammotropic	O
hormones	O
that	O
contribute	O
to	O
the	O
alphaERKO	O
mammary	O
phenotype	O
.	O

We	O
report	O
that	O
circulating	O
PRL	B
is	O
reduced	O
in	O
the	O
female	O
alphaERKO	O
mouse	O
.	O

Implantation	O
of	O
an	O
age	O
-	O
matched	O
,	O
heterozygous	O
ERalpha	B
pituitary	O
isograft	O
under	O
the	O
renal	O
capsule	O
of	O
25-day	O
-	O
old	O
or	O
12-week	O
-	O
old	O
alphaERKO	O
mice	O
increased	O
circulating	O
PRL	B
and	O
progesterone	O
levels	O
,	O
and	O
induced	O
mammary	O
gland	O
development	O
.	O

Grafted	O
alphaERKO	O
mice	O
also	O
possessed	O
hypertrophied	O
corpora	O
lutea	O
demonstrating	O
that	O
PRL	B
is	O
luteotropic	O
in	O
the	O
alphaERKO	O
ovary	O
.	O

By	O
contrast	O
,	O
ovariectomy	O
at	O
the	O
time	O
of	O
pituitary	O
grafting	O
prevented	O
mammary	O
gland	O
development	O
in	O
alphaERKO	O
mice	O
despite	O
elevated	O
PRL	B
levels	O
.	O

Hormone	O
replacement	O
using	O
pellet	O
implants	O
demonstrated	O
that	O
pharmacological	O
doses	O
of	O
estradiol	O
induced	O
limited	O
mammary	O
ductal	O
elongation	O
,	O
and	O
estradiol	O
in	O
combination	O
with	O
progesterone	O
stimulated	O
lobuloalveolar	O
development	O
.	O

PRL	B
alone	O
or	O
in	O
combination	O
with	O
progesterone	O
or	O
estradiol	O
did	O
not	O
induce	O
alphaERKO	O
mammary	O
growth	O
.	O

Estradiol	O
and	O
progesterone	O
are	O
required	O
for	O
the	O
structural	O
development	O
of	O
the	O
alphaERKO	O
mammary	O
gland	O
,	O
and	O
PRL	B
contributes	O
to	O
this	O
development	O
by	O
inducing	O
ovarian	O
progesterone	O
levels	O
.	O

Therefore	O
,	O
the	O
manifestation	O
of	O
the	O
alphaERKO	O
mammary	O
phenotype	O
appears	O
due	O
to	O
the	O
lack	O
of	O
direct	O
estrogen	O
action	O
at	O
the	O
mammary	O
gland	O
and	O
an	O
indirect	O
contributory	O
role	O
of	O
estrogen	O
signaling	O
at	O
the	O
hypothalamic	O
/	O
pituitary	O
axis	O
.	O

The	O
gene	O
encoding	O
the	O
major	O
intrinsic	O
protein	O
(	O
Mip	B
)	O
of	O
eye	O
-	O
lens	O
-	O
fibre	O
cell	O
membranes	O
has	O
been	O
assigned	O
to	O
region	O
D1	O
of	O
mouse	O
Chromosome	O
10	O
by	O
in	O
situ	O
hybridisation	O
of	O
a	O
cDNA	O
for	O
rat	O
MIP	B
to	O
G	O
-	O
banded	O
metaphase	O
chromosomes	O
.	O

The	O
mouse	O
Mip	B
gene	O
maps	O
within	O
or	O
near	O
to	O
a	O
segment	O
homoeologous	O
with	O
human	O
chromosome	O
12q	O
and	O
may	O
be	O
linked	O
to	O
the	O
Cat	B
locus	O
at	O
the	O
distal	O
end	O
of	O
mouse	O
Chromosome	O
10	O
.	O

The	O
mnd2	B
mutation	O
on	O
mouse	O
chromosome	O
6	O
produces	O
a	O
progressive	O
neuromuscular	O
disorder	O
.	O

To	O
determine	O
the	O
gene	O
content	O
of	O
the	O
400-kb	O
mnd2	B
nonrecombinant	O
region	O
,	O
we	O
sequenced	O
108	O
kb	O
of	O
mouse	O
genomic	O
DNA	O
and	O
92	O
kb	O
of	O
human	O
genomic	O
sequence	O
from	O
the	O
corresponding	O
region	O
of	O
chromosome	O
2p13.3	O
.	O

Three	O
genes	O
with	O
the	O
indicated	O
sizes	O
and	O
intergenic	O
distances	O
were	O
identified	O
:	O
D6Mm5e	B
(	O
>	O
/=81	O
kb	O
)	O
-787	O
bp	O
-	O
DOK	O
(	O
2	O
kb	O
)	O
-845	O
bp	O
-	O
LOR2	B
(	O
>	O
/=6	O
kb	O
)	O
.	O

D6Mm5e	B
is	O
expressed	O
in	O
many	O
tissues	O
at	O
very	O
low	O
abundance	O
and	O
the	O
predicted	O
526-residue	O
protein	O
contains	O
no	O
known	O
functional	O
domains	O
.	O

DOK	O
encodes	O
the	O
p62	O
(	O
dok	O
)	O
rasGAP	O
binding	O
protein	O
involved	O
in	O
signal	O
transduction	O
.	O

LOR2	B
encodes	O
a	O
novel	O
lysyl	O
oxidase	O
-	O
related	O
protein	O
of	O
757	O
amino	O
acid	O
residues	O
.	O

We	O
describe	O
a	O
simple	O
search	O
protocol	O
for	O
identification	O
of	O
conserved	O
internal	O
exons	O
in	O
genomic	O
sequence	O
.	O

Evolutionary	O
conservation	O
proved	O
to	O
be	O
a	O
useful	O
criterion	O
for	O
distinguishing	O
between	O
authentic	O
exons	O
and	O
artifactual	O
products	O
obtained	O
by	O
exon	O
amplification	O
,	O
RT	O
-	O
PCR	O
,	O
and	O
5	O
'	O
RACE	O
.	O

Conserved	O
noncoding	O
sequence	O
elements	O
longer	O
than	O
80	O
bp	O
with	O
>	O
/=75	O
%	O
nucleotide	O
sequence	O
identity	O
comprise	O
approximately	O
1	O
%	O
of	O
the	O
genomic	O
sequence	O
in	O
this	O
region	O
.	O

Comparative	O
analysis	O
of	O
this	O
human	O
and	O
mouse	O
genomic	O
DNA	O
sequence	O
was	O
an	O
efficient	O
method	O
for	O
gene	O
identification	O
and	O
is	O
independent	O
of	O
developmental	O
stage	O
or	O
quantitative	O
level	O
of	O
gene	O
expression	O
.	O

[	O
The	O
sequence	O
data	O
described	O
in	O
this	O
paper	O
have	O
been	O
submitted	O
to	O
the	O
GenBank	O
data	O
library	O
under	O
the	O
following	O
accession	O
numbers	O
:	O
AC003061	O
,	O
mouse	O
BAC	O
clone	O
245c12	O
;	O
AC003065	O
,	O
human	O
BAC	O
clone	O
h173	O
(	O
E10	O
)	O
;	O
AF053368	O
,	O
mouse	O
Lor2	B
cDNA	O
;	O
AF084363	O
,	O
108-kb	O
contig	O
from	O
mouse	O
BAC	O
245c12	O
;	O
AF084364	O
,	O
mouse	O
D6Mm5e	B
cDNA	O
.	O
]	O

The	O
reticular	O
lamina	O
of	O
the	O
mammalian	O
cochlea	O
is	O
formed	O
by	O
the	O
tightly	O
joined	O
apical	O
surfaces	O
of	O
hair	O
cells	O
and	O
supporting	O
cells	O
.	O

This	O
lamina	O
creates	O
a	O
barrier	O
separating	O
endolymph	O
and	O
perilymph	O
,	O
two	O
fluids	O
of	O
different	O
composition	O
.	O

The	O
preservation	O
of	O
this	O
fluid	O
barrier	O
is	O
a	O
requirement	O
of	O
cochlear	O
function	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
whether	O
the	O
calcium	O
-	O
dependent	O
,	O
cell	O
adhesion	O
molecule	O
,	O
E	B
-	I
cadherin	I
was	O
appropriately	O
placed	O
both	O
temporally	O
and	O
spatially	O
to	O
contribute	O
to	O
the	O
formation	O
and	O
maintenance	O
of	O
the	O
reticular	O
lamina	O
.	O

Cochleas	O
aged	O
E15	O
to	O
P31	O
were	O
stained	O
immunocytochemically	O
for	O
E	B
-	I
cadherin	I
.	O

In	O
the	O
P31	O
organ	O
of	O
Corti	O
,	O
E	B
-	I
cadherin	I
is	O
localized	O
to	O
the	O
apical	O
intercellular	O
junctions	O
of	O
supporting	O
cells	O
,	O
but	O
is	O
absent	O
from	O
supporting	O
cell	O
-	O
hair	O
cell	O
borders	O
.	O

During	O
development	O
,	O
E	B
-	I
cadherin	I
is	O
present	O
only	O
on	O
the	O
apices	O
and	O
lateral	O
edges	O
of	O
those	O
cells	O
which	O
will	O
eventually	O
lie	O
adjacent	O
to	O
fluid	O
spaces	O
--	O
pillar	O
,	O
outer	O
hair	O
and	O
Deiters	O
cells	O
.	O

The	O
molecule	O
disappears	O
from	O
the	O
lateral	O
cell	O
membranes	O
at	O
about	O
the	O
time	O
in	O
development	O
that	O
fluid	O
spaces	O
form	O
.	O

These	O
data	O
suggest	O
that	O
E	B
-	I
cadherin	I
plays	O
a	O
role	O
in	O
maintaining	O
the	O
reticular	O
lamina	O
by	O
mediating	O
inter	O
-	O
supporting	O
cell	O
adhesion	O
and	O
raise	O
the	O
possibility	O
that	O
fluid	O
space	O
opening	O
in	O
the	O
organ	O
of	O
Corti	O
is	O
facilitated	O
by	O
the	O
down	O
-	O
regulation	O
or	O
redistribution	O
of	O
E	B
-	I
cadherin	I
.	O

The	O
renin	O
-	O
angiotensin	O
system	O
plays	O
an	O
important	O
role	O
in	O
blood	O
pressure	O
homeostasis	O
,	O
but	O
the	O
contribution	O
of	O
the	O
type	O
2	O
angiotensin	O
II	O
receptor	O
(	O
AT2R	O
)	O
is	O
still	O
unclear	O
.	O

The	O
reports	O
that	O
the	O
AT2R	O
gene	O
has	O
been	O
mapped	O
to	O
the	O
X	O
chromosome	O
in	O
human	O
and	O
rat	O
and	O
the	O
previous	O
report	O
of	O
a	O
gene	O
,	O
Bp3	O
,	O
on	O
the	O
X	O
chromosome	O
responsible	O
for	O
an	O
increase	O
in	O
blood	O
pressure	O
have	O
suggested	O
that	O
the	O
rat	O
AT2R	O
gene	O
(	O
Agtr2	B
)	O
could	O
be	O
this	O
gene	O
.	O

To	O
elucidate	O
whether	O
Agtr2	B
is	O
Bp3	O
,	O
Agtr2	B
was	O
cloned	O
.	O

A	O
simple	O
sequence	O
repeat	O
in	O
the	O
3'-flanking	O
region	O
of	O
this	O
gene	O
was	O
identified	O
and	O
used	O
as	O
a	O
genetic	O
marker	O
to	O
map	O
Agtr2	B
to	O
the	O
X	O
chromosome	O
at	O
18.1	O
cM	O
distal	O
to	O
the	O
androgen	O
receptor	O
locus	O
.	O

This	O
map	O
position	O
is	O
outside	O
the	O
confidence	O
interval	O
reported	O
for	O
Bp3	O
,	O
demonstrating	O
that	O
Agtr2	B
can	O
not	O
be	O
Bp3	O
.	O

However	O
,	O
these	O
data	O
will	O
enhance	O
the	O
research	O
into	O
the	O
AT2R	O
biology	O
as	O
well	O
as	O
the	O
study	O
of	O
the	O
X	O
chromosome	O
.	O

The	O
multiple	B
intestinal	I
neoplasia	I
(	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
)	O
mouse	O
possesses	O
a	O
germline	O
mutation	O
at	O
codon	O
850	O
of	O
the	O
adenomatous	O
polyposis	O
coli	O
(	O
Apc	B
)	O
gene	O
resulting	O
in	O
the	O
formation	O
of	O
a	O
nonfunctional	O
truncated	O
gene	O
product	O
.	O

Following	O
a	O
somatic	O
mutation	O
of	O
the	O
remaining	O
wild	O
-	O
type	O
allele	O
,	O
mice	O
spontaneously	O
develop	O
approximately	O
40	O
-	O
50	O
tumors	O
throughout	O
the	O
intestinal	O
tract	O
.	O

This	O
mouse	O
model	O
has	O
been	O
used	O
to	O
study	O
intestinal	O
tumorigenesis	O
because	O
this	O
mutation	O
is	O
analogous	O
to	O
the	O
inherited	O
APC	B
mutation	O
in	O
humans	O
with	O
familial	O
adenomatous	O
polyposis	O
(	O
FAP	O
)	O
.	O

These	O
individuals	O
characteristically	O
develop	O
numerous	O
adenomas	O
throughout	O
their	O
intestinal	O
tracts	O
.	O

Only	O
a	O
few	O
studies	O
have	O
evaluated	O
the	O
effects	O
of	O
dietary	O
fatty	O
acids	O
on	O
tumorigenesis	O
in	O
this	O
animal	O
model	O
with	O
varying	O
results	O
,	O
and	O
none	O
have	O
linked	O
these	O
effects	O
to	O
alterations	O
in	O
arachidonic	O
acid	O
(	O
AA	O
)	O
metabolism	O
.	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
antitumorigenic	O
effect	O
of	O
dietary	O
(	O
n-3	O
)	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
)	O
in	O
the	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
mouse	O
model	O
and	O
to	O
determine	O
whether	O
these	O
effects	O
are	O
related	O
to	O
inhibition	O
of	O
AA	O
metabolism	O
.	O

Male	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
mice	O
were	O
fed	O
diets	O
supplemented	O
with	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
)	O
,	O
AA	O
or	O
a	O
combination	O
of	O
AA	O
+	O
EPA	O
.	O

Mean	O
tumor	O
number	O
in	O
the	O
EPA	O
group	O
was	O
68	O
%	O
lower	O
(	O
P<0.05	O
)	O
compared	O
with	O
the	O
control	O
group	O
,	O
whereas	O
AA	O
supplementation	O
did	O
not	O
significantly	O
alter	O
tumor	O
load	O
.	O

The	O
reduction	O
in	O
tumor	O
load	O
coincided	O
with	O
significant	O
reductions	O
in	O
intestinal	O
AA	O
content	O
and	O
levels	O
of	O
prostaglandins	O
.	O

However	O
,	O
supplementing	O
AA	O
to	O
the	O
EPA	O
diet	O
(	O
AA	O
+	O
EPA	O
)	O
abolished	O
the	O
antitumorigenic	O
effect	O
of	O
EPA	O
,	O
increased	O
tissue	O
AA	O
content	O
fourfold	O
and	O
prostaglandin	O
production	O
two-	O
to	O
fourfold	O
.	O

These	O
results	O
indicate	O
that	O
AA	O
is	O
involved	O
in	O
tumorigenesis	O
and	O
suggest	O
that	O
EPA	O
's	O
ability	O
to	O
reduce	O
tumor	O
load	O
in	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
mice	O
is	O
related	O
to	O
reductions	O
in	O
tissue	O
AA	O
content	O
or	O
its	O
metabolism	O
.	O

A	O
modified	O
AFLP	O
(	O
amplified	O
fragment	O
length	O
polymorphism	O
)	O
method	O
was	O
employed	O
to	O
isolate	O
genes	O
differentially	O
expressed	O
in	O
renal	O
carcinogenesis	O
of	O
Tsc2	B
gene	O
mutant	O
(	O
Eker	O
)	O
rats	O
.	O

One	O
gene	O
,	O
selected	O
for	O
further	O
investigation	O
,	O
was	O
named	O
""""	O
Niban	B
""""	O
""""	O
second	O
""""	O
in	O
Japanese	O
)	O
,	O
because	O
it	O
is	O
the	O
second	O
new	O
gene	O
to	O
be	O
found	O
after	O
Erc	O
(	O
expressed	O
in	O
renal	O
carcinoma	O
)	O
in	O
our	O
laboratory	O
.	O

Importantly	O
,	O
""""	O
Niban	B
""""	O
is	O
well	O
expressed	O
even	O
in	O
small	O
primary	O
rat	O
Eker	O
renal	O
tumors	O
,	O
more	O
than	O
in	O
progressed	O
cell	O
lines	O
,	O
and	O
is	O
also	O
expressed	O
in	O
human	O
renal	O
carcinoma	O
cells	O
,	O
but	O
not	O
in	O
normal	O
human	O
or	O
rat	O
kidneys	O
.	O

Chromosome	O
assignment	O
was	O
to	O
RNO	O
13	O
in	O
the	O
rat	O
,	O
and	O
HSA	O
1	O
.	O

This	O
""""	O
Niban	B
""""	O
gene	O
is	O
a	O
candidate	O
as	O
a	O
marker	O
for	O
renal	O
tumor	O
,	O
especially	O
early	O
-	O
stage	O
renal	O
carcinogenesis	O
.	O

We	O
previously	O
found	O
that	O
a	O
novel	O
DNA	O
endonuclease	O
named	O
DLAD	B
(	O
DNase	O
II	O
-	O
Like	O
Acid	O
DNase	O
)	O
is	O
specifically	O
expressed	O
in	O
murine	O
liver	O
.	O

Here	O
,	O
we	O
describe	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
human	O
DLAD	B
and	O
mouse	O
Dlad	B
genes	O
.	O

Both	O
DLAD	B
and	O
Dlad	B
consist	O
of	O
6	O
exons	O
.	O

DLAD	B
encodes	O
a	O
361	O
amino	O
acid	O
protein	O
sharing	O
34.6	O
%	O
amino	O
acid	O
identity	O
with	O
human	O
DNase	O
II	O
.	O

Although	O
a	O
recombinant	O
protein	O
for	O
the	O
putative	O
human	O
DLAD	B
has	O
a	O
divalent	O
cation	O
-	O
independent	O
acid	O
DNase	O
activity	O
,	O
expression	O
of	O
the	O
DLAD	B
mRNA	O
containing	O
the	O
entire	O
open	O
reading	O
frame	O
was	O
not	O
detected	O
in	O
any	O
human	O
tissues	O
tested	O
,	O
except	O
for	O
lung	O
,	O
in	O
which	O
a	O
short	O
1.1	O
kb	O
transcript	O
lacking	O
the	O
first	O
two	O
exons	O
is	O
expressed	O
.	O

Interestingly	O
,	O
sequence	O
analysis	O
of	O
Dlad	B
showed	O
that	O
the	O
1st	O
exon	O
of	O
the	O
urate	B
oxidase	I
gene	O
,	O
Uox	B
,	O
is	O
located	O
on	O
the	O
opposite	O
strand	O
in	O
its	O
5'-flanking	O
region	O
.	O

The	O
head	O
-	O
to	O
-	O
head	O
organization	O
of	O
DLAD	B
and	O
UOX	B
is	O
conserved	O
in	O
the	O
human	O
genomic	O
sequence	O
.	O

Promoter	O
analysis	O
revealed	O
that	O
the	O
intergenic	O
region	O
between	O
Dlad	B
and	O
Uox	B
has	O
promoter	O
activity	O
for	O
both	O
the	O
Dlad	B
and	O
Uox	B
directions	O
,	O
however	O
,	O
the	O
corresponding	O
human	O
genomic	O
fragment	O
has	O
promoter	O
activity	O
only	O
for	O
DLAD	B
.	O

It	O
is	O
known	O
that	O
murine	O
Uox	B
is	O
expressed	O
only	O
in	O
the	O
liver	O
,	O
whereas	O
human	O
UOX	B
has	O
been	O
inactivated	O
as	O
a	O
pseudogene	O
.	O

On	O
the	O
basis	O
of	O
these	O
results	O
,	O
the	O
expression	O
of	O
DLAD	B
/	O
Dlad	B
and	O
UOX	B
/	O
Uox	B
is	O
suggested	O
to	O
be	O
coordinated	O
by	O
a	O
common	O
regulatory	O
mechanism	O
(	O
s	O
)	O
,	O
and	O
the	O
balance	O
between	O
the	O
two	O
enzymes	O
is	O
thought	O
to	O
be	O
important	O
for	O
maintaining	O
the	O
purine	O
nucleotide	O
pool	O
in	O
the	O
liver	O
.	O

Acoustic	O
overstimulation	O
is	O
one	O
of	O
the	O
major	O
causes	O
of	O
hearing	O
loss	O
.	O

Glutamate	O
is	O
the	O
most	O
likely	O
candidate	O
neurotransmitter	O
for	O
afferent	O
synapses	O
in	O
the	O
peripheral	O
auditory	O
system	O
,	O
so	O
it	O
was	O
proposed	O
that	O
glutamate	O
excitotoxicity	O
may	O
be	O
involved	O
in	O
noise	O
trauma	O
.	O

However	O
,	O
there	O
has	O
been	O
no	O
direct	O
evidence	O
that	O
noise	O
trauma	O
is	O
caused	O
by	O
excessive	O
release	O
of	O
glutamate	O
from	O
the	O
inner	O
hair	O
cells	O
(	O
IHCs	O
)	O
during	O
sound	O
exposure	O
because	O
studies	O
have	O
been	O
hampered	O
by	O
powerful	O
glutamate	O
uptake	O
systems	O
in	O
the	O
cochlea	O
.	O

GLAST	B
is	O
a	O
glutamate	O
transporter	O
highly	O
expressed	O
in	O
the	O
cochlea	O
.	O

Here	O
we	O
show	O
that	O
after	O
acoustic	O
overstimulation	O
,	O
GLAST	B
-	O
deficient	O
mice	O
show	O
increased	O
accumulation	O
of	O
glutamate	O
in	O
perilymphs	O
,	O
resulting	O
in	O
exacerbation	O
of	O
hearing	O
loss	O
.	O

These	O
results	O
suggest	O
that	O
GLAST	B
plays	O
an	O
important	O
role	O
in	O
keeping	O
the	O
concentration	O
of	O
glutamate	O
in	O
the	O
perilymph	O
at	O
a	O
nontoxic	O
level	O
during	O
acoustic	O
overstimulation	O
.	O

These	O
findings	O
also	O
provide	O
further	O
support	O
for	O
the	O
hypothesis	O
that	O
IHCs	O
use	O
glutamate	O
as	O
a	O
neurotransmitter	O
.	O

Hair	O
vibrissa	O
follicle	O
morphogenesis	O
involves	O
several	O
cell	O
segregation	O
phases	O
,	O
in	O
the	O
dermis	O
as	O
well	O
as	O
in	O
the	O
epidermis	O
.	O

The	O
expression	O
of	O
Notch	O
-	O
related	O
genes	O
,	O
which	O
are	O
well	O
established	O
mediators	O
of	O
multiple	O
cell	O
segregation	O
events	O
in	O
Drosophila	O
development	O
,	O
was	O
studied	O
by	O
in	O
situ	O
hybridisation	O
during	O
embryonic	O
mouse	O
vibrissa	O
follicle	O
morphogenesis	O
and	O
the	O
first	O
adult	O
hair	O
cycle	O
.	O

The	O
results	O
show	O
that	O
two	O
receptors	O
,	O
Notch1	B
and	O
-2	O
,	O
three	O
ligands	O
,	O
Delta1	B
,	O
Serrate1	O
,	O
and	O
-2	O
,	O
and	O
the	O
three	O
Fringe	O
regulators	O
,	O
Lunatic	O
,	O
Manic	O
,	O
and	O
Radical	O
,	O
are	O
expressed	O
in	O
different	O
locations	O
and	O
morphogenetic	O
stages	O
.	O

First	O
,	O
the	O
appearance	O
of	O
hair	O
vibrissa	O
primordia	O
involves	O
the	O
expression	O
of	O
complementary	O
patterns	O
of	O
Notch2	B
,	O
Delta1	B
,	O
and	O
Lunatic	O
Fringe	O
in	O
the	O
dermis	O
and	O
of	O
Notch1	B
,	O
Serrate2	O
,	O
and	O
Lunatic	O
Fringe	O
in	O
the	O
epidermis	O
.	O

Second	O
,	O
this	O
expression	O
pattern	O
is	O
no	O
longer	O
found	O
after	O
stage	O
3	O
in	O
the	O
dermis	O
.	O

Meanwhile	O
,	O
in	O
the	O
epidermis	O
,	O
the	O
expression	O
of	O
Notch1	B
,	O
Serrate2	O
,	O
and	O
Lunatic	O
Fringe	O
before	O
the	O
formation	O
of	O
the	O
placode	O
may	O
be	O
involved	O
in	O
determining	O
two	O
populations	O
of	O
epidermal	O
cells	O
in	O
the	O
developing	O
follicle	O
.	O

Third	O
,	O
complementary	O
expression	O
patterns	O
for	O
Notch1	B
,	O
Manic	O
,	O
and	O
Lunatic	O
Fringe	O
,	O
as	O
well	O
as	O
Serrate1	O
and	O
-2	O
as	O
previously	O
shown	O
(	O
Powell	O
et	O
al.	O
,	O
1998	O
)	O
,	O
are	O
progressively	O
established	O
from	O
stage	O
4	O
of	O
embryonic	O
development	O
both	O
in	O
the	O
outer	O
root	O
sheath	O
and	O
in	O
the	O
hair	O
matrix	O
.	O

These	O
patterns	O
are	O
consistent	O
with	O
the	O
one	O
found	O
in	O
the	O
adult	O
anagen	O
phase	O
.	O

During	O
the	O
hair	O
vibrissa	O
cycle	O
,	O
Notch1	B
and	O
Manic	O
Fringe	O
display	O
temporal	O
and	O
spatial	O
changes	O
of	O
expression	O
,	O
suggesting	O
that	O
they	O
may	O
intervene	O
as	O
modulators	O
of	O
trichocyte	O
activities	O
.	O

The	O
rhombencephalic	O
neural	O
crest	O
play	O
several	O
roles	O
in	O
craniofacial	O
development	O
.	O

They	O
give	O
rise	O
to	O
the	O
cranial	O
sensory	O
ganglia	O
and	O
much	O
of	O
the	O
craniofacial	O
skeleton	O
,	O
and	O
are	O
vital	O
for	O
patterning	O
of	O
the	O
craniofacial	O
muscles	O
.	O

The	O
loss	O
of	O
Hoxa1	B
or	O
Hoxa2	B
function	O
affects	O
the	O
development	O
of	O
multiple	O
neural	O
crest	O
-	O
derived	O
structures	O
.	O

To	O
understand	O
how	O
these	O
two	O
genes	O
function	O
together	O
in	O
craniofacial	O
development	O
,	O
an	O
allele	O
was	O
generated	O
that	O
disrupts	O
both	O
of	O
these	O
linked	O
genes	O
.	O

Some	O
of	O
the	O
craniofacial	O
defects	O
observed	O
in	O
the	O
double	O
mutants	O
were	O
additive	O
combinations	O
of	O
those	O
that	O
exist	O
in	O
each	O
of	O
the	O
single	O
mutants	O
,	O
indicating	O
that	O
each	O
gene	O
functions	O
independently	O
in	O
the	O
formation	O
of	O
these	O
structures	O
.	O

Other	O
defects	O
were	O
found	O
only	O
in	O
the	O
double	O
mutants	O
demonstrating	O
overlapping	O
or	O
synergistic	O
functions	O
.	O

We	O
also	O
uncovered	O
multiple	O
defects	O
in	O
the	O
attachments	O
and	O
trajectories	O
of	O
the	O
extrinsic	O
tongue	O
and	O
hyoid	O
muscles	O
in	O
Hoxa2	B
mutants	O
.	O

Interestingly	O
,	O
the	O
abnormal	O
trajectory	O
of	O
two	O
of	O
these	O
muscles	O
,	O
the	O
styloglossus	O
and	O
the	O
stylohyoideus	O
,	O
blocked	O
the	O
attachment	O
of	O
the	O
hyoglossus	O
to	O
the	O
greater	O
horn	O
of	O
the	O
hyoid	O
,	O
which	O
in	O
turn	O
correlated	O
exactly	O
with	O
the	O
presence	O
of	O
cleft	O
palate	O
in	O
Hoxa2	B
mutants	O
.	O

We	O
suggest	O
that	O
the	O
hyoglossus	O
,	O
whose	O
function	O
is	O
to	O
depress	O
the	O
lateral	O
edges	O
of	O
the	O
tongue	O
,	O
when	O
unable	O
to	O
make	O
its	O
proper	O
attachment	O
to	O
the	O
greater	O
horn	O
of	O
the	O
hyoid	O
,	O
forces	O
the	O
tongue	O
to	O
adopt	O
an	O
abnormal	O
posture	O
which	O
blocks	O
closure	O
of	O
the	O
palatal	O
shelves	O
.	O

Unexpectedly	O
,	O
in	O
Hoxa1	B
/	O
Hoxa2	B
double	O
mutants	O
,	O
the	O
penetrance	O
of	O
cleft	O
palate	O
is	O
dramatically	O
reduced	O
.	O

We	O
show	O
that	O
two	O
compensatory	O
defects	O
,	O
associated	O
with	O
the	O
loss	O
of	O
Hoxa1	B
function	O
,	O
restore	O
normal	O
attachment	O
of	O
the	O
hyoglossus	O
to	O
the	O
greater	O
horn	O
thereby	O
allowing	O
the	O
palatal	O
shelves	O
to	O
lift	O
and	O
fuse	O
above	O
the	O
flattened	O
tongue	O
.	O

An	O
epidermal	O
cell	O
model	O
in	O
which	O
initiated	O
,	O
benign	O
tumor	O
-	O
producing	O
and	O
carcinoma	O
stages	O
were	O
derived	O
from	O
a	O
cloned	O
parental	O
cell	O
strain	O
was	O
used	O
to	O
examine	O
p53	B
expression	O
during	O
multistage	O
epithelial	O
carcinogenesis	O
.	O

Increased	O
steady	O
-	O
state	O
levels	O
of	O
p53	B
RNA	O
were	O
detected	O
in	O
squamous	O
cell	O
carcinomas	O
compared	O
to	O
papilloma	O
and	O
normal	O
epidermal	O
cells	O
.	O

Nontumorigenic	O
initiated	O
cell	O
precursors	O
of	O
the	O
carcinomas	O
exhibited	O
normal	O
p53	B
expression	O
,	O
localizing	O
altered	O
p53	B
regulation	O
to	O
the	O
malignant	O
conversion	O
stage	O
.	O

Immunoprecipitation	O
and	O
Western	O
immunoblot	O
analyses	O
demonstrated	O
elevated	O
levels	O
of	O
p53	B
protein	O
in	O
the	O
moderately	O
differentiated	O
carcinoma	O
compared	O
to	O
normal	O
cells	O
,	O
and	O
negligible	O
levels	O
of	O
p53	B
in	O
the	O
poorly	O
differentiated	O
carcinoma	O
cells	O
.	O

Sequence	O
analysis	O
of	O
p53	B
complementary	O
DNA	O
from	O
normal	O
and	O
carcinoma	O
cells	O
revealed	O
no	O
mutations	O
in	O
the	O
coding	O
or	O
5'-	O
and	O
3'-untranslated	O
regions	O
,	O
suggesting	O
a	O
novel	O
mechanism	O
of	O
p53	B
inactivation	O
.	O

As	O
part	O
of	O
our	O
mouse	O
model	O
of	O
somatic	O
mutation	O
,	O
we	O
have	O
begun	O
to	O
characterize	O
spontaneously	O
occurring	O
hypoxanthine	O
phosphoribosyltransferase	O
(	O
HPRT	B
)	O
-deficient	O
mouse	O
lymphocytes	O
.	O

Lymphocytes	O
were	O
cloned	O
by	O
in	O
vitro	O
exposure	O
of	O
spleen	O
cells	O
from	O
male	O
C57B1	O
/	O
6	O
mice	O
to	O
the	O
mitogen	O
concanavalin	O
A	O
,	O
conditioned	O
medium	O
containing	O
lymphocyte	O
growth	O
factors	O
,	O
and	O
thioguanine	O
(	O
TG	O
)	O
,	O
in	O
a	O
limiting	O
dilution	O
assay	O
.	O

The	O
17	O
TG	O
-	O
resistant	O
clones	O
recovered	O
were	O
all	O
highly	O
deficient	O
in	O
HPRT	B
activity	O
and	O
were	O
found	O
by	O
analysis	O
of	O
surface	O
antigens	O
to	O
be	O
representative	O
of	O
the	O
major	O
subclasses	O
of	O
T	O
lymphocytes	O
.	O

Southern	O
analysis	O
of	O
lymphocyte	O
genomic	O
DNA	O
detected	O
alterations	O
of	O
the	O
hprt	B
gene	O
in	O
12	O
/	O
17	O
of	O
the	O
HPRT	B
-	O
deficient	O
lymphocyte	O
clones	O
.	O

Of	O
these	O
12	O
,	O
2	O
/	O
17	O
were	O
lacking	O
the	O
entire	O
hprt	B
locus	O
,	O
7	O
/	O
17	O
lacked	O
part	O
of	O
the	O
locus	O
,	O
and	O
3	O
/	O
17	O
had	O
other	O
,	O
unidentified	O
alterations	O
.	O

Peutz	O
-	O
Jeghers	O
syndrome	O
(	O
PJS	O
)	O
is	O
a	O
dominantly	O
inherited	O
human	O
disorder	O
characterized	O
by	O
gastrointestinal	O
hamartomatous	O
polyposis	O
and	O
mucocutaneous	O
melanin	O
pigmentation	O
.	O

LKB1	B
(	O
STK11	B
)	O
serine	O
/	O
threonine	O
kinase	O
is	O
the	O
product	O
of	O
the	O
causative	O
gene	O
of	O
PJS	O
,	O
which	O
has	O
been	O
mapped	O
to	O
chromosome	O
19p13.3	O
.	O

However	O
,	O
several	O
studies	O
have	O
produced	O
results	O
that	O
are	O
not	O
consistent	O
with	O
a	O
link	O
between	O
LKB1	B
gene	O
mutation	O
and	O
PJS	O
.	O

We	O
constructed	O
a	O
knockout	O
gene	O
mutation	O
of	O
Lkb1	B
to	O
determine	O
whether	O
it	O
is	O
the	O
causative	O
gene	O
of	O
PJS	O
and	O
to	O
examine	O
the	O
biological	O
role	O
of	O
the	O
Lkb1	B
gene	O
.	O

Lkb1	B
(	I
-	I
/	I
-	I
)	I
mice	O
died	O
in	O
utero	O
between	O
8.5	O
and	O
9.5	O
days	O
postcoitum	O
.	O

At	O
9.0	O
days	O
postcoitum	O
,	O
Lkb1	B
(	I
-	I
/	I
-	I
)	I
embryos	O
were	O
generally	O
smaller	O
than	O
their	O
age	O
-	O
matched	O
littermates	O
,	O
showed	O
developmental	O
retardation	O
,	O
and	O
did	O
not	O
undergo	O
embryonic	O
turning	O
.	O

Multiple	O
gastric	O
adenomatous	O
polyps	O
were	O
observed	O
in	O
10-	O
to	O
14-month	O
-	O
old	O
Lkb1	B
(	I
+	I
/	I
-	I
)	I
mice	O
.	O

Our	O
results	O
indicate	O
that	O
functional	O
Lkb1	B
is	O
required	O
for	O
normal	O
embryogenesis	O
and	O
that	O
it	O
is	O
related	O
to	O
tumor	O
development	O
.	O

The	O
Lkb1	B
(	I
+	I
/	I
-	I
)	I
mouse	O
is	O
suitable	O
for	O
studying	O
molecular	O
mechanism	O
underlying	O
the	O
development	O
of	O
inherited	O
gastric	O
tumors	O
in	O
PJS	O
.	O

C3H	O
and	O
C57BL	O
/	O
6	O
mice	O
are	O
resistant	O
to	O
Leishmania	O
major	O
but	O
develop	O
chronic	O
lesions	O
with	O
persistent	O
parasite	O
loads	O
when	O
they	O
are	O
infected	O
with	O
Leishmania	O
amazonensis	O
.	O

These	O
lesions	O
develop	O
in	O
the	O
absence	O
of	O
interleukin-4	O
(	O
IL-4	B
)	O
,	O
indicating	O
that	O
susceptibility	O
to	O
this	O
parasite	O
is	O
not	O
a	O
result	O
of	O
development	O
of	O
a	O
Th2	O
response	O
.	O

Expression	O
of	O
the	O
cytokine	O
IL-10	B
during	O
infection	O
could	O
account	O
for	O
the	O
lack	O
of	O
IL-12	O
expression	O
and	O
poor	O
cell	O
-	O
mediated	O
immunity	O
towards	O
the	O
parasite	O
.	O

Therefore	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
IL-10	B
plays	O
a	O
central	O
role	O
in	O
downmodulating	O
the	O
Th1	O
response	O
after	O
L.	O
amazonensis	O
infection	O
.	O

Infection	O
of	O
C57BL	O
/	O
6	O
IL-10-deficient	B
mice	O
indicated	O
that	O
in	O
the	O
absence	O
of	O
IL-10	B
there	O
was	O
early	O
enhancement	O
of	O
a	O
Th1	O
response	O
,	O
which	O
was	O
downregulated	O
during	O
the	O
more	O
chronic	O
stage	O
of	O
infection	O
.	O

In	O
addition	O
,	O
although	O
there	O
were	O
1-	O
to	O
2-log	O
reductions	O
in	O
the	O
parasite	O
loads	O
within	O
the	O
lesions	O
,	O
the	O
parasites	O
continued	O
to	O
persist	O
,	O
and	O
they	O
were	O
associated	O
with	O
chronic	O
lesions	O
whose	O
size	O
was	O
similar	O
to	O
that	O
of	O
the	O
control	O
lesions	O
.	O

These	O
experiments	O
indicated	O
that	O
L.	O
amazonensis	O
resistance	O
to	O
killing	O
in	O
vivo	O
is	O
only	O
partially	O
dependent	O
on	O
expression	O
of	O
host	O
IL-10	B
.	O

However	O
,	O
IL-10-deficient	B
mice	O
had	O
an	O
enhanced	O
delayed	O
-	O
type	O
hypersensitivity	O
response	O
during	O
the	O
chronic	O
phase	O
of	O
infection	O
,	O
indicating	O
that	O
there	O
were	O
Th1	O
type	O
effector	O
cells	O
in	O
vivo	O
at	O
this	O
late	O
stage	O
of	O
infection	O
.	O

These	O
results	O
indicate	O
that	O
although	O
IL-10	B
plays	O
a	O
role	O
in	O
limiting	O
the	O
Th1	O
response	O
during	O
the	O
acute	O
infection	O
phase	O
,	O
other	O
immunomodulatory	O
factors	O
are	O
responsible	O
for	O
limiting	O
the	O
Th1	O
response	O
during	O
the	O
chronic	O
phase	O
.	O

Ovarian	O
steroids	O
have	O
important	O
inter	O
-	O
related	O
roles	O
in	O
many	O
systems	O
and	O
processes	O
required	O
for	O
mammalian	O
reproduction	O
.	O

The	O
female	O
reproductive	O
tract	O
,	O
ovaries	O
,	O
and	O
mammary	O
glands	O
are	O
all	O
targets	O
for	O
both	O
estrogen	O
and	O
progesterone	O
.	O

In	O
addition	O
,	O
the	O
actions	O
of	O
these	O
hormones	O
are	O
intertwined	O
in	O
that	O
,	O
for	O
example	O
,	O
progesterone	O
attenuates	O
the	O
proliferative	O
effect	O
of	O
estrogen	O
in	O
the	O
uterus	O
,	O
whereas	O
estrogen	O
also	O
induces	O
the	O
progesterone	B
receptor	I
(	O
PR	B
)	O
mRNA	O
and	O
protein	O
,	O
thus	O
enhancing	O
progesterone	O
actions	O
.	O

The	O
generation	O
of	O
mice	O
that	O
lacks	O
the	O
progesterone	B
receptor	I
(	O
PRKO	O
)	O
or	O
the	O
estrogen	O
receptoralpha	O
(	O
alphaERKO	O
)	O
has	O
provided	O
numerous	O
insights	O
into	O
the	O
interacting	O
roles	O
of	O
these	O
hormones	O
.	O

The	O
mammary	O
glands	O
of	O
the	O
PRKO	O
mice	O
develop	O
with	O
full	O
epithelial	O
ducts	O
that	O
lack	O
side	O
branching	O
and	O
lobular	O
alveolar	O
structures	O
,	O
whereas	O
the	O
alphaERKO	O
mice	O
develop	O
only	O
an	O
epithelial	O
rudiment	O
.	O

This	O
indicates	O
that	O
estrogen	O
is	O
important	O
for	O
ductal	O
morphogenesis	O
,	O
whereas	O
progesterone	O
is	O
required	O
for	O
ductal	O
branching	O
and	O
alveolar	O
development	O
.	O

Both	O
the	O
alphaERKO	O
and	O
PRKO	O
mice	O
are	O
also	O
anovulatory	O
,	O
but	O
exhibit	O
different	O
causal	O
pathologies	O
.	O

The	O
alphaERKO	O
ovary	O
seems	O
to	O
possess	O
follicles	O
up	O
to	O
the	O
preantral	O
stage	O
and	O
shows	O
a	O
polycystic	O
phenotype	O
as	O
a	O
result	O
of	O
chronic	O
hyperstimulation	O
by	O
LH	O
.	O

The	O
PRKO	O
follicles	O
seem	O
to	O
develop	O
to	O
an	O
ovulatory	O
stage	O
,	O
but	O
are	O
unable	O
to	O
rupture	O
,	O
indicating	O
a	O
role	O
for	O
progesterone	O
in	O
ovulation	O
.	O

The	O
uteri	O
of	O
these	O
two	O
strains	O
seem	O
to	O
develop	O
normally	O
;	O
however	O
,	O
the	O
function	O
and	O
hormone	O
responses	O
are	O
abnormal	O
in	O
each	O
.	O

Because	O
estrogen	O
is	O
known	O
to	O
induce	O
PRs	O
in	O
the	O
uterus	O
,	O
the	O
progesterone	O
responsiveness	O
of	O
the	O
alphaERKO	O
uterus	O
was	O
characterized	O
.	O

PR	B
mRNA	O
was	O
detected	O
but	O
was	O
not	O
up	O
-	O
regulated	O
by	O
estrogen	O
in	O
the	O
alphaERKO	O
tissue	O
.	O

PRs	O
are	O
present	O
in	O
the	O
alphaERKO	O
tissue	O
at	O
60	O
%	O
of	O
the	O
level	O
in	O
wild	O
-	O
type	O
tissue	O
and	O
show	O
a	O
similar	O
amount	O
of	O
A	O
and	O
B	O
isoforms	O
when	O
measured	O
by	O
R5020	O
binding	O
and	O
detected	O
by	O
Western	O
blotting	O
.	O

The	O
PRs	O
were	O
able	O
to	O
mediate	O
induction	O
of	O
two	O
progesterone	O
-	O
responsive	O
uterine	O
genes	O
:	O
calcitonin	O
and	O
amphiregulin	B
.	O

The	O
alphaERKO	O
uterine	O
tissue	O
was	O
also	O
able	O
to	O
undergo	O
a	O
decidual	O
reaction	O
in	O
response	O
to	O
hormonal	O
and	O
intraluminal	O
treatments	O
to	O
mimic	O
implantation	O
;	O
however	O
,	O
unlike	O
normal	O
wild	O
-	O
type	O
uteri	O
,	O
this	O
response	O
was	O
estrogen	O
independent	O
in	O
the	O
alphaERKO	O
uterine	O
tissue	O
.	O

Pelizaeus	O
-	O
Merzbacher	O
disease	O
(	O
PMD	O
)	O
is	O
a	O
dysmyelinating	O
disease	O
resulting	O
from	O
mutations	O
,	O
deletions	O
,	O
or	O
duplications	O
of	O
the	O
proteolipid	O
protein	O
(	O
PLP	B
)	O
gene	O
.	O

Distinguishing	O
features	O
of	O
PMD	O
include	O
pleiotropy	O
and	O
a	O
range	O
of	O
disease	O
severities	O
among	O
patients	O
.	O

Previously	O
,	O
we	O
demonstrated	O
that	O
,	O
when	O
expressed	O
in	O
transfected	O
fibroblasts	O
,	O
many	O
naturally	O
occurring	O
mutant	O
PLP	B
alleles	O
encode	O
proteins	O
that	O
accumulate	O
in	O
the	O
endoplasmic	O
reticulum	O
and	O
are	O
not	O
transported	O
to	O
the	O
cell	O
surface	O
.	O

In	O
the	O
present	O
communication	O
,	O
we	O
show	O
that	O
oligodendrocytes	O
in	O
an	O
animal	O
model	O
of	O
PMD	O
,	O
the	O
msd	B
mouse	O
,	O
accumulate	O
Plp	B
gene	O
products	O
in	O
the	O
perinuclear	O
region	O
and	O
are	O
unable	O
to	O
transport	O
them	O
to	O
the	O
cell	O
surface	O
.	O

Another	O
important	O
aspect	O
of	O
disease	O
in	O
msd	B
mice	O
is	O
oligodendrocyte	O
cell	O
death	O
,	O
which	O
is	O
increased	O
by	O
two-	O
to	O
threefold	O
.	O

We	O
demonstrate	O
in	O
msd	B
mice	O
that	O
this	O
death	O
occurs	O
by	O
apoptosis	O
and	O
show	O
that	O
at	O
the	O
time	O
oligodendrocytes	O
die	O
,	O
they	O
have	O
differentiated	O
,	O
extended	O
processes	O
that	O
frequently	O
contact	O
axons	O
and	O
are	O
expressing	O
myelin	O
structural	O
proteins	O
.	O

Finally	O
,	O
we	O
define	O
a	O
hypothesis	O
that	O
accounts	O
for	O
pathogenesis	O
in	O
most	O
PMD	O
patients	O
and	O
animal	O
models	O
of	O
this	O
disease	O
and	O
,	O
moreover	O
,	O
can	O
be	O
used	O
to	O
develop	O
potential	O
therapeutic	O
strategies	O
for	O
ameliorating	O
the	O
disease	O
phenotype	O
.	O

Neuroglobin	B
is	O
a	O
recently	O
discovered	O
respiratory	O
,	O
porphyrin	O
-	O
containing	O
protein	O
that	O
is	O
expressed	O
in	O
the	O
brain	O
of	O
mouse	O
and	O
man	O
.	O

Here	O
we	O
show	O
that	O
neuroglobin	B
is	O
also	O
present	O
in	O
the	O
teleost	O
fish	O
.	O

Complete	O
cDNA	O
sequences	O
are	O
reported	O
from	O
the	O
pufferfish	O
Tetraodon	O
nigroviridis	O
and	O
the	O
zebrafish	O
Danio	O
rerio	O
.	O

In	O
addition	O
,	O
the	O
neuroglobin	B
gene	O
of	O
T.	O
nigroviridis	O
was	O
sequenced	O
,	O
demonstrating	O
the	O
conservation	O
of	O
the	O
B12.2	O
,	O
E11.0	O
and	O
G7.0	O
introns	O
plus	O
the	O
presence	O
of	O
an	O
additional	O
intron	O
in	O
the	O
5	O
'	O
noncoding	O
region	O
.	O

The	O
fish	O
neuroglobins	O
each	O
comprise	O
159	O
amino	O
acids	O
and	O
are	O
84.3	O
%	O
identical	O
.	O

Phylogenetic	O
analyses	O
show	O
a	O
basal	O
position	O
of	O
the	O
neuroglobins	O
within	O
the	O
metazoan	O
globin	O
tree	O
.	O

An	O
enhanced	O
amino	O
acid	O
substitution	O
rate	O
was	O
estimated	O
for	O
the	O
fish	O
neuroglobins	O
(	O
approximately	O
0.93	O
x	O
10	O
(	O
-9	O
)	O
amino	O
acid	O
substitutions	O
per	O
site	O
and	O
year	O
)	O
compared	O
with	O
their	O
mammalian	O
proteins	O
(	O
approximately	O
0.39	O
x	O
10	O
(	O
-9	O
)	O
replacements	O
per	O
site	O
and	O
year	O
)	O
.	O

The	O
integrins	O
alphavbeta3	O
and	O
alphavbeta3	O
are	O
expressed	O
reciprocally	O
during	O
murine	O
osteoclastogenesis	O
in	O
vitro	O
.	O

Specifically	O
,	O
immature	O
osteoclast	O
precursors	O
,	O
in	O
the	O
form	O
of	O
bone	O
marrow	O
macrophages	O
,	O
contain	O
exclusively	O
alphavbeta5	O
,	O
surface	O
expression	O
of	O
which	O
declines	O
with	O
commitment	O
to	O
the	O
osteoclast	O
phenotype	O
,	O
while	O
levels	O
of	O
alphavbeta3	O
increase	O
concomitantly	O
.	O

The	O
distinct	O
functional	O
significance	O
of	O
alphavbeta5	O
is	O
underscored	O
by	O
the	O
integrin	O
's	O
capacity	O
,	O
unlike	O
alphavbeta3	O
,	O
to	O
mediate	O
both	O
attachment	O
and	O
spreading	O
on	O
ligand	O
,	O
of	O
marrow	O
macrophages	O
,	O
suggesting	O
alphavbeta3	O
negotiates	O
initial	O
recognition	O
,	O
by	O
osteoclast	O
precursors	O
,	O
of	O
bone	O
matrix	O
.	O

Northern	O
analysis	O
demonstrates	O
changes	O
in	O
the	O
two	O
beta	O
-	O
subunits	O
,	O
and	O
not	O
alphav	O
,	O
are	O
responsible	O
for	O
these	O
alterations	O
.	O

Treatment	O
of	O
early	O
precursors	O
with	O
granulocyte	O
-	O
macrophage	O
colony	O
stimulating	O
factor	O
(	O
GM	B
-	I
CSF	I
)	O
leads	O
to	O
alterations	O
in	O
beta3	O
and	O
beta5	B
mRNA	O
and	O
alphavbeta5	O
and	O
alphavbeta3	O
,	O
paralleling	O
those	O
occurring	O
during	O
osteoclastogenesis	O
.	O

Nuclear	O
run	O
-	O
on	O
and	O
message	O
stability	O
studies	O
demonstrate	O
that	O
while	O
GM	B
-	I
CSF	I
treatment	O
of	O
precursors	O
alters	O
beta5	B
transcriptionally	O
,	O
the	O
changes	O
in	O
beta3	O
arise	O
from	O
prolonged	O
mRNA	O
t1	O
/	O
2	O
.	O

Similar	O
to	O
GM	B
-	I
CSF	I
treatment	O
,	O
the	O
rate	O
of	O
beta5	B
transcription	O
falls	O
during	O
authentic	O
osteoclastogenesis	O
.	O

In	O
contrast	O
to	O
cytokine	O
-	O
induced	O
alphavbeta3	O
,	O
however	O
,	O
that	O
attending	O
osteoclastogenesis	O
reflects	O
accelerated	O
transcription	O
of	O
the	O
beta3-subunit	O
.	O

Thus	O
,	O
while	O
GM	B
-	I
CSF	I
may	O
participate	O
in	O
modulation	O
of	O
alphavbeta5	O
during	O
osteoclast	O
differentiation	O
,	O
signals	O
other	O
than	O
those	O
derived	O
from	O
the	O
cytokine	O
must	O
regulate	O
expression	O
of	O
alphavbeta3	O
.	O

The	O
E2F	O
family	O
of	O
transcription	O
factors	O
controls	O
the	O
expression	O
of	O
numerous	O
genes	O
that	O
are	O
required	O
for	O
the	O
G	O
(	O
1	O
)	O
/	O
S	O
transition	O
.	O

Among	O
the	O
mechanisms	O
that	O
modulate	O
the	O
activity	O
of	O
the	O
E2F	O
proteins	O
,	O
cyclin	O
A	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
the	O
down	O
-	O
regulation	O
of	O
E2F-1	B
,	O
-2	O
,	O
and	O
-3A	O
activity	O
after	O
cells	O
have	O
progressed	O
through	O
G	O
(	O
1	O
)	O
/	O
S.	O
Specifically	O
,	O
phosphorylation	O
of	O
these	O
E2F	O
proteins	O
by	O
cyclin	O
A	O
/	O
Cdk2	O
ultimately	O
results	O
in	O
their	O
necessary	O
degradation	O
as	O
cells	O
progress	O
through	O
S	O
phase	O
.	O

E2F-3B	O
was	O
recently	O
identified	O
as	O
an	O
alternatively	O
spliced	O
form	O
of	O
E2F-3A	O
that	O
was	O
predicted	O
to	O
lack	O
a	O
functional	O
cyclin	O
A	O
binding	O
domain	O
.	O

In	O
this	O
paper	O
,	O
we	O
present	O
considerable	O
evidence	O
that	O
contradicts	O
this	O
prediction	O
.	O

First	O
,	O
we	O
demonstrate	O
binding	O
of	O
cyclin	O
A	O
to	O
E2F-3B	O
as	O
bacterially	O
expressed	O
proteins	O
in	O
vitro	O
.	O

Second	O
,	O
we	O
demonstrate	O
binding	O
of	O
cyclin	O
A	O
to	O
E2F-3B	O
in	O
mammalian	O
cells	O
in	O
vivo	O
.	O

Third	O
,	O
we	O
show	O
that	O
co	O
-	O
expression	O
of	O
cyclin	O
A	O
with	O
E2F-3B	O
significantly	O
reduces	O
E2F-3B	O
-	O
mediated	O
transcriptional	O
activity	O
.	O

Finally	O
,	O
in	O
synchronized	O
cells	O
,	O
we	O
observe	O
down	O
-	O
regulation	O
of	O
E2F-3B	O
protein	O
expression	O
coincident	O
with	O
the	O
up	O
-	O
regulation	O
of	O
cyclin	O
A.	O
We	O
conclude	O
that	O
E2F-3B	O
is	O
a	O
physiological	O
target	O
of	O
cyclin	O
A.	O

Loop	O
-	O
tail	O
(	O
Lp	B
)	O
is	O
unique	O
among	O
mouse	O
mutants	O
in	O
failing	O
to	O
initiate	O
neural	O
tube	O
closure	O
at	O
the	O
cervical	O
/	O
hindbrain	O
boundary	O
(	O
so	O
-	O
called	O
'	O
Closure	O
1	O
'	O
)	O
,	O
at	O
the	O
5	O
-	O
7	O
somite	O
stage	O
.	O

Lp	B
/	O
Lp	B
embryos	O
go	O
on	O
to	O
develop	O
a	O
malformation	O
that	O
closely	O
resembles	O
cranio	O
-	O
rachischisis	O
,	O
the	O
most	O
severe	O
neural	O
tube	O
defect	O
found	O
in	O
humans	O
.	O

We	O
investigated	O
several	O
possible	O
embryological	O
mechanisms	O
that	O
may	O
underlie	O
this	O
failure	O
of	O
neural	O
tube	O
closure	O
in	O
Lp	B
.	O

The	O
genotypes	O
of	O
Lp	B
/	O
Lp	B
,	O
Lp	B
/	O
+	O
and	O
+	O
/+	O
embryos	O
from	O
mixed	O
litters	O
were	O
identified	O
using	O
the	O
polymerase	O
chain	O
reaction	O
to	O
amplify	O
a	O
polymorphic	O
microsatellite	O
sequence	O
that	O
is	O
very	O
closely	O
linked	O
to	O
Lp	B
.	O

At	O
post	O
-	O
neurulation	O
stages	O
of	O
development	O
,	O
Lp	B
/	O
Lp	B
embryos	O
have	O
a	O
shortened	O
body	O
axis	O
,	O
which	O
could	O
suggest	O
a	O
defect	O
of	O
axial	O
elongation	O
as	O
the	O
primary	O
anomaly	O
in	O
Lp	B
.	O

However	O
,	O
we	O
found	O
that	O
axial	O
elongation	O
is	O
normal	O
in	O
Lp	B
homozygotes	O
prior	O
to	O
the	O
stage	O
of	O
defective	O
Closure	O
1	O
,	O
indicating	O
that	O
the	O
shortened	O
body	O
axis	O
of	O
later	O
embryos	O
is	O
a	O
secondary	O
effect	O
of	O
the	O
neurulation	O
anomaly	O
,	O
or	O
an	O
independent	O
effect	O
of	O
the	O
Lp	B
mutation	O
.	O

Some	O
workers	O
have	O
reported	O
cell	O
proliferation	O
rates	O
to	O
be	O
abnormal	O
in	O
later	O
stage	O
Lp	B
/	O
Lp	B
embryos	O
.	O

We	O
observed	O
variations	O
in	O
[	O
3H	O
]	O
thymidine	O
labelling	O
index	O
,	O
and	O
mitotic	O
index	O
,	O
between	O
embryonic	O
tissues	O
,	O
and	O
between	O
embryos	O
at	O
different	O
somite	O
stages	O
.	O

However	O
,	O
Lp	B
/	O
Lp	B
,	O
Lp	B
/	O
+	O
and	O
+	O
/+	O
embryos	O
had	O
closely	O
similar	O
cell	O
proliferation	O
parameters	O
,	O
arguing	O
against	O
a	O
mechanism	O
based	O
on	O
faulty	O
embryonic	O
growth	O
.	O

Thirdly	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
the	O
defect	O
in	O
loop	O
-	O
tail	O
results	O
from	O
an	O
inability	O
of	O
the	O
neural	O
folds	O
to	O
become	O
apposed	O
,	O
specifically	O
at	O
the	O
site	O
of	O
Closure	O
1	O
.	O

By	O
tying	O
a	O
silk	O
suture	O
around	O
the	O
embryonic	O
axis	O
,	O
at	O
the	O
future	O
site	O
of	O
Closure	O
1	O
,	O
we	O
were	O
able	O
to	O
effect	O
convergence	O
of	O
the	O
neural	O
folds	O
at	O
this	O
site	O
.	O

Neural	O
fold	O
closure	O
failed	O
to	O
progress	O
along	O
the	O
body	O
axis	O
in	O
sutured	O
Lp	B
/	O
Lp	B
embryos	O
,	O
however	O
,	O
in	O
contrast	O
to	O
operated	O
Lp	B
/	O
+	O
and	O
+	O
/+	O
embryos	O
which	O
exhibited	O
normal	O
progression	O
of	O
neural	O
tube	O
closure	O
.	O

The	O
embryonic	O
defect	O
in	O
loop	O
-	O
tail	O
appears	O
,	O
therefore	O
,	O
to	O
involve	O
either	O
a	O
general	O
inability	O
of	O
the	O
spinal	O
neural	O
folds	O
to	O
become	O
apposed	O
along	O
the	O
spinal	O
region	O
,	O
or	O
a	O
defect	O
in	O
the	O
process	O
of	O
neural	O
fold	O
fusion	O
.	O

The	O
mammalian	O
auditory	O
sensory	O
epithelium	O
,	O
the	O
organ	O
of	O
Corti	O
,	O
comprises	O
the	O
hair	O
cells	O
and	O
supporting	O
cells	O
that	O
are	O
pivotal	O
for	O
hearing	O
function	O
.	O

The	O
origin	O
and	O
development	O
of	O
their	O
precursors	O
are	O
poorly	O
understood	O
.	O

Here	O
we	O
show	O
that	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
in	O
mouse	O
fibroblast	B
growth	I
factor	I
receptor	I
1	I
(	O
Fgfr1	B
)	O
cause	O
a	O
dose	O
-	O
dependent	O
disruption	O
of	O
the	O
organ	O
of	O
Corti	O
.	O

Full	O
inactivation	O
of	O
Fgfr1	B
in	O
the	O
inner	O
ear	O
epithelium	O
by	O
Foxg1-Cre	B
-	O
mediated	O
deletion	O
leads	O
to	O
an	O
85	O
%	O
reduction	O
in	O
the	O
number	O
of	O
auditory	O
hair	O
cells	O
.	O

The	O
primary	O
cause	O
appears	O
to	O
be	O
reduced	O
precursor	O
cell	O
proliferation	O
in	O
the	O
early	O
cochlear	O
duct	O
.	O

Thus	O
,	O
during	O
development	O
,	O
FGFR1	B
is	O
required	O
for	O
the	O
generation	O
of	O
the	O
precursor	O
pool	O
,	O
which	O
gives	O
rise	O
to	O
the	O
auditory	O
sensory	O
epithelium	O
.	O

Our	O
data	O
also	O
suggest	O
that	O
FGFR1	B
might	O
have	O
a	O
distinct	O
later	O
role	O
in	O
intercellular	O
signaling	O
within	O
the	O
differentiating	O
auditory	O
sensory	O
epithelium	O
.	O

Ets-1	B
,	O
a	O
developmentally	O
-	O
regulated	O
protooncogene	O
,	O
is	O
expressed	O
in	O
multiple	O
tissues	O
during	O
different	O
stages	O
of	O
mouse	O
development	O
and	O
cellular	O
differentiation	O
including	O
high	O
levels	O
in	O
lymphoid	O
organs	O
and	O
endothelium	O
.	O

The	O
putative	O
roles	O
of	O
this	O
DNA	O
-	O
binding	O
protein	O
in	O
lymphoid	O
development	O
and	O
maturation	O
,	O
as	O
well	O
as	O
in	O
angiogenesis	O
and	O
tumor	O
vascularization	O
,	O
suggest	O
that	O
the	O
regulation	O
of	O
Ets-1	B
may	O
be	O
critical	O
to	O
understanding	O
these	O
important	O
developmental	O
processes	O
.	O

We	O
have	O
cloned	O
the	O
mouse	O
Ets-1	B
5	O
'	O
flanking	O
region	O
which	O
shows	O
significant	O
homology	O
to	O
the	O
human	O
5	O
'	O
flanking	O
region	O
,	O
including	O
potential	O
transcription	O
factor	O
binding	O
sites	O
.	O

Various	O
amounts	O
of	O
mouse	O
Ets-1	B
5	O
'	O
flanking	O
,	O
exon	O
and	O
intron	O
sequences	O
have	O
been	O
fused	O
to	O
the	O
E.	O
coli	O
lacZ	O
reporter	O
gene	O
and	O
introduced	O
into	O
the	O
mouse	O
germline	O
to	O
identify	O
genomic	O
regions	O
which	O
regulate	O
the	O
developmental	O
and	O
tissue	O
-	O
specific	O
expression	O
of	O
Ets-1	B
.	O

The	O
2.4	O
kb	O
5	O
'	O
flanking	O
region	O
of	O
Ets-1	B
directs	O
lacZ	O
expression	O
to	O
the	O
folding	O
neural	O
tube	O
of	O
embryos	O
at	O
gestational	O
day	O
8.5	O
which	O
is	O
identical	O
to	O
the	O
endogenous	O
expression	O
pattern	O
of	O
Ets-1	B
.	O

However	O
,	O
at	O
later	O
times	O
in	O
gestation	O
,	O
up	O
to	O
5.3	O
kb	O
of	O
5	O
'	O
flanking	O
region	O
results	O
only	O
in	O
aberrant	O
expression	O
and	O
is	O
not	O
able	O
to	O
confer	O
lacZ	O
expression	O
in	O
lymphoid	O
or	O
vascular	O
tissues	O
.	O

When	O
the	O
first	O
exon	O
and	O
9	O
kb	O
of	O
the	O
first	O
intron	O
are	O
included	O
with	O
5	O
'	O
flanking	O
sequences	O
,	O
using	O
an	O
enhancer	O
-	O
trap	O
-	O
strategy	O
,	O
lacZ	O
expression	O
is	O
observed	O
in	O
developing	O
vessels	O
,	O
meninges	O
and	O
choroid	O
plexus	O
which	O
correlates	O
to	O
endogenous	O
Ets-1	B
expression	O
.	O

Further	O
characterization	O
of	O
the	O
vascular	O
-	O
specific	O
element	O
contained	O
within	O
intron	O
I	O
will	O
provide	O
important	O
insights	O
into	O
the	O
mechanisms	O
controlling	O
gene	O
expression	O
during	O
angiogenesis	O
.	O

The	O
interleukin	O
2	O
receptor	O
(	O
IL2RA	B
)	O
,	O
a	O
human	O
Chromosome	O
(	O
Chr	O
)	O
10p	O
locus	O
,	O
was	O
mapped	O
to	O
sheep	O
Chr	O
13q12-q15	O
by	O
in	O
situ	O
hybridization	O
.	O

Two	O
loci	O
from	O
human	O
Chr	O
10q	O
,	O
cytochrome	O
P450	O
subfamily	O
XVII	O
(	O
CYP17	B
)	O
and	O
the	O
tachykinin	O
2	O
receptor	O
(	O
TAC2R	O
)	O
,	O
were	O
assigned	O
to	O
sheep	O
Chrs	O
22q21-q23	O
and	O
25q14-q23	O
respectively	O
.	O

The	O
assignment	O
of	O
IL2RA	B
allows	O
the	O
provisional	O
assignment	O
of	O
the	O
previously	O
unassigned	O
sheep	O
syntenic	O
group	O
U15	O
to	O
sheep	O
Chr	O
13	O
.	O

Sheep	O
linkage	O
group	O
5	O
is	O
predicted	O
to	O
be	O
located	O
on	O
sheep	O
Chr	O
25	O
on	O
the	O
basis	O
of	O
the	O
TAC2R	O
assignment	O
.	O

Thyroid	O
-	O
hormone	O
and	O
retinoic	O
-	O
acid	O
receptors	O
exert	O
their	O
regulatory	O
functions	O
by	O
acting	O
as	O
both	O
activators	O
and	O
repressors	O
of	O
gene	O
expression	O
.	O

A	O
nuclear	O
receptor	O
co	O
-	O
repressor	O
(	O
N	B
-	I
CoR	I
)	O
of	O
relative	O
molecular	O
mass	O
270	O
K	O
has	O
been	O
identified	O
which	O
mediates	O
ligand	O
-	O
independent	O
inhibition	O
of	O
gene	O
transcription	O
by	O
these	O
receptors	O
,	O
suggesting	O
that	O
the	O
molecular	O
mechanisms	O
of	O
repression	O
by	O
thyroid	O
-	O
hormone	O
and	O
retinoic	O
-	O
acid	O
receptors	O
are	O
analogous	O
to	O
the	O
co	O
-	O
repressor	O
-	O
dependent	O
transcriptional	O
inhibitory	O
mechanisms	O
of	O
yeast	O
and	O
Drosophila	O
.	O

Germline	O
mutations	O
distributed	O
across	O
the	O
PTEN	B
tumor	O
-	O
suppressor	O
gene	O
have	O
been	O
found	O
to	O
result	O
in	O
a	O
wide	O
spectrum	O
of	O
phenotypic	O
features	O
.	O

Originally	O
shown	O
to	O
be	O
a	O
major	O
susceptibility	O
gene	O
for	O
both	O
Cowden	O
syndrome	O
(	O
CS	O
)	O
,	O
which	O
is	O
characterized	O
by	O
multiple	O
hamartomas	O
and	O
an	O
increased	O
risk	O
of	O
breast	O
,	O
thyroid	O
,	O
and	O
endometrial	O
cancers	O
,	O
and	O
Bannayan	O
-	O
Riley	O
-	O
Ruvalcaba	O
syndrome	O
,	O
which	O
is	O
characterized	O
by	O
lipomatosis	O
,	O
macrocephaly	O
,	O
and	O
speckled	O
penis	O
,	O
the	O
PTEN	B
hamartoma	O
tumor	O
syndrome	O
spectrum	O
has	O
broadened	O
to	O
include	O
Proteus	O
syndrome	O
and	O
Proteus	O
-	O
like	O
syndromes	O
.	O

Exon	O
5	O
,	O
which	O
encodes	O
the	O
core	O
motif	O
,	O
is	O
a	O
hotspot	O
for	O
mutations	O
likely	O
due	O
to	O
the	O
biology	O
of	O
the	O
protein	O
.	O

PTEN	B
is	O
a	O
major	O
lipid	O
3-phosphatase	O
,	O
which	O
signals	O
down	O
the	O
PI3	O
kinase	O
/	O
AKT	O
pro	O
-	O
apoptotic	O
pathway	O
.	O

Furthermore	O
,	O
PTEN	B
is	O
a	O
protein	O
phosphatase	O
,	O
with	O
the	O
ability	O
to	O
dephosphorylate	O
both	O
serine	O
and	O
threonine	O
residues	O
.	O

The	O
protein	O
-	O
phosphatase	O
activity	O
has	O
also	O
been	O
shown	O
to	O
regulate	O
various	O
cell	O
-	O
survival	O
pathways	O
,	O
such	O
as	O
the	O
mitogen	O
-	O
activated	O
kinase	O
(	O
MAPK	O
)	O
pathway	O
.	O

Although	O
it	O
is	O
well	O
established	O
that	O
PTEN	B
's	O
lipid	O
-	O
phosphatase	O
activity	O
,	O
via	O
the	O
PI3K	B
/	O
AKT	O
pathway	O
,	O
mediates	O
growth	O
suppression	O
,	O
there	O
is	O
accumulating	O
evidence	O
that	O
the	O
protein	O
-	O
phosphatase	O
/	O
MAPK	O
pathway	O
is	O
equally	O
important	O
in	O
the	O
mediation	O
of	O
growth	O
arrest	O
and	O
other	O
crucial	O
cellular	O
functions	O
.	O

The	O
mechanisms	O
of	O
broad	O
cross	O
-	O
protection	O
to	O
influenza	O
viruses	O
of	O
different	O
subtypes	O
,	O
termed	O
heterosubtypic	O
immunity	O
,	O
remain	O
incompletely	O
understood	O
.	O

We	O
used	O
knockout	O
mouse	O
strains	O
to	O
examine	O
the	O
potential	O
for	O
heterosubtypic	O
immunity	O
in	O
mice	O
lacking	O
IgA	B
,	O
all	O
Ig	O
and	O
B	O
cells	O
,	O
NKT	O
cells	O
(	O
CD1	O
knockout	O
mice	O
)	O
,	O
or	O
gamma	O
(	O
delta	O
)	O
T	O
cells	O
.	O

Mice	O
were	O
immunized	O
with	O
live	O
influenza	O
A	O
virus	O
and	O
compared	O
with	O
controls	O
immunized	O
with	O
unrelated	O
influenza	O
B	O
virus	O
.	O

IgA	B
(	I
-	I
/	I
-	I
)	I
mice	O
survived	O
full	O
respiratory	O
tract	O
challenge	O
with	O
heterosubtypic	O
virus	O
that	O
was	O
lethal	O
to	O
controls	O
.	O

IgA	B
(	I
-	I
/	I
-	I
)	I
mice	O
also	O
cleared	O
virus	O
from	O
the	O
nasopharynx	O
and	O
lungs	O
following	O
heterosubtypic	O
challenge	O
limited	O
to	O
the	O
upper	O
respiratory	O
tract	O
,	O
where	O
IgA	B
has	O
been	O
shown	O
to	O
play	O
an	O
important	O
role	O
.	O

Ig	O
(	O
-	O
/	O
-	O
)	O
mice	O
controlled	O
the	O
replication	O
of	O
heterosubtypic	O
challenge	O
virus	O
in	O
the	O
lungs	O
.	O

Acute	O
depletion	O
of	O
CD4	O
+	O
or	O
CD8	O
+	O
T	O
cell	O
subsets	O
abrogated	O
this	O
clearance	O
of	O
virus	O
,	O
thus	O
indicating	O
that	O
both	O
CD4	O
+	O
and	O
CD8	O
+	O
T	O
cells	O
are	O
required	O
for	O
protection	O
in	O
the	O
absence	O
of	O
Ig	O
.	O

These	O
results	O
in	O
Ig	O
(	O
-	O
/	O
-	O
)	O
mice	O
indicate	O
that	O
CD4	O
+	O
T	O
cells	O
can	O
function	O
by	O
mechanisms	O
other	O
than	O
providing	O
help	O
to	O
B	O
cells	O
for	O
the	O
generation	O
of	O
Abs	O
.	O

Like	O
wild	O
-	O
type	O
mice	O
,	O
CD1	O
(	O
-	O
/	O
-	O
)	O
mice	O
and	O
gamma	O
(	O
delta	O
)	O
(	O
-	O
/	O
-	O
)	O
mice	O
survived	O
lethal	O
heterosubtypic	O
challenge	O
.	O

Acute	O
depletion	O
of	O
CD4	O
+	O
and	O
CD8	O
+	O
cells	O
abrogated	O
heterosubtypic	O
protection	O
in	O
gamma	O
(	O
delta	O
)	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
but	O
not	O
B6	O
controls	O
,	O
suggesting	O
a	O
contribution	O
of	O
gamma	O
(	O
delta	O
)	O
T	O
cells	O
.	O

Our	O
results	O
demonstrate	O
that	O
the	O
Ab	O
and	O
cellular	O
subsets	O
deficient	O
in	O
these	O
knockout	O
mice	O
are	O
not	O
required	O
for	O
heterosubtypic	O
protection	O
,	O
but	O
each	O
may	O
play	O
a	O
role	O
in	O
a	O
multifaceted	O
response	O
that	O
as	O
a	O
whole	O
is	O
more	O
effective	O
than	O
any	O
of	O
its	O
parts	O
.	O

Of	O
the	O
nine	O
known	O
members	O
of	O
a	O
human	O
paired	O
box	O
-	O
containing	O
gene	O
family	O
(	O
Pax	O
)	O
,	O
only	O
PAX4	B
has	O
not	O
been	O
precisely	O
localized	O
.	O

We	O
screened	O
a	O
cosmid	O
library	O
of	O
human	O
genomic	O
DNA	O
using	O
polymerase	O
chain	O
reaction	O
products	O
for	O
PAX4	B
as	O
a	O
probe	O
and	O
isolated	O
three	O
positive	O
cosmid	O
clones	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
at	O
least	O
two	O
of	O
them	O
had	O
exon	O
-	O
like	O
sequences	O
and	O
showed	O
extensive	O
homology	O
to	O
Pax-4	B
in	O
the	O
mouse	O
.	O

These	O
two	O
cosmid	O
clones	O
were	O
mapped	O
to	O
human	O
chromosome	O
band	O
7q32	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

TCR	B
delta	I
-	O
chain	O
gene	O
rearrangements	O
were	O
analyzed	O
at	O
different	O
stages	O
of	O
thymic	O
ontogeny	O
.	O

The	O
VDJ	O
delta	O
junctional	O
sequences	O
of	O
the	O
dominantly	O
expressed	O
TCR	B
delta	I
-	O
chain	O
V7	O
subfamily	O
are	O
highly	O
conserved	O
in	O
fetal	O
and	O
neonatal	O
thymocytes	O
.	O

They	O
are	O
equally	O
conserved	O
in	O
C	O
delta	O
-	O
targeted	O
mice	O
lacking	O
cell	O
surface	O
expression	O
of	O
gamma	O
delta	O
receptors	O
,	O
indicating	O
evolutionary	O
selection	O
acting	O
at	O
the	O
level	O
of	O
DNA	O
rearrangement	O
.	O

Yet	O
,	O
in	O
C	O
delta	O
-	O
mutant	O
mice	O
,	O
the	O
frequency	O
of	O
in	O
-	O
frame	O
transcripts	O
is	O
reduced	O
to	O
61	O
%	O
,	O
from	O
88	O
%	O
in	O
wild	O
-	O
type	O
mice	O
,	O
suggesting	O
cellular	O
selection	O
of	O
this	O
DV7-overexpressing	O
gamma	O
delta	O
thymocyte	O
subset	O
.	O

In	O
contrast	O
,	O
in	O
genomic	O
DNA	O
rearrangements	O
,	O
no	O
difference	O
was	O
found	O
in	O
the	O
frequency	O
of	O
productive	O
rearrangements	O
between	O
mutant	O
(	O
26	O
%	O
)	O
and	O
wild	O
-	O
type	O
mice	O
(	O
31	O
%	O
)	O
.	O

This	O
in	O
-	O
frame	O
rate	O
,	O
characteristic	O
of	O
random	O
rearrangements	O
,	O
indicates	O
that	O
positive	O
selection	O
is	O
not	O
required	O
for	O
thymic	O
maturation	O
of	O
gamma	O
delta	O
T	O
cells	O
.	O

The	O
results	O
are	O
discussed	O
with	O
regard	O
to	O
models	O
of	O
alpha	O
beta	O
/	O
gamma	O
delta	O
lineage	O
commitment	O
.	O

We	O
have	O
isolated	O
a	O
series	O
of	O
human	O
testis	O
poly	O
(	O
A	O
)	O
cDNA	O
clones	O
by	O
cross	O
-	O
hybridization	O
to	O
SPGY1	O
,	O
a	O
Y	O
gene	O
homologous	O
to	O
DAZ	O
.	O

Their	O
sequence	O
analysis	O
revealed	O
an	O
identical	O
nucleotide	O
composition	O
in	O
different	O
'	O
full	O
-	O
length	O
'	O
clones	O
,	O
suggesting	O
that	O
all	O
were	O
encoded	O
by	O
the	O
same	O
gene	O
.	O

We	O
mapped	O
this	O
gene	O
to	O
the	O
short	O
arm	O
of	O
chromosome	O
3	O
and	O
designated	O
it	O
SPGYLA	O
(	O
SPGY	O
like	O
autosomal	O
)	O
.	O

Comparison	O
of	O
the	O
SPGYLA	O
cDNA	O
sequence	O
with	O
the	O
cDNA	O
sequences	O
of	O
DAZ	O
and	O
SPGY1	O
revealed	O
two	O
prominent	O
differences	O
.	O

The	O
tandem	O
repetitive	O
structure	O
of	O
72	O
bp	O
sequence	O
units	O
(	O
DAZ	O
repeats	O
)	O
is	O
absent	O
.	O

SPGYLA	O
contains	O
only	O
one	O
72	O
bp	O
sequence	O
unit	O
.	O

Downstream	O
of	O
it	O
,	O
a	O
specific	O
130	O
bp	O
sequence	O
domain	O
is	O
present	O
which	O
is	O
absent	O
in	O
DAZ	O
and	O
SPGY1	O
but	O
present	O
in	O
the	O
mouse	O
gene	O
Dazla	B
and	O
in	O
the	O
Drosophila	O
gene	O
boule	O
.	O

SPGYLA	O
encodes	O
an	O
RNA	O
binding	O
protein	O
expressed	O
only	O
in	O
the	O
human	O
male	O
gonad	O
.	O

The	O
data	O
presented	O
give	O
strong	O
evidence	O
that	O
not	O
DAZ	O
but	O
SPGYLA	O
is	O
the	O
functional	O
human	O
homologue	O
of	O
Dazla	B
and	O
boule	O
.	O

The	O
complete	O
AIF	B
cDNA	O
comprising	O
the	O
amino	O
-	O
terminal	O
mitochondrial	O
localization	O
sequence	O
(	O
MLS	O
)	O
and	O
the	O
oxidoreductase	O
domain	O
has	O
been	O
fused	O
in	O
its	O
carboxyl	O
terminus	O
to	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
,	O
thereby	O
engineering	O
an	O
AIF	B
-	O
GFP	O
fusion	O
protein	O
that	O
is	O
selectively	O
targeted	O
to	O
the	O
mitochondrial	O
intermembrane	O
space	O
.	O

Upon	O
induction	O
of	O
apoptosis	O
,	O
the	O
AIF	B
-	O
GFP	O
protein	O
translocates	O
together	O
with	O
cytochrome	O
c	O
(	O
Cyt	O
-	O
c	O
)	O
to	O
the	O
extramitochondrial	O
compartment	O
.	O

Microinjection	O
of	O
recombinant	O
AIF	B
leads	O
to	O
the	O
release	O
of	O
AIF	B
-	O
GFP	O
and	O
Cyt	O
-	O
c	O
-	O
GFP	O
,	O
indicating	O
that	O
ectopic	O
AIF	B
can	O
favor	O
permeabilization	O
of	O
the	O
outer	O
mitochondrial	O
membrane	O
.	O

These	O
mitochondrial	O
effects	O
of	O
AIF	B
are	O
caspase	O
independent	O
,	O
whereas	O
the	O
Cyt	O
-	O
c	O
-	O
microinjection	O
induced	O
translocation	O
of	O
AIF	B
-	O
GFP	O
and	O
Cyt	O
-	O
c	O
-	O
GFP	O
is	O
suppressed	O
by	O
the	O
pan	O
-	O
caspase	O
inhibitor	O
Z-VAD.fmk	O
.	O

Upon	O
prolonged	O
culture	O
,	O
transfection	O
-	O
enforced	O
overexpression	O
of	O
AIF	B
results	O
in	O
spontaneous	O
translocation	O
of	O
AIF	B
-	O
GFP	O
from	O
mitochondria	O
,	O
nuclear	O
chromatin	O
condensation	O
,	O
and	O
cell	O
death	O
.	O

These	O
effects	O
are	O
caspase	O
independent	O
and	O
do	O
not	O
rely	O
on	O
the	O
oxidoreductase	O
function	O
of	O
AIF	B
.	O

Spontaneous	O
AIF	B
-	O
GFP	O
translocation	O
and	O
subsequent	O
nuclear	O
apoptosis	O
can	O
be	O
retarded	O
by	O
overexpression	O
of	O
a	O
Bcl-2	B
protein	O
selectively	O
targeted	O
to	O
mitochondria	O
,	O
but	O
not	O
by	O
a	O
Bcl-2	B
protein	O
targeted	O
to	O
the	O
endoplasmic	O
reticulum	O
.	O

Overexpression	O
of	O
a	O
mutant	O
AIF	B
protein	O
in	O
which	O
the	O
MLS	O
has	O
been	O
deleted	O
(	O
AIF	B
Delta	O
1	O
-	O
100	O
)	O
results	O
in	O
the	O
primary	O
cytosolic	O
accumulation	O
of	O
AIF	B
.	O

AIF	B
Delta	O
1	O
-	O
100-induced	O
cell	O
death	O
is	O
suppressed	O
by	O
neither	O
Z-VAD.fmk	O
or	O
by	O
Bcl-2	B
.	O

Thus	O
,	O
extramitochondrially	O
targeted	O
AIF	B
is	O
a	O
dominant	O
cell	O
death	O
inducer	O
.	O

In	O
murine	O
rodents	O
the	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
(	O
GAPDH	B
)	O
multigene	O
family	O
includes	O
more	O
than	O
300	O
retroprocessed	O
pseudogenes	O
.	O

Its	O
single	O
functional	O
gene	O
encodes	O
GAPDH	B
,	O
an	O
enzyme	O
of	O
glycolysis	O
.	O

Because	O
of	O
its	O
manageable	O
size	O
,	O
this	O
family	O
is	O
a	O
good	O
model	O
for	O
the	O
study	O
of	O
genome	O
cohesion	O
and	O
evolution	O
.	O

By	O
sequence	O
comparison	O
of	O
several	O
GAPDH	B
pseudogenes	O
in	O
Rattus	O
norvegicus	O
and	O
Mus	O
musculus	O
,	O
we	O
have	O
obtained	O
evidence	O
that	O
(	O
i	O
)	O
the	O
GAPDH	B
family	O
still	O
generates	O
new	O
pseudogenes	O
;	O
we	O
note	O
in	O
each	O
species	O
the	O
beginning	O
of	O
a	O
process	O
of	O
species	O
-	O
specific	O
evolution	O
since	O
the	O
pseudogenes	O
of	O
one	O
genus	O
on	O
average	O
cluster	O
more	O
with	O
one	O
another	O
than	O
they	O
do	O
with	O
those	O
of	O
the	O
other	O
genus	O
,	O
and	O
(	O
ii	O
)	O
the	O
GAPDH	B
family	O
contains	O
diversified	O
subfamilies	O
.	O

These	O
findings	O
suggest	O
a	O
certain	O
level	O
of	O
transcription	O
and	O
transposition	O
of	O
the	O
pseudogenes	O
independent	O
of	O
the	O
functional	O
gene	O
which	O
may	O
result	O
from	O
various	O
mechanisms	O
.	O

The	O
homogenization	O
we	O
observe	O
may	O
be	O
due	O
to	O
the	O
pseudogenes	O
themselves	O
(	O
concerted	O
evolution	O
in	O
a	O
strict	O
sense	O
)	O
,	O
which	O
explains	O
the	O
occurrence	O
of	O
long	O
-	O
term	O
homogenization	O
of	O
old	O
sequences	O
and	O
subfamily	O
groupings	O
.	O

We	O
have	O
cloned	O
and	O
characterized	O
a	O
mouse	O
cytosolic	B
aspartate	I
aminotransferase	I
(	O
AspAT	O
)	O
(	O
EC	O
2.6.1.1	O
)	O
gene	O
,	O
which	O
is	O
about	O
32,000	O
base	O
-	O
pairs	O
long	O
and	O
is	O
interrupted	O
by	O
eight	O
introns	O
.	O

The	O
5	O
'	O
and	O
3'-flanking	O
regions	O
,	O
and	O
the	O
exact	O
sizes	O
and	O
boundaries	O
of	O
the	O
exon	O
blocks	O
,	O
including	O
the	O
transcription	O
-	O
initiation	O
sites	O
,	O
were	O
determined	O
.	O

The	O
5	O
'	O
end	O
of	O
the	O
gene	O
lacks	O
the	O
TATA	O
and	O
CAAT	O
boxes	O
characteristic	O
of	O
eukaryotic	O
promoters	O
,	O
but	O
contains	O
G	O
+	O
C	O
-	O
rich	O
sequences	O
,	O
three	O
putative	O
binding	O
sites	O
for	O
a	O
cellular	O
transcription	O
factor	O
,	O
Sp1	B
,	O
and	O
multiple	O
transcription	O
-	O
initiation	O
sites	O
.	O

The	O
sequences	O
around	O
the	O
transcription	O
-	O
initiation	O
sites	O
are	O
compatible	O
with	O
the	O
formation	O
of	O
a	O
number	O
of	O
potentially	O
stable	O
stem	O
-	O
loop	O
structures	O
.	O

We	O
compared	O
the	O
structural	O
organization	O
of	O
the	O
mouse	O
cytosolic	O
AspAT	O
gene	O
with	O
that	O
of	O
the	O
mouse	O
mitochondrial	O
AspAT	O
gene	O
,	O
which	O
has	O
nine	O
introns	O
.	O

We	O
found	O
that	O
the	O
promoter	O
regions	O
share	O
a	O
high	O
level	O
of	O
homology	O
and	O
five	O
of	O
the	O
introns	O
are	O
at	O
identical	O
places	O
.	O

This	O
close	O
matching	O
leads	O
to	O
the	O
tentative	O
conclusion	O
that	O
the	O
introns	O
were	O
in	O
place	O
before	O
the	O
divergence	O
of	O
cytosolic	O
and	O
mitochondrial	O
isoenzyme	O
genes	O
.	O

High	O
mobility	O
group	O
2	O
protein	O
(	O
Hmgb2	B
)	O
is	O
a	O
member	O
of	O
the	O
HMGB	O
protein	O
family	O
,	O
which	O
includes	O
the	O
ubiquitous	O
Hmgb1	B
and	O
the	O
embryo	O
-	O
specific	O
Hmgb3	B
.	O

The	O
three	O
proteins	O
are	O
more	O
than	O
80	O
%	O
identical	O
at	O
the	O
amino	O
acid	O
level	O
and	O
their	O
biochemical	O
properties	O
are	O
indistinguishable	O
.	O

Hmgb1	B
is	O
an	O
abundant	O
component	O
of	O
all	O
mammalian	O
nuclei	O
and	O
acts	O
as	O
an	O
architectural	O
factor	O
that	O
bends	O
DNA	O
and	O
promotes	O
protein	O
assembly	O
on	O
specific	O
DNA	O
targets	O
.	O

Cells	O
that	O
lack	O
Hmgb1	B
can	O
survive	O
,	O
although	O
mutant	O
mice	O
die	O
shortly	O
after	O
birth	O
.	O

As	O
Hmgb2	B
is	O
present	O
in	O
all	O
cultured	O
cells	O
and	O
is	O
abundant	O
in	O
thymus	O
,	O
the	O
preferred	O
source	O
for	O
HMGB	O
proteins	O
,	O
it	O
was	O
considered	O
a	O
ubiquitous	O
variant	O
of	O
Hmgb1	B
.	O

We	O
show	O
that	O
in	O
adult	O
mice	O
Hmgb2	B
is	O
restricted	O
mainly	O
to	O
lymphoid	O
organs	O
and	O
testes	O
,	O
although	O
it	O
is	O
widely	O
expressed	O
during	O
embryogenesis	O
.	O

Mice	O
that	O
lack	O
Hmgb2	B
are	O
viable	O
.	O

However	O
,	O
male	O
Hmgb2	B
(	I
-	I
/	I
-	I
)	I
mice	O
have	O
reduced	O
fertility	O
,	O
that	O
correlates	O
with	O
Sertoli	O
and	O
germ	O
cell	O
degeneration	O
in	O
seminiferous	O
tubules	O
and	O
immotile	O
spermatozoa	O
.	O

Significantly	O
,	O
Hmgb2	B
is	O
expressed	O
at	O
very	O
high	O
levels	O
in	O
primary	O
spermatocytes	O
,	O
while	O
it	O
is	O
barely	O
detectable	O
in	O
spermatogonia	O
and	O
elongated	O
spermatids	O
.	O

This	O
peculiar	O
pattern	O
of	O
expression	O
and	O
the	O
phenotype	O
of	O
mutants	O
indicate	O
that	O
Hmgb2	B
has	O
a	O
specialised	O
role	O
in	O
germ	O
cell	O
differentiation	O
.	O

Recombinant	O
human	O
IL-11	B
(	O
rhIL-11	O
)	O
is	O
an	O
anti	O
-	O
inflammatory	O
cytokine	O
that	O
can	O
reduce	O
the	O
production	O
of	O
inflammatory	O
mediators	O
such	O
as	O
TNF	O
-	O
alpha	O
,	O
IL-1beta	O
,	O
IL-12	O
,	O
IL-6	O
,	O
and	O
nitric	O
oxide	O
.	O

Inhibition	O
of	O
proinflammatory	O
cytokine	O
production	O
from	O
activated	O
macrophages	O
was	O
associated	O
with	O
a	O
reduction	O
in	O
the	O
levels	O
of	O
LPS	O
-	O
induced	O
TNF	O
-	O
alpha	O
,	O
IL-1beta	O
,	O
IL-6	O
,	O
and	O
IL-12	O
p40	O
mRNA	O
.	O

Analysis	O
of	O
rhIL-11	O
effects	O
on	O
transcription	O
factors	O
that	O
activate	O
proinflammatory	O
cytokines	O
demonstrated	O
that	O
the	O
level	O
of	O
LPS	O
-	O
induced	O
NF	O
-	O
kappaB	O
binding	O
activity	O
in	O
the	O
nucleus	O
of	O
rhIL-11-treated	O
peritoneal	O
macrophages	O
was	O
significantly	O
reduced	O
.	O

The	O
block	O
to	O
NF	O
-	O
kappaB	O
nuclear	O
translocation	O
correlated	O
with	O
the	O
ability	O
of	O
rhIL-11	O
to	O
maintain	O
or	O
increase	O
protein	O
levels	O
of	O
the	O
inhibitors	O
of	O
NF	O
-	O
kappaB	O
,	O
IkappaB	O
-	O
alpha	O
,	O
and	O
IkappaB	O
-	O
beta	O
following	O
LPS	O
treatment	O
.	O

Furthermore	O
,	O
rhIL-11-treatment	O
of	O
LPS	O
macrophages	O
resulted	O
in	O
significant	O
elevation	O
of	O
IkappaB	O
-	O
alpha	O
and	O
IkappaB	O
-	O
beta	O
mRNA	O
levels	O
.	O

These	O
results	O
suggest	O
that	O
the	O
anti	O
-	O
inflammatory	O
activity	O
of	O
rhIL-11	O
is	O
mediated	O
in	O
part	O
by	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
-	O
dependent	O
transcriptional	O
activation	O
.	O

Furthermore	O
,	O
these	O
studies	O
demonstrate	O
for	O
the	O
first	O
time	O
the	O
regulation	O
of	O
IkappaB	O
-	O
beta	O
by	O
an	O
anti	O
-	O
inflammatory	O
cytokine	O
.	O

Given	O
the	O
finding	O
that	O
inappropriate	O
activation	O
of	O
NF	O
-	O
kappaB	O
contributes	O
to	O
multiple	O
inflammatory	O
conditions	O
,	O
the	O
ability	O
of	O
rhIL-11	O
to	O
inhibit	O
the	O
binding	O
activity	O
of	O
this	O
pleiotropic	O
transcription	O
factor	O
indicates	O
that	O
rhIL-11	O
has	O
therapeutic	O
potential	O
in	O
a	O
wide	O
range	O
of	O
diseases	O
.	O

Mice	O
that	O
carry	O
the	O
recessive	O
mutation	O
tub	B
develop	O
neurosensory	O
defects	O
including	O
retinal	O
and	O
cochlear	O
degeneration	O
,	O
as	O
well	O
as	O
maturity	O
-	O
onset	O
obesity	O
associated	O
with	O
insulin	O
resistance	O
.	O

The	O
biological	O
function	O
of	O
the	O
gene	O
and	O
the	O
mechanism	O
by	O
which	O
it	O
induces	O
its	O
phenotypes	O
are	O
still	O
unclear	O
.	O

In	O
order	O
to	O
elucidate	O
the	O
pathways	O
through	O
which	O
tub	B
functions	O
,	O
in	O
the	O
current	O
study	O
,	O
QTL	O
modifiers	O
were	O
identified	O
in	O
an	O
F2	O
intercross	O
between	O
(	O
C57BL	O
/	O
6J-	O
tub	B
/	O
tub	B
and	O
AKR	O
/	O
J-+	O
/	O
+	O
)	O
F1	O
hybrids	O
(	O
AKR	O
intercross	O
)	O
.	O

The	O
thickness	O
of	O
the	O
outer	O
nuclear	O
layer	O
of	O
the	O
retina	O
and	O
the	O
number	O
of	O
photoreceptor	O
nuclei	O
were	O
assessed	O
in	O
F2	O
mice	O
homozygous	O
for	O
the	O
tub	B
mutation	O
.	O

A	O
genome	O
-	O
wide	O
scan	O
revealed	O
a	O
significant	O
linkage	O
on	O
chromosome	O
11	O
(	O
named	O
motr1	O
)	O
and	O
two	O
suggestive	O
linkages	O
on	O
chromosomes	O
2	O
and	O
8	O
.	O

Interestingly	O
,	O
the	O
same	O
chromosome	O
2	O
region	O
identified	O
for	O
the	O
hearing	O
modifier	O
of	O
tubby	O
,	O
the	O
moth1	B
locus	O
,	O
showed	O
a	O
peak	O
lod	O
score	O
of	O
2.3	O
for	O
protection	O
from	O
retinal	O
degeneration	O
.	O

This	O
result	O
suggests	O
that	O
the	O
gene	O
responsible	O
for	O
the	O
QTL	O
on	O
chromosome	O
2	O
might	O
be	O
involved	O
in	O
a	O
common	O
pathway	O
through	O
which	O
retinal	O
and	O
cochlear	O
degeneration	O
are	O
induced	O
in	O
tubby	O
mice	O
.	O

We	O
have	O
isolated	O
cDNA	O
and	O
genomic	O
clones	O
of	O
murine	O
Hsp40	B
(	O
mmDjB1	O
)	O
.	O

The	O
murine	O
Hsp40	B
gene	O
was	O
expressed	O
at	O
a	O
high	O
level	O
in	O
testis	O
and	O
was	O
induced	O
by	O
heat	O
shock	O
.	O

The	O
transcriptional	O
initiation	O
sites	O
were	O
different	O
between	O
heat	O
-	O
induced	O
transcripts	O
and	O
constitutive	O
ones	O
.	O

The	O
heat	O
-	O
induced	O
transcripts	O
initiated	O
22	O
to	O
28	O
bp	O
downstream	O
of	O
the	O
TATA	O
box	O
,	O
whereas	O
constitutive	O
transcripts	O
initiated	O
from	O
multiple	O
sites	O
,	O
many	O
of	O
which	O
initiated	O
upstream	O
of	O
the	O
TATA	O
box	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
on	O
the	O
heat	O
shock	O
-	O
dependent	O
usage	O
of	O
transcriptional	O
start	O
sites	O
of	O
a	O
heat	O
shock	O
gene	O
.	O

Accessory	O
/	O
co	O
-	O
stimulatory	O
molecules	O
on	O
the	O
surface	O
of	O
T	O
cells	O
are	O
capable	O
of	O
regulating	O
activation	O
signals	O
.	O

Two	O
of	O
these	O
,	O
CD5	B
and	O
CD6	B
,	O
are	O
molecules	O
from	O
the	O
scavenger	O
receptor	O
cysteine	O
rich	O
(	O
SRCR	O
)	O
superfamily	O
.	O

Partial	O
sequences	O
for	O
the	O
ligands	O
of	O
these	O
molecules	O
,	O
known	O
as	O
CD72	B
and	O
CD166	B
(	O
or	O
ALCAM	B
)	O
,	O
respectively	O
,	O
are	O
provided	O
for	O
Bos	O
taurus	O
in	O
this	O
communication	O
.	O

Using	O
highly	O
conserved	O
regions	O
between	O
the	O
corresponding	O
human	O
and	O
mouse	O
genes	O
,	O
primers	O
were	O
designed	O
and	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
was	O
used	O
to	O
generate	O
cDNA	O
from	O
bovine	O
PBMC	O
RNA	O
.	O

cDNA	O
clones	O
of	O
several	O
hundred	O
base	O
pairs	O
in	O
length	O
were	O
created	O
and	O
sequenced	O
.	O

The	O
results	O
showed	O
81	O
%	O
homology	O
between	O
bovine	O
and	O
human	O
CD72	B
nucleotide	O
sequences	O
and	O
93	O
%	O
homology	O
for	O
the	O
CD166	B
sequences	O
.	O

Similar	O
levels	O
of	O
homology	O
are	O
seen	O
between	O
the	O
corresponding	O
human	O
and	O
mouse	O
cDNA	O
sequences	O
.	O

Insulin	O
and	O
tumor	B
necrosis	I
factor	I
alpha	O
(	O
TNF	B
alpha	I
)	O
produce	O
potent	O
and	O
opposing	O
physiological	O
signals	O
in	O
adipocytes	O
.	O

However	O
,	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
by	O
the	O
hormone	O
and	O
cytokine	O
during	O
and	O
after	O
adipocyte	O
differentiation	O
have	O
not	O
been	O
characterized	O
.	O

Using	O
3T3-L1	O
cells	O
,	O
we	O
have	O
studied	O
the	O
regulation	O
of	O
the	O
expression	O
of	O
genes	O
encoding	O
acyl	O
-	O
CoA	O
synthetase	O
(	O
ACS	B
)	O
,	O
and	O
stearoyl	O
CoA	O
desaturase-1	O
(	O
SCD-1	B
)	O
,	O
two	O
enzymes	O
that	O
play	O
key	O
roles	O
in	O
the	O
metabolism	O
of	O
long	O
chain	O
fatty	O
acids	O
.	O

Insulin	O
is	O
required	O
for	O
triggering	O
the	O
transcriptional	O
activation	O
of	O
the	O
ACS	B
and	O
SCD-1	B
genes	O
at	O
an	O
early	O
stage	O
in	O
adipocyte	O
differentiation	O
.	O

In	O
mature	O
adipocytes	O
insulin	O
elicits	O
a	O
4-fold	O
increase	O
in	O
the	O
rates	O
of	O
transcription	O
of	O
the	O
two	O
genes	O
.	O

However	O
,	O
when	O
3T3-L1	O
adipocytes	O
are	O
treated	O
with	O
TNF	B
alpha	I
the	O
cytokine	O
causes	O
a	O
75	O
-	O
90	O
%	O
decrease	O
in	O
the	O
levels	O
of	O
ACS	B
and	O
SCD-1	B
mRNAs	O
.	O

The	O
decline	O
in	O
mRNA	O
content	O
is	O
associated	O
with	O
similar	O
decrements	O
in	O
the	O
rates	O
of	O
transcription	O
of	O
the	O
ACS	B
and	O
SCD-1	B
genes	O
.	O

Thus	O
,	O
the	O
ACS	B
and	O
SCD-1	B
genes	O
are	O
subject	O
to	O
stimulation	O
and	O
counter	O
-	O
regulation	O
(	O
at	O
the	O
transcriptional	O
level	O
)	O
by	O
insulin	O
and	O
TNF	B
alpha	I
,	O
respectively	O
.	O

The	O
opposing	O
effects	O
of	O
insulin	O
and	O
TNF	B
alpha	I
are	O
observed	O
in	O
developing	O
and	O
terminally	O
differentiated	O
adipocytes	O
.	O

Unlike	O
the	O
ACS	B
and	O
SCD-1	B
genes	O
,	O
the	O
genes	O
that	O
encode	O
the	O
lipogenic	O
enzymes	O
lipoprotein	O
lipase	O
and	O
malic	O
enzyme	O
are	O
not	O
subject	O
to	O
counter	O
-	O
regulation	O
by	O
insulin	O
and	O
TNF	B
alpha	I
at	O
the	O
transcriptional	O
level	O
in	O
3T3-L1	O
adipocytes	O
.	O

These	O
observations	O
on	O
the	O
control	O
of	O
ACS	B
and	O
SCD-1	B
expression	O
suggest	O
possible	O
mechanisms	O
by	O
which	O
adipocytes	O
can	O
markedly	O
adjust	O
their	O
capacity	O
for	O
long	O
chain	O
fatty	O
acid	O
metabolism	O
in	O
response	O
to	O
external	O
stimuli	O
.	O

The	O
basic	O
-	O
helix	O
-	O
loop	O
-	O
helix	O
-	O
leucine	O
zipper	O
(	O
bHLHZip	O
)	O
proteins	O
Myc	B
,	O
Mad	O
and	O
Mnt	B
are	O
part	O
of	O
a	O
transcription	O
activation	O
/	O
repression	O
system	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
proliferation	O
.	O

The	O
function	O
of	O
these	O
proteins	O
as	O
transcription	O
factors	O
is	O
mediated	O
by	O
heterodimerization	O
with	O
the	O
small	O
bHLHZip	O
protein	O
Max	B
,	O
which	O
is	O
required	O
for	O
their	O
specific	O
DNA	O
binding	O
to	O
E	O
-	O
box	O
sequences	O
.	O

We	O
have	O
identified	O
a	O
novel	O
Max	B
-	O
interacting	O
protein	O
,	O
Mga	B
,	O
which	O
contains	O
a	O
Myc	B
-	O
like	O
bHLHZip	O
motif	O
,	O
but	O
otherwise	O
shows	O
no	O
relationship	O
with	O
Myc	B
or	O
other	O
Max	B
-	O
interacting	O
proteins	O
.	O

Like	O
Myc	B
,	O
Mad	O
and	O
Mnt	B
proteins	O
,	O
Mga	B
requires	O
heterodimerization	O
with	O
Max	B
for	O
binding	O
to	O
the	O
preferred	O
Myc	B
-	O
Max	B
-	O
binding	O
site	O
CACGTG	O
.	O

In	O
addition	O
to	O
the	O
bHLHZip	O
domain	O
,	O
Mga	B
contains	O
a	O
second	O
DNA	O
-	O
binding	O
domain	O
:	O
the	O
T	O
-	O
box	O
or	O
T	O
-	O
domain	O
.	O

The	O
T	O
-	O
domain	O
is	O
a	O
highly	O
conserved	O
DNA	O
-	O
binding	O
motif	O
originally	O
defined	O
in	O
Brachyury	O
and	O
characteristic	O
of	O
the	O
Tbx	O
family	O
of	O
transcription	O
factors	O
.	O

Mga	B
binds	O
the	O
preferred	O
Brachyury	O
-	O
binding	O
sequence	O
and	O
represses	O
transcription	O
of	O
reporter	O
genes	O
containing	O
promoter	O
-	O
proximal	O
Brachyury	O
-	O
binding	O
sites	O
.	O

Surprisingly	O
,	O
Mga	B
is	O
converted	O
to	O
a	O
transcription	O
activator	O
of	O
both	O
Myc	B
-	O
Max	B
and	O
Brachyury	O
site	O
-	O
containing	O
reporters	O
in	O
a	O
Max	B
-	O
dependent	O
manner	O
.	O

Our	O
results	O
suggest	O
that	O
Mga	B
functions	O
as	O
a	O
dual	O
-	O
specificity	O
transcription	O
factor	O
that	O
regulates	O
the	O
expression	O
of	O
both	O
Max	B
-	O
network	O
and	O
T	O
-	O
box	O
family	O
target	O
genes	O
.	O

Circadian	O
oscillations	O
in	O
mammalian	O
physiology	O
and	O
behavior	O
are	O
regulated	O
by	O
an	O
endogenous	O
biological	O
clock	B
.	O

Here	O
we	O
show	O
that	O
loss	O
of	O
the	O
PAS	O
protein	O
MOP3	B
(	O
also	O
known	O
as	O
BMAL1	B
)	O
in	O
mice	O
results	O
in	O
immediate	O
and	O
complete	O
loss	O
of	O
circadian	O
rhythmicity	O
in	O
constant	O
darkness	O
.	O

Additionally	O
,	O
locomotor	O
activity	O
in	O
light	O
-	O
dark	O
(	O
LD	O
)	O
cycles	O
is	O
impaired	O
and	O
activity	O
levels	O
are	O
reduced	O
in	O
Mop3-	B
/	O
-	O
mice	O
.	O

Analysis	O
of	O
Period	O
gene	O
expression	O
in	O
the	O
suprachiasmatic	O
nucleus	O
(	O
SCN	O
)	O
indicates	O
that	O
these	O
behavioral	O
phenotypes	O
arise	O
from	O
loss	O
of	O
circadian	O
function	O
at	O
the	O
molecular	O
level	O
.	O

These	O
results	O
provide	O
genetic	O
evidence	O
that	O
MOP3	B
is	O
the	O
bona	O
fide	O
heterodimeric	O
partner	O
of	O
mCLOCK	O
.	O

Furthermore	O
,	O
these	O
data	O
demonstrate	O
that	O
MOP3	B
is	O
a	O
nonredundant	O
and	O
essential	O
component	O
of	O
the	O
circadian	O
pacemaker	O
in	O
mammals	O
.	O

Monophosphoryl	O
lipid	O
A	O
(	O
MPL	O
)	O
is	O
a	O
nontoxic	O
derivative	O
of	O
the	O
lipid	O
A	O
region	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)	O
that	O
is	O
being	O
developed	O
as	O
both	O
an	O
adjuvant	O
and	O
prophylactic	O
drug	O
for	O
septic	O
shock	O
.	O

We	O
compared	O
the	O
ability	O
of	O
LPS	O
and	O
MPL	O
to	O
induce	O
interleukin-10	O
(	O
IL-10	B
)	O
,	O
IL-12	O
p35	B
,	O
IL-12	B
p40	I
,	O
gamma	O
interferon	O
(	O
IFN	B
-	I
gamma	I
)	O
,	O
glucocorticoid	B
receptor	I
(	O
GR	B
)	O
,	O
IL-1	O
receptor	O
antagonist	O
(	O
IL-1ra	B
)	O
,	O
and	O
inducible	O
nitric	O
oxide	O
synthase	O
mRNA	O
expression	O
in	O
murine	O
peritoneal	O
macrophages	O
.	O

These	O
genes	O
were	O
chosen	O
for	O
their	O
ability	O
to	O
positively	O
or	O
negatively	O
regulate	O
the	O
host	O
immune	O
response	O
and	O
thus	O
for	O
their	O
potential	O
involvement	O
in	O
MPL	O
-	O
induced	O
adjuvanticity	O
or	O
in	O
its	O
ability	O
to	O
protect	O
against	O
sepsis	O
.	O

LPS	O
was	O
a	O
more	O
potent	O
inducer	O
of	O
IL-12	O
p35	B
,	O
IL-12	B
p40	I
,	O
and	O
IFN	B
-	I
gamma	I
mRNA	O
,	O
as	O
well	O
as	O
of	O
IL-12	O
protein	O
,	O
than	O
MPL	O
.	O

In	O
contrast	O
,	O
MPL	O
induced	O
higher	O
levels	O
of	O
IL-10	B
mRNA	O
than	O
did	O
LPS	O
from	O
1	O
to	O
1,000	O
ng	O
/	O
ml	O
.	O

In	O
general	O
,	O
MPL	O
was	O
not	O
a	O
more	O
potent	O
inducer	O
of	O
negative	O
regulatory	O
genes	O
,	O
since	O
MPL	O
and	O
LPS	O
induced	O
similar	O
levels	O
of	O
GR	B
and	O
IL-1ra	B
mRNA	O
.	O

Addition	O
of	O
anti	O
-	O
IL-10	B
antibody	O
to	O
cultures	O
increased	O
the	O
induction	O
of	O
MPL	O
-	O
induced	O
IL-12	O
p35	B
,	O
IL-12	B
p40	I
,	O
and	O
IFN	B
-	I
gamma	I
mRNA	O
,	O
suggesting	O
that	O
the	O
enhanced	O
production	O
of	O
IL-10	B
by	O
MPL	O
-	O
stimulated	O
macrophages	O
contributes	O
to	O
decreased	O
production	O
of	O
mRNA	O
for	O
IL-12	O
(	O
p35	B
and	O
p40	B
)	O
and	O
IFN	B
-	I
gamma	I
.	O

Conversely	O
,	O
the	O
addition	O
of	O
exogenous	O
IL-10	B
to	O
LPS	O
-	O
treated	O
macrophages	O
reduced	O
the	O
mRNA	O
expression	O
of	O
these	O
cytokine	O
genes	O
.	O

These	O
studies	O
suggest	O
that	O
enhanced	O
production	O
of	O
IL-10	B
by	O
MPL	O
-	O
stimulated	O
macrophages	O
may	O
contribute	O
to	O
the	O
reduced	O
toxicity	O
of	O
MPL	O
through	O
its	O
negative	O
action	O
on	O
induction	O
of	O
cytokines	O
shown	O
to	O
enhance	O
endotoxicity	O
.	O

Although	O
nonsteroidal	O
antiinflammatory	O
drugs	O
(	O
NSAIDs	O
)	O
show	O
great	O
promise	O
as	O
therapies	O
for	O
colon	O
cancer	O
,	O
a	O
dispute	O
remains	O
regarding	O
their	O
mechanism	O
of	O
action	O
.	O

NSAIDs	O
are	O
known	O
to	O
inhibit	O
cyclooxygenase	O
(	O
COX	O
)	O
enzymes	O
,	O
which	O
convert	O
arachidonic	O
acid	O
(	O
AA	O
)	O
to	O
prostaglandins	O
(	O
PGs	O
)	O
.	O

Therefore	O
,	O
NSAIDs	O
may	O
suppress	O
tumorigenesis	O
by	O
inhibiting	O
PG	O
synthesis	O
.	O

However	O
,	O
various	O
experimental	O
studies	O
have	O
suggested	O
the	O
possibility	O
of	O
PG	O
-	O
independent	O
mechanisms	O
.	O

Notably	O
,	O
disruption	O
of	O
the	O
mouse	O
group	O
IIA	O
secretory	O
phospholipase	O
A	O
(	O
2	O
)	O
locus	O
(	O
Pla2g2a	B
)	O
,	O
a	O
potential	O
source	O
of	O
AA	O
for	O
COX-2	O
,	O
increases	O
tumor	O
number	O
despite	O
the	O
fact	O
that	O
the	O
mutation	O
has	O
been	O
predicted	O
to	O
decrease	O
PG	O
production	O
.	O

Some	O
authors	O
have	O
attempted	O
to	O
reconcile	O
the	O
results	O
by	O
suggesting	O
that	O
the	O
level	O
of	O
the	O
precursor	O
(	O
AA	O
)	O
,	O
not	O
the	O
products	O
(	O
PGs	O
)	O
,	O
is	O
the	O
critical	O
factor	O
.	O

To	O
clarify	O
the	O
role	O
of	O
AA	O
in	O
tumorigenesis	O
,	O
we	O
have	O
examined	O
the	O
effect	O
of	O
deleting	O
the	O
group	O
IV	O
cytosolic	O
phospholipase	O
A	O
(	O
2	O
)	O
(	O
cPLA	O
(	O
2	O
)	O
)	O
locus	O
(	O
Pla2g4	B
)	O
.	O

We	O
report	O
that	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
,	O
cPLA	O
(	O
2	O
)	O
(	O
-	O
/	O
-	O
)	O
mice	O
show	O
an	O
83	O
%	O
reduction	O
in	O
tumor	O
number	O
in	O
the	O
small	O
intestine	O
compared	O
with	O
littermates	O
with	O
genotypes	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
,	O
cPLA	O
(	O
2	O
)	O
(	O
+	O
/	O
-	O
)	O
and	O
Apc	B
(	I
Min	I
/	I
+	I
)	I
,	O
cPLA	O
(	O
2	O
)	O
(	O
+	O
/	O
+	O
)	O
.	O

This	O
tumor	O
phenotype	O
parallels	O
that	O
of	O
COX-2	O
knockout	O
mice	O
,	O
suggesting	O
that	O
cPLA	O
(	O
2	O
)	O
is	O
the	O
predominant	O
source	O
of	O
AA	O
for	O
COX-2	O
in	O
the	O
intestine	O
.	O

The	O
protective	O
effect	O
of	O
cPLA	O
(	O
2	O
)	O
deletion	O
is	O
thus	O
most	O
likely	O
attributed	O
to	O
a	O
decrease	O
in	O
the	O
AA	O
supply	O
to	O
COX-2	O
and	O
a	O
resultant	O
decrease	O
in	O
PG	O
synthesis	O
.	O

The	O
tumorigenic	O
effect	O
of	O
sPLA	O
(	O
2	O
)	O
mutations	O
is	O
likely	O
to	O
be	O
through	O
a	O
completely	O
different	O
pathway	O
.	O

Stromelysin-1	B
is	O
a	O
member	O
of	O
the	O
metalloproteinase	O
family	O
of	O
extracellular	O
matrix	O
-	O
degrading	O
enzymes	O
that	O
regulates	O
tissue	O
remodeling	O
.	O

We	O
previously	O
established	O
a	O
transgenic	O
mouse	O
model	O
in	O
which	O
rat	O
stromelysin-1	B
targeted	O
to	O
the	O
mammary	O
gland	O
augmented	O
expression	O
of	O
endogenous	O
stromelysin-1	B
,	O
disrupted	O
functional	O
differentiation	O
,	O
and	O
induced	O
mammary	O
tumors	O
.	O

A	O
cell	O
line	O
generated	O
from	O
an	O
adenocarcinoma	O
in	O
one	O
of	O
these	O
animals	O
and	O
a	O
previously	O
described	O
mammary	O
tumor	O
cell	O
line	O
generated	O
in	O
culture	O
readily	O
invaded	O
both	O
a	O
reconstituted	O
basement	O
membrane	O
and	O
type	O
I	O
collagen	O
gels	O
,	O
whereas	O
a	O
nonmalignant	O
,	O
functionally	O
normal	O
epithelial	O
cell	O
line	O
did	O
not	O
.	O

Invasion	O
of	O
Matrigel	O
by	O
tumor	O
cells	O
was	O
largely	O
abolished	O
by	O
metalloproteinase	O
inhibitors	O
,	O
but	O
not	O
by	O
inhibitors	O
of	O
other	O
proteinase	O
families	O
.	O

Inhibition	O
experiments	O
with	O
antisense	O
oligodeoxynucleotides	O
revealed	O
that	O
Matrigel	O
invasion	O
of	O
both	O
cell	O
lines	O
was	O
critically	O
dependent	O
on	O
stromelysin-1	B
expression	O
.	O

Invasion	O
of	O
collagen	O
,	O
on	O
the	O
other	O
hand	O
,	O
was	O
reduced	O
by	O
only	O
40	O
-	O
50	O
%	O
.	O

Stromelysin-1	B
was	O
expressed	O
in	O
both	O
malignant	O
and	O
nonmalignant	O
cells	O
grown	O
on	O
plastic	O
substrata	O
.	O

Its	O
expression	O
was	O
completely	O
inhibited	O
in	O
nonmalignant	O
cells	O
,	O
but	O
up	O
-	O
regulated	O
in	O
tumor	O
cells	O
,	O
in	O
response	O
to	O
Matrigel	O
.	O

Thus	O
misregulation	O
of	O
stromelysin-1	B
expression	O
appears	O
to	O
be	O
an	O
important	O
aspect	O
of	O
mammary	O
tumor	O
cell	O
progression	O
to	O
an	O
invasive	O
phenotype	O
.	O

The	O
resilience	O
and	O
strength	O
of	O
bone	O
is	O
due	O
to	O
the	O
orderly	O
mineralization	O
of	O
a	O
specialized	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
composed	O
of	O
type	O
I	O
collagen	O
(	O
90	O
%	O
)	O
and	O
a	O
host	O
of	O
non	O
-	O
collagenous	O
proteins	O
that	O
are	O
,	O
in	O
general	O
,	O
also	O
found	O
in	O
other	O
tissues	O
.	O

Biglycan	B
(	O
encoded	O
by	O
the	O
gene	O
Bgn	B
)	O
is	O
an	O
ECM	O
proteoglycan	O
that	O
is	O
enriched	O
in	O
bone	O
and	O
other	O
non	O
-	O
skeletal	O
connective	O
tissues	O
.	O

In	O
vitro	O
studies	O
indicate	O
that	O
Bgn	B
may	O
function	O
in	O
connective	O
tissue	O
metabolism	O
by	O
binding	O
to	O
collagen	O
fibrils	O
and	O
TGF	O
-	O
beta	O
(	O
refs	O
5,6	O
)	O
,	O
and	O
may	O
promote	O
neuronal	O
survival	O
.	O

To	O
study	O
the	O
role	O
of	O
Bgn	B
in	O
vivo	O
,	O
we	O
generated	O
Bgn	B
-	O
deficient	O
mice	O
.	O

Although	O
apparently	O
normal	O
at	O
birth	O
,	O
these	O
mice	O
display	O
a	O
phenotype	O
characterized	O
by	O
a	O
reduced	O
growth	O
rate	O
and	O
decreased	O
bone	O
mass	O
due	O
to	O
the	O
absence	O
of	O
Bgn	B
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
in	O
which	O
deficiency	O
of	O
a	O
non	O
-	O
collagenous	O
ECM	O
protein	O
leads	O
to	O
a	O
skeletal	O
phenotype	O
that	O
is	O
marked	O
by	O
low	O
bone	O
mass	O
that	O
becomes	O
more	O
obvious	O
with	O
age	O
.	O

These	O
mice	O
may	O
serve	O
as	O
an	O
animal	O
model	O
to	O
study	O
the	O
role	O
of	O
ECM	O
proteins	O
in	O
osteoporosis	O
.	O

Following	O
skin	O
sensitization	O
a	O
proportion	O
of	O
epidermal	O
Langerhans	O
cells	O
(	O
LC	O
)	O
are	O
stimulated	O
to	O
leave	O
the	O
skin	O
and	O
to	O
migrate	O
,	O
via	O
afferent	O
lymphatics	O
,	O
to	O
draining	O
lymph	O
nodes	O
where	O
they	O
accumulate	O
as	O
immunostimulatory	O
dendritic	O
cells	O
(	O
DC	O
)	O
.	O

It	O
has	O
been	O
demonstrated	O
previously	O
that	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	B
-	I
alpha	I
)	O
,	O
an	O
inducible	O
product	O
of	O
epidermal	O
keratinocytes	O
,	O
and	O
interleukin	O
(	O
IL	O
)	O
-1beta	O
,	O
produced	O
exclusively	O
by	O
LC	O
in	O
murine	O
epidermis	O
,	O
provide	O
important	O
signals	O
for	O
the	O
initiation	O
of	O
this	O
response	O
.	O

Recently	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
IL-18	B
,	O
a	O
cytokine	O
produced	O
by	O
both	O
LC	O
and	O
keratinocytes	O
within	O
the	O
epidermis	O
,	O
may	O
also	O
participate	O
in	O
immune	O
responses	O
induced	O
following	O
skin	O
sensitization	O
.	O

In	O
the	O
present	O
investigations	O
,	O
the	O
ability	O
of	O
IL-18	B
to	O
contribute	O
to	O
the	O
regulation	O
of	O
LC	O
migration	O
and	O
the	O
accumulation	O
of	O
DC	O
in	O
draining	O
lymph	O
nodes	O
has	O
been	O
examined	O
.	O

It	O
was	O
found	O
that	O
,	O
like	O
IL-1beta	B
,	O
IL-18	B
administered	O
intradermally	O
to	O
mice	O
resulted	O
in	O
a	O
significant	O
reduction	O
in	O
epidermal	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
class	O
II+	O
LC	O
densities	O
and	O
a	O
marked	O
increase	O
in	O
lymph	O
node	O
DC	O
numbers	O
.	O

Using	O
neutralizing	O
anti	O
-	O
TNF	B
-	I
alpha	I
and	O
blocking	O
anti	O
-	O
type	O
I	O
IL-1	O
receptor	O
(	O
IL-1RI	O
)	O
antibodies	O
,	O
it	O
was	O
shown	O
also	O
that	O
the	O
induction	O
by	O
IL-18	B
of	O
both	O
LC	O
mobilization	O
and	O
DC	O
accumulation	O
in	O
regional	O
lymph	O
nodes	O
was	O
dependent	O
upon	O
availability	O
of	O
TNF	B
-	I
alpha	I
and	O
the	O
integrity	O
of	O
IL-1RI	O
signalling	O
.	O

Furthermore	O
,	O
using	O
IL-1beta	B
converting	O
enzyme	O
(	O
caspase-1	B
)	O
knockout	O
mice	O
,	O
IL-18-induced	B
LC	O
migration	O
was	O
found	O
to	O
have	O
a	O
mandatory	O
requirement	O
for	O
active	O
IL-1beta	B
.	O

Importantly	O
,	O
not	O
only	O
was	O
IL-18	B
able	O
to	O
contribute	O
to	O
the	O
regulation	O
of	O
LC	O
migration	O
,	O
it	O
was	O
found	O
to	O
be	O
essential	O
for	O
the	O
manifestation	O
of	O
these	O
processes	O
in	O
response	O
to	O
topical	O
sensitization	O
with	O
the	O
contact	O
allergen	O
oxazolone	O
.	O

Duchenne	O
and	O
Becker	O
muscular	O
dystrophy	O
(	O
DMD	B
and	O
BMD	B
)	O
are	O
X	B
-	O
linked	O
recessive	O
diseases	O
caused	O
by	O
defective	O
expression	O
of	O
dystrophin	O
.	O

The	O
mdx	B
mouse	O
,	O
an	O
animal	O
model	O
for	O
DMD	B
,	O
has	O
a	O
mutation	O
that	O
eliminates	O
expression	O
of	O
the	O
427	O
K	O
muscle	O
and	O
brain	O
isoforms	O
of	O
dystrophin	O
.	O

Although	O
these	O
animals	O
do	O
not	O
display	O
overt	O
muscle	O
weakness	O
or	O
impaired	O
movement	O
,	O
the	O
diaphragm	O
muscle	O
of	O
the	O
mdx	B
mouse	O
is	O
severely	O
affected	O
and	O
shows	O
progressive	O
myofibre	O
degeneration	O
and	O
fibrosis	O
which	O
closely	O
resembles	O
the	O
human	O
disease	O
.	O

Here	O
we	O
explore	O
the	O
feasibility	O
of	O
gene	O
therapy	O
for	O
DMD	B
by	O
examining	O
the	O
potential	O
of	O
a	O
full	O
-	O
length	O
dystrophin	O
transgene	O
to	O
correct	O
dystrophic	O
symptoms	O
in	O
mdx	B
mice	O
.	O

We	O
find	O
that	O
expression	O
of	O
dystrophin	O
in	O
muscles	O
of	O
transgenic	O
mdx	B
mice	O
eliminates	O
the	O
morphological	O
and	O
immunohistological	O
symptoms	O
of	O
muscular	O
dystrophy	O
.	O

In	O
addition	O
,	O
overexpression	O
of	O
dystrophin	O
prevents	O
the	O
development	O
of	O
the	O
abnormal	O
mechanical	O
properties	O
associated	O
with	O
dystrophic	O
muscle	O
without	O
causing	O
deleterious	O
side	O
effects	O
.	O

Our	O
results	O
provide	O
functional	O
evidence	O
for	O
the	O
feasibility	O
of	O
gene	O
therapy	O
for	O
DMD	B
.	O

It	O
has	O
been	O
proposed	O
that	O
the	O
male	O
-	O
specific	O
transplantation	O
antigen	O
H	B
-	I
Y	I
is	O
the	O
trigger	O
for	O
testis	O
formation	O
(	O
Ohno	O
's	O
hypothesis	O
)	O
.	O

We	O
have	O
tested	O
this	O
hypothesis	O
by	O
examining	O
the	O
H	B
-	I
Y	I
status	O
of	O
a	O
number	O
of	O
mice	O
with	O
abnormal	O
or	O
aberrant	O
karyotypes	O
relative	O
to	O
their	O
gonad	O
development	O
.	O

This	O
analysis	O
includes	O
the	O
discussion	O
of	O
published	O
results	O
of	O
XX	O
males	O
carrying	O
the	O
Sxr	B
mutation	O
and	O
XO	O
females	O
,	O
and	O
the	O
presentation	O
of	O
unpublished	O
data	O
from	O
XY	O
females	O
carrying	O
the	O
YPOS	O
or	O
YORB	O
chromosome	O
,	O
XY	O
females	O
carrying	O
Thp	O
on	O
chromosome	O
17	O
,	O
and	O
a	O
series	O
of	O
mice	O
carrying	O
X	B
-	O
Y	B
recombination	O
products	O
derived	O
from	O
the	O
Y	B
*	O
chromosome	O
.	O

The	O
XX	O
Sxr	B
males	O
have	O
testes	O
and	O
are	O
H	B
-	I
Y	I
transplantation	O
antigen	O
positive	O
;	O
XO	O
females	O
have	O
ovaries	O
and	O
are	O
H	B
-	I
Y	I
negative	O
;	O
mice	O
with	O
X	B
-	O
Y	B
reciprocal	O
recombinant	O
chromosomes	O
resulting	O
from	O
an	O
abnormal	O
Y	B
chromosome	O
show	O
concordance	O
between	O
the	O
presence	O
of	O
testes	O
and	O
the	O
presence	O
of	O
the	O
H	B
-	I
Y	I
antigen	O
.	O

All	O
of	O
these	O
findings	O
are	O
in	O
accord	O
with	O
Ohno	O
's	O
hypothesis	O
.	O

In	O
contrast	O
are	O
our	O
findings	O
that	O
three	O
types	O
of	O
C57BL	O
/	O
6J	O
XY	O
females	O
are	O
H	B
-	I
Y	I
positive	O
,	O
two	O
inheriting	O
a	O
Y	B
chromosome	O
from	O
the	O
mouse	O
species	O
Mus	O
domesticus	O
,	O
either	O
YPOS	O
or	O
YORB	O
,	O
and	O
the	O
other	O
a	O
mutation	O
associated	O
with	O
Thp	O
.	O

Genetic	O
analysis	O
of	O
the	O
inheritance	O
of	O
this	O
paradoxical	O
phenotype	O
indicates	O
that	O
normal	O
testis	O
differentiation	O
involves	O
the	O
interaction	O
of	O
two	O
or	O
three	O
genes	O
,	O
and	O
is	O
not	O
simply	O
a	O
function	O
of	O
a	O
Y	B
-	O
linked	O
gene	O
product	O
.	O

We	O
conclude	O
that	O
H	B
-	I
Y	I
is	O
not	O
the	O
sole	O
Y	B
-	O
linked	O
testis	O
determining	O
gene	O
.	O

The	O
polymorphic	O
variation	O
of	O
liver	O
GM1	O
(	O
NeuGc	O
)	O
ganglioside	O
was	O
found	O
in	O
inbred	O
strains	O
of	O
the	O
mouse	O
.	O

The	O
genetic	O
analysis	O
using	O
C57BL	O
/	O
10	O
(	O
GM1-negative	O
)	O
and	O
SWR	O
(	O
GM1-positive	O
)	O
mice	O
revealed	O
that	O
a	O
single	O
autosomal	O
gene	O
(	O
Ggm-1	B
)	O
was	O
involved	O
in	O
the	O
expression	O
of	O
liver	O
GM1	O
(	O
NeuGc	O
)	O
and	O
that	O
C57BL	O
/	O
10	O
mice	O
lacking	O
GM1	O
(	O
NeuGc	O
)	O
expression	O
carried	O
a	O
defective	O
gene	O
on	O
Ggm-1	B
.	O

Since	O
our	O
previous	O
study	O
on	O
H-2	O
congenic	O
mice	O
indicated	O
that	O
Ggm-1	B
was	O
linked	O
to	O
the	O
H-2	O
complex	O
,	O
in	O
this	O
study	O
we	O
measured	O
recombination	O
frequencies	O
among	O
Ggm-1	B
,	O
Glo-1	B
and	O
H-2	B
K	I
in	O
the	O
backcross	O
progeny	O
between	O
(	O
C57BL	O
/	O
10	O
X	O
SWR	O
)	O
F1	O
and	O
C57BL	O
/	O
10	O
.	O

Ggm-1	B
was	O
mapped	O
1	O
cM	O
centromeric	O
to	O
H-2	B
K	I
on	O
chromosome	O
17	O
.	O

We	O
have	O
isolated	O
the	O
RPN9	B
gene	O
by	O
two	O
-	O
hybrid	O
screening	O
with	O
,	O
as	O
bait	O
,	O
RPN10	B
(	O
formerly	O
SUN1	B
)	O
,	O
which	O
encodes	O
a	O
multiubiquitin	O
chain	O
receptor	O
residing	O
in	O
the	O
regulatory	O
particle	O
of	O
the	O
26S	O
proteasome	O
.	O

Rpn9	B
is	O
a	O
nonessential	O
subunit	O
of	O
the	O
regulatory	O
particle	O
of	O
the	O
26S	O
proteasome	O
,	O
but	O
the	O
deletion	O
of	O
this	O
gene	O
results	O
in	O
temperature	O
-	O
sensitive	O
growth	O
.	O

At	O
the	O
restrictive	O
temperature	O
,	O
the	O
Deltarpn9	O
strain	O
accumulated	O
multiubiquitinated	O
proteins	O
,	O
indicating	O
that	O
the	O
RPN9	B
function	O
is	O
needed	O
for	O
the	O
26S	O
proteasome	O
activity	O
at	O
a	O
higher	O
temperature	O
.	O

We	O
analyzed	O
the	O
proteasome	O
fractions	O
separated	O
by	O
glycerol	O
density	O
gradient	O
centrifugation	O
by	O
native	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
found	O
that	O
a	O
smaller	O
amount	O
of	O
the	O
26S	O
proteasome	O
was	O
produced	O
in	O
the	O
Deltarpn9	O
cells	O
and	O
that	O
the	O
26S	O
proteasome	O
was	O
shifted	O
to	O
lighter	O
fractions	O
than	O
expected	O
.	O

The	O
incomplete	O
proteasome	O
complexes	O
were	O
found	O
to	O
accumulate	O
in	O
the	O
Deltarpn9	O
cells	O
.	O

Furthermore	O
,	O
Rpn10	B
was	O
not	O
detected	O
in	O
the	O
fractions	O
containing	O
proteasomes	O
of	O
the	O
Deltarpn9	O
cells	O
.	O

These	O
results	O
indicate	O
that	O
Rpn9	B
is	O
needed	O
for	O
incorporating	O
Rpn10	B
into	O
the	O
26S	O
proteasome	O
and	O
that	O
Rpn9	B
participates	O
in	O
the	O
assembly	O
and/or	O
stability	O
of	O
the	O
26S	O
proteasome	O
.	O

The	O
machinery	O
that	O
inserts	O
mitochondrially	O
encoded	O
proteins	O
into	O
the	O
inner	O
membrane	O
and	O
translocates	O
their	O
hydrophilic	O
domains	O
through	O
the	O
membrane	O
is	O
poorly	O
understood	O
.	O

We	O
have	O
developed	O
a	O
genetic	O
screen	O
for	O
Saccharomyces	O
cerevisiae	O
mutants	O
defective	O
in	O
this	O
export	O
process	O
.	O

The	O
screen	O
is	O
based	O
on	O
the	O
fact	O
that	O
the	O
hydrophilic	O
polypeptide	O
Arg8	B
(	I
m	I
)	I
p	O
is	O
exported	O
from	O
the	O
matrix	O
if	O
it	O
is	O
synthesized	O
within	O
mitochondria	O
as	O
a	O
bifunctional	O
Cox2p	O
-	O
Arg8	B
(	I
m	I
)	I
p	O
fusion	O
protein	O
.	O

Since	O
export	O
of	O
Arg8	B
(	I
m	I
)	I
p	O
causes	O
an	O
Arg	O
(	O
-	O
)	O
phenotype	O
,	O
defective	O
mutants	O
can	O
be	O
selected	O
as	O
Arg	O
(	O
+	O
)	O
.	O

Here	O
we	O
show	O
that	O
mutations	O
in	O
the	O
nuclear	O
gene	O
PNT1	B
block	O
the	O
translocation	O
of	O
mitochondrially	O
encoded	O
fusion	O
proteins	O
across	O
the	O
inner	O
membrane	O
.	O

Pnt1p	O
is	O
a	O
mitochondrial	O
integral	O
inner	O
membrane	O
protein	O
that	O
appears	O
to	O
have	O
two	O
hydrophilic	O
domains	O
in	O
the	O
matrix	O
,	O
flanking	O
a	O
central	O
hydrophobic	O
hairpin	O
-	O
like	O
anchor	O
.	O

While	O
an	O
S.	O
cerevisiae	O
pnt1	B
deletion	O
mutant	O
was	O
more	O
sensitive	O
to	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
than	O
the	O
wild	O
type	O
was	O
,	O
it	O
was	O
respiration	O
competent	O
and	O
able	O
to	O
export	O
wild	O
-	O
type	O
Cox2p	O
.	O

However	O
,	O
deletion	O
of	O
the	O
PNT1	B
orthologue	O
from	O
Kluyveromyces	O
lactis	O
,	O
KlPNT1	O
,	O
caused	O
a	O
clear	O
nonrespiratory	O
phenotype	O
,	O
absence	O
of	O
cytochrome	O
oxidase	O
activity	O
,	O
and	O
a	O
defect	O
in	O
the	O
assembly	O
of	O
KlCox2p	O
that	O
appears	O
to	O
be	O
due	O
to	O
a	O
block	O
of	O
C	O
-	O
tail	O
export	O
.	O

Since	O
PNT1	B
was	O
previously	O
described	O
as	O
a	O
gene	O
affecting	O
resistance	O
to	O
the	O
antibiotic	O
pentamidine	O
,	O
our	O
data	O
support	O
a	O
mitochondrial	O
target	O
for	O
this	O
drug	O
.	O

Mammalian	O
cells	O
contain	O
several	O
chromatin	O
-	O
remodeling	O
complexes	O
associated	O
with	O
the	O
Brm	O
and	O
Brg1	O
helicase	O
-	O
like	O
proteins	O
.	O

These	O
complexes	O
likely	O
represent	O
the	O
functional	O
homologs	O
of	O
the	O
SWI	O
/	O
SNF	O
and	O
RSC	O
complexes	O
found	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
mammalian	O
chromatin	O
-	O
remodeling	O
complexes	O
are	O
involved	O
in	O
both	O
activation	O
and	O
repression	O
of	O
a	O
variety	O
of	O
genes	O
.	O

Several	O
lines	O
of	O
evidence	O
also	O
indicate	O
that	O
they	O
play	O
a	O
specific	O
role	O
in	O
the	O
regulation	O
of	O
cell	O
growth	O
.	O

Brm	O
is	O
down	O
-	O
regulated	O
by	O
ras	O
signaling	O
and	O
its	O
forced	O
re	O
-	O
expression	O
suppresses	O
transformation	O
by	O
this	O
oncogene	O
.	O

Besides	O
,	O
the	O
Brg1	O
gene	O
is	O
silenced	O
or	O
mutated	O
in	O
several	O
tumors	O
cell	O
lines	O
and	O
a	O
Brg1-associated	O
complex	O
was	O
recently	O
found	O
to	O
co	O
-	O
purify	O
with	O
BRCA1	O
,	O
involved	O
in	O
breast	O
and	O
ovarian	O
cancers	O
.	O

Finally	O
,	O
the	O
gene	O
encoding	O
SNF5	B
/	O
Ini1	O
,	O
a	O
subunit	O
common	O
to	O
all	O
mammalian	O
SWI	O
/	O
SNF	O
complexes	O
,	O
is	O
inactivated	O
in	O
rhabdoid	O
sarcomas	O
,	O
a	O
very	O
aggressive	O
form	O
of	O
pediatric	O
cancer	O
.	O

The	O
current	O
review	O
will	O
address	O
observations	O
made	O
upon	O
inactivation	O
of	O
Brm	O
,	O
Brg1	O
and	O
SNF5	B
/	O
Ini1	O
by	O
homologous	O
recombination	O
in	O
the	O
mouse	O
,	O
as	O
well	O
as	O
the	O
possible	O
implication	O
of	O
these	O
factors	O
in	O
the	O
regulation	O
of	O
the	O
Retinoblastoma	O
pRb	O
-	O
mediated	O
repression	O
of	O
the	O
transcription	O
factor	O
E2F	O
.	O

The	O
finding	O
in	O
animal	O
species	O
of	O
complexes	O
homologous	O
to	O
the	O
products	O
of	O
six	O
Saccharomyces	O
cerevisiae	O
genes	O
,	O
origin	O
of	O
replication	O
recognition	O
complex	O
(	O
ORC	O
)	O
,	O
has	O
suggested	O
that	O
ORC	O
-	O
related	O
mechanisms	O
have	O
been	O
conserved	O
in	O
all	O
eukaryotes	O
.	O

In	O
plants	O
,	O
however	O
,	O
the	O
only	O
cloned	O
putative	O
homologs	O
of	O
ORC	O
subunits	O
are	O
the	O
Arabidopsis	O
ORC2	B
and	O
the	O
rice	O
ORC1	B
.	O

Homologs	O
of	O
other	O
subunits	O
of	O
plant	O
origin	O
have	O
not	O
been	O
cloned	O
and	O
characterized	O
.	O

A	O
striking	O
observation	O
was	O
the	O
absence	O
from	O
the	O
Arabidopsis	O
genome	O
of	O
an	O
obvious	O
candidate	O
gene	O
-	O
homolog	O
of	O
ORC4	B
.	O

This	O
fact	O
raised	O
compelling	O
questions	O
of	O
whether	O
plants	O
,	O
in	O
general	O
,	O
and	O
Arabidopsis	O
,	O
in	O
particular	O
,	O
may	O
have	O
lost	O
the	O
ORC4	B
gene	O
,	O
whether	O
ORC	O
-	O
homologous	O
subunits	O
function	O
within	O
a	O
complex	O
in	O
plants	O
,	O
whether	O
an	O
ORC	O
complex	O
may	O
form	O
and	O
function	O
without	O
an	O
ORC4	B
subunit	O
,	O
whether	O
a	O
functional	O
(	O
but	O
not	O
sequence	O
)	O
protein	O
homolog	O
may	O
have	O
taken	O
up	O
the	O
role	O
of	O
ORC4	B
in	O
Arabidopsis	O
,	O
and	O
whether	O
lack	O
of	O
ORC4	B
is	O
a	O
plant	O
feature	O
,	O
in	O
general	O
.	O

Here	O
,	O
we	O
report	O
the	O
first	O
cloned	O
and	O
molecularly	O
characterized	O
five	O
genes	O
coding	O
for	O
the	O
maize	O
putative	O
homologs	O
of	O
ORC	O
subunits	O
ZmORC1	O
,	O
ZmORC2	O
,	O
ZmORC3	O
,	O
ZmORC4	O
and	O
ZmORC5	O
.	O

Their	O
expression	O
profiles	O
in	O
tissues	O
with	O
different	O
cell	O
-	O
dividing	O
activities	O
are	O
compatible	O
with	O
a	O
role	O
in	O
DNA	O
replication	O
.	O

Based	O
on	O
the	O
potential	O
of	O
ORC	O
-	O
homologous	O
maize	O
proteins	O
to	O
bind	O
each	O
other	O
in	O
yeast	O
,	O
we	O
propose	O
a	O
model	O
for	O
their	O
possible	O
assembly	O
within	O
a	O
maize	O
ORC	O
.	O

The	O
isolation	O
and	O
molecular	O
characterization	O
of	O
an	O
ORC4-homologous	B
gene	O
from	O
maize	O
argues	O
that	O
,	O
in	O
its	O
evolution	O
,	O
Arabidopsis	O
may	O
have	O
lost	O
the	O
homologous	O
ORC4	B
gene	O
.	O

We	O
have	O
purified	O
peroxisomal	O
membranes	O
from	O
Saccharomyces	O
cerevisiae	O
after	O
induction	O
of	O
peroxisomes	O
in	O
oleic	O
acid	O
-	O
containing	O
media	O
.	O

About	O
30	O
distinct	O
proteins	O
could	O
be	O
discerned	O
among	O
the	O
HPLC-	O
and	O
SDS	O
-	O
PAGE	O
-	O
separated	O
proteins	O
of	O
the	O
high	O
salt	O
-	O
extracted	O
peroxisomal	O
membranes	O
.	O

The	O
most	O
abundant	O
of	O
these	O
,	O
Pmp27p	O
,	O
was	O
purified	O
and	O
the	O
corresponding	O
gene	O
PMP27	B
was	O
cloned	O
and	O
sequenced	O
.	O

Its	O
primary	O
structure	O
is	O
32	O
%	O
identical	O
to	O
PMP31	O
and	O
PMP32	O
of	O
the	O
yeast	O
Candida	O
biodinii	O
(	O
Moreno	O
,	O
M.	O
,	O
R.	O
Lark	O
,	O
K.	O
L.	O
Campbell	O
,	O
and	O
M.	O
J.	O
Goodman	O
.	O
1994	O
.	O

Yeast	O
.	O

10:1447	O
-	O
1457	O
)	O
.	O

Immunoelectron	O
microscopic	O
localization	O
of	O
Pmp27p	O
showed	O
labeling	O
of	O
the	O
peroxisomal	O
membrane	O
,	O
but	O
also	O
of	O
matrix	O
-	O
less	O
and	O
matrix	O
containing	O
tubular	O
membranes	O
nearby	O
.	O

Electronmicroscopical	O
data	O
suggest	O
that	O
some	O
of	O
these	O
tubular	O
extensions	O
might	O
interconnect	O
peroxisomes	O
to	O
form	O
a	O
peroxisomal	O
reticulum	O
.	O

Cells	O
with	O
a	O
disrupted	O
PMP27	B
gene	O
(	O
delta	O
pmp27	B
)	O
still	O
grew	O
well	O
on	O
glucose	O
or	O
ethanol	O
,	O
but	O
they	O
failed	O
to	O
grow	O
on	O
oleate	O
although	O
peroxisomes	O
were	O
still	O
induced	O
by	O
transfer	O
to	O
oleate	O
-	O
containing	O
media	O
.	O

The	O
induced	O
peroxisomes	O
of	O
delta	O
pmp27	B
cells	O
were	O
fewer	O
but	O
considerably	O
larger	O
than	O
those	O
of	O
wild	O
-	O
type	O
cells	O
,	O
suggesting	O
that	O
Pmp27p	O
may	O
be	O
involved	O
in	O
parceling	O
of	O
peroxisomes	O
into	O
regular	O
quanta	O
.	O

delta	O
pmp27	B
cells	O
cultured	O
in	O
oleate	O
-	O
containing	O
media	O
form	O
multiple	O
buds	O
,	O
of	O
which	O
virtually	O
all	O
are	O
peroxisome	O
deficient	O
.	O

The	O
growth	O
defect	O
of	O
delta	O
pmp27	B
cells	O
on	O
oleic	O
acid	O
appears	O
to	O
result	O
from	O
the	O
inability	O
to	O
segregate	O
the	O
giant	O
peroxisomes	O
to	O
daughter	O
cells	O
.	O

By	O
sequencing	O
of	O
the	O
DNA	O
adjacent	O
to	O
the	O
Candida	O
albicans	O
SEC61	O
gene	O
,	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
polypeptide	O
of	O
331	O
amino	O
acids	O
was	O
found	O
.	O

The	O
predicted	O
protein	O
showed	O
a	O
strong	O
homology	O
with	O
the	O
fructose-1,6-bisphosphatase	O
[	O
FbPase	O
]	O
from	O
other	O
organisms	O
,	O
and	O
conserved	O
regions	O
included	O
the	O
catalytic	O
motif	O
found	O
in	O
all	O
known	O
FbPases	O
.	O

Although	O
the	O
cloned	O
gene	O
did	O
not	O
complement	O
the	O
growth	O
failure	O
of	O
a	O
Saccharomyces	O
cerevisiae	O
fbp1	B
mutant	O
in	O
media	O
with	O
gluconeogenic	O
carbon	O
sources	O
,	O
it	O
was	O
transcribed	O
in	O
the	O
transformants	O
in	O
a	O
fashion	O
that	O
indicates	O
a	O
partial	O
repression	O
by	O
glucose	O
.	O

A	O
similar	O
control	O
on	O
the	O
transcription	O
of	O
this	O
gene	O
and	O
on	O
FbPase	O
activity	O
was	O
found	O
in	O
wild	O
-	O
type	O
C.	O
albicans	O
,	O
where	O
the	O
cloned	O
gene	O
(	O
CaFBP1	O
)	O
was	O
shown	O
to	O
be	O
localized	O
in	O
a	O
single	O
chromosomal	O
locus	O
in	O
the	O
genome	O
.	O

Retinoblastoma	O
protein	O
(	O
Rb	O
)	O
plays	O
important	O
roles	O
in	O
cell	O
cycle	O
progression	O
and	O
cellular	O
differentiation	O
.	O

It	O
may	O
also	O
participate	O
in	O
M	O
phase	O
events	O
,	O
although	O
heretofore	O
only	O
circumstantial	O
evidence	O
has	O
suggested	O
such	O
involvement	O
.	O

Here	O
we	O
show	O
that	O
Rb	O
interacts	O
,	O
through	O
an	O
IxCxE	O
motif	O
and	O
specifically	O
during	O
G	O
(	O
2	O
)	O
/	O
M	O
phase	O
,	O
with	O
hsHec1p	O
,	O
a	O
protein	O
essential	O
for	O
proper	O
chromosome	O
segregation	O
.	O

The	O
interaction	O
between	O
Rb	O
and	O
hsHec1p	O
was	O
reconstituted	O
in	O
a	O
yeast	O
strain	O
in	O
which	O
human	O
hsHEC1	O
rescues	O
the	O
null	O
mutation	O
of	O
scHEC1	O
.	O

Expression	O
of	O
Rb	O
reduced	O
chromosome	O
segregation	O
errors	O
fivefold	O
in	O
yeast	O
cells	O
sustained	O
by	O
a	O
temperature	O
-	O
sensitive	O
(	O
ts	O
)	O
hshec1	O
-	O
113	O
allele	O
and	O
enhanced	O
the	O
ability	O
of	O
wild	O
-	O
type	O
hsHec1p	O
to	O
suppress	O
lethality	O
caused	O
by	O
a	O
ts	O
smc1	B
mutation	O
.	O

The	O
interaction	O
between	O
Hec1p	O
and	O
Smc1p	O
was	O
important	O
for	O
the	O
specific	O
DNA	O
-	O
binding	O
activity	O
of	O
Smc1p	O
.	O

Expression	O
of	O
Rb	O
restored	O
part	O
of	O
the	O
inactivated	O
function	O
of	O
hshec1	O
-	O
113p	O
and	O
thereby	O
increased	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
Smc1p	O
.	O

Rb	O
thus	O
increased	O
the	O
fidelity	O
of	O
chromosome	O
segregation	O
mediated	O
by	O
hsHec1p	O
in	O
a	O
heterologous	O
yeast	O
system	O
.	O

Genes	O
encoding	O
two	O
distinct	O
fatty	O
acid	O
delta9-desaturases	O
were	O
isolated	O
from	O
strains	O
of	O
the	O
oleaginous	O
fungus	O
Mortierella	O
alpina	O
.	O

Two	O
genomic	O
sequences	O
,	O
delta9	O
-	O
1	O
and	O
delta9	O
-	O
2	O
,	O
each	O
containing	O
a	O
single	O
intron	O
,	O
were	O
cloned	O
from	O
strain	O
CBS	O
528.72	O
while	O
one	O
cDNA	O
clone	O
,	O
LM9	O
,	O
was	O
isolated	O
from	O
strain	O
CBS	O
210.32	O
.	O

The	O
delta9	O
-	O
1	O
gene	O
encoded	O
a	O
protein	O
of	O
445	O
aa	O
which	O
shared	O
99	O
%	O
identity	O
with	O
the	O
LM9	O
gene	O
product	O
.	O

These	O
proteins	O
also	O
showed	O
40	O
-	O
60	O
%	O
identity	O
to	O
the	O
delta9-desaturases	O
(	O
Ole1p	O
)	O
of	O
other	O
fungi	O
and	O
contained	O
the	O
three	O
conserved	O
histidine	O
boxes	O
,	O
C	O
-	O
terminal	O
cytochrome	O
b5	O
fusion	O
and	O
transmembrane	O
domains	O
characteristic	O
of	O
endoplasmic	O
reticulum	O
membrane	O
-	O
bound	O
delta9-desaturases	O
.	O

LM9	O
and	O
delta9	O
-	O
1	O
are	O
therefore	O
considered	O
to	O
represent	O
the	O
same	O
gene	O
(	O
ole1	B
)	O
.	O

The	O
ole1	B
gene	O
was	O
transcriptionally	O
active	O
in	O
all	O
M.	O
alpina	O
strains	O
tested	O
and	O
its	O
function	O
was	O
confirmed	O
by	O
complementation	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
ole1	B
mutation	O
.	O

Fatty	O
acid	O
analysis	O
of	O
yeast	O
transformants	O
expressing	O
the	O
CBS	O
210.32	O
ole1	B
gene	O
showed	O
an	O
elevated	O
level	O
of	O
oleic	O
acid	O
(	O
18:1	O
)	O
compared	O
to	O
palmitoleic	O
acid	O
(	O
16:1	O
)	O
,	O
the	O
major	O
fatty	O
acid	O
component	O
of	O
wild	O
-	O
type	O
S.	O
cerevisiae	O
.	O

This	O
indicated	O
that	O
the	O
M.	O
alpina	O
delta9-desaturase	O
had	O
a	O
substrate	O
preference	O
for	O
stearic	O
acid	O
(	O
18:0	O
)	O
rather	O
than	O
palmitic	O
acid	O
(	O
16:0	O
)	O
.	O

Genomic	O
clone	O
delta9	O
-	O
2	O
(	O
ole2	O
)	O
also	O
encoded	O
a	O
protein	O
of	O
445	O
aa	O
which	O
had	O
86	O
%	O
identity	O
to	O
the	O
delta9	O
-	O
1	O
and	O
LM9	O
proteins	O
and	O
whose	O
ORF	O
also	O
complemented	O
the	O
yeast	O
ole1	B
mutation	O
.	O

The	O
transcript	O
from	O
this	O
gene	O
could	O
only	O
be	O
detected	O
in	O
one	O
of	O
the	O
six	O
M.	O
alpina	O
strains	O
tested	O
,	O
suggesting	O
that	O
its	O
expression	O
may	O
be	O
strain	O
-	O
specific	O
or	O
induced	O
under	O
certain	O
physiological	O
conditions	O
.	O

Transcription	O
of	O
SUC2	B
,	O
the	O
gene	O
that	O
encodes	O
the	O
cytoplasmic	O
and	O
secreted	O
forms	O
of	O
the	O
enzyme	O
invertase	O
,	O
is	O
controlled	O
by	O
glucose	O
repression	O
and	O
derepression	O
mechanisms	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Several	O
regulatory	O
factors	O
such	O
as	O
the	O
Mig1p	O
-	O
Tup1p	O
-	O
Ssn6p	O
repressor	O
complex	O
and	O
the	O
Snf1p	O
kinase	O
complex	O
have	O
been	O
identified	O
previously	O
as	O
regulators	O
of	O
SUC2	B
expression	O
.	O

We	O
show	O
that	O
,	O
in	O
addition	O
to	O
these	O
factors	O
,	O
expression	O
of	O
SUC2	B
is	O
affected	O
by	O
mutations	O
in	O
the	O
gene	O
GCR1	B
that	O
encodes	O
the	O
glycolysis	O
regulatory	O
protein	O
Gcr1p	O
.	O

Expression	O
of	O
Suc2-LacZ	B
was	O
not	O
repressed	O
by	O
glucose	O
in	O
gcr1	B
mutant	O
yeast	O
cells	O
exposed	O
to	O
glucose	O
.	O

Furthermore	O
,	O
secreted	O
invertase	O
activity	O
was	O
constitutively	O
expressed	O
under	O
glucose	O
-	O
repressed	O
and	O
derepressed	O
conditions	O
in	O
gcr1	B
mutants	O
.	O

DNA	O
gel	O
mobility	O
shift	O
assays	O
and	O
in	O
-	O
vitro	O
DNase	O
I	O
protection	O
experiments	O
mapped	O
a	O
DNA	O
binding	O
site	O
for	O
Gcr1p	O
in	O
the	O
transcriptional	O
control	O
region	O
of	O
the	O
SUC2	B
gene	O
,	O
next	O
to	O
a	O
previously	O
mapped	O
Mig1p	O
binding	O
site	O
.	O

However	O
,	O
the	O
mechanism	O
by	O
which	O
gcr1	B
mutations	O
relieve	O
glucose	O
repression	O
remains	O
obscure	O
.	O

MSB2	B
was	O
identified	O
previously	O
as	O
a	O
multicopy	O
suppressor	O
of	O
a	O
temperature	O
-	O
sensitive	O
mutation	O
in	O
CDC24	B
,	O
a	O
gene	O
required	O
for	O
polarity	O
establishment	O
and	O
bud	O
formation	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
inferred	O
MSB2	B
product	O
contains	O
1306	O
amino	O
acids	O
,	O
42	O
%	O
of	O
which	O
are	O
Ser	O
or	O
Thr	O
.	O

Its	O
Ser+Thr	O
-	O
richness	O
and	O
hydrophobicity	O
profile	O
suggest	O
that	O
Msb2p	O
may	O
be	O
an	O
integral	O
membrane	O
protein	O
containing	O
a	O
long	O
,	O
periplasmic	O
,	O
N	O
-	O
terminal	O
domain	O
and	O
a	O
short	O
,	O
cytoplasmic	O
,	O
C	O
-	O
terminal	O
domain	O
.	O

Cells	O
that	O
lack	O
MSB2	B
display	O
no	O
obvious	O
mutant	O
phenotypes	O
.	O

MSB2	B
is	O
located	O
between	O
the	O
centromere	O
and	O
KSS1	B
on	O
the	O
right	O
arm	O
of	O
chromosome	O
VII	O
.	O

Although	O
physical	O
mapping	O
suggests	O
that	O
MSB2	B
and	O
LEU1	B
(	O
on	O
the	O
left	O
arm	O
of	O
chromosome	O
VII	O
)	O
are	O
approximately	O
40	O
kb	O
apart	O
,	O
the	O
genetic	O
map	O
distance	O
observed	O
between	O
leu1	B
and	O
an	O
msb2::URA3	B
marker	O
was	O
only	O
2.3	O
cM.	O

The	O
alpha	O
and	O
beta	O
components	O
of	O
the	O
secreted	O
K1	O
killer	O
toxin	O
of	O
Saccharomyces	O
cerevisiae	O
are	O
derived	O
from	O
residues	O
45	O
-	O
147	O
and	O
234	O
-	O
316	O
,	O
respectively	O
,	O
of	O
the	O
316	O
residue	O
preprotoxin	O
(	O
ppTox	O
)	O
.	O

The	O
beta	O
N	O
-	O
terminus	O
is	O
produced	O
by	O
Kex2	B
cleavage	O
after	O
Lys	O
Arg233	O
;	O
when	O
beta	O
la	O
(	O
the	O
mature	O
sequence	O
of	O
beta	O
-	O
lactamase	O
)	O
is	O
fused	O
at	O
this	O
site	O
and	O
the	O
fusion	O
is	O
expressed	O
from	O
the	O
PGK	O
promoter	O
in	O
pDT17	O
,	O
a	O
multicopy	O
plasmid	O
,	O
unexpectedly	O
modest	O
levels	O
of	O
beta	O
la	O
secretion	O
resulted	O
.	O

Over	O
-	O
expression	O
of	O
Kex2	B
failed	O
to	O
increase	O
beta	O
la	O
secretion	O
while	O
a	O
kex2-null	B
mutation	O
reduced	O
secretion	O
by	O
98	O
%	O
.	O

beta	O
la	O
secretion	O
in	O
a	O
Kex+	O
strain	O
was	O
not	O
enhanced	O
by	O
inactivation	O
of	O
the	O
alpha	O
toxin	O
component	O
or	O
by	O
deletion	O
of	O
most	O
of	O
its	O
central	O
hydrophobic	O
segments	O
.	O

However	O
SP	O
-	O
beta	O
la	O
,	O
produced	O
by	O
deletion	O
of	O
ppTox	O
residues	O
35	O
-	O
176	O
,	O
expressed	O
10-fold	O
higher	O
beta	O
la	O
activity	O
and	O
the	O
precursor	O
was	O
now	O
secreted	O
with	O
similar	O
efficiency	O
in	O
a	O
kex2-null	B
strain	O
.	O

Fusions	O
of	O
beta	O
la	O
to	O
ppTox	O
at	O
Ala34	O
or	O
Ala46	O
also	O
led	O
to	O
efficient	O
secretion	O
in	O
both	O
KEX2	B
and	O
kex2-null	B
strains	O
.	O

Since	O
these	O
beta	O
la	O
fusions	O
differ	O
only	O
in	O
segments	O
well	O
downstream	O
of	O
the	O
signal	O
peptide	O
and	O
all	O
had	O
similar	O
transcript	O
levels	O
,	O
the	O
efficiency	O
of	O
beta	O
la	O
secretion	O
is	O
apparently	O
determined	O
by	O
the	O
efficiency	O
with	O
which	O
these	O
fusions	O
are	O
translocated	O
to	O
the	O
Golgi	O
compartment	O
where	O
Kex2	B
is	O
active	O
.	O

Efficiency	O
is	O
high	O
for	O
the	O
shorter	O
fusions	O
,	O
but	O
is	O
10	O
%	O
or	O
less	O
for	O
the	O
longer	O
fusions	O
;	O
even	O
this	O
fraction	O
is	O
apparently	O
diverted	O
to	O
the	O
vacuole	O
if	O
not	O
cleaved	O
by	O
Kex2	B
.	O

SP	O
-	O
beta	O
la	O
was	O
the	O
most	O
efficient	O
construct	O
tested	O
;	O
secreted	O
beta	O
la	O
reached	O
4	O
%	O
of	O
total	O
cell	O
protein	O
,	O
modestly	O
exceeding	O
levels	O
produced	O
by	O
fusion	O
to	O
the	O
MF	O
alpha	O
1-encoded	O
prepro	O
alpha	O
-	O
factor	O
,	O
suggesting	O
potential	O
for	O
the	O
production	O
of	O
foreign	O
proteins	O
in	O
yeast	O
.	O

Two	O
Saccharomyces	O
cerevisiae	O
genes	O
previously	O
unknown	O
to	O
be	O
required	O
for	O
DNA	O
synthesis	O
have	O
been	O
identified	O
by	O
screening	O
a	O
collection	O
of	O
temperature	O
-	O
sensitive	O
mutants	O
.	O

The	O
effects	O
of	O
mutations	O
in	O
DNA43	B
and	O
DNA52	B
on	O
the	O
rate	O
of	O
S	O
phase	O
DNA	O
synthesis	O
were	O
detected	O
by	O
monitoring	O
DNA	O
synthesis	O
in	O
synchronous	O
populations	O
that	O
were	O
obtained	O
by	O
isopycnic	O
density	O
centrifugation	O
.	O

dna43	B
-	I
1	I
and	O
dna52	B
-	I
1	I
cells	O
undergo	O
cell	O
-	O
cycle	O
arrest	O
at	O
the	O
restrictive	O
temperature	O
(	O
37	O
degrees	O
C	O
)	O
,	O
exhibiting	O
a	O
large	O
-	O
budded	O
terminal	O
phenotype	O
;	O
the	O
nuclei	O
of	O
arrested	O
cells	O
are	O
located	O
at	O
the	O
neck	O
of	O
the	O
bud	O
and	O
have	O
failed	O
to	O
undergo	O
DNA	O
replication	O
.	O

These	O
phenotypes	O
suggest	O
that	O
DNA43	B
and	O
DNA52	B
are	O
required	O
for	O
entry	O
into	O
or	O
completion	O
of	O
S	O
phase	O
.	O

DNA43	B
and	O
DNA52	B
were	O
cloned	O
by	O
their	O
abilities	O
to	O
suppress	O
the	O
temperature	O
-	O
sensitive	O
lethal	O
phenotypes	O
of	O
dna43	B
-	I
1	I
and	O
dna52	B
-	I
1	I
cells	O
,	O
respectively	O
.	O

DNA	O
sequence	O
analysis	O
suggested	O
that	O
DNA43	B
and	O
DNA52	B
encode	O
proteins	O
of	O
59.6	O
and	O
80.6	O
kDa	O
,	O
respectively	O
.	O

Both	O
DNA43	B
and	O
DNA52	B
are	O
essential	O
for	O
viability	O
and	O
genetic	O
mapping	O
experiments	O
indicate	O
that	O
they	O
represent	O
previously	O
unidentified	O
genes	O
:	O
DNA43	B
is	O
located	O
on	O
chromosome	O
IX	O
,	O
32	O
cM	O
distal	O
from	O
his5	B
and	O
DNA52	B
is	O
located	O
on	O
chromosome	O
IV	O
,	O
0.9	O
cM	O
from	O
cdc34	B
.	O

Expression	O
of	O
the	O
Mdr2-protein	O
in	O
secretory	O
vesicules	O
(	O
SVs	O
)	O
from	O
the	O
yeast	O
mutant	O
sec6	B
-	I
4	I
causes	O
a	O
time-	O
and	O
temperature	O
-	O
dependent	O
enhancement	O
of	O
phosphatidylcholine	O
(	O
PC	O
)	O
translocation	O
from	O
the	O
outer	O
to	O
the	O
inner	O
leaflet	O
of	O
the	O
SV	O
lipid	O
bilayer	O
.	O

We	O
show	O
that	O
this	O
activity	O
is	O
independent	O
of	O
changes	O
either	O
in	O
the	O
membrane	O
potential	O
or	O
the	O
pH	O
gradient	O
(	O
inside	O
positive	O
)	O
generated	O
in	O
these	O
SVs	O
by	O
the	O
yeast	O
proton	O
-	O
translocating	O
PMA1	B
ATPase	O
.	O

However	O
,	O
loading	O
of	O
the	O
SVs	O
with	O
the	O
primary	O
bile	O
salt	O
taurocholate	O
results	O
in	O
an	O
apparent	O
enhancement	O
of	O
Mdr2-mediated	O
PC	O
translocation	O
activity	O
.	O

Reducing	O
the	O
intravesicular	O
taurocholate	O
(	O
TC	O
)	O
concentration	O
by	O
dissipating	O
the	O
electrochemical	O
potential	O
across	O
the	O
SV	O
membranes	O
eliminates	O
the	O
enhancing	O
effect	O
of	O
TC	O
.	O

Three	O
lines	O
of	O
evidence	O
suggest	O
that	O
the	O
enhanced	O
Mdr2-mediated	O
PC	O
translocation	O
activity	O
is	O
not	O
caused	O
by	O
a	O
regulatory	O
effect	O
of	O
TC	O
on	O
Mdr2	O
but	O
rather	O
reflected	O
the	O
formation	O
of	O
TC	O
/	O
PC	O
aggregates	O
or	O
micelles	O
in	O
the	O
lumen	O
of	O
SVs	O
.	O

First	O
,	O
significantly	O
higher	O
detergent	O
concentrations	O
are	O
required	O
to	O
reveal	O
the	O
fluorescence	O
of	O
(	O
7-nitro-2	O
-	O
1,3-benzoxadiazol-4-yl	O
)	O
amino	O
-	O
PC	O
molecules	O
translocated	O
in	O
Mdr2-SV	O
under	O
conditions	O
of	O
TC	O
stimulation	O
than	O
under	O
control	O
conditions	O
;	O
second	O
,	O
the	O
nonmicelle	O
-	O
forming	O
bile	O
salt	O
taurodehydrocholate	O
does	O
not	O
cause	O
enhancement	O
of	O
PC	O
translocation	O
in	O
Mdr2-SVs	O
;	O
third	O
,	O
enzyme	O
marker	O
studies	O
indicate	O
that	O
TC	O
behaves	O
as	O
a	O
potent	O
lipid	O
solubilizer	O
directly	O
extracting	O
PC	O
molecules	O
out	O
of	O
the	O
bilayer	O
without	O
causing	O
leakage	O
.	O

This	O
results	O
in	O
the	O
formation	O
of	O
intravesicular	O
aggregates	O
or	O
mixed	O
micelles	O
,	O
and	O
provokes	O
the	O
apparent	O
stimulation	O
of	O
Mdr2	O
activity	O
.	O

These	O
data	O
demonstrate	O
a	O
unique	O
relationship	O
between	O
Mdr2	O
,	O
PC	O
,	O
and	O
TC	O
in	O
the	O
process	O
of	O
bile	O
formation	O
and	O
secretion	O
.	O

The	O
role	O
played	O
by	O
histone	O
acetyltransferase	O
(	O
HAT	O
)	O
,	O
GCN5	B
,	O
in	O
transcriptional	O
co	O
-	O
activation	O
has	O
been	O
analysed	O
in	O
detail	O
in	O
yeast	O
and	O
mammals	O
.	O

Here	O
,	O
we	O
present	O
the	O
cloning	O
and	O
expression	O
pattern	O
of	O
Zmgcn5	O
,	O
the	O
maize	O
homologue	O
.	O

The	O
enzymatic	O
activity	O
of	O
the	O
recombinant	O
ZmGCN5	O
was	O
analysed	O
with	O
histone	O
and	O
nucleosome	O
substrates	O
.	O

In	O
situ	O
hybridisation	O
of	O
developing	O
maize	O
kernels	O
using	O
Zmgcn5	O
as	O
probe	O
shows	O
that	O
the	O
transcript	O
is	O
concentrated	O
in	O
rapidly	O
dividing	O
cells	O
.	O

To	O
investigate	O
the	O
role	O
of	O
ZmGCN5	O
in	O
the	O
transcription	O
of	O
specific	O
plant	O
genes	O
,	O
direct	O
protein	O
-	O
protein	O
interactions	O
were	O
tested	O
.	O

A	O
cDNA	O
clone	O
encoding	O
a	O
putative	O
interacting	O
partner	O
in	O
GCN5-adapter	B
complexes	O
,	O
ZmADA2	O
,	O
was	O
isolated	O
and	O
the	O
interaction	O
between	O
ZmGCN5	O
and	O
ZmADA2	O
was	O
confirmed	O
by	O
a	O
GST	O
-	O
spin	O
down	O
experiment	O
.	O

Co	O
-	O
immunoprecipitation	O
of	O
the	O
plant	O
transcriptional	O
activator	O
Opaque-2	O
and	O
ZmADA2	O
in	O
nuclear	O
extracts	O
suggests	O
ADA2	B
/	O
GCN5-containing	B
complexes	O
to	O
mediate	O
transcriptional	O
activation	O
by	O
binding	O
of	O
this	O
bZIP	O
factor	O
.	O

For	O
a	O
more	O
general	O
analysis	O
of	O
the	O
effects	O
of	O
histone	O
acetylation	O
on	O
plant	O
gene	O
expression	O
,	O
2500	O
ESTs	O
spotted	O
on	O
filters	O
were	O
hybridised	O
with	O
cDNA	O
probes	O
derived	O
either	O
from	O
maize	O
cell	O
lines	O
treated	O
with	O
Trichostatin	O
A	O
(	O
TSA	O
)	O
,	O
or	O
from	O
a	O
transgenic	O
line	O
expressing	O
the	O
ZmGCN5	O
antisense	O
transcript	O
.	O

Several	O
sequences	O
showing	O
marked	O
changes	O
in	O
abundance	O
were	O
confirmed	O
by	O
RNA	O
blot	O
analysis	O
.	O

Inhibition	O
of	O
histone	O
deacetylation	O
with	O
TSA	O
is	O
accompanied	O
by	O
a	O
decrease	O
in	O
the	O
abundance	O
of	O
ZmGCN5	O
acetylase	O
protein	O
,	O
but	O
by	O
increases	O
in	O
mRNAs	O
for	O
histones	O
H2A	O
,	O
H2B	O
,	O
H3	O
and	O
H4	O
.	O

The	O
elevated	O
histone	O
mRNA	O
levels	O
were	O
not	O
reflected	O
in	O
increasing	O
histone	O
protein	O
concentrations	O
,	O
suggesting	O
hyperacetylated	O
histones	O
arising	O
from	O
TSA	O
treatment	O
may	O
be	O
preferentially	O
degraded	O
and	O
substituted	O
by	O
de	O
novo	O
synthesised	O
histones	O
.	O

The	O
ZmGCN5	O
antisense	O
material	O
showed	O
suppression	O
of	O
the	O
endogenous	O
ZmGCN5	O
transcript	O
and	O
the	O
profiling	O
analysis	O
revealed	O
increased	O
mRNA	O
levels	O
for	O
H2A	O
,	O
H2B	O
and	O
H4	O
.	O

Furthermore	O
,	O
in	O
the	O
antisense	O
line	O
,	O
a	O
reduction	O
in	O
the	O
amount	O
of	O
the	O
RPD3-type	O
HD1B	O
-	O
I	O
histone	O
deacetylase	O
protein	O
was	O
observed	O
.	O

A	O
model	O
for	O
linked	O
regulation	O
of	O
histone	O
acetylation	O
and	O
histone	O
mRNA	O
transcription	O
is	O
discussed	O
.	O

We	O
have	O
purified	O
the	O
protein	O
that	O
confers	O
selective	O
promoter	O
recognition	O
on	O
the	O
core	O
subunit	O
of	O
the	O
yeast	O
mitochondrial	O
RNA	O
polymerase	O
.	O

The	O
N	O
-	O
terminal	O
sequence	O
of	O
the	O
43-kDa	O
specificity	O
factor	O
identified	O
it	O
as	O
the	O
product	O
of	O
the	O
MTF1	B
gene	O
described	O
by	O
Lisowsky	O
and	O
Michaelis	O
(	O
1988	O
)	O
.	O

We	O
confirmed	O
that	O
MTF1	B
encoded	O
the	O
specificity	O
factor	O
by	O
analyzing	O
extracts	O
from	O
a	O
yeast	O
strain	O
bearing	O
a	O
disruption	O
of	O
the	O
gene	O
.	O

The	O
extracts	O
contained	O
normal	O
levels	O
of	O
core	O
RNA	O
polymerase	O
but	O
lacked	O
selective	O
transcription	O
activity	O
;	O
adding	O
the	O
purified	O
43-kDa	O
protein	O
restored	O
selective	O
transcription	O
.	O

Comparison	O
of	O
the	O
MTF1	B
protein	O
sequence	O
to	O
the	O
family	O
of	O
bacterial	O
sigma	O
factors	O
has	O
revealed	O
striking	O
similarity	O
to	O
domains	O
identified	O
with--10	O
promoter	O
recognition	O
,	O
promoter	O
melting	O
,	O
and	O
holoenzyme	O
stability	O
.	O

A	O
highly	O
conserved	O
signal	O
cascade	O
functions	O
subsequent	O
to	O
receptor	O
tyrosine	O
kinase	O
activation	O
.	O

Signaling	O
by	O
the	O
sevenless	O
receptor	O
,	O
required	O
for	O
differentiation	O
of	O
the	O
R7	O
photoreceptor	O
neuron	O
in	O
Drosophila	O
,	O
is	O
reduced	O
by	O
mutations	O
in	O
E	O
(	O
sev	O
)	O
3A	O
and	O
E	O
(	O
sev	O
)	O
3B	O
.	O

We	O
show	O
here	O
that	O
E	O
(	O
sev	O
)	O
3A	O
is	O
a	O
member	O
of	O
the	O
Hsp90	O
family	O
of	O
stress	O
proteins	O
and	O
that	O
E	O
(	O
sev	O
)	O
3B	O
encodes	O
a	O
homolog	O
of	O
the	O
cell	O
cycle	O
control	O
protein	O
Cdc37	B
from	O
S.	O
cerevisiae	O
.	O

Mutations	O
in	O
E	O
(	O
sev	O
)	O
3B	O
also	O
dominantly	O
enhance	O
mutations	O
in	O
Dmcdc2	O
,	O
the	O
gene	O
encoding	O
the	O
p34	O
protein	O
kinase	O
that	O
regulates	O
the	O
G2	O
/	O
M	O
transition	O
.	O

Together	O
,	O
these	O
data	O
support	O
a	O
role	O
for	O
Hsp90	O
proteins	O
in	O
tyrosine	O
kinase	O
regulation	O
and	O
suggest	O
that	O
signals	O
promoting	O
neuronal	O
differentiation	O
may	O
involve	O
cell	O
cycle	O
control	O
.	O

The	O
SAC6	B
gene	O
was	O
found	O
by	O
suppression	O
of	O
a	O
yeast	O
actin	O
mutation	O
.	O

Its	O
protein	O
product	O
,	O
Sac6p	O
(	O
previously	O
referred	O
to	O
as	O
ABP67	B
)	O
,	O
was	O
independently	O
isolated	O
by	O
actin	O
-	O
filament	O
affinity	O
chromatography	O
and	O
colocalizes	O
with	O
actin	O
in	O
vivo	O
.	O

Thus	O
Sac6p	O
binds	O
to	O
actin	O
in	O
vitro	O
,	O
and	O
functionally	O
associates	O
with	O
actin	O
structures	O
involved	O
in	O
the	O
development	O
and	O
maintenance	O
of	O
cell	O
polarity	O
in	O
vivo	O
.	O

We	O
report	O
here	O
that	O
Sac6p	O
is	O
an	O
actin	O
-	O
filament	O
bundling	O
protein	O
43	O
%	O
identical	O
in	O
amino	O
-	O
acid	O
sequence	O
to	O
the	O
vertebrate	O
bundling	O
protein	O
fimbrin	O
.	O

This	O
yeast	O
fimbrin	O
homologue	O
contains	O
two	O
putative	O
actin	O
-	O
binding	O
regions	O
homologous	O
to	O
domains	O
of	O
dystrophin	O
,	O
beta	O
-	O
spectrin	O
,	O
filamin	O
,	O
actin	O
-	O
gelation	O
protein	O
and	O
alpha	O
-	O
actinin	O
.	O

Mutants	O
lacking	O
Sac6p	O
do	O
not	O
form	O
normal	O
actin	O
structures	O
and	O
are	O
defective	O
in	O
morphogenesis	O
.	O

These	O
findings	O
demonstrate	O
an	O
in	O
vivo	O
role	O
for	O
the	O
well	O
-	O
documented	O
biochemical	O
interaction	O
between	O
fimbrin	O
and	O
actin	O
.	O

Precocious	O
entry	O
into	O
S	O
phase	O
due	O
to	O
overproduction	O
of	O
G1	O
regulators	O
can	O
cause	O
genomic	O
instability	O
.	O

The	O
mechanisms	O
of	O
this	O
phenomenon	O
are	O
largely	O
unknown	O
.	O

We	O
explored	O
the	O
consequences	O
of	O
precocious	O
S	O
phase	O
in	O
yeast	O
by	O
overproducing	O
a	O
deregulated	O
form	O
of	O
Swi4	B
(	O
Swi4-t	B
)	O
.	O

Swi4	B
is	O
a	O
late	O
G1-specific	O
transcriptional	O
activator	O
that	O
,	O
in	O
complex	O
with	O
Swi6	B
,	O
binds	O
to	O
SCB	O
elements	O
and	O
activates	O
late	O
G1-specific	O
genes	O
,	O
including	O
G1	O
cyclins	O
.	O

We	O
find	O
that	O
wild	O
-	O
type	O
cells	O
tolerate	O
Swi4-t	B
,	O
whereas	O
checkpoint	O
-	O
deficient	O
rad53	B
-	I
11	I
cells	O
lose	O
viability	O
within	O
several	O
divisions	O
when	O
Swi4-t	B
is	O
overproduced	O
.	O

Rad53	B
kinase	O
activity	O
is	O
increased	O
in	O
cells	O
overproducing	O
Swi4-t	B
,	O
indicating	O
activation	O
of	O
the	O
checkpoint	O
.	O

We	O
monitored	O
the	O
transition	O
from	O
G1	O
to	O
S	O
in	O
cells	O
with	O
Swi4-t	B
and	O
found	O
that	O
there	O
is	O
precocious	O
S	O
-	O
phase	O
entry	O
and	O
that	O
the	O
length	O
of	O
S	O
phase	O
is	O
extended	O
.	O

Moreover	O
,	O
there	O
were	O
more	O
replication	O
intermediates	O
,	O
and	O
firing	O
of	O
at	O
least	O
a	O
subset	O
of	O
origins	O
may	O
have	O
been	O
more	O
extensive	O
in	O
the	O
cells	O
expressing	O
Swi4-t	B
.	O

Our	O
working	O
hypothesis	O
is	O
that	O
Rad53	B
modulates	O
origin	O
firing	O
based	O
upon	O
growth	O
conditions	O
to	O
optimize	O
the	O
rate	O
of	O
S	O
-	O
phase	O
progression	O
without	O
adversely	O
affecting	O
fidelity	O
.	O

This	O
regulation	O
becomes	O
essential	O
when	O
S	O
phase	O
is	O
influenced	O
by	O
Swi4-t	B
.	O

Candida	O
albicans	O
is	O
a	O
diploid	O
dimorphic	O
yeast	O
with	O
no	O
known	O
sexual	O
cycle	O
.	O

The	O
development	O
of	O
a	O
DNA	O
transformation	O
system	O
would	O
greatly	O
improve	O
the	O
prospects	O
for	O
genetic	O
analyses	O
of	O
this	O
yeast	O
.	O

Plasmids	O
were	O
isolated	O
from	O
a	O
Candida	O
Sau3A	O
partial	O
library	O
which	O
complements	O
the	O
ade2	B
-	I
1	I
and	O
ade2	B
-	I
5	I
mutations	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

These	O
plasmids	O
contain	O
a	O
common	O
region	O
,	O
part	O
of	O
which	O
,	O
when	O
subcloned	O
,	O
produces	O
ade2	B
complementation	O
.	O

Among	O
the	O
small	O
number	O
of	O
auxotrophs	O
previously	O
isolated	O
in	O
C.	O
albicans	O
,	O
red	O
adenine	O
-	O
requiring	O
mutants	O
had	O
been	O
identified	O
by	O
several	O
groups	O
.	O

In	O
two	O
of	O
these	O
strains	O
,	O
the	O
cloned	O
Candida	O
DNA	O
transformed	O
the	O
mutants	O
to	O
ADE+	O
at	O
frequencies	O
of	O
0.5	O
to	O
5	O
transformants	O
per	O
micrograms	O
of	O
DNA	O
.	O

In	O
about	O
50	O
%	O
of	O
the	O
transformants	O
,	O
plasmid	O
DNA	O
sequences	O
became	O
stably	O
integrated	O
into	O
the	O
host	O
genome	O
and	O
,	O
in	O
the	O
several	O
cases	O
analyzed	O
by	O
Southern	O
hybridization	O
,	O
the	O
DNA	O
was	O
integrated	O
at	O
the	O
site	O
of	O
the	O
ADE2	B
gene	O
in	O
one	O
of	O
the	O
chromosomal	O
homologs	O
.	O

Saccharomyces	O
cells	O
with	O
one	O
unrepaired	O
double	O
-	O
strand	O
break	O
(	O
DSB	O
)	O
adapt	O
after	O
checkpoint	O
-	O
mediated	O
G2	O
/	O
M	O
arrest	O
.	O

Adaptation	O
is	O
accompanied	O
by	O
loss	O
of	O
Rad53p	O
checkpoint	O
kinase	O
activity	O
and	O
Chk1p	O
phosphorylation	O
.	O

Rad53p	O
kinase	O
remains	O
elevated	O
in	O
yku70delta	O
and	O
cdc5-ad	B
cells	O
that	O
fail	O
to	O
adapt	O
.	O

Permanent	O
G2	O
/	O
M	O
arrest	O
in	O
cells	O
with	O
increased	O
single	O
-	O
stranded	O
DNA	O
is	O
suppressed	O
by	O
the	O
rfa1-t11	B
mutation	O
,	O
but	O
this	O
RPA	O
mutation	O
does	O
not	O
suppress	O
permanent	O
arrest	O
in	O
cdc5-ad	B
cells	O
.	O

Checkpoint	O
kinase	O
activation	O
and	O
inactivation	O
can	O
be	O
followed	O
in	O
G2-arrested	O
cells	O
,	O
but	O
there	O
is	O
no	O
kinase	O
activation	O
in	O
G1-arrested	O
cells	O
.	O

We	O
conclude	O
that	O
activation	O
of	O
the	O
checkpoint	O
kinases	O
in	O
response	O
to	O
a	O
single	O
DNA	O
break	O
is	O
cell	O
cycle	O
regulated	O
and	O
that	O
adaptation	O
is	O
an	O
active	O
process	O
by	O
which	O
these	O
kinases	O
are	O
inactivated	O
.	O

The	O
respiratory	O
deficiency	O
of	O
yeast	O
strains	O
previously	O
assigned	O
to	O
complementation	O
group	O
G7	O
has	O
been	O
ascribed	O
to	O
the	O
absence	O
in	O
the	O
mutants	O
of	O
functional	O
cytochrome	O
b.	O
Since	O
G7	O
mutants	O
are	O
capable	O
of	O
synthesizing	O
the	O
apoprotein	O
,	O
the	O
primary	O
effect	O
of	O
the	O
mutations	O
is	O
to	O
prevent	O
maturation	O
of	O
this	O
electron	O
carrier	O
.	O

The	O
recombinant	O
plasmid	O
pG7	O
/	O
T1	O
with	O
a	O
6.7-kilobase	O
pairs	O
(	O
kb	O
)	O
insert	O
of	O
wild	O
type	O
yeast	O
nuclear	O
DNA	O
has	O
been	O
selected	O
from	O
a	O
genomic	O
library	O
by	O
transformation	O
of	O
a	O
G7	O
mutant	O
to	O
respiratory	O
competency	O
.	O

The	O
genetically	O
active	O
region	O
of	O
the	O
pG7	O
/	O
T1	O
insert	O
has	O
been	O
subcloned	O
on	O
a	O
3-kb	O
fragment	O
of	O
DNA	O
which	O
has	O
been	O
shown	O
to	O
contain	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
50,236	O
Mr.	O
In	O
situ	O
disruption	O
of	O
the	O
reading	O
frame	O
causes	O
a	O
deficiency	O
in	O
cytochrome	O
b.	O

The	O
strain	O
with	O
the	O
disrupted	O
gene	O
fails	O
to	O
complement	O
G7	O
mutants	O
thereby	O
confirming	O
the	O
correct	O
identification	O
of	O
the	O
gene	O
henceforth	O
referred	O
to	O
as	O
COR1	B
.	O

The	O
carboxyl	O
-	O
terminal	O
half	O
of	O
the	O
COR1	B
gene	O
has	O
been	O
fused	O
to	O
the	O
amino	O
-	O
terminal	O
half	O
of	O
the	O
Escherichia	O
coli	O
trpE	O
gene	O
in	O
the	O
high	O
expression	O
vector	O
pATH2	O
.	O

This	O
plasmid	O
construct	O
promotes	O
a	O
high	O
level	O
of	O
expression	O
of	O
the	O
trpE	O
/	O
COR1	B
hybrid	O
protein	O
.	O

Antibodies	O
against	O
the	O
purified	O
hybrid	O
protein	O
react	O
with	O
a	O
44	O
kDa	O
protein	O
subunit	O
of	O
yeast	O
coenzyme	O
QH2-cytochrome	O
c	O
reductase	O
corresponding	O
to	O
the	O
largest	O
core	O
subunit	O
of	O
the	O
complex	O
.	O

These	O
data	O
indicate	O
that	O
the	O
yeast	O
nuclear	O
gene	O
COR1	B
codes	O
for	O
the	O
44-kDa	O
core	O
protein	O
and	O
that	O
the	O
latter	O
is	O
required	O
for	O
the	O
conversion	O
of	O
apocytochrome	O
b	O
to	O
mature	O
cytochrome	O
b.	O

The	O
members	O
of	O
the	O
RecQ	O
family	O
of	O
DNA	O
helicases	O
play	O
conserved	O
roles	O
in	O
the	O
preservation	O
of	O
genome	O
integrity	O
.	O

RecQ	O
helicases	O
are	O
implicated	O
in	O
Bloom	O
and	O
Werner	O
syndromes	O
,	O
which	O
are	O
associated	O
with	O
genomic	O
instability	O
and	O
predisposition	O
to	O
cancers	O
.	O

The	O
human	O
BLM	O
and	O
WRN	O
helicases	O
are	O
required	O
for	O
normal	O
S	O
phase	O
progression	O
.	O

In	O
contrast	O
,	O
Saccharomyces	O
cerevisiae	O
cells	O
deleted	O
for	O
SGS1	B
grow	O
with	O
wild	O
-	O
type	O
kinetics	O
.	O

To	O
investigate	O
the	O
role	O
of	O
Sgs1p	O
in	O
DNA	O
replication	O
,	O
we	O
have	O
monitored	O
S	O
phase	O
progression	O
in	O
sgs1Delta	O
cells	O
.	O

Unexpectedly	O
,	O
we	O
find	O
that	O
these	O
cells	O
progress	O
faster	O
through	O
S	O
phase	O
than	O
their	O
wild	O
-	O
type	O
counterparts	O
.	O

Using	O
bromodeoxyuridine	O
incorporation	O
and	O
DNA	O
combing	O
,	O
we	O
show	O
that	O
replication	O
forks	O
are	O
moving	O
more	O
rapidly	O
in	O
the	O
absence	O
of	O
the	O
Sgs1	B
helicase	O
.	O

However	O
,	O
completion	O
of	O
DNA	O
replication	O
is	O
strongly	O
retarded	O
at	O
the	O
rDNA	O
array	O
of	O
sgs1Delta	O
cells	O
,	O
presumably	O
because	O
of	O
their	O
inability	O
to	O
prevent	O
recombination	O
at	O
stalled	O
forks	O
,	O
which	O
are	O
very	O
abundant	O
at	O
this	O
locus	O
.	O

These	O
data	O
suggest	O
that	O
Sgs1p	O
is	O
not	O
required	O
for	O
processive	O
DNA	O
synthesis	O
but	O
prevents	O
genomic	O
instability	O
by	O
coordinating	O
replication	O
and	O
recombination	O
events	O
during	O
S	O
phase	O
.	O

Progression	O
of	O
the	O
eukaryotic	O
cell	O
cycle	O
is	O
controlled	O
by	O
cyclin	O
-	O
dependent	O
kinases	O
(	O
CDKs	O
)	O
.	O

Cdc28	B
,	O
the	O
budding	O
yeast	O
homologue	O
of	O
Cdc2	O
(	O
Cdk1	B
)	O
,	O
is	O
required	O
for	O
both	O
the	O
G1	O
/	O
S	O
and	O
G2	O
/	O
M	O
transitions	O
of	O
the	O
cell	O
cycle	O
.	O

The	O
functional	O
specificity	O
of	O
the	O
Cdc28	B
kinase	O
is	O
determined	O
by	O
its	O
association	O
with	O
G1	O
or	O
G2	O
cyclins	O
.	O

Alternation	O
of	O
cell	O
cycle	O
phases	O
is	O
thus	O
mainly	O
due	O
to	O
mechanisms	O
that	O
ensure	O
that	O
one	O
cyclin	O
family	O
succeeds	O
another	O
.	O

Here	O
we	O
show	O
that	O
the	O
G2	O
cyclins	O
Clb1	B
,	O
Clb2	B
,	O
Clb3	B
and	O
Clb4	B
are	O
required	O
for	O
the	O
proteolysis	O
of	O
the	O
G1	O
cyclins	O
Cln1	B
and	O
Cln2	B
,	O
providing	O
a	O
mechanism	O
for	O
coupling	O
synthesis	O
of	O
G2	O
cyclins	O
with	O
the	O
disappearance	O
of	O
G1	O
cyclins	O
.	O

Our	O
data	O
indicate	O
that	O
this	O
pathway	O
involves	O
the	O
Ubc9	B
ubiquitin	O
-	O
conjugating	O
enzyme	O
.	O

The	O
Cdc34	B
ubiquitin	O
-	O
conjugating	O
activity	O
may	O
function	O
redundantly	O
with	O
Ubc9	B
,	O
or	O
it	O
may	O
only	O
be	O
involved	O
in	O
Cln1,2	B
turnover	O
through	O
its	O
role	O
in	O
promoting	O
the	O
degradation	O
of	O
Sic1	B
,	O
a	O
specific	O
inhibitor	O
of	O
Cdc28-Clb	B
complexes	O
.	O

Pseudouridylation	O
of	O
snRNAs	O
in	O
vertebrates	O
is	O
guided	O
by	O
small	O
nucleolar	O
/	O
Cajal	O
body	O
-	O
specific	O
RNAs	O
(	O
sno	O
/	O
scaRNAs	O
)	O
.	O

We	O
developed	O
an	O
in	O
vitro	O
system	O
using	O
cell	O
extracts	O
and	O
single	O
site	O
-	O
radiolabeled	O
U2	O
snRNAs	O
to	O
study	O
pseudouridylation	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Micrococcal	O
nuclease	O
-	O
treated	O
cell	O
extracts	O
are	O
fully	O
competent	O
to	O
catalyze	O
U2	O
pseudouridylation	O
,	O
suggesting	O
an	O
RNA	O
-	O
independent	O
process	O
.	O

A	O
pseudouridylase	O
activity	O
for	O
Psi	O
(	O
35	O
)	O
within	O
yeast	O
U2	O
is	O
identified	O
via	O
a	O
screen	O
of	O
an	O
S.cerevisiae	O
GST	O
-	O
ORF	O
protein	O
library	O
.	O

This	O
activity	O
is	O
associated	O
with	O
YOR243c	B
ORF	O
,	O
which	O
has	O
not	O
previously	O
been	O
assigned	O
function	O
.	O

When	O
the	O
GST	O
-	O
YOR243c	B
protein	O
is	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
pseudouridylation	O
activity	O
is	O
comparable	O
to	O
that	O
expressed	O
in	O
S.cerevisiae	O
,	O
demonstrating	O
that	O
this	O
protein	O
(	O
designated	O
Pus7	B
)	O
alone	O
can	O
catalyze	O
Psi	O
(	O
35	O
)	O
formation	O
in	O
U2	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	O
analyses	O
using	O
wild	O
-	O
type	O
and	O
pus7-Delta	B
strains	O
show	O
that	O
Pus7	B
is	O
indispensable	O
for	O
Psi	O
(	O
35	O
)	O
formation	O
in	O
U2	O
.	O

Using	O
site	O
-	O
specific	O
radiolabeled	O
U2	O
and	O
U2	O
fragments	O
,	O
we	O
show	O
that	O
Pus7	B
activity	O
is	O
specific	O
for	O
Psi	O
(	O
35	O
)	O
and	O
that	O
the	O
U2	O
stem-	O
loop	O
II	O
region	O
is	O
essential	O
for	O
the	O
pseudouridylation	O
reaction	O
.	O

A	O
BLAST	O
search	O
revealed	O
Pus7	B
homologs	O
in	O
various	O
organisms	O
.	O

When	O
Saccharomyces	O
cerevisiae	O
cells	O
growing	O
on	O
galactose	O
are	O
transferred	O
onto	O
glucose	O
medium	O
containing	O
cycloheximide	O
,	O
an	O
inhibitor	O
of	O
protein	O
synthesis	O
,	O
a	O
rapid	O
reduction	O
of	O
Gal2p	O
-	O
mediated	O
galactose	O
uptake	O
is	O
observed	O
.	O

We	O
show	O
that	O
glucose	O
-	O
induced	O
inactivation	O
of	O
Gal2p	O
is	O
due	O
to	O
its	O
degradation	O
.	O

Stabilization	O
of	O
Gal2p	O
in	O
pra1	B
mutant	O
cells	O
devoid	O
of	O
vacuolar	O
proteinase	O
activity	O
is	O
observed	O
.	O

Subcellular	O
fractionation	O
and	O
indirect	O
immunofluorescence	O
showed	O
that	O
the	O
Gal2	B
transporter	O
accumulates	O
in	O
the	O
vacuole	O
of	O
the	O
mutant	O
cells	O
,	O
directly	O
demonstrating	O
that	O
its	O
degradation	O
requires	O
vacuolar	O
proteolysis	O
.	O

In	O
contrast	O
,	O
Gal2p	O
degradation	O
is	O
proteasome	O
independent	O
since	O
its	O
half	O
-	O
life	O
is	O
unaffected	O
in	O
pre1	B
-	I
1	I
pre2	B
-	I
2	I
,	O
cim3	B
-	I
1	I
,	O
and	O
cim5	B
-	I
1	I
mutants	O
defective	O
in	O
several	O
subunits	O
of	O
the	O
protease	O
complex	O
.	O

In	O
addition	O
,	O
vacuolar	O
delivery	O
of	O
Gal2p	O
was	O
shown	O
to	O
be	O
blocked	O
in	O
conditional	O
end3	B
and	O
end4	B
mutants	O
at	O
the	O
nonpermissive	O
temperature	O
,	O
indicating	O
that	O
delivery	O
of	O
Gal2p	O
to	O
the	O
vacuole	O
occurs	O
via	O
the	O
endocytic	O
pathway	O
.	O

Taken	O
together	O
,	O
the	O
results	O
presented	O
here	O
demonstrate	O
that	O
glucose	O
-	O
induced	O
proteolysis	O
of	O
Gal2p	O
is	O
dependent	O
on	O
endocytosis	O
and	O
vacuolar	O
proteolysis	O
and	O
is	O
independent	O
of	O
the	O
functional	O
proteasome	O
.	O

Moreover	O
,	O
we	O
show	O
that	O
Gal2p	O
is	O
ubiquitinated	O
under	O
conditions	O
of	O
glucose	O
-	O
induced	O
inactivation	O
.	O

1	O
.	O

Two	O
oligomycin	O
-	O
resistant	O
strains	O
of	O
Saccharomyces	O
cerevisiae	O
have	O
been	O
isolated	O
and	O
shown	O
to	O
have	O
mutations	O
in	O
the	O
oli2	B
region	O
of	O
the	O
mitochondrial	O
DNA	O
.	O

On	O
solid	O
media	O
containing	O
a	O
non	O
-	O
fermentable	O
energy	O
source	O
,	O
the	O
mutant	O
strains	O
were	O
able	O
to	O
grow	O
only	O
slowly	O
at	O
28	O
degrees	O
C	O
and	O
not	O
at	O
all	O
at	O
18	O
degrees	O
C	O
or	O
36	O
degrees	O
C.	O
2	O
.	O

When	O
grown	O
in	O
a	O
glucose	O
-	O
limited	O
chemostat	O
at	O
28	O
degrees	O
C	O
,	O
the	O
mutant	O
strains	O
were	O
almost	O
completely	O
defective	O
in	O
oxidative	O
metabolism	O
.	O

The	O
mutant	O
mitochondria	O
contained	O
significant	O
levels	O
of	O
all	O
respiratory	O
enzymes	O
,	O
and	O
an	O
active	O
,	O
oligomycin	O
-	O
sensitive	O
ATPase	O
,	O
but	O
the	O
ATP-32Pi	O
exchange	O
activity	O
and	O
P	O
:	O
O	O
ratio	O
were	O
very	O
low	O
.	O

3	O
.	O

The	O
mutations	O
in	O
these	O
strains	O
are	O
genetically	O
closely	O
linked	O
to	O
mit	O
mutations	O
which	O
have	O
been	O
shown	O
to	O
affect	O
a	O
20	O
000-dalton	O
ATPase	O
subunit	O
(	O
Roberts	O
,	O
H.	O
,	O
Choo	O
,	O
W.M.	O
,	O
Murphy	O
,	O
M.	O
,	O
Marzuki	O
,	O
S.	O
,	O
Lukins	O
,	O
H.B.	O
and	O
Linnane	O
,	O
A.W.	O
(	O
1979	O
)	O
FEBS	O
Lett	O
.	O

108	O
,	O
501	O
-	O
504	O
)	O
.	O

Since	O
the	O
mitochondrial	O
ATPase	O
in	O
these	O
mutant	O
strains	O
appears	O
to	O
be	O
fully	O
assembled	O
,	O
the	O
defect	O
in	O
the	O
coupling	O
mechanism	O
is	O
probably	O
a	O
result	O
of	O
a	O
small	O
alteration	O
in	O
the	O
structure	O
of	O
the	O
20	O
000-dalton	O
ATPase	O
subunit	O
.	O

4	O
.	O

When	O
the	O
mutant	O
strains	O
were	O
grown	O
at	O
18	O
degrees	O
C	O
,	O
the	O
mitochondria	O
had	O
very	O
low	O
cytochrome	O
oxidase	O
activities	O
,	O
and	O
reduced	O
levels	O
of	O
cytochrome	O
aa3	O
.	O

The	O
largest	O
subunit	O
(	O
Mr	O
40	O
000	O
)	O
of	O
this	O
enzyme	O
was	O
not	O
synthesized	O
.	O

We	O
have	O
genetically	O
reverted	O
HIS4	B
initiator	O
codon	O
mutants	O
in	O
yeast	O
and	O
identified	O
three	O
unlinked	O
genes	O
,	O
sui1	B
,	O
sui2	B
,	O
and	O
SUI3	B
(	O
suppressors	O
of	O
initiator	O
codon	O
mutants	O
)	O
,	O
which	O
when	O
mutated	O
confer	O
the	O
ability	O
to	O
initiate	O
at	O
HIS4	B
despite	O
the	O
absence	O
of	O
an	O
AUG	O
start	O
codon	O
.	O

Molecular	O
and	O
biochemical	O
characterization	O
shows	O
that	O
SUI3	B
encodes	O
the	O
beta	O
-	O
subunit	O
of	O
the	O
eukaryotic	O
translation	O
initiation	O
factor	O
eIF-2	O
.	O

SUI3	B
suppressor	O
genes	O
contain	O
single	O
base	O
changes	O
at	O
a	O
Zn	O
(	O
II	O
)	O
finger	O
motif	O
.	O

This	O
motif	O
is	O
present	O
in	O
a	O
cDNA	O
sequence	O
encoding	O
the	O
human	O
eIF-2	O
beta	O
gene	O
product	O
.	O

Mutations	O
in	O
SUI3	B
suppressor	O
alleles	O
change	O
amino	O
acids	O
that	O
are	O
conserved	O
in	O
the	O
yeast	O
and	O
human	O
motifs	O
.	O

Protein	O
sequence	O
analysis	O
shows	O
that	O
a	O
mutant	O
beta	O
-	O
subunit	O
allows	O
initiation	O
at	O
a	O
UUG	O
codon	O
in	O
the	O
absence	O
of	O
an	O
AUG	O
start	O
codon	O
at	O
HIS4	B
.	O

Taken	O
together	O
,	O
these	O
data	O
implicate	O
a	O
nucleic	O
acid	O
-	O
binding	O
domain	O
of	O
eIF-2	O
as	O
an	O
important	O
component	O
of	O
the	O
""""	O
scanning	O
""""	O
ribosome	O
that	O
participates	O
in	O
recognition	O
of	O
a	O
start	O
codon	O
.	O

